concept_id	concept_synonym_name	language_concept_id
42539172	Angioplasty of right renal artery using fluoroscopic guidance with contrast	4180186
42539172	Angioplasty of right renal artery using fluoroscopic guidance with contrast (procedure)	4180186
42539173	Pelvic mass in pregnancy (disorder)	4180186
42539174	Plain X-ray of right clavicle (procedure)	4180186
42539174	X-ray of right clavicle	4180186
42539176	Monoplegia of left dominant lower limb (disorder)	4180186
42539179	Radioisotope scan of whole body using radiolabeled white blood cells for localization of inflammation	4180186
42539179	Radioisotope scan of whole body using radiolabelled white blood cells for localisation of inflammation	4180186
42539179	Radionuclide scan of whole body using radiolabeled white blood cells for localization of inflammation (procedure)	4180186
42539179	Radionuclide scan of whole body using radiolabelled white blood cells for localisation of inflammation	4180186
42539180	Monoplegia of right nondominant upper limb due to and following cerebrovascular accident	4180186
42539180	Monoplegia of right nondominant upper limb due to and following cerebrovascular accident (disorder)	4180186
42539180	Monoplegia of right nondominant upper limb as sequela of cerebrovascular accident	4180186
42539181	Angioplasty of artery of right upper limb using fluoroscopic guidance with contrast (procedure)	4180186
42539181	Angioplasty of artery of right upper limb using fluoroscopic guidance with contrast	4180186
42539182	Plain X-ray of left scaphoid (procedure)	4180186
42539182	X-ray of left scaphoid	4180186
42539183	Spontaneous haemorrhage of subarachnoid space from right posterior communicating artery (disorder)	4180186
42539183	Nontraumatic hemorrhage of subarachnoid space from right posterior communicating artery	4180186
42539183	Nontraumatic haemorrhage of subarachnoid space from right posterior communicating artery	4180186
42539183	Spontaneous haemorrhage of subarachnoid space from right posterior communicating artery	4180186
42539186	Pre-existing maternal disease complicating pregnancy (disorder)	4180186
42539187	Right median neuropathy	4180186
42539187	Disorder of right median nerve (disorder)	4180186
42539188	Left median neuropathy	4180186
42539188	Disorder of left median nerve (disorder)	4180186
42539189	Peroneal tendinitis of bilateral lower legs	4180186
42539189	Peroneal tendinitis of bilateral lower legs (disorder)	4180186
42539189	Peroneal tendinitis of both lower legs	4180186
42539190	Multiple marker screen positive for increased neural tube defects (finding)	4180186
42539191	Instability of left sacroiliac joint (finding)	4180186
42539192	Pre-existing severe obesity in mother complicating pregnancy (disorder)	4180186
42539192	Pre-existing severe obesity in mother complicating pregnancy	4180186
42539194	Venous thoracic outlet syndrome of left subclavian vein	4180186
42539194	Venous thoracic outlet syndrome of left subclavian vein (disorder)	4180186
42539196	Angioplasty of right femoral artery using fluoroscopic guidance with contrast (procedure)	4180186
42539196	Angioplasty of right femoral artery using fluoroscopic guidance with contrast	4180186
42539197	Glomerulonephritis co-occurrent and due to antineutrophil cytoplasmic antibody positive vasculitis (disorder)	4180186
42539197	Glomerulonephritis due to antineutrophil cytoplasmic antibody (ANCA) positive vasculitis	4180186
42539199	Arthritis of finger of left hand due to trauma (disorder)	4180186
42539202	Derangement of patella of left knee (disorder)	4180186
42539203	Exostosis of right humerus (disorder)	4180186
42539205	Tendinitis of left quadriceps tendon (disorder)	4180186
42539206	Ultrasound scan of left inguinal region	4180186
42539206	Ultrasonography of left inguinal region (procedure)	4180186
42539206	Ultrasound of left inguinal region	4180186
42539207	Computed tomography of left acromioclavicular joint (procedure)	4180186
42539207	Computed tomography of left acromioclavicular joint	4180186
42539208	Polyneuropathy caused by ionising radiation	4180186
42539208	Polyneuropathy caused by ionizing radiation	4180186
42539208	Polyneuropathy caused by ionizing radiation (disorder)	4180186
42539209	Tophus of right elbow co-occurrent and due to gout (disorder)	4180186
42539209	Tophus of right elbow co-occurrent and due to gout	4180186
42539213	Chondrocalcinosis of right ankle (disorder)	4180186
42539214	Osteoarthritis of left sacroiliac joint (disorder)	4180186
42539215	Ultrasound of right kidney	4180186
42539215	Ultrasonography of right kidney (procedure)	4180186
42539215	Ultrasound scan of right kidney	4180186
42539216	Bilateral ulnar neuropathy	4180186
42539216	Disorder of bilateral ulnar nerves (disorder)	4180186
42539216	Disorder of bilateral ulnar nerves	4180186
42539216	Disorder of both ulnar nerves	4180186
42539219	Subcoracoid impingement of right shoulder region (disorder)	4180186
42539221	Bone cyst of left shoulder (disorder)	4180186
42539222	Lesion of left lower leg bone (disorder)	4180186
42539222	Lesion of bone in left lower leg	4180186
42539223	Angioplasty of right iliac artery and insertion of stent using fluoroscopic guidance with contrast (procedure)	4180186
42539223	Angioplasty of right iliac artery and insertion of stent using fluoroscopic guidance with contrast	4180186
42539224	Angioplasty of left renal artery and insertion of stent using fluoroscopic guidance with contrast (procedure)	4180186
42539224	Angioplasty of left renal artery and insertion of stent using fluoroscopic guidance with contrast	4180186
42539226	Fluoroscopic venography of bilateral upper limbs with contrast (procedure)	4180186
42539226	Fluoroscopic venogram of both upper extremities with contrast	4180186
42539226	Fluoroscopic venography of left and right upper limb with contrast	4180186
42539228	History of preterm premature rupture of membranes (situation)	4180186
42539230	Fluoroscopic venogram of inferior vena cava with contrast with serialography	4180186
42539230	Fluoroscopic venography of inferior vena cava with contrast with serialography (procedure)	4180186
42539233	Improper medication administration technique (finding)	4180186
42539238	Needle aspiration of bursa of right shoulder bursa using computed tomography guidance	4180186
42539238	Needle aspiration of bursa of right shoulder bursa using computed tomography guidance (procedure)	4180186
42539239	Disease condition determination, poorly controlled (finding)	4180186
42539241	Doppler ultrasound of vascular structure of right upper limb	4180186
42539241	Doppler ultrasonography of vascular structure of right upper limb (procedure)	4180186
42539241	Doppler ultrasonography of right upper extremity blood vessel	4180186
42539243	Ultrasonography of right upper limb (procedure)	4180186
42539243	Ultrasound of right upper limb	4180186
42539243	Ultrasound scan of right upper limb	4180186
42539244	Doppler ultrasonography of left and right subclavian artery	4180186
42539244	Doppler ultrasonography of bilateral subclavian arteries (procedure)	4180186
42539244	Doppler ultrasound of both subclavian arteries	4180186
42539245	Doppler ultrasonography of bilateral upper extremity blood vessels	4180186
42539245	Doppler ultrasound of vascular structure of both upper limbs	4180186
42539245	Doppler ultrasonography of vascular structure of left and right upper limb	4180186
42539245	Doppler ultrasonography of vascular structure of bilateral upper limbs (procedure)	4180186
42539246	History of pregnancy loss in non-pregnant woman (situation)	4180186
42539248	Medial epicondyle apophysitis of left elbow due to overuse (disorder)	4180186
42539250	Acquired overriding toes of both feet	4180186
42539250	Acquired overriding toes of bilateral feet	4180186
42539250	Acquired overriding toes of bilateral feet (disorder)	4180186
42539253	Disorder of right cervical nerve root	4180186
42539253	Right cervical radiculopathy	4180186
42539253	Disorder of right cervical nerve root (disorder)	4180186
42539254	Weakness of right facial muscle due to and following cerebrovascular disease	4180186
42539254	Weakness of right facial muscle due to and following cerebrovascular disease (disorder)	4180186
42539254	Right facial weakness as late effect of cerebrovascular disease	4180186
42539256	Cognitive deficit as sequela of cerebrovascular disease	4180186
42539256	Cognitive deficit due to and following cerebrovascular disease (disorder)	4180186
42539257	Bilateral sacral insufficiency fracture (disorder)	4180186
42539258	Brachial neuritis of right upper limb (disorder)	4180186
42539259	Thoracic outlet syndrome of left thoracic outlet	4180186
42539259	Thoracic outlet syndrome of left thoracic outlet (disorder)	4180186
42539260	Right facial weakness as late effect of stroke	4180186
42539260	Weakness of right facial muscle due to and following cerebrovascular accident	4180186
42539260	Weakness of right facial muscle due to and following cerebrovascular accident (disorder)	4180186
42539261	Gouty arthritis of bilateral ankles (disorder)	4180186
42539261	Gouty arthritis of both ankles	4180186
42539261	Gouty arthritis of bilateral ankles	4180186
42539263	Derangement of right ankle joint (disorder)	4180186
42539264	Left trigeminal neuropathy	4180186
42539264	Disorder of left trigeminal nerve (disorder)	4180186
42539265	Allergy to food additive (finding)	4180186
42539274	Neuralgia of right pudendal nerve (finding)	4180186
42539275	Left sural neuropathy	4180186
42539275	Disorder of left sural nerve (disorder)	4180186
42539278	Lesion of right thigh bone (disorder)	4180186
42539278	Lesion of bone in right thigh	4180186
42539279	Lesion of right upper arm bone (disorder)	4180186
42539279	Lesion of bone right upper arm	4180186
42539281	Ossification of anterior longitudinal ligament of spine (disorder)	4180186
42539282	Insertion of indwelling tunnelled catheter with cuff by percutaneous approach using radiologic guidance	4180186
42539282	Insertion of indwelling tunneled catheter with cuff by percutaneous approach using radiologic guidance (procedure)	4180186
42539284	Magnetic resonance imaging for cardiac velocity flow mapping (procedure)	4180186
42539284	Magnetic resonance imaging for cardiac velocity flow mapping	4180186
42539287	Arthritis of right hand caused by bacteria (disorder)	4180186
42539291	Scapulothoracic bursitis of right shoulder (disorder)	4180186
42539292	Bone cyst of left humerus (disorder)	4180186
42539294	Magnetic resonance imaging of both hips	4180186
42539294	Magnetic resonance imaging of bilateral hips	4180186
42539294	Magnetic resonance imaging of bilateral hips (procedure)	4180186
42539294	Magnetic resonance imaging of left and right hip	4180186
42539295	Plain X-ray of right femur (procedure)	4180186
42539295	X-ray of right femur	4180186
42539299	Structure of ciliary body of left eye (body structure)	4180186
42539301	Structure of right auricular region (body structure)	4180186
42539302	Structure of phalanx of left little finger (body structure)	4180186
42539302	Structure of phalanx of little finger of left hand	4180186
42539303	Structure of subcapital section of head of right femur (body structure)	4180186
42539304	Bone structure of shaft of left radius (body structure)	4180186
42539306	Structure of ligament of right hand (body structure)	4180186
42539309	Doppler ultrasonography of right iliac vessel (procedure)	4180186
42539309	Doppler ultrasound of right iliac vessel	4180186
42539310	Doppler ultrasonography of left and right iliac vessel	4180186
42539310	Doppler ultrasound of both iliac vessels	4180186
42539310	Doppler ultrasonography of bilateral iliac vessels (procedure)	4180186
42539311	Doppler ultrasound scan of artery of left and right upper extremity	4180186
42539311	Doppler ultrasonography of arteries of bilateral upper limbs (procedure)	4180186
42539311	Doppler ultrasound of arteries of both upper limbs	4180186
42539312	Fluoroscopic venogram of left and right renal vein with contrast	4180186
42539312	Fluoroscopic venogram of both renal veins with contrast	4180186
42539312	Fluoroscopic venography of bilateral renal veins with contrast (procedure)	4180186
42539316	Abemaciclib (substance)	4180186
42539319	Assessment using Karnofsky Performance Status (procedure)	4180186
42539319	Assessment using Karnofsky Performance Status	4180186
42539320	PSQI (Pittsburgh Sleep Quality Index) score	4180186
42539320	Pittsburgh Sleep Quality Index score (observable entity)	4180186
42539321	Repair of right direct and indirect inguinal hernia	4180186
42539321	Repair of right direct and indirect inguinal hernia (procedure)	4180186
42539322	Rhizobium rhizoryzae (organism)	4180186
42539324	Structure of supracondylar part of left humerus (body structure)	4180186
42539326	Structure of posterior process of distal left tibia (body structure)	4180186
42539328	Structure of neck of metacarpal bone of right hand (body structure)	4180186
42539329	Musculoskeletal structure of right foot (body structure)	4180186
42539331	Structure of epiphyseal plate of lesser toe of left foot (body structure)	4180186
42539333	Lupus sensitive with 1:1 pooled normal plasma technique (qualifier value)	4180186
42539334	Structure of metacarpal bone of right hand (body structure)	4180186
42539335	Structure of shaft of fifth metacarpal bone of left hand (body structure)	4180186
42539336	Structure of neck of first metacarpal bone of left hand (body structure)	4180186
42539337	Structure of neck of fourth metacarpal bone of left hand (body structure)	4180186
42539341	Structure of right pectoral muscle (body structure)	4180186
42539342	Skin structure of left hand (body structure)	4180186
42539343	Structure of right little finger (body structure)	4180186
42539343	Structure of little finger of right hand	4180186
42539345	Structure of tendon of anterior thigh muscle of left lower limb (body structure)	4180186
42539346	Pre-excited atrial fibrillation	4180186
42539346	Preexcited atrial fibrillation (disorder)	4180186
42539347	Disseminated gonococcal infection	4180186
42539347	Disseminated infection caused by Neisseria gonorrhoeae (disorder)	4180186
42539349	Functional nausea (disorder)	4180186
42539350	Bacterial toxin-mediated cutaneous reaction	4180186
42539350	Cutaneous reaction caused by bacterial toxin (disorder)	4180186
42539355	Sleep disorder caused by stimulant (disorder)	4180186
42539358	Traumatic injury of right visual pathway (disorder)	4180186
42539360	Cleft soft palate with right cleft lip (disorder)	4180186
42539364	Screening for congenital malformation (procedure)	4180186
42539365	Repair of recurrent paraumbilical hernia with surgical sutures (procedure)	4180186
42539366	Complex burn of neck (disorder)	4180186
42539373	Postprocedural cardiac valve disorder	4180186
42539373	Disorder of cardiac valve following procedure (disorder)	4180186
42539374	Occupational allergic contact dermatitis caused by hairdressing product (disorder)	4180186
42539376	Chronic secondary facial pain (finding)	4180186
42539377	Quadruplets with all four stillborn (finding)	4180186
42539378	Acellular blood (substance)	4180186
42539382	Pigmentation of skin caused by artificial ultraviolet light (finding)	4180186
42539382	Artificial ultraviolet-induced skin pigmentation	4180186
42539384	Entire skin and subcutaneous tissue of face (body structure)	4180186
42539385	Edible substance (substance)	4180186
42539387	Bone structure of proximal phalanx of right ring finger (body structure)	4180186
42539387	Bone structure of proximal phalanx of ring finger of right hand	4180186
42539388	Bone structure of proximal phalanx of middle finger of right hand	4180186
42539388	Bone structure of proximal phalanx of right middle finger (body structure)	4180186
42539389	Bone structure of middle phalanx of right index finger (body structure)	4180186
42539389	Bone structure of middle phalanx of index finger of right hand	4180186
42539390	Bone structure of phalanx of left hand (body structure)	4180186
42539391	Structure of anterior interosseous nerve in right forearm (body structure)	4180186
42539391	Structure of anterior interosseous nerve in right forearm	4180186
42539391	Anterior interosseous nerve in right forearm (body structure)	4180186
42539394	Perioperative hematoma (disorder)	4180186
42539394	Perioperative haematoma	4180186
42539396	Arthritis of right elbow caused by bacteria (disorder)	4180186
42539397	Retrocalcaneal bursitis of left foot (disorder)	4180186
42539398	Generalized spacing of mandibular teeth (finding)	4180186
42539398	Generalised spacing of mandibular teeth	4180186
42539399	Amycolatopsis magusensis (organism)	4180186
42539404	Pseudomonas arsenicoxydans (organism)	4180186
42539406	Massilia kyonggiensis (organism)	4180186
42539409	Time out behavior strategy (regime/therapy)	4180186
42539409	Time out behaviour strategy	4180186
42539412	Specimen from mass of nasopharynx (specimen)	4180186
42539412	Specimen from nasopharyngeal mass	4180186
42539413	Alpha-thalassemia intellectual disability syndrome linked to chromosome 16 (disorder)	4180186
42539413	Alpha thalassaemia intellectual disability syndrome, deletion type	4180186
42539413	ATR-16 syndrome	4180186
42539413	Alpha thalassemia intellectual disability syndrome, deletion type	4180186
42539413	Alpha-thalassaemia intellectual disability syndrome linked to chromosome 16	4180186
42539414	Bone structure of right pubis (body structure)	4180186
42539416	Left carotid artery thrombosis	4180186
42539416	Thrombosis of left carotid artery (disorder)	4180186
42539417	Thrombosis of right carotid artery (disorder)	4180186
42539417	Right carotid artery thrombosis	4180186
42539419	Structure of left saphenous nerve (body structure)	4180186
42539420	Structure of lateral femoral cutaneous nerve of left lower limb (body structure)	4180186
42539422	Structure of left lumbosacral plexus (body structure)	4180186
42539426	Congenital hydrothorax (disorder)	4180186
42539427	Structure of left cerebellar artery (body structure)	4180186
42539428	Selenium dioxide (substance)	4180186
42539429	Etilefrine hydrochloride (substance)	4180186
42539430	Ceftobiprole (substance)	4180186
42539434	Aetiopathic disposition	4180186
42539434	Etiopathic disposition (disposition)	4180186
42539435	Enzyme inhibitor (disposition)	4180186
42539436	Metformin pamoate (substance)	4180186
42539436	Metformin embonate	4180186
42539437	Aminotransferase inhibitor (disposition)	4180186
42539439	Angiogenesis inhibitor (disposition)	4180186
42539446	Quinagolide hydrochloride (substance)	4180186
42539447	Renal hormone (disposition)	4180186
42539449	Dihydroxyphenylalanine decarboxylase inhibitor	4180186
42539449	Dihydroxyphenylalanine decarboxylase inhibitor (disposition)	4180186
42539450	Alpha adrenergic receptor antagonist (disposition)	4180186
42539451	N-methyl-D-aspartate receptor antagonist (disposition)	4180186
42539454	Right iliac vessel	4180186
42539454	Structure of right iliac vessel (body structure)	4180186
42539455	Structure of right hemiscrotum (body structure)	4180186
42539460	Venom (disposition)	4180186
42539461	Irritant (disposition)	4180186
42539464	Injury of female genital organ due to obstetric procedure (disorder)	4180186
42539467	Spacing of anterior maxillary teeth (finding)	4180186
42539471	Number of prescriptions for reliever inhaler per year (observable entity)	4180186
42539471	Number of prescriptions for rescue inhaler per year	4180186
42539472	Embolus of left middle cerebral artery (disorder)	4180186
42539473	Histidine hydrochloride	4180186
42539473	L-histidine monohydrochloride	4180186
42539473	Histidine monohydrochloride (substance)	4180186
42539475	Nerve of hand	4180186
42539475	Structure of peripheral nerve of hand (body structure)	4180186
42539475	Peripheral nerve of hand	4180186
42539476	Sweet potato (substance)	4180186
42539477	Fixation of left testis (procedure)	4180186
42539477	Left orchidopexy	4180186
42539482	Nickel gluconate (substance)	4180186
42539482	Niccolum gluconicum	4180186
42539483	Fordyce angiokeratoma of scrotum (disorder)	4180186
42539483	Angiokeratoma of scrotum	4180186
42539485	Genus Faecalitalea (organism)	4180186
42539485	Genus Faecalitalea	4180186
42539486	Structure of right ulnar nerve of wrist region (body structure)	4180186
42539486	Structure of right ulnar nerve of wrist region	4180186
42539486	Right ulnar nerve at wrist	4180186
42539486	Structure of right ulnar nerve at wrist (body structure)	4180186
42539487	Angiotensin-converting enzyme inhibitor (disposition)	4180186
42539490	Excision of left testis (procedure)	4180186
42539490	Left orchidectomy	4180186
42539491	Degeneration of cervical intervertebral disc co-occurrent with osteophyte of cervical vertebra (disorder)	4180186
42539491	Degeneration of cervical intervertebral disc co-occurrent with osteophyte of cervical vertebra	4180186
42539492	Traumatic rupture of volar plate of metacarpophalangeal joint of finger (disorder)	4180186
42539493	Fish (substance)	4180186
42539494	Under care of podiatric surgeon (finding)	4180186
42539496	Open biopsy of breast (procedure)	4180186
42539497	Structure of soft tissue of cervical spine	4180186
42539497	Structure of soft tissue of cervical vertebral column (body structure)	4180186
42539500	Fluoroscopy guided revision of cardiac biventricular implantable cardioverter defibrillator lead	4180186
42539500	Revision of cardiac biventricular implantable cardioverter defibrillator lead using fluoroscopic guidance (procedure)	4180186
42539501	Popping of bilateral temporomandibular joints on opening	4180186
42539501	Popping of both temporomandibular joints on opening	4180186
42539501	Popping of bilateral temporomandibular joints on opening (finding)	4180186
42539502	Transplanted kidney present (finding)	4180186
42539503	Structure of bone marrow of right hand (body structure)	4180186
42539504	Structure of right infrapatellar bursa (body structure)	4180186
42539505	Structure of left suprapatellar bursa (body structure)	4180186
42539511	Closed reduction of fracture of right femur and internal fixation using dynamic hip screw plate (procedure)	4180186
42539511	Closed reduction and dynamic hip screw of fracture of right femur	4180186
42539512	Cation exchange resin (disposition)	4180186
42539513	Barley (substance)	4180186
42539514	Occlusion of right cerebellar artery (disorder)	4180186
42539517	Plication of hydrocoele of bilateral testes	4180186
42539517	Plication of hydrocele of bilateral testes (procedure)	4180186
42539517	Lord operation for bilateral hydrocele	4180186
42539517	Lord operation for bilateral hydrocoele	4180186
42539519	Medically unfit for prison transfer (finding)	4180186
42539520	Papaya (substance)	4180186
42539520	Pawpaw	4180186
42539521	Reconstruction of right breast (procedure)	4180186
42539522	Harmful oral hygiene habit (finding)	4180186
42539524	Structure of deep vein of thigh (body structure)	4180186
42539528	Family Hantaviridae (organism)	4180186
42539528	Family Hantaviridae	4180186
42539529	Aspergillus minisclerotigenes (organism)	4180186
42539530	Candida stellimalicola (organism)	4180186
42539531	Candida quercitrusa (organism)	4180186
42539533	Acute hypoxemic respiratory failure co-occurrent with acute hypercapnic respiratory failure (disorder)	4180186
42539533	Acute hypoxemic respiratory failure co-occurrent with acute hypercapnic respiratory failure	4180186
42539534	Cytochrome P450 inhibitor (disposition)	4180186
42539536	Food hypersensitivity	4180186
42539536	Hypersensitivity reaction caused by food (disorder)	4180186
42539539	Complete prolapse of vaginal vault (disorder)	4180186
42539541	Deep partial thickness burn of perineum (disorder)	4180186
42539542	Complex burn of foot (disorder)	4180186
42539546	Infectious granuloma of central nervous system	4180186
42539546	Infection causing granuloma of central nervous system (disorder)	4180186
42539548	Acquired abnormality of coronary sinus (disorder)	4180186
42539549	Uncomplicated allergic asthma (disorder)	4180186
42539553	Excessive crying of adult (finding)	4180186
42539554	Closed traumatic injury of bilateral eyeballs (disorder)	4180186
42539554	Closed traumatic injury of both eyeballs	4180186
42539554	Closed traumatic injury of bilateral eyeballs	4180186
42539555	Retained nonmagnetic foreign body in bilateral eyes due to and following eye injury	4180186
42539555	Retained nonmagnetic foreign body in bilateral eyes due to and following eye injury (disorder)	4180186
42539555	Retained nonmagnetic foreign body in both eyes with eye injury	4180186
42539555	Retained nonmagnetic foreign body in bilateral eyes with eye injury	4180186
42539555	Retained nonmagnetic foreign body in both eyes due to and following eye injury	4180186
42539556	Primary chondrosarcoma of bone (disorder)	4180186
42539558	Angiodysplasia of oesophagus	4180186
42539558	Angiodysplasia of esophagus (disorder)	4180186
42539559	Structure of third metacarpal bone of left hand (body structure)	4180186
42539562	Superficial partial thickness burn of trunk (disorder)	4180186
42539564	Structure of left oculomotor nerve (body structure)	4180186
42539565	Antiplatelet therapy contraindicated (situation)	4180186
42539567	Neonatal haemolysis with systemic bacterial infection	4180186
42539567	Neonatal hemolysis co-occurrent and due to systemic bacterial infection (disorder)	4180186
42539567	Neonatal haemolysis co-occurrent and due to systemic bacterial infection	4180186
42539567	Neonatal hemolysis co-occurrent and due to systemic bacterial infection	4180186
42539568	Cardiac contusion and haemopericardium	4180186
42539568	Contusion of heart and haemopericardium	4180186
42539568	Contusion of heart co-occurrent with haemopericardium	4180186
42539568	Contusion of heart co-occurrent with hemopericardium	4180186
42539568	Contusion of heart co-occurrent with hemopericardium (disorder)	4180186
42539568	Cardiac contusion and hemopericardium	4180186
42539576	Open bite of foot (disorder)	4180186
42539578	Traumatic dislocation of tarsometatarsal joint (disorder)	4180186
42539580	Postural hypotension following exercise (disorder)	4180186
42539580	Post-exercise postural hypotension	4180186
42539581	Primary malignant neoplasm of lacrimal caruncle (disorder)	4180186
42539582	Acquired absence of genital organ (disorder)	4180186
42539583	Acute headache (finding)	4180186
42539584	Vesicular amine transporter 2 inhibitor	4180186
42539584	Synaptic vesicular amine transporter inhibitor (disposition)	4180186
42539590	Seen by podiatric surgeon (finding)	4180186
42539591	Angina self management plan (record artifact)	4180186
42539594	Genus Brunneomyces (organism)	4180186
42539594	Genus Brunneomyces	4180186
42539595	Data storage card (physical object)	4180186
42539598	Radial surgical retractor seal cap (physical object)	4180186
42539602	Dehydrogenase (disposition)	4180186
42539608	Penicillium primulinum (organism)	4180186
42539608	Talaromyces primulinus	4180186
42539611	Chronic obstructive pulmonary disease clinical management plan (record artifact)	4180186
42539613	Magnetic resonance imaging of bilateral acromioclavicular joints	4180186
42539613	Magnetic resonance imaging of left and right acromioclavicular joint	4180186
42539613	Magnetic resonance imaging of both acromioclavicular joints	4180186
42539613	Magnetic resonance imaging of bilateral acromioclavicular joints (procedure)	4180186
42539614	Structure of soft tissue of knee region (body structure)	4180186
42539615	Dissociative neurological symptom disorder co-occurrent with symptom of speech production (disorder)	4180186
42539617	Structure of soft tissue of wrist region (body structure)	4180186
42539621	Minor gynaecology surgery inpatient care plan	4180186
42539621	Minor gynecology surgery inpatient care plan (record artifact)	4180186
42539622	Anticipatory care plan (record artifact)	4180186
42539626	Chemotherapy care plan (record artifact)	4180186
42539629	Chronic idiopathic pain syndrome (disorder)	4180186
42539630	Has dose form intended site (attribute)	4180186
42539632	Structure of mucous membrane of right nasal cavity (body structure)	4180186
42539633	Has state of matter (attribute)	4180186
42539634	Entire mucous membrane of choana (body structure)	4180186
42539634	Entire mucous membrane of posterior naris	4180186
42539635	Penicillium ochrochloron variant paraherquei	4180186
42539635	Penicillium paraherquei (organism)	4180186
42539635	Penicillium ochrochloron var. paraherquei	4180186
42539636	Local excision of periurethral tissue (procedure)	4180186
42539637	Brigatinib (substance)	4180186
42539638	Right bronchus	4180186
42539638	Structure of right bronchus (body structure)	4180186
42539640	Paecilomyces formosa	4180186
42539640	Paecilomyces formosus (organism)	4180186
42539640	Monilia formosa	4180186
42539642	Insertion of JJ stent into right ureter (procedure)	4180186
42539642	Insertion of double-J stent into right ureter	4180186
42539644	Normal dentofacial function	4180186
42539644	Dentofacial function normal (finding)	4180186
42539645	PAM (Patient Activation Measure) assessment offered	4180186
42539645	Patient Activation Measure assessment offered (situation)	4180186
42539646	History of disorder of digestive system (situation)	4180186
42539648	Entire soft tissue of cervical spine	4180186
42539648	Entire soft tissue of cervical vertebral column (body structure)	4180186
42539649	Pedicle deltopectoral flap (substance)	4180186
42539653	Open repair of strangulated incisional hernia using prosthesis (procedure)	4180186
42539653	Open repair of strangulated incisional hernia using prosthesis	4180186
42539655	Education for transdermal contraceptive patch (procedure)	4180186
42539656	Impaction of tooth in palate	4180186
42539656	Impaction of tooth in palate (disorder)	4180186
42539657	Pibrentasvir (substance)	4180186
42539658	Closure of enterovesicovaginal fistula (procedure)	4180186
42539659	Vascular structure of face (body structure)	4180186
42539659	Blood vessel of face	4180186
42539663	Radionuclide scan of whole body for localisation of inflammation	4180186
42539663	Radioisotope scan of whole body for localisation of inflammation	4180186
42539663	Radioisotope scan of whole body for localization of inflammation	4180186
42539663	Radionuclide scan of whole body for localization of inflammation (procedure)	4180186
42539665	Intravascular occluding catheter, navigational-sensing (physical object)	4180186
42539667	Botryotrichum piluliferum (organism)	4180186
42539668	Chaetophoma species	4180186
42539668	Genus Chaetophoma	4180186
42539668	Genus Chaetophoma (organism)	4180186
42539669	Cryptococcus neoformans variant grubii genotype VNI	4180186
42539669	Cryptococcus neoformans variant grubii genotype VNI (organism)	4180186
42539670	Osteoporotic fracture probability score using fracture risk assessment tool (observable entity)	4180186
42539670	Osteoporotic fracture probability score using fracture risk assessment tool	4180186
42539671	Allograft bypass of one coronary artery (procedure)	4180186
42539672	Structure of female pelvis (body structure)	4180186
42539672	Female pelvis	4180186
42539673	Plastic surgery inpatient care plan (record artifact)	4180186
42539675	Acute nasolabial angle (finding)	4180186
42539676	Mild acquired hearing loss (disorder)	4180186
42539678	Repair of hypogastric hernia using prosthesis (procedure)	4180186
42539680	Serum specimen from control (specimen)	4180186
42539682	FTI (free thyroxine index) calculation technique	4180186
42539682	FT4I (free thyroxine index) calculation technique	4180186
42539682	Free thyroxine index calculation technique (qualifier value)	4180186
42539683	Lupus sensitive technique (qualifier value)	4180186
42539687	Interstitial lung disease due to granulomatous disease (disorder)	4180186
42539688	Motility disorder of large intestine (disorder)	4180186
42539689	Lymphangitis caused by bacterium (disorder)	4180186
42539689	Bacterial lymphangitis	4180186
42539690	Non-traumatic rupture of synovium (disorder)	4180186
42539690	Spontaneous rupture of synovium	4180186
42539691	Histiocytic neoplasm (disorder)	4180186
42539694	Injury of tendon of pelvis (disorder)	4180186
42539695	Eye appearance abnormal (finding)	4180186
42539697	External hearing aid in situ (finding)	4180186
42539699	Primary chronic pain (disorder)	4180186
42539700	Primary squamous cell carcinoma of sublingual gland (disorder)	4180186
42539701	Embolism due to and following ectopic pregnancy (disorder)	4180186
42539703	Occupational exposure to ergonomic risk (event)	4180186
42539710	Structure of bone marrow of right tibia (body structure)	4180186
42539711	Structure of left second metatarsal (body structure)	4180186
42539712	Structure of medial epicondyle of left humerus (body structure)	4180186
42539713	Minor surgery care management (procedure)	4180186
42539714	Drainage of bilateral lower limbs using fluoroscopic guidance	4180186
42539714	Drainage of left and right lower limb using fluoroscopic guidance	4180186
42539714	Drainage of both lower limbs using fluoroscopic guidance	4180186
42539714	Drainage of bilateral lower limbs using fluoroscopic guidance (procedure)	4180186
42539715	Structure of articular cartilage of left elbow joint (body structure)	4180186
42539716	Butyricimonas faecihominis (organism)	4180186
42539718	Paenibacillus segetis (organism)	4180186
42539720	Structure of tendon of medial muscle of right thigh (body structure)	4180186
42539720	Structure of tendon of adductor compartment of right thigh	4180186
42539722	Structure of bursa of right shoulder (body structure)	4180186
42539723	Structure of bursa of right foot (body structure)	4180186
42539726	Allograft of skin to skin of neck (procedure)	4180186
42539727	Structure of synovial membrane of right ankle (body structure)	4180186
42539728	Structure of right psoas bursa (body structure)	4180186
42539729	Referral to prosthetic service (procedure)	4180186
42539732	Structure of flexor tendon sheath (body structure)	4180186
42539734	Structure of trochanteric bursa of right lower limb (body structure)	4180186
42539739	Hydnum septentrionale	4180186
42539739	Creolophus septentrionalis	4180186
42539739	Climacodon septentrionalis (organism)	4180186
42539739	Steccherinum septentrionale	4180186
42539742	Escherichia coli serogroup O77 (organism)	4180186
42539742	Escherichia coli O77	4180186
42539742	Escherichia coli serotype O77	4180186
42539742	E. coli O77	4180186
42539742	E. coli serogroup O77	4180186
42539743	Hysteroscopic resection device (physical object)	4180186
42539744	Uridine diphosphate glucuronosyltransferase family 1 member A1 intermediate metabolizer	4180186
42539744	Uridine diphosphate glucuronosyltransferase family 1 member A1 intermediate metaboliser	4180186
42539744	Uridine diphosphate glucuronosyltransferase family 1 member A1 intermediate metabolizer (finding)	4180186
42539744	UGT1A1 intermediate metaboliser	4180186
42539745	Partial resection of colon with stoma (procedure)	4180186
42539745	Partial colectomy with stoma	4180186
42539746	Structure of tendon sheath of left ankle (body structure)	4180186
42539746	Structure of tendon sheath within left ankle	4180186
42539746	Structure of tendon sheath within left ankle (body structure)	4180186
42539748	Insertion of cerebrospinal fluid drain (procedure)	4180186
42539751	Intrauterine (intended site)	4180186
42539752	Transdermal (intended site)	4180186
42539754	Powder (basic dose form)	4180186
42539756	Drainage of right lower limb using fluoroscopic guidance (procedure)	4180186
42539756	Drainage of right lower limb using fluoroscopic guidance	4180186
42539757	Left axillary lymph node group	4180186
42539757	Lymph node group of left axilla (body structure)	4180186
42539760	Entire transplanted pulmonary valve (body structure)	4180186
42539762	Complete spinal cord injury (disorder)	4180186
42539764	Infant of subject (person)	4180186
42539765	Population of all cells positive for CD3 antigen and CD4 antigen in portion of fluid (body structure)	4180186
42539767	Total hysterectomy with left salpingectomy (procedure)	4180186
42539769	Inhale (administration method)	4180186
42539770	Polyadenosine 5'-diphosphoribose polymerase inhibitor (disposition)	4180186
42539770	PARP (polyadenosine 5'-diphosphoribose polymerase) inhibitor	4180186
42539771	COPD (chronic obstructive pulmonary disease) education	4180186
42539771	Education about chronic obstructive pulmonary disease (procedure)	4180186
42539772	Population of all cells positive for CD19 antigen and IgD antigen in portion of fluid (body structure)	4180186
42539773	Left recurrent femoral hernia (disorder)	4180186
42539774	Structure of bursa of left ankle (body structure)	4180186
42539775	Primary school started but not finished (finding)	4180186
42539777	Skeletal muscle structure of left lower limb (body structure)	4180186
42539778	Under care of drug misuse service (finding)	4180186
42539783	Referral to hand therapy service (procedure)	4180186
42539785	Every three to four hours as required (qualifier value)	4180186
42539785	Every 3-4 hours as required	4180186
42539785	Every 3-4 hours as needed	4180186
42539785	Every three to four hours as required	4180186
42539787	Occlusion of right posterior cerebral artery (disorder)	4180186
42687699	Eluxadoline (substance)	4180186
42687701	Glucarpidase (substance)	4180186
42687703	Carmoisine (substance)	4180186
42687704	Perflutren-containing microspheres of heat treated human albumin (substance)	4180186
42687709	Ceftazidime + Avibactam (product)	4180186
42687710	Glucarpidase (product)	4180186
42687713	Carmoisine (product)	4180186
42687714	Zinc hyaluronate (product)	4180186
42687715	Perflutren-containing albumin microspheres (product)	4180186
42687718	Dorzolamide 20mg/ml eye drops preservative free (product)	4180186
42687720	Generic HealthAid Osteoflex & Omega 3 tablets and capsules (product)	4180186
42687721	Generic HealthAid Osteoflex Plus modified-release tablets (product)	4180186
42687722	Generic HealthAid Osteoflex Fizzy effervescent tablets sugar free (product)	4180186
42687723	Alverine 60mg / Simeticone 300mg capsules (product)	4180186
42687725	Magnesium hydroxide 8% oral suspension (product)	4180186
42687727	Tracheostomy dressing sterile 6cm x 7cm (physical object)	4180186
42687728	Macrogol 3350 oral powder 8.5g sachets sugar free (product)	4180186
42687731	Capsaicin 0.03% nebuliser liquid 5ml bottles (product)	4180186
42687733	Carmoisine 1% cutaneous solution (product)	4180186
42687735	Colecalciferol 5,600unit capsules (product)	4180186
42687737	Histamine phosphate 1mg/ml nebuliser liquid 6ml ampoules (product)	4180186
42687738	Histamine phosphate 2mg/ml nebuliser liquid 6ml ampoules (product)	4180186
42687741	Histamine phosphate 32mg/ml nebuliser liquid 10ml ampoules (product)	4180186
42687743	Amoxicillin 500mg/50ml infusion bags (product)	4180186
42687745	Aminophylline 500mg/500ml solution for infusion bottles (product)	4180186
42687746	Generic Urostemol Prosta capsules (product)	4180186
42687747	Histamine phosphate 30micrograms/ml nebuliser liquid 10ml bottles (product)	4180186
42687748	Histamine phosphate 60micrograms/ml nebuliser liquid 10ml bottles (product)	4180186
42687753	Histamine phosphate 500micrograms/ml nebuliser liquid 10ml bottles (product)	4180186
42687754	Colecalciferol 200unit / Calcium phosphate 250mg chewable tablets (product)	4180186
42687756	Propofol 500mg/50ml emulsion for infusion ampoules (product)	4180186
42687757	Generic Urostemol capsules (product)	4180186
42687758	Glucarpidase 1,000unit powder for solution for injection vials (product)	4180186
42687762	Generic Health Plus Omega Complex capsules (product)	4180186
42687764	Generic Health Plus Omega Flaxseed Oil 450mg capsules (product)	4180186
42687766	Cytarabine 5g/50ml solution for infusion vials (product)	4180186
42687768	Generic G & G MSM 500mg capsules (product)	4180186
42687772	Ceftazidime 2g / Avibactam 500mg powder for solution for infusion vials (product)	4180186
42687773	Generic Synocrom Mini 10mg/1ml injection pre-filled syringes (product)	4180186
42687776	Generic Synocrom 20mg/2ml injection pre-filled syringes (product)	4180186
42687778	Generic Synopsis 40mg/2ml injection pre-filled syringes (product)	4180186
42687779	Generic Ostenil 20mg/2ml injection pre-filled syringes (product)	4180186
42687780	Generic Arthrum H 40mg/2ml injection pre-filled syringes (product)	4180186
42687782	Generic Ostenil Plus 40mg/2ml injection pre-filled syringes (product)	4180186
42687785	Tracheostomy dressing sterile 9cm x 9.8cm (physical object)	4180186
42687789	Generic Aquagel lubricating jelly (product)	4180186
42687790	Generic Elite lubricating jelly (product)	4180186
42687791	Generic OptiLube Active CHG Free sterile lubricating jelly (product)	4180186
42687792	Generic OptiLube Active sterile lubricating jelly (product)	4180186
42687794	Generic Sutherland lubricating jelly (product)	4180186
42687796	Generic Cathejell Lidocain (product)	4180186
42687799	Generic K-Y Jelly non-sterile (product)	4180186
42687800	Cyanocobalamin 10microgram tablets (product)	4180186
42687801	Methotrexate 7.5mg/0.3ml solution for injection pre-filled disposable devices (product)	4180186
42687803	Methotrexate 12.5mg/0.5ml solution for injection pre-filled disposable devices (product)	4180186
42687805	Methotrexate 17.5mg/0.7ml solution for injection pre-filled disposable devices (product)	4180186
42687806	Methotrexate 20mg/0.8ml solution for injection pre-filled disposable devices (product)	4180186
42687807	Methotrexate 22.5mg/0.9ml solution for injection pre-filled disposable devices (product)	4180186
42687811	Everolimus 5mg dispersible tablets sugar free (product)	4180186
42687814	Abiraterone 500mg tablets (product)	4180186
42687815	Generic Aveeno Bath & Shower oil (product)	4180186
42687816	Generic LaBiNIC oral drops sugar free (product)	4180186
42687818	Generic Bach Rescue Remedy spray sugar free (product)	4180186
42687821	Levobupivacaine hydrochloride 625mg/500ml / Fentanyl 2mg/500ml infusion bags (product)	4180186
42687822	Levobupivacaine hydrochloride 625mg/500ml / Fentanyl 1mg/500ml infusion bags (product)	4180186
42687823	Vitamin A 100,000units/2ml solution for injection vials (product)	4180186
42687824	Sodium bicarbonate mixture paediatric (product)	4180186
42687825	Metronidazole 100mg/20ml solution for infusion ampoules (product)	4180186
42687826	Cisatracurium besilate 150mg/30ml solution for injection vials (product)	4180186
42687830	Metoclopramide 100mg/20ml solution for injection ampoules (product)	4180186
42687834	Fermathron 20mg/2ml injection pre-filled syringes (Biomet Europe) (product)	4180186
42687840	Suplasyn 20mg/2ml injection pre-filled syringes (Teva UK Ltd) (product)	4180186
42687841	Ostenil Plus 40mg/2ml injection pre-filled syringes (TRB Chemidica (UK) Ltd) (product)	4180186
42687843	TendoVis 12mg/1.2ml solution for injection pre-filled syringes (Holy Stone Biotech Co Ltd) (product)	4180186
42687844	Fiasp FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product)	4180186
42687845	Fiasp Penfill 100units/ml solution for injection 3ml cartridges (Novo Nordisk Ltd) (product)	4180186
42687848	Omnican Fine hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/31gauge (B.Braun Medical Ltd) (physical object)	4180186
42687849	Mepilex dressing 11cm x 20cm (Molnlycke Health Care Ltd) (physical object)	4180186
42687850	Mepilex dressing 20cm x 21cm (Molnlycke Health Care Ltd) (physical object)	4180186
42687852	Neckfix Duo K tracheostomy tube holder 32630 (Severn Healthcare Technologies Ltd) (physical object)	4180186
42687853	Sensotrach Uno Slit tracheostomy dressing 9cm x 9.8cm 30521 (Severn Healthcare Technologies Ltd) (physical object)	4180186
42687855	Sensotrach Alu Slit tracheostomy dressing 8cm x 10cm 30030 (Severn Healthcare Technologies Ltd) (physical object)	4180186
42687858	Spirit sterile leg bag DSLB350S 350ml bag, 10cm short tube (Bard Ltd) (physical object)	4180186
42687863	Spirit sterile leg bag DSLB750L 750ml bag, 30cm long tube (Bard Ltd) (physical object)	4180186
42687864	Spirit sterile leg bag DSLB750V 750ml bag, 60cm variable tube (Bard Ltd) (physical object)	4180186
42687865	Onexila XL 40mg tablets (Aspire Pharma Ltd) (product)	4180186
42687866	Onexila XL 10mg tablets (Aspire Pharma Ltd) (product)	4180186
42687868	Onexila XL 80mg tablets (Aspire Pharma Ltd) (product)	4180186
42687871	Elite lubricating jelly (Farnhurst Medical Ltd) (product)	4180186
42687872	OptiLube Active CHG Free sterile lubricating jelly (Optimum Medical Solutions Ltd) (product)	4180186
42687874	OptiLube sterile lubricating jelly (Optimum Medical Solutions Ltd) (product)	4180186
42687875	Sutherland lubricating jelly (Sutherland Health Ltd) (product)	4180186
42687876	Cathejell Lidocaine C (Teleflex) (product)	4180186
42687877	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42687878	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42687879	Cathejell Lidocain CJLL12501 (Teleflex) (product)	4180186
42687880	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42687882	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42687884	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42687885	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42687887	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short extra large Black (Gardamed Ltd) (physical object)	4180186
42687889	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42687890	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42687893	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42687894	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42687896	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42687897	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42687901	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42687902	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42687903	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42687904	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42687905	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42687906	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42687907	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42687910	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42687911	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42687914	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42687915	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42687917	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42687918	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42687919	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42687921	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42687929	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42687931	K-Y Jelly non-sterile (Thornton & Ross Ltd) (product)	4180186
42687933	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42687934	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42687935	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42687938	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42687939	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42687940	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42687946	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42687947	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42687948	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42687954	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42687955	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42687962	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42687964	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42687965	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42687966	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42687967	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42687968	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42687969	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42687970	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42687973	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42687974	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42687975	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42687976	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42687977	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42687983	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42687993	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42687994	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42687998	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42687999	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688001	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688002	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688003	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42688004	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42688005	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42688006	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688008	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688012	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42688013	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688014	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42688016	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688019	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688021	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688022	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688023	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42688026	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688027	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42688028	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688029	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42688030	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688033	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688036	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688039	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688041	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688042	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short extra small left Beige (Gardamed Ltd) (physical object)	4180186
42688043	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short small left Beige (Gardamed Ltd) (physical object)	4180186
42688044	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short medium left Beige (Gardamed Ltd) (physical object)	4180186
42688045	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short large left Beige (Gardamed Ltd) (physical object)	4180186
42688046	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short extra large left Beige (Gardamed Ltd) (physical object)	4180186
42688048	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long small left Beige (Gardamed Ltd) (physical object)	4180186
42688049	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long medium left Beige (Gardamed Ltd) (physical object)	4180186
42688050	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long large left Beige (Gardamed Ltd) (physical object)	4180186
42688057	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long extra small right Beige (Gardamed Ltd) (physical object)	4180186
42688058	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long small right Beige (Gardamed Ltd) (physical object)	4180186
42688059	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long medium right Beige (Gardamed Ltd) (physical object)	4180186
42688060	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long large right Beige (Gardamed Ltd) (physical object)	4180186
42688061	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long extra large right Beige (Gardamed Ltd) (physical object)	4180186
42688062	Bach Rescue Remedy spray (Nelsons) (product)	4180186
42688063	Bach Rescue Remedy oral drops (Nelsons) (product)	4180186
42688064	Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) (product)	4180186
42688066	Amitriptyline 25mg tablets (Genesis Pharmaceuticals Ltd) (product)	4180186
42688068	Eprosartan 400mg tablets (Genesis Pharmaceuticals Ltd) (product)	4180186
42688070	Leandra 30microgram/150microgram tablets (Genesis Pharmaceuticals Ltd) (product)	4180186
42688071	Levobupivacaine hydrochloride 625mg/500ml / Fentanyl 2mg/500ml infusion bags (Special Order) (product)	4180186
42688072	Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) (product)	4180186
42688073	Levobupivacaine hydrochloride 625mg/500ml / Fentanyl 1mg/500ml infusion bags (Special Order) (product)	4180186
42688080	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra small left Beige (Gardamed Ltd) (physical object)	4180186
42688081	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short small left Beige (Gardamed Ltd) (physical object)	4180186
42688082	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short medium left Beige (Gardamed Ltd) (physical object)	4180186
42688083	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short large left Beige (Gardamed Ltd) (physical object)	4180186
42688087	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long medium left Beige (Gardamed Ltd) (physical object)	4180186
42688088	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long large left Beige (Gardamed Ltd) (physical object)	4180186
42688090	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra small right Beige (Gardamed Ltd) (physical object)	4180186
42688093	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short large right Beige (Gardamed Ltd) (physical object)	4180186
42688094	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra large right Beige (Gardamed Ltd) (physical object)	4180186
42688096	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long small right Beige (Gardamed Ltd) (physical object)	4180186
42688097	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long medium right Beige (Gardamed Ltd) (physical object)	4180186
42688098	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long large right Beige (Gardamed Ltd) (physical object)	4180186
42688099	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra large right Beige (Gardamed Ltd) (physical object)	4180186
42688103	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42688106	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688108	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688109	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short extra large Black (Gardamed Ltd) (physical object)	4180186
42688113	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42688114	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688115	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42688118	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42688120	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688122	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42688124	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688128	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688130	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42688132	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42688136	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42688139	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688140	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688141	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42688143	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42688144	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688145	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42688149	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short extra large Black (Gardamed Ltd) (physical object)	4180186
42688153	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42688154	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42688158	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688161	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short extra small Beige (Gardamed Ltd) (physical object)	4180186
42688166	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42688168	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42688169	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688170	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short extra large Black (Gardamed Ltd) (physical object)	4180186
42688172	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688173	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42688176	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42688177	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42688178	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688180	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688184	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42688187	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688188	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42688191	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42688192	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688193	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42688194	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42688195	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688198	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688200	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long extra large Black (Gardamed Ltd) (physical object)	4180186
42688202	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short extra small Black (Gardamed Ltd) (physical object)	4180186
42688203	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short small Beige (Gardamed Ltd) (physical object)	4180186
42688205	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short medium Beige (Gardamed Ltd) (physical object)	4180186
42688208	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42688209	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688211	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42688213	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42688216	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42688217	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42688225	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42688229	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42688230	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688231	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short extra large Black (Gardamed Ltd) (physical object)	4180186
42688233	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688235	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42688236	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688240	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long extra large Beige (Gardamed Ltd) (physical object)	4180186
42688245	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short small Black (Gardamed Ltd) (physical object)	4180186
42688247	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short medium Black (Gardamed Ltd) (physical object)	4180186
42688248	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short large Beige (Gardamed Ltd) (physical object)	4180186
42688249	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short large Black (Gardamed Ltd) (physical object)	4180186
42688250	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra large Beige (Gardamed Ltd) (physical object)	4180186
42688252	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra small Beige (Gardamed Ltd) (physical object)	4180186
42688253	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra small Black (Gardamed Ltd) (physical object)	4180186
42688254	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long small Beige (Gardamed Ltd) (physical object)	4180186
42688255	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long small Black (Gardamed Ltd) (physical object)	4180186
42688256	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long medium Beige (Gardamed Ltd) (physical object)	4180186
42688257	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long medium Black (Gardamed Ltd) (physical object)	4180186
42688258	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long large Beige (Gardamed Ltd) (physical object)	4180186
42688259	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long large Black (Gardamed Ltd) (physical object)	4180186
42688264	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short medium left Beige (Gardamed Ltd) (physical object)	4180186
42688267	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long extra small left Beige (Gardamed Ltd) (physical object)	4180186
42688270	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long large left Beige (Gardamed Ltd) (physical object)	4180186
42688273	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short small right Beige (Gardamed Ltd) (physical object)	4180186
42688274	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short medium right Beige (Gardamed Ltd) (physical object)	4180186
42688275	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short large right Beige (Gardamed Ltd) (physical object)	4180186
42688276	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short extra large right Beige (Gardamed Ltd) (physical object)	4180186
42688277	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long extra small right Beige (Gardamed Ltd) (physical object)	4180186
42688278	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long small right Beige (Gardamed Ltd) (physical object)	4180186
42688279	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long medium right Beige (Gardamed Ltd) (physical object)	4180186
42688280	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long large right Beige (Gardamed Ltd) (physical object)	4180186
42688281	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long extra large right Beige (Gardamed Ltd) (physical object)	4180186
42688283	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short small left Beige (Gardamed Ltd) (physical object)	4180186
42688286	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra large left Beige (Gardamed Ltd) (physical object)	4180186
42688287	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra small left Beige (Gardamed Ltd) (physical object)	4180186
42688288	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long small left Beige (Gardamed Ltd) (physical object)	4180186
42688290	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long large left Beige (Gardamed Ltd) (physical object)	4180186
42688293	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short small right Beige (Gardamed Ltd) (physical object)	4180186
42688294	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short medium right Beige (Gardamed Ltd) (physical object)	4180186
42688296	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra large right Beige (Gardamed Ltd) (physical object)	4180186
42688297	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra small right Beige (Gardamed Ltd) (physical object)	4180186
42688301	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra large right Beige (Gardamed Ltd) (physical object)	4180186
42688302	Droperidol 2.5mg/1ml solution for injection ampoules (Panpharma UK Ltd) (product)	4180186
42688305	Jobst Elvarex SoftFit for lymphoedema garment upper extremities U-A018 Beige (BSN medical Ltd) (physical object)	4180186
42688306	Jobst Elvarex Soft SoftFit for lymphoedema garment upper extremities U-A018S Beige (BSN medical Ltd) (physical object)	4180186
42688312	Tetrabenazine 25mg tablets (AOP Orphan Ltd) (product)	4180186
42688318	Nordimet 12.5mg/0.5ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product)	4180186
42688319	Nordimet 15mg/0.6ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product)	4180186
42688326	Votubia 5mg dispersible tablet (Novartis Pharmaceuticals UK Ltd) (product)	4180186
42688329	Kalms Night One-a-Night 500mg tablets (G.R. Lane Health Products Ltd) (product)	4180186
42688331	Imatinib 400mg tablets (Sandoz Ltd) (product)	4180186
42688332	Co-careldopa 12.5mg/50mg tablets (Zentiva Pharma UK Ltd) (product)	4180186
42688334	Memantine 5mg tablets (Lupin (Europe) Ltd) (product)	4180186
42688336	Memantine 15mg tablets (Lupin (Europe) Ltd) (product)	4180186
42688337	Relevtec 70micrograms/hour transdermal patches (Sandoz Ltd) (product)	4180186
42688341	SunVit-D3 400unit capsules (SunVit-D3 Ltd) (product)	4180186
42688342	SunVit-D3 2,200unit capsules (SunVit-D3 Ltd) (product)	4180186
42688344	SunVit-D3 10,000unit capsules (SunVit-D3 Ltd) (product)	4180186
42688345	SunVit-D3 50,000unit capsules (SunVit-D3 Ltd) (product)	4180186
42688346	Saline 0.9% nebuliser liquid 2.5ml Steri-Neb unit dose ampoules (Teva UK Ltd) (product)	4180186
42688348	Aspirin 75mg tablets (Accord Healthcare Ltd) (product)	4180186
42688349	Trolactin 200mg modified-release capsules (Actavis UK Ltd) (product)	4180186
42688353	Zonisamide 25mg capsules (Accord Healthcare Ltd) (product)	4180186
42688354	Zonisamide 50mg capsules (Accord Healthcare Ltd) (product)	4180186
42688355	Zonisamide 100mg capsules (Accord Healthcare Ltd) (product)	4180186
42688356	Cisplatin 50mg/50ml concentrate for solution for infusion vials (Sandoz Ltd) (product)	4180186
42688359	Ralvo 700mg medicated plasters (Grunenthal Ltd) (product)	4180186
42688360	G & G Natural Betacarotene 15mg capsules (G & G Food Supplies Ltd) (product)	4180186
42688361	Tivicay 10mg tablets (ViiV Healthcare UK Ltd) (product)	4180186
42688362	Tivicay 25mg tablets (ViiV Healthcare UK Ltd) (product)	4180186
42688364	G & G Magnesium citrate 100mg capsules (G & G Food Supplies Ltd) (product)	4180186
42688365	G & G Zinc citrate 50mg capsules (G & G Food Supplies Ltd) (product)	4180186
42688369	Vencarm XL 150mg capsules (Aspire Pharma Ltd) (product)	4180186
42688370	Vencarm XL 75mg capsules (Aspire Pharma Ltd) (product)	4180186
42688371	Vencarm XL 37.5mg capsules (Aspire Pharma Ltd) (product)	4180186
42688372	Ellanite 0.03mg/3mg tablets (Stragen UK Ltd) (product)	4180186
42688373	Phillips' Milk of Magnesia 415mg/5ml oral suspension (Omega Pharma Ltd) (product)	4180186
42688374	Magnesium hydroxide 7.45-8.35% oral suspension BP (A A H Pharmaceuticals Ltd) (product)	4180186
42688375	Magnesium hydroxide 7.45-8.35% oral suspension BP (Thornton & Ross Ltd) (product)	4180186
42688376	Magnesium hydroxide 8% oral suspension (A A H Pharmaceuticals Ltd) (product)	4180186
42688377	Magnesium hydroxide 8% oral suspension (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688379	G & G Vitamin B2 50mg capsules (G & G Food Supplies Ltd) (product)	4180186
42688381	Medi Derma-Pro Foam & Spray incontinence cleanser 63582 (Medicareplus International Ltd) (physical object)	4180186
42688384	G & G Natural Vitamin E 400unit softgels capsules (G & G Food Supplies Ltd) (product)	4180186
42688385	G & G Omega 3 1000mg softgels capsules (G & G Food Supplies Ltd) (product)	4180186
42688386	G & G Selenium 200microgram capsules (G & G Food Supplies Ltd) (product)	4180186
42688387	Colchicine 500microgram tablets (Morningside Healthcare Ltd) (product)	4180186
42688388	Health Plus High Potency Omega-3 EPA capsules (Health+Plus Ltd) (product)	4180186
42688392	Metformin 850mg/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) (product)	4180186
42688393	Metformin 1g/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) (product)	4180186
42688394	Olmesartan medoxomil 10mg tablets (A A H Pharmaceuticals Ltd) (product)	4180186
42688395	Olmesartan medoxomil 20mg tablets (A A H Pharmaceuticals Ltd) (product)	4180186
42688396	Olmesartan medoxomil 40mg tablets (A A H Pharmaceuticals Ltd) (product)	4180186
42688397	Sevelamer 2.4g oral powder sachets sugar free (A A H Pharmaceuticals Ltd) (product)	4180186
42688399	Health Plus Omega Complex capsules (Health+Plus Ltd) (product)	4180186
42688400	Health Plus Omega Flaxseed Oil 1000mg capsules (Health+Plus Ltd) (product)	4180186
42688401	Health Plus Omega Flaxseed Oil 450mg capsules (Health+Plus Ltd) (product)	4180186
42688405	Cytarabine 4g/40ml solution for injection vials (Accord Healthcare Ltd) (product)	4180186
42688406	Cytarabine 5g/50ml solution for infusion vials (Accord Healthcare Ltd) (product)	4180186
42688407	G & G MSM 500mg & Vitamin C 100mg capsules (G & G Food Supplies Ltd) (product)	4180186
42688408	Neocate Junior powder strawberry (Nutricia Ltd) (product)	4180186
42688413	Acetylcysteine 200mg oral powder sachets sugar free (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688417	Ethosuximide 250mg/5ml syrup (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688418	Folic acid 5mg/5ml oral solution sugar free (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688419	Naproxen 50mg/ml oral suspension (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688422	Olmesartan medoxomil 20mg tablets (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688423	Olmesartan medoxomil 40mg tablets (Alliance Healthcare (Distribution) Ltd) (product)	4180186
42688425	Rabipur vaccine powder and solvent for solution for injection 1ml pre-filled syringes (Valneva UK Ltd) (product)	4180186
42688426	Alecensa 150mg capsules (Roche Products Ltd) (product)	4180186
42688427	Tretinoin 10mg capsules (Neon Healthcare Ltd) (product)	4180186
42688428	Lamberts Vitamin B12 100microgram tablets (Lamberts Healthcare Ltd) (product)	4180186
42688430	Amytal sodium 500mg powder for solution for injection vials (Imported (United States)) (product)	4180186
42688431	Mitomycin 0.02% eye drops (Special Order) (product)	4180186
42688439	Optiflausch tracheostomy tube holder 32550 (Severn Healthcare Technologies Ltd) (physical object)	4180186
42688440	Optiflausch tracheostomy tube holder 32555 Child (Severn Healthcare Technologies Ltd) (physical object)	4180186
42688442	Nanova therapy unit (KCI Medical Ltd) (physical object)	4180186
42688443	Antistatic Space Chamber Plus with medium mask (Medical Developments International Ltd) (physical object)	4180186
42688445	Antistatic Space Chamber Plus Compact (Medical Developments International Ltd) (physical object)	4180186
42688446	Antistatic Space Chamber Plus Compact with small mask (Medical Developments International Ltd) (physical object)	4180186
42688449	Mepilex Border Lite dressing 10cm x 10.5cm (Molnlycke Health Care Ltd) (physical object)	4180186
42688450	Chemipore-PE tape 2.5cm (Medicareplus International Ltd) (physical object)	4180186
42688451	Chemipore-PE tape 5cm (Medicareplus International Ltd) (physical object)	4180186
42688454	Chemifix tape 20cm (Medicareplus International Ltd) (physical object)	4180186
42688458	Propofol-Lipuro 1% emulsion for infusion 50ml ampoules (B.Braun Melsungen AG) (product)	4180186
42688459	Colecalciferol 400unit / Calcium carbonate 1.5g chewable tablets (Alissa Healthcare Research Ltd) (product)	4180186
42688460	CoaguChek XS PT Test PST testing strips 07671687019 (Roche Diagnostics Ltd) (physical object)	4180186
42688464	Urostemol capsules (Omega Pharma Ltd) (product)	4180186
42688466	Histamine phosphate 30micrograms/ml nebuliser liquid 10ml bottles (Special Order) (product)	4180186
42688467	Neria Soft 90 subcutaneous drug delivery device 110cm tubing 6mm needle 27gauge 722110-5226 (Unomedical Ltd) (physical object)	4180186
42688468	Histamine phosphate 60micrograms/ml nebuliser liquid 10ml bottles (Special Order) (product)	4180186
42688476	Haliborange Mr.Men Little Miss Calcium & Vitamin D softies chewable tablets (Seven Seas Ltd) (product)	4180186
42688477	Haliborange Kids Vitamin D Calcium softies chewable tablets (Seven Seas Ltd) (product)	4180186
42688478	Conform 2 two piece ostomy system CeraPlus skin barrier floating flange 14200 45mm flange, cut to fit 13mm-30mm (Hollister Ltd) (physical object)	4180186
42688480	Conform 2 two piece ostomy system CeraPlus skin barrier floating flange 17200 70mm flange, cut to fit 13mm-55mm (Hollister Ltd) (physical object)	4180186
42688482	Conform 2 two piece ostomy system CeraPlus convex skin barrier floating flange 15100 55mm flange, cut to fit 13mm-38mm (Hollister Ltd) (physical object)	4180186
42688483	Conform 2 two piece ostomy system CeraPlus convex skin barrier floating flange 17100 70mm flange, cut to fit 13mm-51mm (Hollister Ltd) (physical object)	4180186
42688484	Histamine phosphate 1mg/ml nebuliser liquid 6ml ampoules (Special Order) (product)	4180186
42688487	Histamine phosphate 16mg/ml nebuliser liquid 10ml bottles (Special Order) (product)	4180186
42688488	Histamine phosphate 32mg/ml nebuliser liquid 10ml ampoules (Special Order) (product)	4180186
42688489	Histamine phosphate 40mg/ml nebuliser liquid 5ml ampoules (Special Order) (product)	4180186
42688490	Ximaract 50mg powder for solution for injection vials (Bausch & Lomb UK Ltd) (product)	4180186
42688496	Almuriva 9.5mg/24hours transdermal patches (Sandoz Ltd) (product)	4180186
42688500	Capsaicin 0.03% nebuliser liquid 5ml bottles (Special Order) (product)	4180186
42688501	Tioguanine 50mg/5ml oral suspension (Special Order) (product)	4180186
42688502	Carmoisine 1% cutaneous solution (Special Order) (product)	4180186
42688504	InVita D3 25,000unit capsules (Consilient Health Ltd) (product)	4180186
42688506	Metoclopramide 5mg/5ml oral solution sugar free (Healthcare Pharma Ltd) (product)	4180186
42688507	Zonisamide 50mg capsules (Zentiva Pharma UK Ltd) (product)	4180186
42688508	MagnaPhos 48.6mg (2mmol) capsules (TriOn Pharma Ltd) (product)	4180186
42688509	MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) (product)	4180186
42688510	MagnaPhos 97.2mg (4mmol) chewable tablets (TriOn Pharma Ltd) (product)	4180186
42688512	Propranolol 5mg/5ml oral solution sugar free (Thame Laboratories Ltd) (product)	4180186
42688516	Propranolol 50mg/5ml oral solution sugar free (Thame Laboratories Ltd) (product)	4180186
42688517	Zacco 5mg/5ml oral suspension (Thame Laboratories Ltd) (product)	4180186
42688521	Haloperidol 5mg/5ml oral solution sugar free (Thame Laboratories Ltd) (product)	4180186
42688523	Carbocisteine 375mg capsules (Healthcare Pharma Ltd) (product)	4180186
42688525	Optison 570micrograms/3ml dispersion for injection vials (GE Healthcare AS) (product)	4180186
42688527	Genius gluten free seeded brown farmhouse loaf sliced (Genius Foods Ltd) (product)	4180186
42688530	Zonisamide 100mg capsules (Par Laboratories Europe Ltd) (product)	4180186
42688531	Xeljanz 5mg tablets (Pfizer Ltd) (product)	4180186
42688533	HealthAid Osteoflex Plus modified-release tablets (HealthAid Ltd) (product)	4180186
42688534	Esmolol hydrochloride 100mg/10ml solution for injection vials (AOP Orphan Ltd) (product)	4180186
42688535	HealthAid Osteoflex Fizzy effervescent tablets (HealthAid Ltd) (product)	4180186
42688536	HealthAid Vitamin C 100% Pure Ultra-fine powder (HealthAid Ltd) (product)	4180186
42688539	FSC High Strength Vitamin D3 2,500unit capsules (Bee Health Ltd) (product)	4180186
42688541	Esmolol hydrochloride 2.5g/10ml concentrate for solution for infusion ampoules (AOP Orphan Ltd) (product)	4180186
42688544	Dorzolamide 20mg/ml eye drops preservative free 5 ml (product)	4180186
42688545	Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops preservative free 5 ml (product)	4180186
42688547	Colecalciferol 2,500unit capsules 60 capsule (product)	4180186
42688548	Generic HealthAid Osteoflex Fizzy effervescent tablets sugar free 20 tablet (product)	4180186
42688555	Alverine 60mg / Simeticone 300mg capsules 90 capsule (product)	4180186
42688556	Perflutren-containing microspheres of heat treated human albumin 570micrograms/3ml dispersion for injection vials 5 vial (product)	4180186
42688558	Haloperidol 200micrograms/ml oral solution sugar free 200 ml (product)	4180186
42688563	Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules 50 capsule (product)	4180186
42688564	Colecalciferol 5,600unit capsules 4 capsule (product)	4180186
42688566	Colecalciferol 50,000unit capsules 3 capsule (product)	4180186
42688567	Carmoisine 1% cutaneous solution 10 ml (product)	4180186
42688568	Carmoisine 1% cutaneous solution 1 ml (product)	4180186
42688570	Capsaicin 0.03% nebuliser liquid 5ml bottles 1 bottle (product)	4180186
42688575	Amoxicillin 500mg/50ml infusion bags 1 bag (product)	4180186
42688579	Histamine phosphate 32mg/ml nebuliser liquid 10ml ampoules 1 ampoule (product)	4180186
42688580	Histamine phosphate 16mg/ml nebuliser liquid 10ml bottles 1 bottle (product)	4180186
42688581	Histamine phosphate 4mg/ml nebuliser liquid 10ml ampoules 5 ampoule (product)	4180186
42688583	Histamine phosphate 2mg/ml nebuliser liquid 6ml ampoules 5 ampoule (product)	4180186
42688584	Histamine phosphate 2mg/ml nebuliser liquid 6ml ampoules 1 ampoule (product)	4180186
42688586	Histamine phosphate 1mg/ml nebuliser liquid 6ml ampoules 1 ampoule (product)	4180186
42688587	Colecalciferol 200unit / Calcium phosphate 250mg chewable tablets 30 tablet (product)	4180186
42688589	Histamine phosphate 500micrograms/ml nebuliser liquid 10ml bottles 1 bottle (product)	4180186
42688592	Histamine phosphate 250micrograms/ml nebuliser liquid 6ml ampoules 5 ampoule (product)	4180186
42688593	Histamine phosphate 125micrograms/ml nebuliser liquid 10ml bottles 1 bottle (product)	4180186
42688595	Generic Urostemol Men capsules 60 capsule (product)	4180186
42688596	Histamine phosphate 60micrograms/ml nebuliser liquid 10ml bottles 1 bottle (product)	4180186
42688605	Permeable non-woven synthetic adhesive tape BP 1988 7.5cm 5 m (physical object)	4180186
42688607	Tracheostomy dressing sterile 6cm x 7cm 1 dressing (physical object)	4180186
42688608	Mitomycin 0.04% eye drops 10 ml (product)	4180186
42688610	Mitomycin 0.02% eye drops 10 ml (product)	4180186
42688614	Chlorhexidine gluconate 0.5% / Isopropyl alcohol 70% solution 500 ml (product)	4180186
42688615	Cyanocobalamin 100microgram tablets 100 tablet (product)	4180186
42688618	Potassium phosphate 17.42% (potassium 2mmol/ml) oral solution 10 ml (product)	4180186
42688619	Generic G & G MSM 500mg capsules 100 capsule (product)	4180186
42688620	Generic Neocate Junior powder 400 gram (product)	4180186
42688621	Generic G & G MSM 500mg & Vitamin C 100mg capsules 120 capsule (product)	4180186
42688622	Cytarabine 5g/50ml solution for infusion vials 1 vial (product)	4180186
42688623	Cytarabine 4g/40ml solution for injection vials 1 vial (product)	4180186
42688624	Generic Health Plus Omega Flaxseed Oil 450mg capsules 90 capsule (product)	4180186
42688627	Generic Health Plus Omega Complex capsules 90 capsule (product)	4180186
42688628	Generic Health Plus Omega Complex capsules 30 capsule (product)	4180186
42688629	Eicosapentaenoic acid 460mg / Docosahexaenoic acid 380mg capsules 90 capsule (product)	4180186
42688633	Magnesium hydroxide 8% oral suspension 500 ml (product)	4180186
42688634	Magnesium hydroxide 8% oral suspension 200 ml (product)	4180186
42688637	Ceftazidime 2g / Avibactam 500mg powder for solution for infusion vials 10 vial (product)	4180186
42688638	Generic G & G Glucosamine with Chondroitin & Vitamin C capsules 120 capsule (product)	4180186
42688640	Dolutegravir 10mg tablets 30 tablet (product)	4180186
42688641	Colecalciferol 10,000unit capsules 28 capsule (product)	4180186
42688643	Colecalciferol 2,200unit capsules 28 capsule (product)	4180186
42688645	Valerian root extract 500mg tablets 21 tablet (product)	4180186
42688647	Everolimus 5mg dispersible tablets sugar free 30 tablet (product)	4180186
42688650	Methotrexate 25mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection (product)	4180186
42688651	Methotrexate 22.5mg/0.9ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection (product)	4180186
42688652	Methotrexate 20mg/0.8ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection (product)	4180186
42688654	Methotrexate 15mg/0.6ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection (product)	4180186
42688660	Cyanocobalamin 10microgram tablets 100 tablet (product)	4180186
42688664	Generic LaBiNIC oral drops sugar free 5 ml (product)	4180186
42688665	Methylcellulose 5mg/ml enema 1000 ml (product)	4180186
42688666	Methylcellulose 5mg/ml enema 1 ml (product)	4180186
42688669	Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials 1 vial (product)	4180186
42688670	Generic Bach Rescue Remedy oral drops sugar free 20 ml (product)	4180186
42688674	Generic K-Y Jelly non-sterile 75 gram (product)	4180186
42688675	Generic K-Y Jelly non-sterile 50 gram (product)	4180186
42688677	Generic Cathejell Mono 12.5 gram (product)	4180186
42688681	Generic Cathejell Lidocain 8.5 gram (product)	4180186
42688684	Generic Sutherland lubricating jelly 82 gram (product)	4180186
42688687	Generic OptiLube sterile lubricating jelly 11 ml (product)	4180186
42688688	Generic OptiLube sterile lubricating jelly 6 ml (product)	4180186
42688689	Generic OptiLube sterile lubricating jelly 82 gram (product)	4180186
42688692	Generic OptiLube Active sterile lubricating jelly 11 ml (product)	4180186
42688694	Generic OptiLube Active CHG Free sterile lubricating jelly 11 ml (product)	4180186
42688696	Generic Elite lubricating jelly 50 ml (product)	4180186
42688699	Generic Aquagel lubricating jelly 5 gram (product)	4180186
42688704	Oxycodone 10mg modified-release tablets 28 tablet (product)	4180186
42688705	Oxycodone 40mg modified-release tablets 28 tablet (product)	4180186
42688707	Tracheostomy dressing sterile 8cm x 10cm 10 dressing (physical object)	4180186
42688711	Generic TendoVis 12mg/1.2ml solution for injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688713	Generic Synolis 40mg/2ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688714	Generic Suplasyn 20mg/2ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688715	Generic Ostenil Plus 40mg/2ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688717	Generic Ostenil 20mg/2ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688719	Generic Euflexxa 20mg/2ml injection pre-filled syringes 3 pre-filled disposable injection (product)	4180186
42688720	Generic Synocrom 20mg/2ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688723	Generic Synocrom Mini 10mg/1ml injection pre-filled syringes 1 pre-filled disposable injection (product)	4180186
42688724	Synocrom Mini 10mg/1ml injection pre-filled syringes (Dee Pharmaceuticals Ltd) 1 pre-filled disposable injection (product)	4180186
42688725	Ostenil Mini 10mg/1ml injection pre-filled syringes (TRB Chemidica (UK) Ltd) 1 pre-filled disposable injection (product)	4180186
42688727	Synocrom 20mg/2ml injection pre-filled syringes (Dee Pharmaceuticals Ltd) 1 pre-filled disposable injection (product)	4180186
42688729	Ostenil 20mg/2ml injection pre-filled syringes (TRB Chemidica (UK) Ltd) 1 pre-filled disposable injection (product)	4180186
42688730	Synopsis 40mg/2ml injection pre-filled syringes (AMCo) 1 pre-filled disposable injection (product)	4180186
42688732	Suplasyn 20mg/2ml injection pre-filled syringes (Teva UK Ltd) 1 pre-filled disposable injection (product)	4180186
42688734	Synolis 40mg/2ml injection pre-filled syringes (Unimedical Ltd) 1 pre-filled disposable injection (product)	4180186
42688736	TendoVis 12mg/1.2ml solution for injection pre-filled syringes (Holy Stone Biotech Co Ltd) 1 pre-filled disposable injection (product)	4180186
42688737	Fiasp FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) 5 pre-filled disposable injection (product)	4180186
42688738	Fiasp Penfill 100units/ml solution for injection 3ml cartridges (Novo Nordisk Ltd) 5 cartridge (product)	4180186
42688741	Omnican Fine hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/31gauge (B.Braun Medical Ltd) 100 needle (physical object)	4180186
42688742	Mepilex dressing 11cm x 20cm (Molnlycke Health Care Ltd) 1 dressing (physical object)	4180186
42688743	Mepilex dressing 11cm x 20cm (Molnlycke Health Care Ltd) 5 dressing (physical object)	4180186
42688745	Mepilex dressing 20cm x 21cm (Molnlycke Health Care Ltd) 5 dressing (physical object)	4180186
42688746	Hypromellose 0.3% eye drops (Sai-Meds Ltd) 10 ml (product)	4180186
42688751	Sensotrach Duo Slit tracheostomy dressing 9cm x 9.8cm 30609 (Severn Healthcare Technologies Ltd) 10 dressing (physical object)	4180186
42688752	Sensotrach Alu Slit tracheostomy dressing 8cm x 10cm 30030 (Severn Healthcare Technologies Ltd) 1 dressing (physical object)	4180186
42688755	Spirit Bed bag drainable night drainage bag DSBB2000 2litre (Bard Ltd) 10 device (physical object)	4180186
42688756	Spirit sterile leg bag DSLB350S 350ml bag, 10cm short tube (Bard Ltd) 10 device (physical object)	4180186
42688757	Spirit sterile leg bag DSLB350L 350ml bag, 30cm long tube (Bard Ltd) 10 device (physical object)	4180186
42688758	Spirit sterile leg bag DSLB500S 500ml bag, 10cm short tube (Bard Ltd) 10 device (physical object)	4180186
42688761	Spirit sterile leg bag DSLB750L 750ml bag, 30cm long tube (Bard Ltd) 10 device (physical object)	4180186
42688762	Spirit sterile leg bag DSLB750V 750ml bag, 60cm variable tube (Bard Ltd) 10 device (physical object)	4180186
42688763	Onexila XL 40mg tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42688766	Onexila XL 80mg tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42688769	Aquagel lubricating jelly (Ecolab Healthcare Division) 5 gram 1 x 5g sachet (product)	4180186
42688771	Aquagel lubricating jelly (Ecolab Healthcare Division) 82 gram (product)	4180186
42688773	OptiLube Active CHG Free sterile lubricating jelly (Optimum Medical Solutions Ltd) 6 ml 1 x 6ml syringe 1167 (product)	4180186
42688776	OptiLube Active sterile lubricating jelly (Optimum Medical Solutions Ltd) 11 ml 1 x 11ml syringe 1161 (product)	4180186
42688778	OptiLube sterile lubricating jelly (Optimum Medical Solutions Ltd) 42 gram 1121 (product)	4180186
42688779	OptiLube sterile lubricating jelly (Optimum Medical Solutions Ltd) 82 gram 1122 (product)	4180186
42688783	Sutherland lubricating jelly (Sutherland Health Ltd) 42 gram (product)	4180186
42688784	Sutherland lubricating jelly (Sutherland Health Ltd) 82 gram (product)	4180186
42688785	Cathejell Lidocaine C (Teleflex) 8.5 gram CJL 08501 (product)	4180186
42688787	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688790	Cathejell Lidocain CJLL12501 (Teleflex) 8.5 gram CJLL08501 (product)	4180186
42688791	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688793	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688794	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688795	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688796	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688798	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688800	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688801	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688803	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688805	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688807	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688809	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688811	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688816	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688817	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688823	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688827	Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688833	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688837	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688839	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688840	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688841	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688843	K-Y Jelly non-sterile (Thornton & Ross Ltd) 75 gram (product)	4180186
42688844	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688845	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688846	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688847	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688848	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688849	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688850	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688851	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688852	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688853	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688854	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688855	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688857	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688860	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688861	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688862	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688863	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688866	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688869	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688870	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688871	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688872	Gloria Med Comfort class 1 (18-21mmHg) below knee closed toe max lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688874	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688875	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688879	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688880	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688881	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688883	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688889	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688891	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688892	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688896	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688897	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688898	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688904	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688905	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688907	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688912	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688913	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe max lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688915	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688916	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688917	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688918	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688919	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688923	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688925	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688926	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688928	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688929	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688931	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688934	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688935	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688936	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688942	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688943	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688945	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688947	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688948	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42688949	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688950	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42688951	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688952	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688953	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42688956	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short medium left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688958	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short extra large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688960	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688961	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long medium left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688966	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short medium right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688967	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688968	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment short extra large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688969	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long extra small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688971	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long medium right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688972	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment lymphoedema garment long large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688974	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42688975	Bach Rescue Remedy spray (Nelsons) 7 ml (product)	4180186
42688979	Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) 1 vial (product)	4180186
42688981	Amitriptyline 25mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42688982	Eprosartan 300mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42688983	Eprosartan 400mg tablets (Genesis Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product)	4180186
42688985	Leandra 30microgram/150microgram tablets (Genesis Pharmaceuticals Ltd) 63 tablet 3 x 21 tablets (product)	4180186
42688986	Levobupivacaine hydrochloride 625mg/500ml / Fentanyl 2mg/500ml infusion bags (Special Order) 1 bag (product)	4180186
42688987	Ibandronic Acid 150mg tablets (Genesis Pharmaceuticals Ltd) 1 tablet (product)	4180186
42688991	PKU yellow cooler10 liquid (Vitaflo International Ltd) 87 ml (product)	4180186
42688993	PKU Air20 yellow liquid (Vitaflo International Ltd) 174 ml (product)	4180186
42688994	Desloratadine 5mg tablets (Crescent Pharma Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42688995	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688996	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42688997	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short medium left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689000	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689001	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689006	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689008	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689009	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689010	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689012	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long medium right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689013	Gloria Med Comfort class 1 (18-21mmHg) thigh length open toe with waist attachment max lymphoedema garment long large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689019	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689024	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689025	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689027	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689029	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689030	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689032	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689033	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689034	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689035	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689036	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689037	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689040	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689042	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689045	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689046	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689051	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689052	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689054	Gloria Med Comfort class 2 (23-32mmHg) below knee open toe max lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689056	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689057	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689059	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689060	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689062	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689063	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689066	Methylcellulose 5mg/ml enema (Special Order) 1000 ml (product)	4180186
42689067	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689068	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689072	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689073	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689074	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689081	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689082	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689083	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689088	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689089	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689090	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689091	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689092	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689096	Gloria Med Comfort class 2 (23-32mmHg) below knee closed toe max lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689101	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689102	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short medium Black (Gardamed Ltd) 2 device (physical object)	4180186
42689103	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689104	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689106	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689107	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689110	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689111	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689113	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689114	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689116	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689117	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689120	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689124	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689125	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689126	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689127	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689129	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689130	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689133	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689134	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689136	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe max lymphoedema garment long extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689137	LaBiNIC oral drops (Biofloratech Ltd) 5 ml (product)	4180186
42689138	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689139	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689141	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689142	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689144	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689145	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689146	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short extra large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689147	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689148	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689149	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long extra small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689151	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689154	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689155	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689165	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689167	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment short extra large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689168	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long extra small Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689171	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long small Black (Gardamed Ltd) 2 device (physical object)	4180186
42689172	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long medium Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689174	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long large Beige (Gardamed Ltd) 2 device (physical object)	4180186
42689175	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with silicone top band max lymphoedema garment long large Black (Gardamed Ltd) 2 device (physical object)	4180186
42689178	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short extra small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689179	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689184	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689189	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689190	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short medium right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689192	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment short extra large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689194	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689195	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long medium right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689197	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment lymphoedema garment long extra large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689198	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689199	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689200	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short medium left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689201	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689203	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689204	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long small left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689205	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long medium left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689207	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long extra large left Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689208	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689212	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment short extra large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689214	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long small right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689216	Gloria Med Comfort class 2 (23-32mmHg) thigh length open toe with waist attachment max lymphoedema garment long large right Beige (Gardamed Ltd) 1 device (physical object)	4180186
42689219	Jobst Elvarex SoftFit for lymphoedema garment lower extremities L-A016 Beige (BSN medical Ltd) 1 device (physical object)	4180186
42689220	Jobst Elvarex Soft SoftFit for lymphoedema garment lower extremities L-A016S Beige (BSN medical Ltd) 1 device (physical object)	4180186
42689223	Aveeno Bath & Shower oil (Johnson & Johnson Ltd) 300 ml	4180186
42689223	Aveeno Bath & Shower oil (Johnson & Johnson Ltd) 300 ml (product)	4180186
42689224	Maalox Plus oral suspension (Sanofi) 180 ml (product)	4180186
42689229	Lamberts Vitamin D3 4,000unit capsules (Lamberts Healthcare Ltd) 120 capsule (product)	4180186
42689232	Trifluoperazine 1mg tablets (Ennogen Pharma Ltd) 112 tablet (product)	4180186
42689236	Nordimet 10mg/0.4ml solution for injection pre-filled pens (Nordic Pharma Ltd) 1 pre-filled disposable injection (product)	4180186
42689238	Nordimet 15mg/0.6ml solution for injection pre-filled pens (Nordic Pharma Ltd) 1 pre-filled disposable injection (product)	4180186
42689239	Nordimet 17.5mg/0.7ml solution for injection pre-filled pens (Nordic Pharma Ltd) 1 pre-filled disposable injection (product)	4180186
42689241	Nordimet 22.5mg/0.9ml solution for injection pre-filled pens (Nordic Pharma Ltd) 1 pre-filled disposable injection (product)	4180186
42689242	Nordimet 25mg/1ml solution for injection pre-filled pens (Nordic Pharma Ltd) 1 pre-filled disposable injection (product)	4180186
42689243	Votubia 2mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689247	Kalms Lavender One-a-Day 80mg capsules (G.R. Lane Health Products Ltd) 14 capsule (product)	4180186
42689254	Memantine 10mg tablets (Lupin (Europe) Ltd) 7 tablet (product)	4180186
42689255	Memantine 20mg tablets (Lupin (Europe) Ltd) 7 tablet (product)	4180186
42689256	Memantine 15mg tablets (Lupin (Europe) Ltd) 7 tablet (product)	4180186
42689261	Prednisolone 5mg soluble tablets (Phoenix Labs Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689262	PharmaClinix Acnex Clear cream (Ambe Ltd) 50 ml (product)	4180186
42689265	SunVit-D3 10,000unit capsules (SunVit-D3 Ltd) 28 capsule (product)	4180186
42689266	SunVit-D3 50,000unit capsules (SunVit-D3 Ltd) 10 capsule (product)	4180186
42689267	Saline 0.9% nebuliser liquid 2.5ml Steri-Neb unit dose ampoules (Teva UK Ltd) 20 unit dose 4 x 5 unit dose ampoules (product)	4180186
42689270	Aspirin 75mg tablets (Accord Healthcare Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42689272	Olmesartan medoxomil 10mg tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42689274	Olmesartan medoxomil 40mg tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets (product)	4180186
42689275	Zonisamide 25mg capsules (Accord Healthcare Ltd) 14 capsule 2 x 7 capsules (product)	4180186
42689279	Cisplatin 10mg/10ml concentrate for solution for infusion vials (Sandoz Ltd) 1 vial (product)	4180186
42689282	G & G Natural Betacarotene 15mg capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689284	Tivicay 25mg tablets (ViiV Healthcare UK Ltd) 30 tablet (product)	4180186
42689287	G & G Zinc citrate 50mg capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689291	Vencarm XL 150mg capsules (Aspire Pharma Ltd) 28 capsule 2 x 14 capsules (product)	4180186
42689294	Ellanite 0.03mg/3mg tablets (Stragen UK Ltd) 63 tablet 3 x 21 tablets (product)	4180186
42689296	Magnesium hydroxide 7.45-8.35% oral suspension BP (A A H Pharmaceuticals Ltd) 500 ml (product)	4180186
42689297	Magnesium hydroxide 7.45-8.35% oral suspension BP (Thornton & Ross Ltd) 500 ml (product)	4180186
42689299	Magnesium hydroxide 8% oral suspension (Alliance Healthcare (Distribution) Ltd) 500 ml (product)	4180186
42689304	Medi Derma-Pro Foam & Spray incontinence cleanser 63582 (Medicareplus International Ltd) 250 ml (physical object)	4180186
42689308	G & G Omega 3 1000mg softgels capsules (G & G Food Supplies Ltd) 90 capsule (product)	4180186
42689309	G & G Selenium 200microgram capsules (G & G Food Supplies Ltd) 120 capsule (product)	4180186
42689313	Health Plus High Potency Omega-3 EPA capsules (Health+Plus Ltd) 90 capsule (product)	4180186
42689315	Carbamazepine 125mg suppositories (A A H Pharmaceuticals Ltd) 5 suppository (product)	4180186
42689316	Imatinib 100mg capsules (A A H Pharmaceuticals Ltd) 60 capsule (product)	4180186
42689317	Metformin 850mg/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) 150 ml (product)	4180186
42689321	Olmesartan medoxomil 40mg tablets (A A H Pharmaceuticals Ltd) 28 tablet (product)	4180186
42689322	Sevelamer 2.4g oral powder sachets sugar free (A A H Pharmaceuticals Ltd) 60 sachet (product)	4180186
42689324	Health Plus Omega Complex capsules (Health+Plus Ltd) 30 capsule (product)	4180186
42689325	Health Plus Omega Complex capsules (Health+Plus Ltd) 90 capsule (product)	4180186
42689331	Health Plus Super Cod Liver Oil 1000mg capsules (Health+Plus Ltd) 90 capsule (product)	4180186
42689333	Cytarabine 4g/40ml solution for injection vials (Accord Healthcare Ltd) 1 vial (product)	4180186
42689336	Neocate Junior powder strawberry (Nutricia Ltd) 400 gram (product)	4180186
42689337	Neocate Junior powder vanilla (Nutricia Ltd) 400 gram (product)	4180186
42689338	Neocate Junior powder unflavoured (Nutricia Ltd) 400 gram (product)	4180186
42689343	Calcitonin (salmon) 50units/1ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd) 5 ampoule (product)	4180186
42689344	Calcitonin (salmon) 100units/1ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd) 5 ampoule (product)	4180186
42689345	Calcitonin (salmon) 400units/2ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) 1 vial (product)	4180186
42689346	Ethosuximide 250mg/5ml syrup (Alliance Healthcare (Distribution) Ltd) 200 ml (product)	4180186
42689348	Naproxen 50mg/ml oral suspension (Alliance Healthcare (Distribution) Ltd) 100 ml (product)	4180186
42689349	Nortriptyline 10mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689351	Nortriptyline 50mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689352	Olmesartan medoxomil 10mg tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet (product)	4180186
42689355	Tramadol 75mg / Paracetamol 650mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets (product)	4180186
42689356	Vancomycin 500mg powder for solution for infusion vials (Alliance Healthcare (Distribution) Ltd) 10 vial (product)	4180186
42689360	Tretinoin 10mg capsules (Neon Healthcare Ltd) 100 capsule (product)	4180186
42689362	Chlorhexidine gluconate 0.5% / Isopropyl alcohol 70% solution (Special Order) 500 ml (product)	4180186
42689363	Voraxaze 1,000unit powder for solution for injection vials (Imported (United States)) 1 vial (product)	4180186
42689364	Amytal sodium 500mg powder for solution for injection vials (Imported (United States)) 1 vial (product)	4180186
42689365	Mitomycin 0.02% eye drops (Special Order) 1 ml (product)	4180186
42689366	Mitomycin 0.02% eye drops (Special Order) 10 ml (product)	4180186
42689369	Jobst FarrowWrap (20-30mmHg) lite gauntlet lymphoedema garment extra small Beige (BSN medical Ltd) 1 device (physical object)	4180186
42689370	Jobst FarrowWrap (20-30mmHg) lite gauntlet lymphoedema garment small Beige (BSN medical Ltd) 1 device (physical object)	4180186
42689371	Jobst FarrowWrap (20-30mmHg) lite gauntlet lymphoedema garment medium Beige (BSN medical Ltd) 1 device (physical object)	4180186
42689373	Jobst FarrowWrap (20-30mmHg) lite gauntlet lymphoedema garment large Beige (BSN medical Ltd) 1 device (physical object)	4180186
42689374	Antistatic Space Chamber Plus with small mask (Medical Developments International Ltd) 1 device (physical object)	4180186
42689380	Antistatic Space Chamber Plus Compact with large mask (Medical Developments International Ltd) 1 device (physical object)	4180186
42689381	Mepilex Border Lite dressing 10cm x 10.5cm (Molnlycke Health Care Ltd) 1 dressing (physical object)	4180186
42689382	Mepilex Border Lite dressing 10cm x 10.5cm (Molnlycke Health Care Ltd) 10 dressing (physical object)	4180186
42689389	Chemipore-PE tape 2.5cm (Medicareplus International Ltd) 10 m (physical object)	4180186
42689390	Chemipore-PE tape 5cm (Medicareplus International Ltd) 5 m (physical object)	4180186
42689392	Chemifix tape 15cm (Medicareplus International Ltd) 10 m (physical object)	4180186
42689393	Chemifix tape 20cm (Medicareplus International Ltd) 10 m (physical object)	4180186
42689395	U-drain consumable extension pack U/D-CTN-001 (U-drain Ltd) 1 device (physical object)	4180186
42689400	Brava skin cleanser wipes 12080 (Coloplast Ltd) 45 device (physical object)	4180186
42689401	Imatinib 100mg tablets (Mylan Ltd) 60 tablet (product)	4180186
42689402	Imatinib 400mg tablets (Mylan Ltd) 30 tablet (product)	4180186
42689403	Urostemol capsules (Omega Pharma Ltd) 50 capsule (product)	4180186
42689409	Histamine phosphate 60micrograms/ml nebuliser liquid 10ml bottles (Special Order) 1 bottle (product)	4180186
42689410	Urostemol Men capsules (Omega Pharma Ltd) 60 capsule (product)	4180186
42689414	Histamine phosphate 500micrograms/ml nebuliser liquid 10ml bottles (Special Order) 1 bottle (product)	4180186
42689417	Histamine phosphate 250micrograms/ml nebuliser liquid 6ml ampoules (Special Order) 1 ampoule (product)	4180186
42689419	AirFluSal 25micrograms/dose / 250micrograms/dose inhaler (Sandoz Ltd) 120 dose (product)	4180186
42689423	Conform 2 two piece ostomy system CeraPlus skin barrier floating flange 15200 55mm flange, cut to fit 13mm-40mm (Hollister Ltd) 5 device (physical object)	4180186
42689425	Conform 2 two piece ostomy system CeraPlus convex skin barrier floating flange 14100 45mm flange, cut to fit 13mm-25mm (Hollister Ltd) 5 device (physical object)	4180186
42689427	Conform 2 two piece ostomy system CeraPlus convex skin barrier floating flange 17100 70mm flange, cut to fit 13mm-51mm (Hollister Ltd) 5 device (physical object)	4180186
42689429	Histamine phosphate 1mg/ml nebuliser liquid 6ml ampoules (Special Order) 5 ampoule (product)	4180186
42689430	Histamine phosphate 2mg/ml nebuliser liquid 6ml ampoules (Special Order) 1 ampoule (product)	4180186
42689432	Histamine phosphate 4mg/ml nebuliser liquid 10ml ampoules (Special Order) 1 ampoule (product)	4180186
42689433	Histamine phosphate 4mg/ml nebuliser liquid 10ml ampoules (Special Order) 5 ampoule (product)	4180186
42689434	Histamine phosphate 16mg/ml nebuliser liquid 10ml bottles (Special Order) 1 bottle (product)	4180186
42689437	Histamine phosphate 40mg/ml nebuliser liquid 5ml ampoules (Special Order) 1 ampoule (product)	4180186
42689438	Histamine phosphate 40mg/ml nebuliser liquid 5ml ampoules (Special Order) 5 ampoule (product)	4180186
42689439	Amoxicillin 500mg/50ml infusion bags (Special Order) 1 bag (product)	4180186
42689440	Sicovit B6 50mg/2ml solution for injection vials (Imported (Romania)) 5 vial (product)	4180186
42689441	Aminophylline 500mg/500ml solution for infusion bottles (Special Order) 1 bottle (product)	4180186
42689442	Oxaliplatin 50mg/10ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) 1 vial (product)	4180186
42689443	Almuriva 4.6mg/24hours transdermal patches (Sandoz Ltd) 30 patch (product)	4180186
42689444	Almuriva 9.5mg/24hours transdermal patches (Sandoz Ltd) 30 patch (product)	4180186
42689449	Capsaicin 0.03% nebuliser liquid 5ml bottles (Special Order) 1 bottle (product)	4180186
42689450	Tioguanine 50mg/5ml oral suspension (Special Order) 1 ml (product)	4180186
42689453	InVita D3 50,000unit capsules (Consilient Health Ltd) 3 capsule (product)	4180186
42689454	InVita D3 25,000unit capsules (Consilient Health Ltd) 3 capsule (product)	4180186
42689456	Metoclopramide 5mg/5ml oral solution sugar free (Healthcare Pharma Ltd) 150 ml (product)	4180186
42689458	MagnaPhos 48.6mg (2mmol) capsules (TriOn Pharma Ltd) 50 capsule (product)	4180186
42689464	TransiSoft oral powder 8.5g sachets (HFA Healthcare Products Ltd) 28 sachet (product)	4180186
42689465	Amisulpride 100mg/ml oral solution sugar free (Thame Laboratories Ltd) 60 ml (product)	4180186
42689466	Propranolol 50mg/5ml oral solution sugar free (Thame Laboratories Ltd) 150 ml (product)	4180186
42689469	Disodium edetate 3.72% solution for injection 2ml ampoules (Special Order) 10 ampoule (product)	4180186
42689471	Freederm Treatment 4% gel (Dermal Laboratories Ltd) 25 gram (product)	4180186
42689472	Haloperidol 5mg/5ml oral solution sugar free (Thame Laboratories Ltd) 100 ml (product)	4180186
42689476	SunVit-D3 400unit capsules (SunVit-D3 Ltd) 28 capsule (product)	4180186
42689479	Promin low protein burger mix (Firstplay Dietary Foods Ltd) 248 gram 4 x 62g sachets (product)	4180186
42689482	Cutan Hand Sanitiser foam (Deb Ltd) 47 ml (product)	4180186
42689487	HealthAid Osteoflex & Omega 3 tablets and capsules (HealthAid Ltd) 1 pack 1 x (30 tablets + 30 capsules) (product)	4180186
42689488	HealthAid Osteoflex Plus modified-release tablets (HealthAid Ltd) 30 tablet (product)	4180186
42689490	HealthAid Osteoflex Fizzy effervescent tablets (HealthAid Ltd) 20 tablet (product)	4180186
42689491	HealthAid Vitamin C 100% Pure Ultra-fine powder (HealthAid Ltd) 60 gram (product)	4180186
42689493	FSC Fish Oil 1000mg capsules (Bee Health Ltd) 60 capsule (product)	4180186
42689494	FSC Fish Oil 1000mg capsules (Bee Health Ltd) 90 capsule (product)	4180186
42689495	FSC Vitamin D 400unit tablets (Bee Health Ltd) 60 tablet (product)	4180186
42689496	FSC High Strength Vitamin D3 2,500unit capsules (Bee Health Ltd) 60 capsule (product)	4180186
42689497	Esmolol hydrochloride 2.5g powder for concentrate for solution for infusion vials (AOP Orphan Ltd) 1 vial (product)	4180186
42689498	Esmolol hydrochloride 2.5g/10ml concentrate for solution for infusion ampoules (AOP Orphan Ltd) 1 ampoule (product)	4180186
42689499	Eylamdo 20mg/ml / 5mg/ml eye drops (Aspire Pharma Ltd) 5 ml (product)	4180186
42689501	Assessment of risk of type 2 diabetes mellitus (procedure)	4180186
42689501	Assessment of risk of type II diabetes mellitus	4180186
42689503	Multisensory stimulation (procedure)	4180186
42689504	Percutaneous IRE (irreversible electroporation) of neoplasm of prostate using computed tomography guidance	4180186
42689504	Percutaneous irreversible electroporation ablation of neoplasm of prostate using computed tomography guidance (procedure)	4180186
42689505	Urinary catheter passport given (finding)	4180186
42689506	Minimally invasive sacroiliac joint fusion by lateral transarticular approach using fluoroscopic guidance (procedure)	4180186
42689507	Minimally invasive sacroiliac joint fusion by dorsal approach using fluoroscopic guidance (procedure)	4180186
42689508	Care leaver (finding)	4180186
42689509	Cervical glandular intraepithelial neoplasia (disorder)	4180186
42689510	Limited life expectancy of approximately one year (finding)	4180186
42689511	Percutaneous insertion of bioresorbable stent into coronary artery using fluoroscopic guidance (procedure)	4180186
42689512	Undecided about sexual orientation (finding)	4180186
42689513	Exercise induced microalbuminuria (finding)	4180186
42689514	Assessment using Podiatric and Surgical Clinical Outcome Measurement 10 (procedure)	4180186
42689517	Declines to provide accommodation details (situation)	4180186
42689518	Referral to acute internal medicine service (procedure)	4180186
42689519	Admission to paediatric cardiology department (procedure)	4180186
42689520	Emergency department care level (regime/therapy)	4180186
42689524	Health visitor contact using Family Partnership Model Antenatal Promotional Guide	4180186
42689524	Health visitor contact using Family Partnership Model Antenatal Promotional Guide (procedure)	4180186
42689526	Child in family is safeguarding concern (situation)	4180186
42689529	Place of occurrence of injury is living room in home environment (finding)	4180186
42689530	Place of occurrence of injury is kitchen in home environment (finding)	4180186
42689533	Place of occurrence of injury is stairway in home environment (finding)	4180186
42689534	Place of occurrence of injury is bathroom in home environment (finding)	4180186
42689536	Place of occurrence of injury is utility room in home environment (finding)	4180186
42689537	Place of occurrence of injury is study in home environment (finding)	4180186
42689542	Place of occurrence of injury is garden pond in home environment (finding)	4180186
42689543	Number of hospital admissions due to chronic obstructive pulmonary disease in past year (observable entity)	4180186
42689548	Injury following barbiturate use (disorder)	4180186
42689549	Injury following lysergic acid diethylamide use (disorder)	4180186
42689550	Injury following nitrous oxide inhalation (disorder)	4180186
42689552	Injury following phencyclidine use (disorder)	4180186
42689554	Provision of written information about female genital mutilation (procedure)	4180186
42689557	Positron emission tomography with computed tomography of whole body using 18F fluoromisonidazole (procedure)	4180186
42689559	Referred by carer (finding)	4180186
42689561	Patient Health Questionnaire 15	4180186
42689561	Patient Health Questionnaire 15 (assessment scale)	4180186
42689563	Patient Health Questionnaire 15 score	4180186
42689563	Patient Health Questionnaire 15 score (observable entity)	4180186
42689565	Type 2 diabetes mellitus risk assessment invitation second letter (procedure)	4180186
42689565	Type II diabetes mellitus risk assessment invitation second letter	4180186
42689566	Type 2 diabetes mellitus risk assessment invitation third letter (procedure)	4180186
42689566	Type II diabetes mellitus risk assessment invitation third letter	4180186
42689567	Type 2 diabetes mellitus risk assessment verbal invitation (procedure)	4180186
42689567	Type II diabetes mellitus risk assessment verbal invitation	4180186
42689572	PAM (Patient Activation Measure) assessment offered	4180186
42689572	Patient Activation Measure assessment offered (situation)	4180186
42689573	Percutaneous transluminal coil embolisation of arteriovenous fistula using fluoroscopic guidance (procedure)	4180186
42689576	Magnetic resonance imaging of coccyx with contrast (procedure)	4180186
42689578	At risk of emotional abuse (finding)	4180186
42689579	Infection caused by glycopeptide resistant enterococcus (disorder)	4180186
42689579	Infection caused by GRE (glycopeptide resistant enterococcus)	4180186
42689581	Social Stories (regime/therapy)	4180186
42689585	SCIP - Social Communication Intervention Programme	4180186
42689585	Social Communication Intervention Programme (regime/therapy)	4180186
42689586	Reading and Language Intervention for Children with Down Syndrome (regime/therapy)	4180186
42689586	RLI (Reading and Language Intervention) for Children with Down Syndrome	4180186
42689587	Psycholinguistic Framework (regime/therapy)	4180186
42689590	Family member of nuclear plant worker (finding)	4180186
42689591	Alleged being subjected to abuse (situation)	4180186
42689591	Disclosed being subjected to abuse	4180186
42689592	Suspected victim of bullying (situation)	4180186
42689593	Detained in hospital under Section 37 of the Mental Health Act 1983 (England and Wales) with Section 41 restrictions (finding)	4180186
42689595	Detained in hospital under Section 48 of the Mental Health Act 1983 (England and Wales) with Section 49 restrictions (finding)	4180186
42689596	Detained in hospital under Section 136 of the Mental Health Act 1983 (England and Wales) (finding)	4180186
42689598	Magnetic resonance imaging of heart with contrast (procedure)	4180186
42689600	Referred by detention centre (finding)	4180186
42689601	Referred by advanced care practitioner (finding)	4180186
42689603	Referred by Coastguard Rescue Service (finding)	4180186
42689608	Referral to outpatients department (procedure)	4180186
42689609	Simple venous leg ulcer (disorder)	4180186
42689612	Subject to guardianship under Section 37 of the Mental Health Act 1983 (England and Wales) (finding)	4180186
42689613	Seasonal influenza vaccination given by midwife (situation)	4180186
42689615	At risk of honour based violence (finding)	4180186
42689618	Chronic obstructive pulmonary disease monitoring email invitation (procedure)	4180186
42689618	COPD (chronic obstructive pulmonary disease) monitoring email invitation	4180186
42689619	Requires hepatitis E virus negative blood components (finding)	4180186
42689619	Requires HEV (hepatitis E virus) negative blood components	4180186
42689621	Integrated Urgent Care Report (record artifact)	4180186
42689625	Left care setting before treatment completed (finding)	4180186
42689626	Accident and Emergency department discharge to Accident and Emergency department short stay ward	4180186
42689626	Emergency department discharge to emergency department short stay ward (procedure)	4180186
42689628	Discharge to hospital at home service (procedure)	4180186
42689630	Accident and Emergency department discharge to CCU (coronary care unit)	4180186
42689630	Emergency department discharge to CCU (coronary care unit)	4180186
42689630	Emergency department discharge to coronary care unit (procedure)	4180186
42689631	Accident and Emergency department discharge to SCBU (special care baby unit)	4180186
42689631	Emergency department discharge to SCBU (special care baby unit)	4180186
42689631	Emergency department discharge to special care baby unit (procedure)	4180186
42689632	Accident and Emergency department discharge to ICU (intensive care unit)	4180186
42689632	Emergency department discharge to ICU (intensive care unit)	4180186
42689632	Emergency department discharge to intensive care unit (procedure)	4180186
42689633	Subject to deprivation of liberty under the Mental Capacity Act 2005 Deprivation of Liberty Safeguards (finding)	4180186
42689634	Injury following industrial alcohol use (disorder)	4180186
42689636	Referred by urgent care service (finding)	4180186
42689640	Able to maintain friendships (finding)	4180186
42689641	Able to show empathy (finding)	4180186
42689645	Able to use single switch scanner (finding)	4180186
42689646	Able to demonstrate socially acceptable behaviour (finding)	4180186
42689647	Healthy Start vitamins declined by parent (situation)	4180186
42689648	On Healthy Start vitamins (finding)	4180186
42689650	Able to communicate request for help (finding)	4180186
42689652	Able to swallow modified diet (finding)	4180186
42689653	Voice prosthesis education (procedure)	4180186
42689656	Better Conversations with Aphasia (regime/therapy)	4180186
42689657	Chin tuck manoeuvre technique (regime/therapy)	4180186
42689658	Speech supplementation strategy (regime/therapy)	4180186
42689662	High intensity psychological intervention in combination with medication (regime/therapy)	4180186
42689665	Chronic obstructive pulmonary disease monitoring short message service text message third invitation (procedure)	4180186
42689666	Chronic heart disease monitoring invitation short message service text message (procedure)	4180186
42689669	Chronic heart disease monitoring short message service text message second invitation (procedure)	4180186
42689670	Chronic heart disease monitoring short message service text message third invitation (procedure)	4180186
42689671	Diabetes monitoring short message service text message first invitation (procedure)	4180186
42689672	Diabetes monitoring short message service text message second invitation (procedure)	4180186
42689675	Hypertension monitoring short message service text message first invitation (procedure)	4180186
42689677	Hypertension monitoring short message service text message third invitation (procedure)	4180186
42689679	Rheumatoid arthritis monitoring invitation by short message service text messaging (procedure)	4180186
42689682	Rheumatoid arthritis monitoring short message service text message third invitation (procedure)	4180186
42689683	On anti-dementia drug therapy (finding)	4180186
42689684	Percutaneous embolisation of facial tumour using fluoroscopic guidance (procedure)	4180186
42689685	Atrial fibrillation not detected (situation)	4180186
42689686	Rotational osteotomy of metatarsal (procedure)	4180186
42689688	Excision of fibroma of plantar fascia (procedure)	4180186
42689690	Excision of exostosis of metatarsocuneiform joint (procedure)	4180186
42689692	Detained in hospital under Section 45A of the Mental Health Act 1983 (England and Wales) with limitation direction in force (finding)	4180186
42689695	Diabulimia	4180186
42689695	Eating disorder co-occurrent with diabetes mellitus type 1 (disorder)	4180186
42689695	ED-DMT1 - Eating disorder-diabetes mellitus type 1	4180186
42689696	PCI (percutaneous coronary intervention) record	4180186
42689696	Percutaneous coronary intervention record (record artifact)	4180186
42689697	Has current Last Will and Testament (finding)	4180186
42689698	Does not have current Last Will and Testament (finding)	4180186
42689700	Documented agreement for verification of expected death by competent clinician (finding)	4180186
42689701	Biopsychosocial assessment (procedure)	4180186
42689704	Started on solid food (finding)	4180186
42689710	Injury whilst playing korfball (disorder)	4180186
42689711	Injury whilst playing American football (disorder)	4180186
42689713	Injury whilst playing lacrosse (disorder)	4180186
42689719	Injury whilst playing snooker (disorder)	4180186
42689720	Injury whilst playing darts (disorder)	4180186
42689723	Injury whilst playing ten-pin bowling (disorder)	4180186
42689728	Injury whilst engaged in leisure activity (disorder)	4180186
42689732	Injury whilst circuit training (disorder)	4180186
42689733	Injury whilst using gym equipment (disorder)	4180186
42689734	Injury whilst weightlifting (disorder)	4180186
42689735	Injury whilst boxing (disorder)	4180186
42689737	Injury whilst rollerblading (disorder)	4180186
42689741	Injury whilst scuba diving (disorder)	4180186
42689742	Injury whilst rowing boat (disorder)	4180186
42689743	Injury whilst sailing (disorder)	4180186
42689744	Injury whilst surfing (disorder)	4180186
42689747	Injury whilst playing ice hockey (disorder)	4180186
42689748	Injury whilst alpine skiing	4180186
42689748	Injury whilst downhill skiing (disorder)	4180186
42689750	Injury whilst snowboarding (disorder)	4180186
42689751	Injury whilst snow walking (disorder)	4180186
42689754	Injury whilst glider flying (disorder)	4180186
42689756	Injury whilst paragliding (disorder)	4180186
42689759	Injury whilst hill walking (disorder)	4180186
42689760	Injury whilst engaged in crafting (disorder)	4180186
42689760	Injury whilst engaged in craftwork	4180186
42689766	Injury whilst engaged in hobby (disorder)	4180186
42689767	Injury whilst running (disorder)	4180186
42689768	Injury whilst jogging (disorder)	4180186
42689769	Injury whilst power-walking (disorder)	4180186
42689771	Injury whilst trampolining (disorder)	4180186
42689772	Injury whilst engaged in judo (disorder)	4180186
42689774	Injury whilst engaged in martial arts activity (disorder)	4180186
42689777	Injury whilst sport curling (disorder)	4180186
42689778	Injury whilst using personal motorised watercraft (disorder)	4180186
42689782	Injury whilst engaged in outdoor recreational activity (disorder)	4180186
42689787	Injury whilst walking outdoors (disorder)	4180186
42689789	Injury whilst consuming food (disorder)	4180186
42689790	Injury whilst receiving healthcare (disorder)	4180186
42689791	Injury whilst bathing (disorder)	4180186
42689792	Injury whilst showering (disorder)	4180186
42689793	Injury whilst gardening (disorder)	4180186
42689798	Injury whilst cycling on track (disorder)	4180186
42689804	Injury whilst delivering healthcare (disorder)	4180186
42689808	Injury whilst engaged in construction work (disorder)	4180186
42689810	Injury whilst undertaking manual work (disorder)	4180186
42689811	Injury whilst engaged in retail work (disorder)	4180186
42689813	Injury whilst walking across road (disorder)	4180186
42689815	Injury whilst riding motorcycle on public highway (disorder)	4180186
42689816	Injury whilst riding motorcycle on track (disorder)	4180186
42689820	Injury whilst driving motor vehicle on track (disorder)	4180186
42689822	Injury whilst hunting (disorder)	4180186
42689826	Difficulty participating in school activities (finding)	4180186
42689828	Difficulty recognising need for pressure area care (finding)	4180186
42689829	Difficulty recognising pain in body part (finding)	4180186
42689834	Difficulty stopping walking (finding)	4180186
42689837	Difficulty transferring to vehicle with supervision (finding)	4180186
42689839	Does not manage own physical health needs (finding)	4180186
42689841	Does not manage urinary catheter care (finding)	4180186
42689842	Does not mobilise using indoor motorised wheelchair (finding)	4180186
42689843	Does not operate mobile phone (finding)	4180186
42689844	Does not participate in playground activities (finding)	4180186
42689845	Does not prepare snack (finding)	4180186
42689846	Does not process information at normal speed (finding)	4180186
42689847	Does not recognise body temperature (finding)	4180186
42689848	Does not recognise letters of alphabet (finding)	4180186
42689852	Does not shop at supermarket (finding)	4180186
42689854	Does not tolerate self-care routines (finding)	4180186
42689857	Does manage pain in body part (finding)	4180186
42689858	Does manage ureterostomy (finding)	4180186
42689861	Does participate in online gaming (finding)	4180186
42689864	Does process information accurately (finding)	4180186
42689865	Does recognise spoken words (finding)	4180186
42689870	Does remember places (finding)	4180186
42689871	Does respond to stimuli (finding)	4180186
42689875	Does sleep (finding)	4180186
42689876	Does stop use of energy (finding)	4180186
42689877	Does think creatively (finding)	4180186
42689880	Does understand care for pressure areas (finding)	4180186
42689881	Does understand pain in body part (finding)	4180186
42689886	Unable to transfer to vehicle independently (finding)	4180186
42689891	Difficulty accessing garden (finding)	4180186
42689893	Difficulty accessing utility meters (finding)	4180186
42689894	Difficulty accessing where car is parked (finding)	4180186
42689899	Difficulty assessing risk (finding)	4180186
42689902	Difficulty being aware of self (finding)	4180186
42689903	Difficulty being optimistic (finding)	4180186
42689906	Difficulty cleaning items at shoulder height (finding)	4180186
42689908	Difficulty cleaning own room (finding)	4180186
42689909	Difficulty communicating in event of emergency (finding)	4180186
42689910	Difficulty directing energy (finding)	4180186
42689911	Difficulty doing homework (finding)	4180186
42689913	Difficulty doing paid work (finding)	4180186
42689914	Difficulty drying lower body (finding)	4180186
42689916	Difficulty engaging in life roles (finding)	4180186
42689922	Difficulty finding way around familiar environment (finding)	4180186
42689926	Difficulty getting out of bed without assistance (finding)	4180186
42689928	Difficulty having confidence in own skills (finding)	4180186
42689929	Difficulty having functional level of stamina (finding)	4180186
42689935	Difficulty learning basic skills (finding)	4180186
42689936	Difficulty learning complex skills (finding)	4180186
42689938	Difficulty making decision on safe entry of visitors (finding)	4180186
42689939	Difficulty making decision on safe information to give over telephone (finding)	4180186
42689940	Difficulty managing colostomy (finding)	4180186
42689941	Difficulty managing external stairs (finding)	4180186
42689942	Difficulty managing external steps (finding)	4180186
42689943	Difficulty managing ileostomy (finding)	4180186
42689944	Difficulty managing incontinence products (finding)	4180186
42689945	Difficulty managing internal stairs (finding)	4180186
42689949	Difficulty managing own symptoms (finding)	4180186
42689950	Difficulty managing pain in body part (finding)	4180186
42689951	Difficulty managing risk at home (finding)	4180186
42689954	Difficulty managing urinary catheter care (finding)	4180186
42689955	Difficulty managing urostomy care (finding)	4180186
42689960	Difficulty mobilising using outdoor motorised wheelchair (finding)	4180186
42689961	Difficulty moving from sitting on edge of bed to lying in bed (finding)	4180186
42689963	Difficulty operating mobile phone (finding)	4180186
42689966	Difficulty participating in playground activities (finding)	4180186
42689971	Difficulty recognising symbols (finding)	4180186
42689974	Difficulty recognising impact of self on others (finding)	4180186
42689976	Difficulty recognising objects (finding)	4180186
42689978	Difficulty recognising own emotional pain and distress (finding)	4180186
42689979	Difficulty recognising surroundings (finding)	4180186
42689981	Difficulty remembering people (finding)	4180186
42689985	Difficulty sequencing tasks and activities (finding)	4180186
42689992	Difficulty sleeping without sedation (finding)	4180186
42689993	Difficulty standing from sitting on edge of bed (finding)	4180186
42689994	Difficulty stopping use of energy (finding)	4180186
42690001	Difficulty tolerating pain in body part (finding)	4180186
42690004	Difficulty transporting food and drink (finding)	4180186
42690005	Difficulty understanding and using money (finding)	4180186
42690006	Difficulty understanding and using numbers (finding)	4180186
42690007	Difficulty understanding care for pressure areas (finding)	4180186
42690008	Difficulty understanding pain in body part (finding)	4180186
42690011	Difficulty using debit card (finding)	4180186
42690012	Difficulty using games console (finding)	4180186
42690014	Difficulty using online social networking (finding)	4180186
42690017	Difficulty using toilet with assistance (finding)	4180186
42690018	Difficulty washing lower body (finding)	4180186
42690020	Difficulty writing for lessons (finding)	4180186
42690021	Difficulty writing messages (finding)	4180186
42690022	Does not access garden (finding)	4180186
42690023	Does not access own home (finding)	4180186
42690030	Does not assess risk (finding)	4180186
42690031	Does not assist in self-care routines (finding)	4180186
42690033	Is not hopeful for future (finding)	4180186
42690034	Is not optimistic (finding)	4180186
42690036	Does not carry out daily routine (finding)	4180186
42690037	Does not choose appropriate clothing (finding)	4180186
42690038	Does not clean items at floor level (finding)	4180186
42690039	Does not clean items at shoulder height (finding)	4180186
42690042	Does not communicate in event of emergency (finding)	4180186
42690044	Does not control behaviour (finding)	4180186
42690047	Does not divide attention (finding)	4180186
42690049	Does not do laundry (finding)	4180186
42690050	Does not do paid work (finding)	4180186
42690051	Does not dry lower body (finding)	4180186
42690052	Does not dry upper body (finding)	4180186
42690053	Does not engage in life roles (finding)	4180186
42690055	Does not establish structure and routine in daily life (finding)	4180186
42690057	Does not fill forms (finding)	4180186
42690060	Does not find way around work environment (finding)	4180186
42690063	Does not get up from floor (finding)	4180186
42690064	Does not have functional level of stamina (finding)	4180186
42690065	Does not identify choices (finding)	4180186
42690067	Does not identify life roles (finding)	4180186
42690073	Does not make decision on safe entry of visitors (finding)	4180186
42690075	Does not make decisions (finding)	4180186
42690077	Does not manage colostomy (finding)	4180186
42690078	Does not manage external stairs (finding)	4180186
42690079	Does not manage external steps (finding)	4180186
42690080	Does not manage ileostomy (finding)	4180186
42690086	Does not manage pain in body part (finding)	4180186
42690087	Does not manage risk at home (finding)	4180186
42690088	Does not manage ureterostomy (finding)	4180186
42690089	Does not manage urostomy care (finding)	4180186
42690091	Does not mobilise using mobility scooter (finding)	4180186
42690096	Does not organise own clothes (finding)	4180186
42690097	Does not participate in online gaming (finding)	4180186
42690099	Does not participate in self-care at school (finding)	4180186
42690100	Does not perform work based activities (finding)	4180186
42690101	Does not prevent undesirable behaviour (finding)	4180186
42690104	Does not recognise own symptoms (finding)	4180186
42690106	Does not recognise symbols (finding)	4180186
42690107	Does not recognise familiar people (finding)	4180186
42690109	Does not recognise objects (finding)	4180186
42690110	Does not recognise objects by sight (finding)	4180186
42690118	Does not shop at corner shop (finding)	4180186
42690119	Does not shop at shopping mall (finding)	4180186
42690120	Does not shop online (finding)	4180186
42690123	Does not sleep with sedation (finding)	4180186
42690124	Does not sort recycling (finding)	4180186
42690125	Does not stand from sitting on edge of bed (finding)	4180186
42690126	Does not sustain attention (finding)	4180186
42690129	Does not tolerate changing nappy (finding)	4180186
42690133	Does not transfer to vehicle independently (finding)	4180186
42690134	Does not transport food and drink (finding)	4180186
42690135	Does not understand and use money (finding)	4180186
42690141	Does not undertake single task (finding)	4180186
42690143	Does not use communication device (finding)	4180186
42690144	Does not use debit card (finding)	4180186
42690145	Does not use online social networking (finding)	4180186
42690146	Does not use picture exchange for communication (finding)	4180186
42690151	Does not write own name (finding)	4180186
42690154	Does access where car is parked (finding)	4180186
42690155	Does adapt to sensory changes in body part (finding)	4180186
42690156	Does analyse information (finding)	4180186
42690158	Does apply for education course (finding)	4180186
42690159	Does apply for voluntary work (finding)	4180186
42690160	Does appraise own abilities (finding)	4180186
42690161	Does rise from chair without assistance (finding)	4180186
42690162	Does assess risk (finding)	4180186
42690164	Does assist with meal preparation (finding)	4180186
42690165	Is aware of self (finding)	4180186
42690166	Is hopeful for future (finding)	4180186
42690167	Is optimistic (finding)	4180186
42690169	Does carry out daily routine (finding)	4180186
42690170	Does choose appropriate clothing (finding)	4180186
42690174	Does communicate in event of emergency (finding)	4180186
42690176	Does control behaviour (finding)	4180186
42690177	Does direct energy (finding)	4180186
42690178	Does divide attention (finding)	4180186
42690179	Does do laundry (finding)	4180186
42690180	Does paid work (finding)	4180186
42690184	Does establish life roles (finding)	4180186
42690185	Does feel confident (finding)	4180186
42690189	Does get up from floor (finding)	4180186
42690194	Does identify interests (finding)	4180186
42690196	Does identify structure and routine in daily life (finding)	4180186
42690197	Does indicate own toileting needs (finding)	4180186
42690203	Does manage body temperature (finding)	4180186
42690204	Does manage external stairs (finding)	4180186
42690206	Does manage generalised pain (finding)	4180186
42690207	Does manage ileostomy (finding)	4180186
42690208	Does manage incontinence products (finding)	4180186
42690210	Does manage own aggression (finding)	4180186
42690213	Does manage risk at home (finding)	4180186
42690217	Does mobilise over uneven ground (finding)	4180186
42690219	Does move in cot (finding)	4180186
42690220	Does move items around home (finding)	4180186
42690222	Does participate in playground activities (finding)	4180186
42690224	Does participate in self-care at school (finding)	4180186
42690225	Does plan (finding)	4180186
42690226	Does prepare snack (finding)	4180186
42690228	Does process information (finding)	4180186
42690229	Does process information at normal speed (finding)	4180186
42690230	Does recognise own symptoms (finding)	4180186
42690231	Does recognise social cues (finding)	4180186
42690232	Does recognise symbols (finding)	4180186
42690233	Does recognise body temperature (finding)	4180186
42690236	Does recognise letters of alphabet (finding)	4180186
42690240	Does recognise own emotional pain and distress (finding)	4180186
42690241	Does recognise pain in body part (finding)	4180186
42690243	Does remember past events (finding)	4180186
42690244	Does remember people (finding)	4180186
42690245	Does remember routines (finding)	4180186
42690246	Does respond to own symptoms (finding)	4180186
42690252	Does sleep with sedation (finding)	4180186
42690253	Does sort recycling (finding)	4180186
42690254	Does sustain attention (finding)	4180186
42690256	Does tolerate generalised pain (finding)	4180186
42690257	Does tolerate pain in body part (finding)	4180186
42690260	Does transfer to vehicle with supervision (finding)	4180186
42690263	Does understand and use numbers (finding)	4180186
42690264	Does understand generalised pain (finding)	4180186
42690265	Does understand own emotions (finding)	4180186
42690267	Does undertake single task (finding)	4180186
42690269	Does use debit card (finding)	4180186
42690270	Does use decision making strategies (finding)	4180186
42690273	Does use playground (finding)	4180186
42690274	Does use through floor lift (finding)	4180186
42690280	Does write own name (finding)	4180186
42690281	Unable to access garden (finding)	4180186
42690282	Unable to access own home (finding)	4180186
42690283	Unable to access where car is parked (finding)	4180186
42690284	Unable to apply for education course (finding)	4180186
42690285	Unable to apply for voluntary work (finding)	4180186
42690286	Unable to appraise own abilities (finding)	4180186
42690287	Unable to assist in self-care routines (finding)	4180186
42690288	Unable to be aware of self (finding)	4180186
42690289	Unable to be hopeful for future (finding)	4180186
42690291	Unable to care for pressure areas (finding)	4180186
42690292	Unable to carry out daily routine (finding)	4180186
42690293	Unable to choose appropriate clothing (finding)	4180186
42690295	Unable to clean items at shoulder level (finding)	4180186
42690296	Unable to clean items at waist level (finding)	4180186
42690297	Unable to clean own room (finding)	4180186
42690302	Unable to do paid work (finding)	4180186
42690303	Unable to dry upper body (finding)	4180186
42690308	Unable to feel confident (finding)	4180186
42690309	Unable to find way around school environment (finding)	4180186
42690310	Unable to find way around work environment (finding)	4180186
42690311	Unable to get into bed without assistance (finding)	4180186
42690314	Unable to have confidence in own skills (finding)	4180186
42690315	Unable to have functional level of stamina (finding)	4180186
42690316	Unable to identify interests (finding)	4180186
42690317	Unable to identify risky behaviour (finding)	4180186
42690318	Unable to identify structure and routine in daily life (finding)	4180186
42690320	Unable to learn basic skills (finding)	4180186
42690326	Unable to manage colostomy (finding)	4180186
42690327	Unable to manage external stairs (finding)	4180186
42690329	Unable to manage generalised pain (finding)	4180186
42690330	Unable to manage ileostomy (finding)	4180186
42690333	Unable to manage own aggression (finding)	4180186
42690334	Unable to manage own energy levels (finding)	4180186
42690337	Unable to manage pain in body part (finding)	4180186
42690339	Unable to manage ureterostomy (finding)	4180186
42690342	Unable to manage visitors at home (finding)	4180186
42690343	Unable to mobilise over uneven ground (finding)	4180186
42690344	Unable to mobilise using indoor motorised wheelchair (finding)	4180186
42690345	Unable to mobilise using outdoor motorised wheelchair (finding)	4180186
42690347	Unable to move items around home (finding)	4180186
42690349	Unable to organise own clothes (finding)	4180186
42690351	Unable to participate in online gaming (finding)	4180186
42690352	Unable to participate in playground activities (finding)	4180186
42690353	Unable to participate in school activities (finding)	4180186
42690357	Unable to recognise social cues (finding)	4180186
42690358	Unable to recognise spoken words (finding)	4180186
42690363	Unable to recognise letters of alphabet (finding)	4180186
42690364	Unable to recognise need for pressure area care (finding)	4180186
42690366	Unable to recognise own emotional pain and distress (finding)	4180186
42690367	Unable to recognise pain in body part (finding)	4180186
42690371	Unable to respond to own symptoms (finding)	4180186
42690372	Unable to sequence events (finding)	4180186
42690374	Unable to shift attention (finding)	4180186
42690380	Unable to sleep without sedation (finding)	4180186
42690381	Unable to sort recycling (finding)	4180186
42690386	Unable to tolerate changing nappy (finding)	4180186
42690388	Unable to tolerate pain in body part (finding)	4180186
42690389	Unable to tolerate self-care routines (finding)	4180186
42690390	Unable to tolerate toileting routine (finding)	4180186
42690391	Unable to transfer to vehicle with assistance (finding)	4180186
42690393	Unable to transport food and drink (finding)	4180186
42690394	Unable to understand and use money (finding)	4180186
42690395	Unable to understand care for pressure areas (finding)	4180186
42690398	Unable to undertake single task (finding)	4180186
42690400	Unable to use debit card (finding)	4180186
42690401	Unable to use online social networking (finding)	4180186
42690402	Unable to use picture exchange for communication (finding)	4180186
42690404	Unable to use toilet with assistance (finding)	4180186
42690408	Unable to write own name (finding)	4180186
42690409	Arthroplasty of metatarsophalangeal joint with implant (procedure)	4180186
42690411	National Health Service continuing healthcare funding required (finding)	4180186
42690413	Abdominal sacrocolpopexy using mesh (procedure)	4180186
42690416	Percutaneous insertion of vertebral craniocaudal expandable implants using fluoroscopic guidance (procedure)	4180186
42690419	No current evidence of sepsis (situation)	4180186
42690420	Implantation of neurostimulator into pterygopalatine ganglion using X-ray guidance	4180186
42690420	Implantation of neurostimulator into sphenopalatine ganglion using X-ray guidance (procedure)	4180186
42690421	Injection of autologous blood into plantar fascia (procedure)	4180186
42690422	Bronchoscopic insertion of endobronchial nitinol coils using fluoroscopic guidance (procedure)	4180186
42690423	Has supply of rescue medication (finding)	4180186
42690424	Insertion of microstructural scaffold into articular cartilage of knee (procedure)	4180186
42690426	Does sit on potty (finding)	4180186
42690427	Able to concentrate (finding)	4180186
42690431	Pretransplant evaluation of heart recipient (procedure)	4180186
42690432	Pretransplant evaluation of heart and lung recipient (procedure)	4180186
42690433	Pretransplant evaluation of multivisceral recipient (procedure)	4180186
42690434	Pretransplant evaluation of modified multivisceral recipient (procedure)	4180186
42690435	Assessment prior to construction of renal dialysis vascular access (procedure)	4180186
42690436	Assessment of existing renal dialysis vascular access (procedure)	4180186
42690437	Pretransplant evaluation of live lung donor (procedure)	4180186
42690439	Argon laser retinopexy	4180186
42690439	Fixation of retina using argon laser (procedure)	4180186
42690442	Doppler ultrasonography compression venography of upper limb (procedure)	4180186
42690442	Doppler ultrasound compression venography of upper limb	4180186
42690442	Doppler ultrasound scan compression venography of upper limb	4180186
42690443	Doppler ultrasonography compression venography of lower limb (procedure)	4180186
42690443	Doppler ultrasound compression venography of lower limb	4180186
42690443	Doppler ultrasound scan compression venography of lower limb	4180186
42690445	Marking of skin over small saphenous vein using Doppler ultrasonographic guidance (procedure)	4180186
42690446	Chelsea Critical Care Physical Assessment tool (assessment scale)	4180186
42690447	Marking of skin over long saphenous vein using Doppler ultrasonographic guidance (procedure)	4180186
42690448	Assessment using Chelsea Critical Care Physical Assessment tool (procedure)	4180186
42690449	Chelsea Critical Care Physical Assessment tool score (observable entity)	4180186
42690452	Postural Assessment Scale for Stroke Patients score (observable entity)	4180186
42690453	Provision of written information about hospice services (procedure)	4180186
42690455	Provision of written information about financial support (procedure)	4180186
42690457	Provision of written information about writing Last Will and Testament (procedure)	4180186
42690461	Removal of nephrostomy tube from transplanted kidney using fluoroscopic guidance (procedure)	4180186
42690462	Cadaver donor with DBD (donation after brain stem death)	4180186
42690462	Cadaver donor with donation after brain stem death (person)	4180186
42690463	Transplant donor CMV (cytomegalovirus) antibody negative	4180186
42690463	Transplant donor cytomegalovirus antibody negative (situation)	4180186
42690468	Provision of voice prosthesis (procedure)	4180186
42690470	Injury whilst using electronic personal transport (disorder)	4180186
42690471	Combined laboratory report (record artifact)	4180186
42690472	Able to use wh-questions	4180186
42690472	Able to use wh questions (finding)	4180186
42690473	Facilitating symbolic play (procedure)	4180186
42690474	Prospectively ECG (electrocardiogram) gated CT angiogram of coronary arteries	4180186
42690474	Prospectively electrocardiogram gated computed tomography angiography of coronary arteries (procedure)	4180186
42690475	Retrospectively ECG (electrocardiogram) gated CT angiogram of coronary arteries	4180186
42690475	Retrospectively electrocardiogram gated computed tomography angiography of coronary arteries (procedure)	4180186
42690477	Able to use Makaton signs (finding)	4180186
42690480	Streamed from emergency department to general practitioner following initial assessment (situation)	4180186
42690480	Streamed from emergency department to GP (general practitioner) following initial assessment	4180186
42690482	Streamed from emergency department to mental health service following initial assessment (situation)	4180186
42690483	Streamed from emergency department to dental service following initial assessment (situation)	4180186
42690486	Streamed from emergency department to falls service following initial assessment (situation)	4180186
42690487	Streamed from emergency department to frailty service following initial assessment (situation)	4180186
42690489	Uses functional communication skills (finding)	4180186
42690493	Unable to provide information on cause of injury (finding)	4180186
42690494	Declines to provide information on cause of injury (situation)	4180186
42690495	Follow-up review in emergency department (finding)	4180186
42690496	Referred by community mental health nurse (finding)	4180186
42690498	Assessment under the Mental Health Act 1983 (England and Wales) completed (situation)	4180186
42690500	Standard level emergency care (regime/therapy)	4180186
42690501	Non-urgent level emergency care (regime/therapy)	4180186
42690502	Magnetic resonance imaging of intestine (procedure)	4180186
42690502	MRI of bowel	4180186
42690503	Transplant donor Epstein-Barr virus antibody negative (situation)	4180186
42690504	Transplant recipient Epstein-Barr virus antibody negative (situation)	4180186
42690510	Nasogastric tube irrigation assessment (procedure)	4180186
42690511	Gastrostomy tube insertion education (procedure)	4180186
42690512	Nasogastric tube insertion education (procedure)	4180186
42690513	Gastrostomy tube irrigation education (procedure)	4180186
42690515	Gastrostomy tube irrigation management (procedure)	4180186
42690517	Hunters Hill Marie Curie Centre Pressure Sore Risk Assessment Tool (assessment scale)	4180186
42690518	Hunters Hill Marie Curie Centre Pressure Sore Risk Assessment Tool score (observable entity)	4180186
42690523	PURPOSE T - Pressure Ulcer Risk Primary or Secondary Evaluation Tool (assessment scale)	4180186
42690524	Assessment using PURPOSE T (Pressure Ulcer Risk Primary or Secondary Evaluation Tool) (procedure)	4180186
42690525	PURPOSE T (Pressure Ulcer Risk Primary or Secondary Evaluation Tool) pathway decision (observable entity)	4180186
42690526	Percutaneous chemosaturation of hepatic artery using fluoroscopic guidance (procedure)	4180186
42690529	Streamed to emergency department following initial assessment (situation)	4180186
42690531	Pressure ulcer primary prevention pathway (regime/therapy)	4180186
42690532	Pressure ulcer not currently at risk pathway (regime/therapy)	4180186
42690533	On pressure ulcer secondary prevention and treatment pathway (situation)	4180186
42690534	On pressure ulcer primary prevention pathway (situation)	4180186
42690535	On pressure ulcer not currently at risk pathway (situation)	4180186
42690536	Magnetic resonance imaging of pelvis and rectum with contrast (procedure)	4180186
42690537	Denosumab allergy (disorder)	4180186
42690543	Default exclusion filter simple reference set (foundation metadata concept)	4180186
42690544	Speech and language diagnosis simple reference set (foundation metadata concept)	4180186
42690545	Therapy Outcome Measure assessment scales simple reference set (foundation metadata concept)	4180186
42690545	TOM (Therapy Outcome Measure) assessment scales simple reference set	4180186
42690547	Therapy Outcome Measure carer wellbeing scale observables simple reference set (foundation metadata concept)	4180186
42690547	TOM (Therapy Outcome Measure) carer wellbeing scale observables simple reference set	4180186
42690550	Therapy Outcome Measure wellbeing scale observables simple reference set (foundation metadata concept)	4180186
42690550	TOM (Therapy Outcome Measure) wellbeing scale observables simple reference set	4180186
42690551	Therapy Outcome Measure assessment procedures simple reference set (foundation metadata concept)	4180186
42690551	TOM (Therapy Outcome Measure) assessment procedures simple reference set	4180186
42690552	Office of Population Censuses and Surveys Classification of Interventions and Procedures Version 4.8 complex map reference set (foundation metadata concept)	4180186
42690552	OPCS (Office of Population Censuses and Surveys) Classification of Interventions and Procedures Version 4.8 complex map reference set	4180186
42690554	Actual place of death findings simple reference set (foundation metadata concept)	4180186
42690555	Dementia diagnosis simple reference set (foundation metadata concept)	4180186
42690558	Measured range of physiological spine movement observables simple reference set (foundation metadata concept)	4180186
42690560	Occupational therapy findings simple reference set (foundation metadata concept)	4180186
42690561	Pathology Bounded Code List observables simple reference set (foundation metadata concept)	4180186
42690561	PBCL (Pathology Bounded Code List) observables simple reference set	4180186
42690562	Person phenotypic sex findings simple reference set (foundation metadata concept)	4180186
42690565	Podiatric assessment scales simple reference set (foundation metadata concept)	4180186
42690566	Podiatric goals simple reference set (foundation metadata concept)	4180186
42690569	Podiatric surgery procedures simple reference set (foundation metadata concept)	4180186
42690572	Emergency care diagnosis qualifier simple reference set (foundation metadata concept)	4180186
42690574	Emergency care discharge status simple reference set (foundation metadata concept)	4180186
42690576	Emergency care source of attendance findings simple reference set (foundation metadata concept)	4180186
42690580	Sexual orientation findings simple reference set (foundation metadata concept)	4180186
42690584	Number of prescriptions for reliever inhaler per year (observable entity)	4180186
42690586	Injury following oxycodone use (disorder)	4180186
42690588	Talking Time intervention (regime/therapy)	4180186
42690589	Subject to guardianship under Section 7 of the Mental Health Act 1983 (England and Wales) (finding)	4180186
42690591	Speech therapy for compensatory articulation (regime/therapy)	4180186
42690593	Injury whilst playing table tennis (disorder)	4180186
42690595	Injury whilst skateboarding (disorder)	4180186
42690596	Injury whilst canoeing (disorder)	4180186
42690597	Injury whilst sport fencing (disorder)	4180186
42690599	Injury whilst playing boules (disorder)	4180186
42690602	Injury whilst engaged in scientific work (disorder)	4180186
42690603	Injury whilst riding motorcycle off-road (disorder)	4180186
42690605	Does not recognise objects by touch (finding)	4180186
42690609	Difficulty being hopeful for future (finding)	4180186
42690611	Difficulty maintaining life roles (finding)	4180186
42690614	Difficulty recognising objects by touch (finding)	4180186
42690615	Difficulty remembering past events (finding)	4180186
42690617	Difficulty writing for examinations (finding)	4180186
42690623	Does not identify risky behaviours (finding)	4180186
42690624	Does not recognise social cues (finding)	4180186
42690625	Does not recognise impact of self on others (finding)	4180186
42690626	Does not recognise own emotional pain and distress (finding)	4180186
42690627	Does not use decision making strategies (finding)	4180186
42690628	Does not wash upper body (finding)	4180186
42690629	Does not write messages (finding)	4180186
42690630	Does access own home (finding)	4180186
42690631	Does establish structure and routine in daily life (finding)	4180186
42690632	Does find way around school environment (finding)	4180186
42690633	Does get out of bed without assistance (finding)	4180186
42690634	Does manage stress (finding)	4180186
42690636	Does participate in classroom activities (finding)	4180186
42690637	Does shop at corner shop (finding)	4180186
42690638	Does stand from sitting on edge of bed (finding)	4180186
42690639	Does tolerate being cleaned during toileting (finding)	4180186
42690643	Unable to assist with meal preparation (finding)	4180186
42690644	Unable to identify dangers (finding)	4180186
42690651	Transplant recipient CMV (cytomegalovirus) antibody positive	4180186
42690651	Transplant recipient cytomegalovirus antibody positive (situation)	4180186
42690652	Transplant donor Epstein-Barr virus antibody positive (situation)	4180186
42690653	Assessment using Diagnosing Advanced Dementia Mandate Tool (procedure)	4180186
42690655	Difficulty choosing appropriate clothing (finding)	4180186
42690657	Does not identify interests (finding)	4180186
42690659	Does not use games console (finding)	4180186
42690660	Unable to manage risk in community (finding)	4180186
42690664	Urgent level emergency care (regime/therapy)	4180186
42690666	Number of times reliever inhaler used per week (observable entity)	4180186
42690668	Injury following aerosol inhalation (disorder)	4180186
42690675	Prosody exercises (regime/therapy)	4180186
42690676	Notification to safeguarding service of child no longer missing (finding)	4180186
42690677	Detained in hospital under Section 135 of the Mental Health Act 1983 (England and Wales) (finding)	4180186
42690678	Referred by Her Majesty's Prison Service (finding)	4180186
42690680	First inactivated seasonal influenza vaccination given by midwife (situation)	4180186
42690681	Requires irradiated blood components (finding)	4180186
42690683	Accident and Emergency department discharge to neonatal intensive care unit	4180186
42690683	Emergency department discharge to neonatal intensive care unit (procedure)	4180186
42690685	Regulated breathing approach (regime/therapy)	4180186
42690687	Compensatory strategy for swallowing (regime/therapy)	4180186
42690688	Chronic obstructive pulmonary disease monitoring short message service text message second invitation (procedure)	4180186
42690692	Injury whilst playing volleyball (disorder)	4180186
42690695	Injury whilst diving (disorder)	4180186
42690696	Injury whilst windsurfing (disorder)	4180186
42690697	Injury whilst cave-diving (disorder)	4180186
42690701	Injury whilst engaged in throwing sports activity (disorder)	4180186
42690703	Injury whilst engaged in indoor recreational activity (disorder)	4180186
42690708	Injury whilst driving motor vehicle off-road (disorder)	4180186
42690710	eConsultation via online application (procedure)	4180186
42690715	Does not sleep without sedation (finding)	4180186
42690716	Does operate mobile phone (finding)	4180186
42690717	Does sleep without sedation (finding)	4180186
42690718	Does transfer to vehicle with assistance (finding)	4180186
42690720	Difficulty anticipating self-care routines (finding)	4180186
42690722	Difficulty dividing attention (finding)	4180186
42690723	Difficulty getting into bed without assistance (finding)	4180186
42690727	Difficulty performing work based activity (finding)	4180186
42690732	Does not assist with meal preparation (finding)	4180186
42690735	Does not manage generalised pain (finding)	4180186
42690737	Does not manage risk in community (finding)	4180186
42690738	Does not participate in classroom activities (finding)	4180186
42690740	Does not recognise generalised pain (finding)	4180186
42690745	Does clean items at waist height (finding)	4180186
42690749	Does find way around work environment (finding)	4180186
42690750	Does identify life roles (finding)	4180186
42690752	Does maintain structure and routine in daily life (finding)	4180186
42690753	Does manage colostomy (finding)	4180186
42690755	Does manage own symptoms (finding)	4180186
42690756	Does manage urinary catheter care (finding)	4180186
42690758	Does understand humour (finding)	4180186
42690759	Does write for examinations (finding)	4180186
42690760	Unable to adapt to sensory changes in body part (finding)	4180186
42690762	Unable to dry lower body (finding)	4180186
42690763	Unable to fill forms (finding)	4180186
42690770	Unable to reflect on own behaviour (finding)	4180186
42690771	Unable to set personal goals (finding)	4180186
42690772	Unable to shop at shopping mall (finding)	4180186
42690773	Unable to sit on potty (finding)	4180186
42690774	Provision of written information about end of life care services (procedure)	4180186
42690775	Discussion about writing Last Will and Testament (procedure)	4180186
42690779	Computed tomography of stomach with contrast (procedure)	4180186
42690780	Streamed from emergency department to ophthalmology service following initial assessment (situation)	4180186
42690781	Referred by community nurse (finding)	4180186
42690782	Transplant recipient Epstein-Barr virus antibody positive (situation)	4180186
42690785	Zoledronic acid allergy (disorder)	4180186
42709743	Swelling of lower leg (finding)	4180186
42709744	X-ray of lower limb for bone length measurement (procedure)	4180186
42709747	Swelling of upper arm (finding)	4180186
42709751	Epidermal burn of multiple sites of lower leg (disorder)	4180186
42709751	Burn erythema of multiple sites of lower leg	4180186
42709751	Superficial burn of multiple sites of lower leg	4180186
42709751	First degree burn of multiple sites of lower leg	4180186
42709754	Injury of blood vessel of upper arm (disorder)	4180186
42709756	Malignant neoplasm of long bone of lower leg (disorder)	4180186
42709757	Neoplasm of uncertain behaviour of lower leg	4180186
42709757	Neoplasm of uncertain behavior of lower leg (disorder)	4180186
42709760	Secondary malignant neoplasm of lower leg (disorder)	4180186
42709761	Secondary malignant neoplasm of upper arm (disorder)	4180186
42709762	Primary malignant neoplasm of skin of lower leg (disorder)	4180186
42709763	Primary malignant neoplasm of lower leg (disorder)	4180186
42709767	Repair of defect of fascia of lower limb (procedure)	4180186
42709769	Reduction of fracture of upper arm with internal fixation (procedure)	4180186
42709772	Stripping and ligation of vein of lower limb (procedure)	4180186
42709774	Reduction of open fracture of lower limb with internal fixation (procedure)	4180186
42709775	Reduction of open fracture of lower leg with internal fixation (procedure)	4180186
42709776	Neoplasm of skin of lower leg (disorder)	4180186
42709777	Neoplasm of skin of upper arm (disorder)	4180186
42709778	Recurrent varicose vein of lower leg (disorder)	4180186
42709785	Transposition of tissue of upper arm (procedure)	4180186
42709787	Transplantation of tissue of lower leg (procedure)	4180186
42709788	Reconstruction of lower limb (procedure)	4180186
42709789	Reconstruction of lower leg (procedure)	4180186
42709790	Closure of lower limb (procedure)	4180186
42709791	Closure of lower leg (procedure)	4180186
42709797	Absence of upper limb (finding)	4180186
42709799	Cellulitis of upper limb (disorder)	4180186
42709801	Injection of upper limb (procedure)	4180186
42709802	Injection of upper arm (procedure)	4180186
42709803	Closure of upper limb (procedure)	4180186
42709805	Reconstruction of upper limb (procedure)	4180186
42709807	Manipulation of upper arm (procedure)	4180186
42709811	Congenital absence of part of upper arm (disorder)	4180186
42709815	Incision and drainage of deep abscess of lower leg (procedure)	4180186
42709816	Blister of lower limb with infection (disorder)	4180186
42709820	Congenital shortening of upper arm (disorder)	4180186
42709822	Implantation of prosthetic device of lower leg (procedure)	4180186
42709823	Elevation of lower limb (procedure)	4180186
42709827	Benign neoplasm of upper arm (disorder)	4180186
42709833	Injection of varicose vein of lower limb (procedure)	4180186
42709834	Injection of varicose vein of lower leg (procedure)	4180186
42709835	Oedema of lower leg	4180186
42709835	Edema of lower leg (finding)	4180186
42709836	Injection of varicose vein of lower limb	4180186
42709836	Injection sclerotherapy of varicose vein of lower limb (procedure)	4180186
42709838	Cellulitis of lower limb (disorder)	4180186
42709840	Acquired deformity of lower leg (disorder)	4180186
42709841	Bowing of upper limb (finding)	4180186
42709847	Full thickness burn of multiple sites of lower leg (disorder)	4180186
42709847	Third degree burn of multiple sites of lower leg	4180186
42709848	Nonvenomous insect bite of lower limb without infection (disorder)	4180186
42709850	Total hypermetropia (disorder)	4180186
42709852	Myopic astigmatism (disorder)	4180186
42709853	Mixed astigmatism (disorder)	4180186
42709854	Oblique astigmatism (disorder)	4180186
42709855	Excisional biopsy of uterus (procedure)	4180186
42709856	Diffuse nodular calcifications of breast (finding)	4180186
42709857	Allergic rhinitis caused by house dust mite	4180186
42709857	House dust mite rhinitis	4180186
42709857	Allergic rhinitis caused by house dust mite (disorder)	4180186
42709858	Autoimmune polyendocrine syndrome type 4 (disorder)	4180186
42709859	Autoimmune polyendocrine syndrome type 3 (disorder)	4180186
42709861	Hyperkeratotic actinic keratosis (disorder)	4180186
42709863	Structural change due to ischemia (morphologic abnormality)	4180186
42709863	Structural change due to ischaemia	4180186
42709864	Finding of periwound skin (finding)	4180186
42709865	Periwound skin bogginess	4180186
42709865	Boggy periwound skin (finding)	4180186
42709866	Inflammation of periwound skin (finding)	4180186
42709869	Wound edges approximated (finding)	4180186
42709870	Hemorrhage of periwound skin (finding)	4180186
42709870	Haemorrhage of periwound skin	4180186
42709872	Induration of wound (finding)	4180186
42709872	Indurated wound	4180186
42709874	Wound slough (finding)	4180186
42709875	Wound edge finding (finding)	4180186
42709876	Wound edges attached (finding)	4180186
42709879	Rolled wound edge (finding)	4180186
42709883	Pressure point of skin related to device (finding)	4180186
42709884	Serosanguineous discharge from wound (finding)	4180186
42709887	Complication of systemic hypertensive disorder (disorder)	4180186
42709887	Complication of systemic hypertensive disorder	4180186
42709887	Complication of systemic hypertension	4180186
42709889	Seropurulent discharge from wound (finding)	4180186
42709890	Bloody discharge from wound	4180186
42709890	Sanguineous discharge from wound (finding)	4180186
42709891	Foreign body gingivitis (disorder)	4180186
42709894	Intramedullary fibrous scar of bone (morphologic abnormality)	4180186
42709895	Intramucosal nevus (morphologic abnormality)	4180186
42709895	Intramucosal naevus	4180186
42709896	Lichenoid foreign body gingivitis (disorder)	4180186
42709898	Botryoid odontogenic cyst (disorder)	4180186
42709900	Scar of periapical tissue of tooth	4180186
42709900	Scar of periapical tissue of tooth (disorder)	4180186
42709902	Radicular dens invaginatus (disorder)	4180186
42709903	Solitary exostosis (disorder)	4180186
42709904	Luetic glossitis (disorder)	4180186
42709909	Bone density below reference range (finding)	4180186
42709909	Bone density below normal	4180186
42709909	Bone density low	4180186
42709910	Papillary gingivitis (disorder)	4180186
42709911	Zoster sine herpete (disorder)	4180186
42709913	Thin attached gingiva (disorder)	4180186
42709916	Crowding of posterior maxillary teeth (disorder)	4180186
42709917	Crowding of anterior mandibular teeth (disorder)	4180186
42709919	Crowding of posterior mandibular teeth (disorder)	4180186
42709922	Haematoma of subdural space of neuraxis	4180186
42709922	Hematoma of subdural space of neuraxis (disorder)	4180186
42709924	Traumatic haematoma of subdural space of neuraxis	4180186
42709924	Traumatic hematoma of subdural space of neuraxis (disorder)	4180186
42709927	SEGA - Subependymal giant cell astrocytoma	4180186
42709927	Subependymal giant cell astrocytoma (disorder)	4180186
42709929	Benign neoplasm of dome of urinary bladder (disorder)	4180186
42709930	Carcinoma in situ of dome of urinary bladder (disorder)	4180186
42709932	Neoplasm of uncertain behaviour of dome of urinary bladder	4180186
42709932	Neoplasm of uncertain behavior of dome of urinary bladder (disorder)	4180186
42709933	Eosinophilic cholangitis (disorder)	4180186
42709934	Stercoral colitis (disorder)	4180186
42709940	Intravasation of drug or medicament (disorder)	4180186
42709941	Saddle anesthesia	4180186
42709941	Numbness of saddle area (finding)	4180186
42709941	Saddle anaesthesia	4180186
42709942	Trigeminal autonomic cephalalgia (disorder)	4180186
42709942	Trigeminal autonomic cephalgia	4180186
42709943	Perianal haematoma	4180186
42709943	Hematoma of perianal region (disorder)	4180186
42709943	Haematoma of perianal region	4180186
42709943	Perianal venous thrombosis	4180186
42709945	Peters plus syndrome (disorder)	4180186
42709946	22q11 partial monosomy syndrome (disorder)	4180186
42709946	Chromosome 22q11 deletion syndrome	4180186
42709946	22q11 deletion syndrome	4180186
42709947	3p partial monosomy syndrome (disorder)	4180186
42709947	Chromosome 3p deletion syndrome	4180186
42709947	3p deletion syndrome	4180186
42709948	Steroid resistant nephrotic syndrome of childhood (disorder)	4180186
42709949	Branchiooculofacial syndrome (disorder)	4180186
42709950	Anomaly of convergence (disorder)	4180186
42709951	Tenosynovitis of thumb (disorder)	4180186
42709953	Cellulitis of thumb (disorder)	4180186
42709954	Phimosis (disorder)	4180186
42709955	Lochia alba (finding)	4180186
42709956	Lochia serosa (finding)	4180186
42709957	Loeffler endocarditis	4180186
42709957	Loeffler's endocarditis (disorder)	4180186
42709958	D-dimer above reference range (finding)	4180186
42709958	Elevated D-dimer	4180186
42709959	Abnormal diffuse intimal thickening of artery (disorder)	4180186
42709960	Labyrinthitis ossificans (disorder)	4180186
42709965	Complex cyst of breast (disorder)	4180186
42709967	Chronic otitis media with sanguineous effusion (disorder)	4180186
42709968	Cochlear prosthesis in situ (finding)	4180186
42709968	Cochlear implant in situ	4180186
42709971	Tissue prosthetic heart valve in situ	4180186
42709971	Biologic cardiac valve prosthesis in situ (finding)	4180186
42709972	Breast implant in situ	4180186
42709972	Breast prosthesis in situ (finding)	4180186
42709973	Adverse reaction caused by mirtazapine (disorder)	4180186
42709973	Adverse reaction caused by mirtazapine	4180186
42709975	Supernumerary permanent mandibular tooth (disorder)	4180186
42709977	Babesia equi	4180186
42709977	Theileria equi (organism)	4180186
42709978	Infection caused by Theileria equi (disorder)	4180186
42709978	Infection caused by Theileria equi	4180186
42709979	Theileria equi antibody (substance)	4180186
42709980	Measurement of Theileria equi antibody (procedure)	4180186
42709982	Serrated polyp (morphologic abnormality)	4180186
42709987	Nontunneled central venous catheter (physical object)	4180186
42709988	Insertion of nontunneled central venous catheter (procedure)	4180186
42709990	Insertion of cuffed central venous catheter (procedure)	4180186
42709991	Insertion of pacemaker for control of atrial fibrillation (procedure)	4180186
42709997	Uses moist tobacco daily (finding)	4180186
42710004	Magnetic resonance imaging for cardiac morphology and function (procedure)	4180186
42710004	Magnetic resonance imaging for cardiac morphology and function	4180186
42710005	Magnetic resonance imaging for cardiac morphology, function, and velocity	4180186
42710005	Magnetic resonance imaging for cardiac morphology, function, and velocity (procedure)	4180186
42710007	Magnetic resonance imaging for cardiac morphology and function with contrast (procedure)	4180186
42710007	Magnetic resonance imaging for cardiac morphology and function with contrast	4180186
42710008	Magnetic resonance imaging for cardiac morphology, function, and velocity with contrast (procedure)	4180186
42710008	Magnetic resonance imaging for cardiac morphology, function, and velocity with contrast	4180186
42710014	Hydrocephalic shunt catheter in situ (finding)	4180186
42710019	Healing wound of perineum (finding)	4180186
42710021	Prothrombin time within target range (finding)	4180186
42710022	Tolerating normal diet (finding)	4180186
42710025	Adductor canal syndrome (disorder)	4180186
42710025	Hunter's canal syndrome	4180186
42710026	Superficial foreign body of lower leg without major open wound and without infection (disorder)	4180186
42710029	Hepatic encephalopathy in fulminant hepatic failure (disorder)	4180186
42710032	Intramedullary glomus arteriovenous malformation of spinal cord	4180186
42710032	Intramedullary glomus arteriovenous malformation of spinal cord (disorder)	4180186
42710033	Intramedullary and extramedullary arteriovenous malformation of spinal cord (disorder)	4180186
42710033	Intramedullary and extramedullary arteriovenous malformation of spinal cord	4180186
42710033	Juvenile arteriovenous malformation of spinal cord	4180186
42710034	Perimedullary arteriovenous fistula of spinal cord	4180186
42710034	Perimedullary arteriovenous fistula of spinal cord (disorder)	4180186
42710035	Palatal tubercle (finding)	4180186
42710042	Superficial foreign body of lower limb without infection and without major open wound (disorder)	4180186
42710044	Peripheral facial nerve paralysis	4180186
42710044	Peripheral facial palsy (disorder)	4180186
42710045	Cramp in lower limb (finding)	4180186
42710046	Cramp in lower leg (finding)	4180186
42710047	Superficial frostbite of upper limb (disorder)	4180186
42710048	Superficial frostbite of upper arm (disorder)	4180186
42710049	Ultrasonography of upper limb (procedure)	4180186
42710049	US (ultrasound) of upper limb	4180186
42710050	Ultrasonography of lower limb (procedure)	4180186
42710051	Destructive procedure on lower limb (procedure)	4180186
42710053	Tuberculosis of bone of upper limb (disorder)	4180186
42868297	MEK Fld-mCnc	4180186
42868297	2-Butanone; 3-butanone; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Butanone; DRUG/TOXICOLOGY; Drugs; Ethyl methyl ketone; Fl; Fld; FLU; Fluid; Level; Mass concentration; MEK; Methyl acetone; Methylethylketone; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868297	甲基乙基甲酮:质量浓度:时间点:体液:定量型	4182948
42868299	A-Ketoglut CSF-sCnc	4180186
42868299	2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; A-Ketoglut; AKG; Alfa; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868299	Alpha 酮戊二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868300	2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; A-Ketoglut; AKG; Alfa; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868300	A-Ketoglut SerPl-sCnc	4180186
42868300	Alpha 酮戊二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868303	2-DCE-IF p IFF Bld-mCnc	4180186
42868303	2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; After; Blood; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
42868303	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后:质量浓度:时间点:全血:定量型	4182948
42868305	2-DCE-IF pre IFF 24h Ur-mCnc	4180186
42868305	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; Before; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; pre IFF; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868305	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后:质量浓度:24小时:尿液:定量型	4182948
42868306	2-DCE-IF 1D p IFF 24h Ur-mRate	4180186
42868306	1 day; 1D p IFF; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Mass rate; Mitoxana; mRate; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868306	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后1天:质量速率:24小时:尿液:定量型	4182948
42868308	1 day; 24 hours; 24HR; 2D p IFF; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Mass rate; Mitoxana; mRate; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868308	2-DCE-IF 2D p IFF 24h Ur-mRate	4180186
42868308	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后2天:质量速率:24小时:尿液:定量型	4182948
42868315	2-DCE-IF 5D p IFF 24h Ur-mCnc	4180186
42868315	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 5D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868315	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后5天:质量浓度:24小时:尿液:定量型	4182948
42868318	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 6D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868318	2-DCE-IF 6D p IFF 24h Ur-mCnc	4180186
42868318	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后6天:质量浓度:24小时:尿液:定量型	4182948
42868321	2-DCE-IF 7D p IFF 24h Ur-mCnc	4180186
42868321	1 day; 24 hours; 24HR; 2-DCE-IF; 2-dechloroethyl-ifosfaminde; 2d-Ifo; 2D-Ifosfamide; 7D p IFF; After; DRUG/TOXICOLOGY; Drugs; Ifex; IFF; Ifosfamide metabolite; II; Level; Mass concentration; Mitoxana; p dose; p IFF; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
42868321	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后7天:质量浓度:24小时:尿液:定量型	4182948
42868323	2-EHA; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868323	2-ethylhydracrylate SerPl-sCnc	4180186
42868323	2-乙基羟丙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868324	2Me-glutarate SerPl-sCnc	4180186
42868324	2Me-glutarate; 2-methylglutaric acid; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868324	2-甲基戊二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868325	Me-succinate Amn-sCnc	4180186
42868325	2-Methylsuccinic acid; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Level; Me-succinate; Methylsuccinic acid; Point in time; Pyrotartaric acid; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
42868325	甲基琥珀酸:物质的量浓度:时间点:羊水:定量型	4182948
42868328	3,4-Dihydroxy phenylacetate; 3,4-Dihydroxy phenylacetic acid; 3,4-Dihydroxyphenylacetic acid; 3,4-DiOH-phenylacetate; CR; Crea; Creat; DOPAC; Dopamine metabolite; DRUG/TOXICOLOGY; Drugs; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
42868328	3,4-DiOH-phenylacetate/Creat Ur-sRto	4180186
42868328	3,4-二羟基苯乙酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
42868329	3OH3Me-glutarate CSF-sCnc	4180186
42868329	3-Hydroxy,3-Methyl glutarate; 3-hydroxy,3-methylglutaric acid; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; Cerebral spinal fluid; Cerebrospinal Fl; dicrotalic acid; DRUG/TOXICOLOGY; Drugs; HMG; Hydrox; III; Level; Meglutol; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; β-hydroxy-β-methylglutaric acid	4180186
42868329	3-羟基,3-甲基戊二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868330	3-Hydroxy,3-Methyl glutarate; 3-hydroxy,3-methylglutaric acid; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; dicrotalic acid; DRUG/TOXICOLOGY; Drugs; HMG; Hydrox; III; Level; Meglutol; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; β-hydroxy-β-methylglutaric acid	4180186
42868330	3OH3Me-glutarate Amn-sCnc	4180186
42868330	3-羟基,3-甲基戊二酸:物质的量浓度:时间点:羊水:定量型	4182948
42868331	3OH3Me-glutarate SerPl-sCnc	4180186
42868331	3-Hydroxy,3-Methyl glutarate; 3-hydroxy,3-methylglutaric acid; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; dicrotalic acid; DRUG/TOXICOLOGY; Drugs; HMG; Hydrox; III; Level; Meglutol; OH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; β-hydroxy-β-methylglutaric acid	4180186
42868331	3-羟基,3-甲基戊二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868335	2-Hydroxy-3-Methyl valerate; 2-hydroxy-3-methylvaleric acid; 2OH3Me-valerate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; HMVA; Hydrox; II; III; Level; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868335	2OH3Me-valerate CSF-sCnc	4180186
42868335	2-羟基-3-甲基戊酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868336	2OH3Me-valerate SerPl-sCnc	4180186
42868336	2-Hydroxy-3-Methyl valerate; 2-hydroxy-3-methylvaleric acid; 2OH3Me-valerate; Chemistry; HMVA; Hydrox; II; III; Level; OH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868336	2-羟基-3-甲基戊酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868337	2OH-adipate CSF-sCnc	4180186
42868337	2-hydroxy-adipate; 2-hydroxyadipic acid; 2OH-adipate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868337	2-羟基已二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868339	A-OH-Butyr CSF-sCnc	4180186
42868339	2-hydroxybutyrate; 2-hydroxybutyric acid; Alfa; Alpha hydroxy butyrate; A-OH-Butyr; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hydroxybutyric acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868339	Alpha 羟基丁酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868341	2OH-gluterate CSF-sCnc	4180186
42868341	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868341	2-羟基戊二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868342	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868342	2OH-gluterate SerPl-sCnc	4180186
42868342	2-羟基戊二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868346	2-Hydroxy-4-methylpentanoate; 2-Hydroxy-4-methylpentanoic acid; 2-hydroxy-isocaproate; 2-hydroxyisocaproic acid; 2OH-isocaproate; alpha-hydroxyisocaproic acid; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868346	2OH-isocaproate SerPl-sCnc	4180186
42868346	2-羟基异己酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868347	3OH-Glutarate Amn-sCnc	4180186
42868347	3-hydroxy-glutarate; 3-hydroxyglutaric acid; 3-OH-GA; 3OH-Glutarate; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
42868347	3-羟基戊二酸:物质的量浓度:时间点:羊水:定量型	4182948
42868348	3-hydroxy-glutarate; 3-hydroxyglutaric acid; 3-OH-GA; 3OH-Glutarate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868348	3OH-Glutarate SerPl-sCnc	4180186
42868348	3-羟基戊二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868349	3-HIBA; 3-hydroxy-2-methylpropanoate; 3-hydroxy-2-methylpropanoic acid; 3-hydroxy-isobutyrate; 3-hydroxyisobutyric acid; 3OH-Isobutyrate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42868349	3OH-Isobutyrate CSF-sCnc	4180186
42868349	3-羟基异丁酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42868350	3OH-Isobutyrate SerPl-sCnc	4180186
42868350	3-HIBA; 3-hydroxy-2-methylpropanoate; 3-hydroxy-2-methylpropanoic acid; 3-hydroxy-isobutyrate; 3-hydroxyisobutyric acid; 3OH-Isobutyrate; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868350	3-羟基异丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868351	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Finding; Findings; Nominal; Point in time; Random	4180186
42868351	Hispanic, latino-a, or spanish	4180186
42868351	西班牙裔血统、拉丁裔血统还是西班牙裔血统:发现:时间点:^患者:名义型	4182948
42868353	Deaf, serious difficulty hearing; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
42868355	Difficulty concentrating remembering making decisions; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
42868357	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS	4180186
42868359	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
42868359	排除准则 - 分析:-:时间点:^患者:-:PhenX	4182948
42868363	Process for assays-HLA PhenX	4180186
42868363	Ag; Human Leukocyte Antigen; Leuc; Leuk; Leukocytes; Lkcs; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Process for assays-HLA; Process variables assays; Random; WBC; WBCs; White blood cell; White blood cells	4180186
42868363	检测的过程变量 - 人类白细胞抗原:-:时间点:^患者:-:PhenX	4182948
42868364	Active dx based pt records; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42868366	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 42; Spec; To be specified in another part of the message; Unspecified	4180186
42868366	Service Cmnt 42-Imp	4180186
42868366	服务注释 42:印象:时间点:XXX:名义型	4182948
42868368	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 44; Spec; To be specified in another part of the message; Unspecified	4180186
42868368	Service Cmnt 44-Imp	4180186
42868368	服务注释 44:印象:时间点:XXX:名义型	4182948
42868370	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 46; Spec; To be specified in another part of the message; Unspecified	4180186
42868370	Service Cmnt 46-Imp	4180186
42868370	服务注释 46:印象:时间点:XXX:名义型	4182948
42868372	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 48; Spec; To be specified in another part of the message; Unspecified	4180186
42868372	Service Cmnt 48-Imp	4180186
42868372	服务注释 48:印象:时间点:XXX:名义型	4182948
42868374	Service Cmnt 50-Imp	4180186
42868374	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 50; Spec; To be specified in another part of the message; Unspecified	4180186
42868374	服务注释 50:印象:时间点:XXX:名义型	4182948
42868375	Service Cmnt 51-Imp	4180186
42868375	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 51; Spec; To be specified in another part of the message; Unspecified	4180186
42868375	服务注释 51:印象:时间点:XXX:名义型	4182948
42868376	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 52; Spec; To be specified in another part of the message; Unspecified	4180186
42868376	Service Cmnt 52-Imp	4180186
42868376	服务注释 52:印象:时间点:XXX:名义型	4182948
42868377	Service Cmnt 53-Imp	4180186
42868377	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 53; Spec; To be specified in another part of the message; Unspecified	4180186
42868377	服务注释 53:印象:时间点:XXX:名义型	4182948
42868378	Service Cmnt 54-Imp	4180186
42868378	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 54; Spec; To be specified in another part of the message; Unspecified	4180186
42868378	服务注释 54:印象:时间点:XXX:名义型	4182948
42868379	Service Cmnt 55-Imp	4180186
42868379	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 55; Spec; To be specified in another part of the message; Unspecified	4180186
42868379	服务注释 55:印象:时间点:XXX:名义型	4182948
42868385	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 61; Spec; To be specified in another part of the message; Unspecified	4180186
42868385	Service Cmnt 61-Imp	4180186
42868385	服务注释 61:印象:时间点:XXX:名义型	4182948
42868386	Service Cmnt 62-Imp	4180186
42868386	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 62; Spec; To be specified in another part of the message; Unspecified	4180186
42868386	服务注释 62:印象:时间点:XXX:名义型	4182948
42868387	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 63; Spec; To be specified in another part of the message; Unspecified	4180186
42868387	Service Cmnt 63-Imp	4180186
42868387	服务注释 63:印象:时间点:XXX:名义型	4182948
42868389	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 65; Spec; To be specified in another part of the message; Unspecified	4180186
42868389	Service Cmnt 65-Imp	4180186
42868389	服务注释 65:印象:时间点:XXX:名义型	4182948
42868390	Service Cmnt 66-Imp	4180186
42868390	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 66; Spec; To be specified in another part of the message; Unspecified	4180186
42868390	服务注释 66:印象:时间点:XXX:名义型	4182948
42868391	Service Cmnt 67-Imp	4180186
42868391	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 67; Spec; To be specified in another part of the message; Unspecified	4180186
42868391	服务注释 67:印象:时间点:XXX:名义型	4182948
42868392	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 68; Spec; To be specified in another part of the message; Unspecified	4180186
42868392	Service Cmnt 68-Imp	4180186
42868392	服务注释 68:印象:时间点:XXX:名义型	4182948
42868394	Service Cmnt 70-Imp	4180186
42868394	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 70; Spec; To be specified in another part of the message; Unspecified	4180186
42868394	服务注释 70:印象:时间点:XXX:名义型	4182948
42868397	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 73; Spec; To be specified in another part of the message; Unspecified	4180186
42868397	Service Cmnt 73-Imp	4180186
42868397	服务注释 73:印象:时间点:XXX:名义型	4182948
42868398	Service Cmnt 74-Imp	4180186
42868398	cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 74; Spec; To be specified in another part of the message; Unspecified	4180186
42868398	服务注释 74:印象:时间点:XXX:名义型	4182948
42868405	Abd; Abd ves; Abd ves+Pelvis ves; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Heart Disease; Imaging; Pelvic; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX; W contr IV; WC	4180186
42868405	CTA Abd ves+Pelvis ves W contr IV	4180186
42868405	多层^采用静脉注射对比剂:发现:时间点:腹部>腹部血管类 & 盆腔>盆腔血管类:文档型:CT.血管造影术	4182948
42868406	100WBC; B/F; Baso; Basophil; Basophils/Masts; Basos; BF; bod; Bodies; Body fluid; Body fluid, unsp; Bph; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Masts; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
42868406	Basophils/Masts/leuk NFr Fld	4180186
42868406	嗜碱性粒细胞+肥大细胞/100 个白细胞:计数型分数:时间点:体液:定量型	4182948
42868409	Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; HiTT; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; TCT; Throm; Thrombin clotting time; Thrombin time; Tilt tube; TT	4180186
42868409	HiTT PPP	4180186
42868409	凝血酶诱导型凝血过程.高剂量:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
42868410	Department of Health and Human Services, Affordable Care Act Section 4302; Ethnicity; Gender; Health and Human Services (HHS) pnl; HHS.ACASec4302; Pan; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
42868411	ABS; Aby; Adeno virus; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HAdV; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
42868411	HAdV IgA Ser Ql IA	4180186
42868411	腺病毒 抗体.IgA:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868414	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; FSME; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; TBEV	4180186
42868414	TBEV IgM Ser Ql IA	4180186
42868414	欧洲蜱传脑炎病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868415	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; FSME; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; TBEV	4180186
42868415	TBEV IgM CSF Ql IA	4180186
42868415	欧洲蜱传脑炎病毒 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
42868417	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; FSME; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; TBEV	4180186
42868417	TBEV IgG Ser Ql IA	4180186
42868417	欧洲蜱传脑炎病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868418	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; FSME; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; TBEV	4180186
42868418	TBEV IgG CSF Ql IA	4180186
42868418	欧洲蜱传脑炎病毒 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
42868421	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; VZ; VZV; Zoster	4180186
42868421	VZV IgM CSF Ql IA	4180186
42868421	水痘带状疱疹病毒 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
42868422	Food Allerg Mix13 IgE Qn	4180186
42868422	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Carrot; f012; f031; f035; f12; f31; f35; Food Allerg Mix13; FP13; fx13; Green pea; Immune globulin E; Immunoglobulin E; Pea; peas; Point in time; Potato; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Vegetable mix; White potato	4180186
42868422	(胡萝卜+菜豆+豌豆+马铃薯) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42868425	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium DNA; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868425	M genitalium DNA Spec Ql NAA+probe	4180186
42868425	生殖支原体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868426	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; G vaginalis; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868426	G vaginalis DNA Spec Ql NAA+probe	4180186
42868426	阴道加德纳菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868427	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; T vaginalis; TMA; To be specified in another part of the message; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Unspecified	4180186
42868427	T vaginalis DNA Spec Ql NAA+probe	4180186
42868427	阴道毛滴虫 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868428	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Astro virus; DNA NUCLEIC ACID PROBE; DNA probe; HAstV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868428	HAstV RNA Spec Ql NAA+probe	4180186
42868428	星状病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868429	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m205; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T rubrum; TMA; Transcription mediated amplification; Ungal nail	4180186
42868429	T rubrum DNA Nail Ql NAA+probe	4180186
42868429	红色毛癣菌 DNA:存在情况或阈值:时间点:甲:序数型:探针法.基因扩增.靶向	4182948
42868430	20M p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868430	Glucose 20M p Lac PO SerPl-sCnc	4180186
42868430	葡萄糖^在口服剂量乳糖之后20分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868431	40M p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868431	Glucose 40M p Lac PO SerPl-sCnc	4180186
42868431	葡萄糖^在口服剂量乳糖之后40分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868432	20M p 50 g lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p 50 g Lact PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868432	Glucose 20M p 50 g lac PO SerPl-sCnc	4180186
42868432	葡萄糖^在口服50 g乳糖之后20分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868435	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; ID; IMMUNE BLOT; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; T pallidum; Treponemal; WB; WBLOT; West blot; West blt; Western blot	4180186
42868435	T pallidum IgM CSF Ql IB	4180186
42868435	梅毒螺旋体 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫印迹法	4182948
42868436	Cardio; Cardiology; Chemistry; Heart Disease; Level; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tg; Trig; Trigly; Triglycerides; Triglycrides	4180186
42868436	Trigl Pcar-sCnc	4180186
42868436	甘油三酯:物质的量浓度:时间点:心包液:定量型	4182948
42868437	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B parapert; B parapertussis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Whooping cough	4180186
42868437	B parapert IgG Ser Ql IA	4180186
42868437	副百日咳博德特菌 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868438	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAP; EBV; EBV capsid Ab; EBV IgG Avidity; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; VCA; Viral capsid	4180186
42868438	EBV VCA IgG Avidity Ser Ql IA	4180186
42868438	Epstein Barr 病毒衣壳 抗体.IgG 亲合力:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868439	Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868439	Hgb Pcar-mCnc	4180186
42868439	血红蛋白:质量浓度:时间点:心包液:定量型	4182948
42868444	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Intest; Intestine; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
42868444	Intestinal goblet cell Ab Ser Ql IA	4180186
42868444	肠道杯状细胞 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868447	Food Allerg Mix15 IgE Qn	4180186
42868447	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Apple; Arbitrary Concentration; Autoantibodies; Autoantibody; Banana; f033; f049; f092; f095; f33; f49; f92; f95; Food Allerg Mix15; FP15; Fruit mix; fx15; Immune globulin E; Immunoglobulin E; Musa sp; Orange; Peach; Point in time; Pyrus malus; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
42868447	(甜橙+苹果+芭蕉属+桃子) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42868450	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; DNA NUCLEIC ACID PROBE; DNA probe; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
42868450	HEV RNA SerPl NAA+probe-aCnc	4180186
42868450	戊型肝炎病毒 RNA:任意型浓度:时间点:血清/血浆:定量型:探针法.基因扩增.靶向	4182948
42868451	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HRSV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RSV; Screen; Serum; SR; SUDS	4180186
42868451	RSV IgM Ser Ql IA	4180186
42868451	呼吸道合胞病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868452	ABL; ABL1; ABL1 transcript; ALL; bcr/abl; BCR1; bcr-abl1; BM; BON; Bone marrow; Breakpoint cluster region; Chronic myeloid leukemia; CML; control gene; D22S11; D22S662; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; major breakpoints; MAR; Marrow (bone); Mbr; Mcr; minimal angle of resolution; Minimum angle of resolution; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Number ratio; p150; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) p190 gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); t(ABL1,BCR)e1a2; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1	4180186
42868452	t(ABL1,BCR)e1a2/control Mar	4180186
42868452	t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 融合转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
42868453	BIC; bicar; Bicarb; Chemistry; HCO3; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; std; Substance Concentration	4180186
42868453	HCO3 std Plas-sCnc	4180186
42868453	碳酸氢盐^^标准:物质的量浓度:时间点:血浆:定量型	4182948
42868457	DOCUMENT.REGULATORY; FDA label; Narrative; Report	4180186
42868457	FDA label NDC labeler code inactivation	4180186
42868457	NDC 贴签厂商代码冻结:-:-:^FDA 产品标签:叙述型	4182948
42868460	Breathing; Dynamic; Exp; FEF 25-75%; Flow; Forced expiratory flow rate; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
42868460	用力呼气 25-75% 时的气体流量:体积速率:时间点:呼吸系统:定量型:预计法	4182948
42868464	Before; Breathing; Dynamic; Flow; Gases; Largest; Lung; Lungs; Maximal; Maximum; Peak; Peak expiratory flow; PEF; Point in time; pre BD; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
42868464	PEF pre BD Airway	4180186
42868464	呼气气体流量.最大值^在支气管扩张之前:体积速率:时间点:呼吸系统.气道:定量型	4182948
42868466	Before; Breathing; Dynamic; Gases; Largest; Lung; Lungs; Maximal; Maximum; Peak; Peak expiratory flow; PEF; Point in time; pre BD; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Relative volume rate; Respiratory; RS	4180186
42868466	PEF/Predicted pre BD Airway	4180186
42868466	呼气气体流量.最大值/呼气气体流量.最大值.预测型^在支气管扩张之前:相对体积速率:时间点:呼吸系统.气道:定量型	4182948
42868467	After; Breathing; Dynamic; Gases; Largest; Lung; Lungs; Maximal; Maximum; p BD; Peak; Peak expiratory flow; PEF; Point in time; PST; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Relative volume rate; Respiratory; RS	4180186
42868467	PEF/Predicted p BD Airway	4180186
42868467	呼气气体流量.最大值/呼气气体流量.最大值.预测型^在支气管扩张之后:相对体积速率:时间点:呼吸系统.气道:定量型	4182948
42868469	After; Breathing; Dynamic; Exp; FEF 50%; FIV 50%; Gases; In; Insp; Inspiratory; Lung; Lungs; p BD; Point in time; PST; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Relative volume rate; Respiratory; RS	4180186
42868469	FEF 50%/FIV 50% p BD	4180186
42868469	用力呼气 50% 时的气体流量/用力吸气 50% 时的气体流量^在支气管扩张之后:相对体积速率:时间点:呼吸系统:定量型	4182948
42868470	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
42868470	哮喘行动计划:发现:时间点:{环境}:文档型:{角色}	4182948
42868472	Breathing; End tidal volume; Exchange; Exp; FEV; FEV1; FEV1 % change; Forced expiratory volume in 1 second; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Replace; Respiratory; RS; S prime; Vet; Vol; Vol exp	4180186
42868472	FEV1 % change	4180186
42868472	用力呼气 1.0 秒过程中所呼出的体积百分数变化:体积百分数差:时间点:呼吸系统:定量型	4182948
42868474	1 day; 24 hours; 24HR; Average; Avg; Breathing; CPAP; Lung; Lungs; MAP; Pos; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; RS	4180186
42868474	CPAP 24h Mean Respiratory	4180186
42868474	压力.气道内持续正向:压力或压强:24小时^平均值:呼吸系统:定量型	4182948
42868475	1 day; 24 hours; 24HR; Breathing; CPAP; Lung; Lungs; Maximum; PAP.95%; Pos; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; RS	4180186
42868475	PAP.95% 24h Max Respiratory	4180186
42868475	压力.气道内持续正向.95%:压力或压强:24小时^最大值:呼吸系统:定量型	4182948
42868477	1 day; 24 hours; 24HR; Lung; PAP device usage; Pos; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory	4180186
42868477	PAP device usage 24h	4180186
42868477	气道正压装置使用:时间:24小时:^患者:定量型	4182948
42868478	1 month; 1 month (30 days); 30 days; Average; Avg; Lung; PAP device usage; Pos; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory	4180186
42868478	PAP device usage 1MO Mean	4180186
42868478	气道正压装置使用:时间:1个月^平均值:^患者:定量型	4182948
42868480	Ident; Identifier; Lung; Model Cd; Nominal; PAP device; Point in time; Pos; PULMONARY; Pulmonology; Random; Respiratory	4180186
42868480	Model Cd PAP device	4180186
42868480	厂商设备机型代码:标识符:时间点:气道正压装置:名义型	4182948
42868483	Ident; Identifier; Nominal; PAP device; Point in time; Pos; Random	4180186
42868483	PAP device Software vers	4180186
42868483	厂商软件版本:标识符:时间点:气道正压装置:名义型	4182948
42868485	1 day; 24 hours; 24HR; Average; Avg; Flow; Lung; PAP device; Pos; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume Rate; vRate	4180186
42868485	Leak 24h Mean PAP device	4180186
42868485	泄漏:体积速率:24小时^平均值:气道正压装置:定量型	4182948
42868486	1 day; 24 hours; 24HR; Flow; Lung; Maximum; PAP device; Pos; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume Rate; vRate	4180186
42868486	Leak.95% 24h Max PAP device	4180186
42868486	泄漏.95%:体积速率:24小时^最大值:气道正压装置:定量型	4182948
42868487	PAP device Leak	4180186
42868487	1 day; 24 hours; 24HR; Flow; Maximum; PAP device; Pos; QNT; Quan; Quant; Quantitative; Volume Rate; vRate	4180186
42868487	泄漏:体积速率:24小时^最大值:气道正压装置:定量型	4182948
42868489	1 day; 24 hours; 24HR; Breathing; CPAP; Lung; Lungs; Pos; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; RS	4180186
42868489	CPAP 24h median Respiratory	4180186
42868489	压力.气道内持续正向:压力或压强:24小时^中值:呼吸系统:定量型	4182948
42868491	1 day; 24 hours; 24HR; AI; Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; OAI; OSA; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory	4180186
42868491	Obstructive apnea index 24h nRate	4180186
42868491	阻塞性窒息:计数型速率:24小时:^患者:定量型	4182948
42868492	1 day; 24 hours; 24HR; AI; CAI; Count/time; CSA; Lung; Neuro; Neurology; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory	4180186
42868492	Central apnea index 24h nRate	4180186
42868492	中枢性呼吸暂停指数:计数型速率:24小时:^患者:定量型	4182948
42868495	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Med mgmt note; notes; Point in time; Random; Visit note	4180186
42868495	Med mgmt note	4180186
42868495	药物管理记录:发现:时间点:{环境}:文档型:{角色}	4182948
42868497	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Entero virus; Enzyme immunoassay; EV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
42868497	EV IgM CSF Ql IA	4180186
42868497	肠道病毒 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
42868498	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Entero virus; Enzyme immunoassay; EV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
42868498	EV IgM SerPl Ql IA	4180186
42868498	肠道病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
42868499	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Entero virus; Enzyme immunoassay; EV; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
42868499	EV IgG CSF Ql IA	4180186
42868499	肠道病毒 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
42868502	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
42868502	CV IgG SerPl Ql IA	4180186
42868502	柯萨奇病毒 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
42868503	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HPIV; HPIV 1+2+3+4; HPIV1; HPIV1+2+3; Human respirovirus 1; i; IAA; ID; II; III; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
42868503	HPIV 1+2+3+4 IgA Ser Ql IA	4180186
42868503	副流感病毒 1+2+3+4 型 抗体.IgA:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868506	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HPIV; HPIV 1+2+3+4; HPIV1; HPIV1+2+3; Human respirovirus 1; i; IAA; ID; II; III; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
42868506	HPIV 1+2+3+4 IgM Ser Ql IA	4180186
42868506	副流感病毒 1+2+3+4 型 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42868509	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B fragilis; B fragilis DNA; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868509	B fragilis DNA Bld Ql NAA+probe	4180186
42868509	脆弱类杆菌 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868512	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C tropicls; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868512	C tropicls DNA Bld Ql NAA+probe	4180186
42868512	热带假丝酵母 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868513	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C parap; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868513	C parap DNA Bld Ql NAA+probe	4180186
42868513	近平滑假丝酵母 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868514	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C krusei; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42868514	C krusei DNA Bld Ql NAA+probe	4180186
42868514	克鲁斯假丝酵母 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868515	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification; WB; Whole blood	4180186
42868515	C glabrata DNA Bld Ql NAA+probe	4180186
42868515	光滑假丝酵母 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42868518	Deprecated Platelets.reticulated NFr Bld	4180186
42868518	Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Immature platelets; Number fraction; Percent; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RP; Thrb; Thrombocyte; Thrombocytes; Tot; Totl; WB; Whole blood; Young platelets	4180186
42868520	100WBC; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868520	Lipophages/leuk NFr CSF Manual	4180186
42868520	噬脂细胞/100 个白细胞:计数型分数:时间点:脑脊液:定量型:手工计数方法	4182948
42868523	100WBC; Auto; Automated detection; Cardio; Cardiology; Cell; Cellularity; Elec; Elect; Electr; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mononuc; Mononuc Cells; Number Fraction; PCAR; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
42868523	Mononuc Cells/leuk NFr Pcar Auto	4180186
42868523	单个核细胞/100 个白细胞:计数型分数:时间点:心包液:定量型:自动化计数方法	4182948
42868524	100WBC; Ascites; Ascitic fluid; Ascitis; Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mononuc; Mononuc Cells; Number Fraction; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
42868524	Mononuc Cells/leuk NFr Prt Auto	4180186
42868524	单个核细胞/100 个白细胞:计数型分数:时间点:腹膜液:定量型:自动化计数方法	4182948
42868525	100WBC; Ascites; Ascitic fluid; Ascitis; Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Peritoneal fluid; PMN; Point in time; Poly; Polys; Prt; QNT; Quan; Quant; Quantitative; Random; Segmented WBC; WBC; WBCs; White blood cell; White blood cells	4180186
42868525	Polys/leuk NFr Prt Auto	4180186
42868525	分叶核白细胞/100 个白细胞:计数型分数:时间点:腹膜液:定量型:自动化计数方法	4182948
42868527	Blood; Follicle stimulating hormone beta; Follicle stimulating hormone beta gene; follicle stimulating hormone, beta polypeptide; Follicle-stimulating hormone beta; Follicle-stimulating hormone beta gene; follicle-stimulating hormone beta subunit; Follicle-stimulating hormone, beta; Follitropin, beta Chain; FSH beta; FSHB c.-211G&gt;T; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42868527	FSHB c.-211G>T Bld/T Ql	4180186
42868527	FSHB 基因.c.-211G>T:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868530	#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Pleural; Pleural fluid; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC; thoracentesis fluid	4180186
42868530	Polys # Plr Auto	4180186
42868530	分叶核白细胞:计数型浓度:时间点:胸膜液:定量型:自动化计数方法	4182948
42868531	#; ABS; absolute; absolutes; Auto; Automated detection; Cardio; Cardiology; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Heart Disease; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC	4180186
42868531	Polys # Pcar Auto	4180186
42868531	分叶核白细胞:计数型浓度:时间点:心包液:定量型:自动化计数方法	4182948
42868533	#; ABS; absolute; absolutes; Ascites; Ascitic fluid; Ascitis; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Mononuc; Mononuc Cells; Number concentration; Number Concentration (count/vol); Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random	4180186
42868533	Mononuc Cells # Prt Auto	4180186
42868533	单个核细胞:计数型浓度:时间点:腹膜液:定量型:自动化计数方法	4182948
42868534	Polys # Prt Auto	4180186
42868534	#; ABS; absolute; absolutes; Ascites; Ascitic fluid; Ascitis; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Peritoneal fluid; PMN; Point in time; Poly; Polys; Prt; QNT; Quan; Quant; Quantitative; Random; Segmented WBC	4180186
42868534	分叶核白细胞:计数型浓度:时间点:腹膜液:定量型:自动化计数方法	4182948
42868535	#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Number concentration; Number Concentration (count/vol); PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Segmented WBC; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
42868535	Polys # Snv Auto	4180186
42868535	分叶核白细胞:计数型浓度:时间点:滑液:定量型:自动化计数方法	4182948
42868538	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868538	HTNV IgG SerPl Ql IF	4180186
42868538	汉坦病毒 汉坦型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868539	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868539	HTNV IgM SerPl Ql IF	4180186
42868539	汉坦病毒 汉坦型 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868543	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; H saaremaa; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
42868543	H saaremaa IgM SerPl Ql IF	4180186
42868543	汉坦病毒 萨列马型 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
42868549	100WBC; Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mononuc; Mononuc Cells; Number Fraction; Percent; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868549	Mononuc Cells/leuk NFr Plr Auto	4180186
42868549	单个核细胞/100 个白细胞:计数型分数:时间点:胸膜液:定量型:自动化计数方法	4182948
42868550	100WBC; Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Pleural; Pleural fluid; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
42868550	Polys/leuk NFr Plr Auto	4180186
42868550	分叶核白细胞/100 个白细胞:计数型分数:时间点:胸膜液:定量型:自动化计数方法	4182948
42868551	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S dysgal eqsmls; S dysgal eqsmls DNA; S dysgalactiae; S dysgalactiae ssp equisimilis; S dysgalactiae subsp equisimilis; Screen; SDA; SDSE; ssp; Strand Displacement Amplification; Strep; Strep dysgalactiae; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868551	S dysgal eqsmls DNA Spec Ql NAA+probe	4180186
42868551	停乳链球菌似马亚种 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868552	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S intermedius; S. intermedius; Screen; SDA; Spec; Strand Displacement Amplification; Strep; Strep intermedius; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868552	S intermedius DNA Spec Ql NAA+probe	4180186
42868552	中间链球菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868553	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S. anginosus; S. milleri group; Screen; SDA; Spec; Strand Displacement Amplification; Strep; Strep anginosus; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868553	S anginosus DNA Spec Ql NAA+probe	4180186
42868553	咽峡炎链球菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868554	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S constellatus; S. constellatus; Screen; SDA; Spec; Strand Displacement Amplification; Strep; Strep constellatus; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868554	S constellatus DNA Spec Ql NAA+probe	4180186
42868554	星座链球菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868555	Ab40 peptide; Abeta; Abeta 40; AL beta40; B; Beta-amyloid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
42868555	AL beta40 CSF-mCnc	4180186
42868555	淀粉样蛋白 Beta 40 肽:质量浓度:时间点:脑脊液:定量型	4182948
42868556	Ab40 peptide; Abeta; Abeta 40; AL beta40; B; Beta-amyloid; Chemistry; Level; Mass concentration; Pept; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868556	AL beta40 Plas-mCnc	4180186
42868556	淀粉样蛋白 Beta 40 肽:质量浓度:时间点:血浆:定量型	4182948
42868558	Alfa; Cerebral spinal fluid; Cerebrospinal Fl; CG Antigen-Specific Helper Factor; Chemistry; Epidermal Cell Derived Thymocyte-Activating Factor; ETAF; i; IL; IL1; IL-1; IL-1a; Il1Alpha; IL-1α; Level; Lymphocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T Helper Factor	4180186
42868558	Il1Alpha CSF-mCnc	4180186
42868558	白细胞介素 1 Alpha:质量浓度:时间点:脑脊液:定量型	4182948
42868561	Il2 Fld-mCnc	4180186
42868561	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Costimulator; Fl; Fld; FLU; Fluid; II; IL; IL2; IL-2; Level; Lymphocyte Mitogenic Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; T-Cell Growth Factor; T-Cell Stimulating Factor; TCGF; Thymocyte Stimulating Factor	4180186
42868561	白细胞介素 2:质量浓度:时间点:体液:定量型	4182948
42868562	Il3 SerPl-mCnc	4180186
42868562	Burst-Promoting Factor, Erythrocyte; Chemistry; Colony-Stimulating Factor 2 Alpha; Colony-Stimulating Factor, Mast-Cell; Colony-Stimulating Factor, Multipotential; Eosinophil-Mast Cell Growth-Factor; III; IL; IL3; IL-3; Level; Mass concentration; P-Cell Stimulating Factor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868562	白细胞介素 3:质量浓度:时间点:血清/血浆:定量型	4182948
42868563	Il3 CSF-mCnc	4180186
42868563	Burst-Promoting Factor, Erythrocyte; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Colony-Stimulating Factor 2 Alpha; Colony-Stimulating Factor, Mast-Cell; Colony-Stimulating Factor, Multipotential; Eosinophil-Mast Cell Growth-Factor; III; IL; IL3; IL-3; Level; Mass concentration; P-Cell Stimulating Factor; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
42868563	白细胞介素 3:质量浓度:时间点:脑脊液:定量型	4182948
42868565	Il4 Fld-mCnc	4180186
42868565	B/F; B-Cell Growth Factor-I; B-Cell Proliferating Factor; B-Cell Stimulating Factor-1; B-Cell Stimulatory Factor-1; BF; Binetrakin; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; IL; IL4; IL-4; Level; Mass concentration; Mast Cell Growth Factor-2; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868565	白细胞介素 4:质量浓度:时间点:体液:定量型	4182948
42868566	Il4 CSF-mCnc	4180186
42868566	B-Cell Growth Factor-I; B-Cell Proliferating Factor; B-Cell Stimulating Factor-1; B-Cell Stimulatory Factor-1; Binetrakin; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; IL; IL4; IL-4; Level; Mass concentration; Mast Cell Growth Factor-2; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
42868566	白细胞介素 4:质量浓度:时间点:脑脊液:定量型	4182948
42868573	Il13 Fld-mCnc	4180186
42868573	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; IL; IL13; IL-13; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42868573	白细胞介素 13:质量浓度:时间点:体液:定量型	4182948
42868580	FDA label Establishment de-registration	4180186
42868580	DOCUMENT.REGULATORY; FDA label; Narrative; Report	4180186
42868580	企业注销:-:-:^FDA 产品标签:叙述型	4182948
42868581	MTX sp10 SerPl-sCnc	4180186
42868581	Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp10; Spec; SR; Substance concentration	4180186
42868581	氨甲喋呤^第10个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868583	MTX sp3 SerPl-sCnc	4180186
42868583	Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; Spec; SR; Substance concentration	4180186
42868583	氨甲喋呤^第3个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868586	MTX sp6 SerPl-sCnc	4180186
42868586	Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; Spec; SR; Substance concentration	4180186
42868586	氨甲喋呤^第6个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868593	# chromosome 18 Amn NAA+probe	4180186
42868593	# chromosome 18; 3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Chromosom; Chromosomes; Cnt; Count; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Molecular pathology; MOLPATH; NAA+probe; NAAT; NASBA; No; Nucleic acid sequence based analysis; Num; Number; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42868593	存在的第18号染色体的数量:数量(计数):时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
42868595	CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Hosp; Integument; Pan; Panel; Panl; Pnl; Point in time; Random; Skin conditions - LTCH; Survey	4180186
42868597	CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Functional status - LTCH; Hosp; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42868598	CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Deglutition; Hosp; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; Swallowing nutritional - LTCH	4180186
42868601	CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Hearing, speech, vision - LTCH; Hosp; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42868602	CARE Survey; Continuity assessment record and evaluation; Continuity Assessment Record and Evaluation (CARE) Pnl; Healed pressure ulcers - LTCH; Hosp; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42868605	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells	4180186
42868605	Squamous Fld Ql	4180186
42868605	上皮细胞.鳞状上皮细胞型:存在情况或阈值:时间点:体液:序数型	4182948
42868606	Ciliated Fld Ql	4180186
42868606	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
42868606	上皮细胞.纤毛化:存在情况或阈值:时间点:体液:序数型	4182948
42868608	ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Yeast Hyphae	4180186
42868608	Yeast Hyphae Spec Ql KOH Prep	4180186
42868608	酵母.菌丝:存在情况或阈值:时间点:XXX:序数型:氢氧化钾制片法	4182948
42868611	CARE Survey; Continuity assessment record and evaluation; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42868613	ACIF; Anticomplement Immunofluorescence; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Rick SF; Rick Typhus; Ricket; Rickettsia TG+SFG IgG+IgM pnl; Rickettsial; Serum; SR; Time Resolved Fluorescence; TRF; Typh; Typhus	4180186
42868613	Rickettsia TG+SFG IgG+IgM pnl Ser IF	4180186
42868613	斑疹伤寒群立克次体与斑点热群立克次体急性期和恢复期抗体.IgG 与 IgM 组套:-:-:血清:-:免疫荧光法	4182948
42868615	Rick Typhus IgG sp2 Titr Ser IF	4180186
42868615	立克次体斑疹伤寒群 抗体.IgG^第2个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42868615	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Convalescent; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; Random; Rick Typhus; Ricket; Rickettsial; Second; Serum; SmQn; sp2; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Typh; Typhus	4180186
42868616	Rick Typhus IgM sp1 Titr Ser IF	4180186
42868616	立克次体斑疹伤寒群 抗体.IgM^第1个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42868616	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Pre immunization; Random; Rick Typhus; Ricket; Rickettsial; Serum; SmQn; sp1; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Typh; Typhus	4180186
42868618	Rick SF IgM sp1 Titr Ser IF	4180186
42868618	斑点热群立克次体 抗体.IgM^第1个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42868618	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Pre immunization; Random; Rick SF; Ricket; Rickettsial; Serum; SmQn; sp1; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42868619	Rick SF IgM sp2 Titr Ser IF	4180186
42868619	斑点热群立克次体 抗体.IgM^第2个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42868619	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Convalescent; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; Random; Rick SF; Ricket; Rickettsial; Second; Serum; SmQn; sp2; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42868622	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
42868622	Benzodiaz Ur Scn-mCnc	4180186
42868622	苯并二氮:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
42868627	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;300 ng/mL; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn	4180186
42868627	Methadone Ur Ql Scn>300 ng/mL	4180186
42868627	美沙酮:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 300 纳克/毫升	4182948
42868629	Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;200 ng/mL; Scr; Screen; Scrn; UA; UR; Urn	4180186
42868629	Barbiturates Ur Ql Scn>200 ng/mL	4180186
42868629	巴比妥类药物:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 200 纳克/毫升	4182948
42868630	ABL; ABL1; ABL1 transcript; Acute myeloid leukemia; AML; Blood; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; inv(16)(CBFB,MYH11) gene inversion; inv(16)(p13;q22); Inversion 16; Log Nrto; Log number ratio; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868630	inv(16)(p13;q22)/control Bld/T-LnRto	4180186
42868630	inv(16)(p13.1;q22.1)(MYH11,CBFB) 融合转录物/对照转录物:对数型数量或计数比率:时间点:全血/组织:定量型	4182948
42868632	Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Time stamp; Timestamp	4180186
42868633	Tdecenoylcarn/C14 DBS-sRto	4180186
42868633	Blood; C14; C14:1; Chemistry; DBS; Dried blood spot; Filter paper; FP; i; Myristoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tdecanoylcarn; Tdecenoylcarn; WB; Whole blood	4180186
42868633	十四烯酰肉碱 (C14:1)/十四烷酰肉碱 (C14):物质的量比率:时间点:全血.斑点:定量型	4182948
42868634	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Reason for assess-CARE-acute; Survey	4180186
42868636	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Genital tract; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification; Urth	4180186
42868636	C trach+GC pnl Urth NAA+probe	4180186
42868636	沙眼衣原体与淋病奈瑟菌 rRNA 组套:-:时间点:尿道:-:探针法.基因扩增.靶向	4182948
42868639	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gen-Probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; T vaginalis; TMA; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42868639	T vaginalis rRNA Vag Ql NAA+probe	4180186
42868639	阴道毛滴虫 rRNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
42868641	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; T vaginalis; TMA; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; UA; UR; Urn	4180186
42868641	T vaginalis rRNA Ur Ql NAA+probe	4180186
42868641	阴道毛滴虫 rRNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
42868642	Hct; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; PCV; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; Volfr; Volume fraction	4180186
42868642	Hct VFr Snv	4180186
42868642	血细胞压积:体积分数:时间点:滑液:定量型	4182948
42868643	Hct; HEMATOLOGY/CELL COUNTS; Lung; PCV; Percent; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; thoracentesis fluid; Volfr; Volume fraction	4180186
42868643	Hct VFr Plr	4180186
42868643	血细胞压积:体积分数:时间点:胸膜液:定量型	4182948
42868644	nRBC/total cells NFr Plr	4180186
42868644	Cell; Cellularity; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; Gated cells; HEMATOLOGY/CELL COUNTS; Normoblasts; nRBC; nRBCs; Nuc; Number fraction; Percent; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; thoracentesis fluid	4180186
42868644	红细胞.有核/100 个细胞:计数型分数:时间点:胸膜液:定量型	4182948
42868648	C14:1DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Very long-chain acyl-CoA dehydrogenase; VLCAD	4180186
42868648	Dicarboxytetradecenoylcarn CSF-sCnc	4180186
42868648	二羧基十四烯酰肉碱 (C14:1-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
42868649	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C14:1DC; Chemistry; Dicarboxylic carnitine; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Very long-chain acyl-CoA dehydrogenase; VLCAD	4180186
42868649	Dicarboxytetradecenoylcarn Amn-sCnc	4180186
42868649	二羧基十四烯酰肉碱 (C14:1-DC):物质的量浓度:时间点:羊水:定量型	4182948
42868651	Dicarboxytetradecenoylcarn Ur-sCnc	4180186
42868651	C14:1DC; Chemistry; Dicarboxylic carnitine; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Very long-chain acyl-CoA dehydrogenase; VLCAD	4180186
42868651	二羧基十四烯酰肉碱 (C14:1-DC):物质的量浓度:时间点:尿液:定量型	4182948
42868653	1Me-hist; Chemistry; Fetal; Gyn; Gynecology; i; Level; methyl-histidine; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868653	1Me-hist SerPl Fetus-sCnc	4180186
42868653	1-甲基组氨酸:物质的量浓度:时间点:血清/血浆^胎儿:定量型	4182948
42868657	Finding; Findings; NEURO; NIHSS; NIHSS interval; Nominal; Point in time; Random; Survey; SURVEY.NEURO	4180186
42868659	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868660	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868662	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868665	Finding; Findings; L; Leg-L; Lower extremity; LT; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868666	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868667	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868668	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868669	Finding; Findings; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NEURO	4180186
42868671	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin metabolite; Illicit; Level; MAM; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
42868671	6MAM Ur Cfm-sCnc	4180186
42868671	6-单乙酰吗啡:物质的量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
42868672	ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hepatology; Hydroxyacetanilide; Illicit; Level; Liver; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tylenol; u209	4180186
42868672	APAP SerPl Scn-sCnc	4180186
42868672	对乙酰氨基酚:物质的量浓度:时间点:血清/血浆:定量型:毒理学筛查试验	4182948
42868679	DRUG/TOXICOLOGY; Drugs; Klonopin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868679	clonazePAM SerPl Scn-sCnc	4180186
42868679	氯硝安定:物质的量浓度:时间点:血清/血浆:定量型:毒理学筛查试验	4182948
42868680	Addiction; c260; C300; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Methylmorphine; Morphine methyl ether; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
42868680	Codeine Ur Cfm-sCnc	4180186
42868680	可待因:物质的量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
42868682	Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Pl; Plasma; Plsm; Point in time; pre 100 g Glc PO; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868682	Glucose pre 100 g Glc PO SerPl-sCnc	4180186
42868682	葡萄糖^在口服100 g葡萄糖之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868683	Haptoglob; HEMATOLOGY/CELL COUNTS; HP; Hpt; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42868683	Haptoglob SerPl-sCnc	4180186
42868683	触珠蛋白:物质的量浓度:时间点:血清/血浆:定量型	4182948
42868684	Addiction; c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Morphine sulfate; MS; MSO4; OMPH; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
42868684	Morphine Ur Cfm-sCnc	4180186
42868684	吗啡:物质的量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
42868686	Nordiazepam SerPl Scn-sCnc	4180186
42868686	Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Level; Madar; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Pl; Plasma; Plsm; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stilny; Substance concentration; Tranxilium N; Vegesan	4180186
42868686	去甲基安定:物质的量浓度:时间点:血清/血浆:定量型:毒理学筛查试验	4182948
42868689	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Lortab; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Vicodin	4180186
42868689	oxyCODONE Ur Cfm-sCnc	4180186
42868689	羟考酮:物质的量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
42868694	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868695	After; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Post traumatic stress disorder (PTSD) checklist - civilian version; PST; PTSD; PTSD civilian; Random; Survey; SURVEY.MTLHLTH	4180186
42868702	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH; Trouble remembering stressful experience	4180186
42868703	1 month; 1 month (30 days); 30 days; Finding; Findings; Loss of interest in things you enjoy; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868704	1 month; 1 month (30 days); 30 days; Feeling cut off from other people; Finding; Findings; month; Ordinal; Othr; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868706	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Feeling future will be cut short; Finding; Findings; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868707	1 month; 1 month (30 days); 30 days; Finding; Findings; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868710	1 month; 1 month (30 days); 30 days; Finding; Findings; month; Ordinal; Past; Post traumatic stress disorder (PTSD) checklist - civilian version; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42868716	3 Self-Sustaining Sequence Replication; 3SR SR; Ag; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; EIEC; enteroinvasive E coli; enteroinvasive Escherichia coli; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shigella; Shigella sp+EIEC ipaH; Shigellosis; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42868716	Shigella sp+EIEC ipaH Stl Ql NAA+probe	4180186
42868716	志贺菌+肠侵袭性大肠埃希菌侵袭质粒抗原 H (ipaH) 基因:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
42868718	2-BP DEL, 394TT; ABC35; ABCC7; Blood; CBAVD; CF; CFA; CFTR 2 base pair deletion; CFTR 2-BP DEL; CFTR c.394delTT; CFTR/MRP; Cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7); dJ760C5.1; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MRP7; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; TNR-CFTR; WB; Whole blood; Whole blood or Tissue	4180186
42868718	CFTR c.394delTT Bld/T Ql	4180186
42868718	CFTR 基因.c.394delTT:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868719	12q23.2; ARG408TRP; Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P prime; PAH p.R408W; PAH, ARG408TRP; PCR; PH; phenylalanine hydroxylase; Phenylalanine hydroxylase gene; PHENYLKETONURIA; PKU; PKU1; Point in time; PR; QL; Qual; Qualitative; Random; rs5030858; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42868719	PAH p.R408W Bld/T Ql	4180186
42868719	PAH 基因.p.R408W:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868723	PDH IgG Ser IA-aCnc	4180186
42868723	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Dehydrog; Dehyrdogenase; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; PDH; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
42868723	丙酮酸脱氢酶 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
42868724	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; IA2; IA-2; IA2-ab; IAA; ICA; ICA512; ICA-512; Immune globulin G; Immunoglobulin G; Islet Cell512; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; protein tyrosine phosphatase-like protein IA2; PtP-IA2; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tyrosine phosphatase	4180186
42868724	Islet Cell512 IgG SerPl Ql IA	4180186
42868724	岛细胞 512 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
42868725	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; IA2; IA-2; IA2-ab; IAA; ICA; ICA512; ICA-512; Immune globulin G; Immunoglobulin G; Islet Cell512; MEIA; Pl; Plasma; Plsm; Point in time; protein tyrosine phosphatase-like protein IA2; PtP-IA2; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tyrosine phosphatase	4180186
42868725	Islet Cell512 IgG SerPl IA-aCnc	4180186
42868725	岛细胞 512 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
42868727	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Follicle stimulating hormone; FSH; IAA; Immune globulin A; Immunoglobulin A; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
42868727	FSH IgA Ser IA-aCnc	4180186
42868727	促卵泡激素 抗体.IgA:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
42868732	Ascites; Ascitic fluid; Ascitis; Chemistry; Periton fld+SerPl; Peritoneal fluid; Pl; Plasma; Plsm; Point in time; Prt; PT-TRIG; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; S-TRIG; Tg; Trig; Trigl Prt; Trigly; Triglycerides; Triglycrides	4180186
42868732	Trigl Prt/Ser	4180186
42868732	甘油三酯.腹膜液/甘油三酯.血清:相对比率:时间点:腹膜液+血清/血浆:定量型	4182948
42868733	Chol Prt/Ser	4180186
42868733	Ascites; Ascitic fluid; Ascitis; Chemistry; Chol; Chol Prt; Choles; Cholest; Cholesterol total; Cholesterols; Lipid; Periton fld+SerPl; Peritoneal fluid; Pl; Plasma; Plsm; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868733	胆固醇.腹膜液/胆固醇.血清:相对比率:时间点:腹膜液+血清/血浆:定量型	4182948
42868735	Cardio; Cardiology; Chemistry; Chol; Chol Pcar; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Lipid; PCAR; Pericard fld+SerPl; Pericardial Fluid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868735	Chol Pcar/Ser	4180186
42868735	胆固醇.心包液/胆固醇.血清:相对比率:时间点:心包液+血清/血浆:定量型	4182948
42868737	Chemistry; Pcar; Pericard fld+SerPl; Pericardial Fluid; Pl; Plasma; Plsm; Point in time; PR; Prot; Prot Pcar; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868737	Prot Pcar/SerPl	4180186
42868737	蛋白质.心包液/蛋白质.血清:相对比率:时间点:心包液+血清/血浆:定量型	4182948
42868738	Creat Prt/Ser	4180186
42868738	Ascites; Ascitic fluid; Ascitis; Chemistry; CR; Crea; Creat; Creat Prt; Periton fld+SerPl; Peritoneal fluid; Pl; Plasma; Plsm; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42868738	肌酐.腹膜液/肌酐.血清:相对比率:时间点:腹膜液+血清/血浆:定量型	4182948
42868743	Patient Health Questionnaire; PHQ; PHQ SADS; PHQ-SADS; PHQ-SADS total score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PHQ; Sx; Tot; Totl	4180186
42868745	Patient Health Questionnaire; PHQ; PHQ 15; PHQ15; PHQ-15; PHQ-15 total score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PHQ; Tot; Totl	4180186
42868749	Arbitrary; Blood; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; III; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; NPM; Nucleolar phosphoprotein b23; Numatrin; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(3;5)(MLF1,NPM1); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868749	t(3;5)(MLF1,NPM1) Bld/T Ql	4180186
42868749	t(3;5)(q25.1;q35.1)(MLF1,NPM1) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868750	21q22.3; Acute myeloid leukemia 1; AML1; Arbitrary; Blood; CBFA2; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; III; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(3;21)(MECOM,RUNX1); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868750	t(3;21)(MECOM,RUNX1) Bld/T Ql	4180186
42868750	t(3;21)(q26;q22.3)(MECOM,RUNX1) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868751	Arbitrary; Blood; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; NPM; NR1B1; Nucleolar phosphoprotein b23; Numatrin; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; Screen; T prime; t(5;17)(NPM1,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868751	t(5;17)(NPM1,RARA) Bld/T Ql	4180186
42868751	t(5;17)(q25.1;q21.1)(NPM1,RARA) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868752	ALL1; ALL-1; Arbitrary; Blood; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; HRX; HTRX; HTRX1; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(6;11)(MLLT4,MLL); Tissue; Tissue, unspecified; translocation; TRX1; WB; Whole blood; Whole blood or Tissue	4180186
42868752	t(6;11)(MLLT4,MLL) Bld/T Ql	4180186
42868752	t(6;11)(q27;q23)(MLLT4,MLL) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868754	ABL; Arbitrary; Blood; DNA; ets variant gene 6; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Ordinal; p150; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(9;12)(ABL1,ETV6); TEL; Tel oncogene; TEL1; Tissue; Tissue, unspecified; translocation; Translocation ets leukemia; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Tissue	4180186
42868754	t(9;12)(ABL1,ETV6) Bld/T Ql	4180186
42868754	t(9;12)(q34.1;p13)(ABL1,ETV6) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868759	ALS6; Amyotrophic lateral sclerosis type 6; Arbitrary; Blood; DNA; ETM4; FUS1; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(16;21)(FUS,ERG); Tissue; Tissue, unspecified; TLS; Translocated in liposarcoma; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868759	t(16;21)(FUS,ERG) Bld/T Ql	4180186
42868759	t(16;21)(p11.2;q22.3)(FUS,ERG) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868760	Arbitrary; Blood; DNA; E2A Immunoglobulin enhancer binding factors E12/E47; gene fusion; gene translocation; Genetics; Heredity; Heritable; Immunoglobulin transcription factor 1; Inherited; ITF1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(17;19)(HLF,TCF3); Tissue; Tissue, unspecified; Transcription factor 3; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868760	t(17;19)(HLF,TCF3) Bld/T Ql	4180186
42868760	t(17;19)(q22;p13.3)(HLF,TCF3) 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868761	Del(1p32)(STIL,TAL1) Bld/T Ql	4180186
42868761	Acute lymphoblastic leukaemia; ALL; Blood; Del(1p32)(STIL,TAL1); del(1p32)(STIL,TAL1) gene deletion; DNA; gene fusion; gene translocation; i; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; SCL/TAL1 interrupting locus; Screen; tal-1 deletions; T-ALL; T-cell acute lymphoblastic leukemia; Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
42868761	del(1)(p32p32)(STIL,TAL1) 融合转录物:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
42868764	3 Self-Sustaining Sequence Replication; 3SR SR; Ameba; Amebiasis; Amebic; Amoeba; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E dispar; E his+dis+ecua+nutt; E histolyt; E histolytica; E histolytica dispar complex; Entamoeba histolytica dispar complex; Entamoeba histolytica/dispar complex; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42868764	E his+dis+ecua+nutt DNA Spec Ql NAA+prb	4180186
42868764	溶组织内阿米巴+迪斯帕内阿米巴+厄瓜多尔内阿米巴+纳氏内阿米巴 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42868765	Amoeba; Deoxyribonucleic acid; high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Next generation sequencing; NGS; Nominal; Other; Point in time; Random; Spec; species; spp; To be specified in another part of the message; Unspecified	4180186
42868765	Entamoeba DNA Spec Seq	4180186
42868765	内阿米巴属单个未知种 DNA:存在与否或特征标识:时间点:XXX:名义型:序列测定	4182948
42868767	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P shigelloides; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
42868767	P shigelloides DNA Stl Ql NAA+probe	4180186
42868767	类志贺毗邻单胞菌 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
42868768	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Pan; Panl; Pnl; Point in time; Pt info panel; Random; Survey	4180186
42868769	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD survey; Mineral metabolism pnl; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42868771	Dialy; Dialysis adequacy Pnl; End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42868772	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain stomach area past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868773	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Headaches past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868774	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Help doing my activities past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868775	Feel tired past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868776	Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Short of breath past 7D; Survey; SURVEY.GNHLTH	4180186
42868777	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Self-conscious about dress past 7D; Survey; SURVEY.GNHLTH	4180186
42868778	Arms are swollen past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868784	Feel like woman past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868785	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble controlling urine past 7D	4180186
42868788	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Gender; Interested in sex past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868789	Able to have erection past 7D; Able to have maintain erection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868791	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Get around by myself past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868793	Bone pain past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868794	Able to concentrate past 7D; Cnc; Conc; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868795	Bothered by chg in personality past 7D; Exchange; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
42868796	Able to make decisions past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868797	Bothered by drop in family contribution past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868799	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Need help caring for self past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868800	Able to put thoughts into action past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868807	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868808	Can remember new things past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868809	Cannot do things I used past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868810	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I am afraid of having a seizure past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868811	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble with eyesight past 7D	4180186
42868812	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868814	Difficulty expressing thoughts past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868815	Bdy temp; bod; Bodies; Finding; Findings; Functional Assessment of Chronic Illness Therapy; I am bothered by fevers past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Temp	4180186
42868817	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Losing weight past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Wt	4180186
42868822	Appear; Appr; bod; Bodies; Finding; Findings; Functional Assessment of Chronic Illness Therapy; I like my body past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868823	Embarrassed by ostomy appliance past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868824	Caring for ostomy appliance diff past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868828	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have strength in legs past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868829	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Numbness in legs past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868830	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain in back past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868831	Disch; Discharge bleeding from vagina past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868832	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Odor from vagina past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868833	Afraid to have sex past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Gender; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868834	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Vagina feels too narrow past 7D	4180186
42868835	Afraid tx will harm body past 7D; bod; Bodies; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42868836	Constipation in past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868837	Discomfort when urinate past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868840	Deglutition; Difficulty swallowing liquids past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868844	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Wake at night because coughing past 7D	4180186
42868846	Discomfort pelvic area past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868847	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hot flashes past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868849	Cold sweats past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868850	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Night sweats past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868853	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain discomfort w intercourse past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868856	Deglutition; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble swallowing food past 7D	4180186
42868857	Bothered by gas past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Gases; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868858	Bothered by reflux heartburn past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868862	Avoid going out to eat d/t illness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868864	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Satisfied how coping past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42868867	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about dying past 7D	4180186
42868869	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I am able to work past 7D; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868870	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work is fulfilling past 7D	4180186
42868871	Able to enjoy life past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868874	Enjoying things do for fun past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868876	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Lack of energy past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868877	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Nausea past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868878	Because of condition trouble meeting the needs past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Past 7D trouble meeting family needs; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868879	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868880	Bothered by side effects of tx past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42868881	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868882	Finding; Findings; Forced to spend time in bed past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868883	Feel close to friends past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868888	Feel close to partner past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Persons; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; World Heatlth Organization	4180186
42868892	Bdy temp; bod; Bodies; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have had fevers past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Temp	4180186
42868895	Discomfort pain stomach area past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868896	Feel weak all over past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868897	Feel fatigued past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868898	Able to eat foods I like past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868903	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have trouble breathing past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868905	Able to eat much food as I want past 7D; Arterial Stenosis; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868906	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Unhappy with face neck look past 7D	4180186
42868910	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit social activity because of condition past 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868913	Coughing past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868914	Feel tightness in my chest past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868921	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Isolated from others b/c of illness past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42868924	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain at melanoma surgical site past 7D; Ql; Qual; Qualitative; Screen; Surg; Survey; SURVEY.GNHLTH	4180186
42868925	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Swelling at melanoma site past 7D	4180186
42868929	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Swelling keeps from doing things past 7D	4180186
42868931	Feel numbness at surgical site past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Surg; Survey; SURVEY.GNHLTH	4180186
42868932	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Good range of movement arm leg past 7D; Last; Lower extremity; Ordinal; Ql; Qual; Qualitative; Rnge; Screen; Survey; SURVEY.GNHLTH; Upper extremity	4180186
42868933	Appearance; Colour; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; New changes in skin past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868934	Appear; Appr; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Surg; Survey; SURVEY.GNHLTH; Worry about surgical scars past 7D	4180186
42868937	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Isolate myself from others b/c of condition past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868940	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Overwhelmed by condition past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868941	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about infections past 7D	4180186
42868943	Bothered by ringing in ears past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868948	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble hearing past 7D	4180186
42868949	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Swelling in stomach area past 7D	4180186
42868950	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868952	bod; Bodies; Certain parts body experience pain past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868954	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42868955	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I bleed easily past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868957	Bothered by discharge from vulva past 7D; Disch; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868959	Bothered by swelling past 7D; Finding; Findings; Fld; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868963	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble bending past 7D	4180186
42868965	Bothered by compression stockings past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868966	FACT; FACT-G; FACT-G - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868967	FACT; FACT-B; FACT-B - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868968	FACT; FACT-Bl; FACT-Bl - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868971	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868976	FACIT; FACIT CA specific measures panel; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Spec; Survey; SURVEY.GNHLTH	4180186
42868977	FACIT; FACIT CA spec symp ind panel; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Spec; Survey; SURVEY.GNHLTH; Sx	4180186
42868979	CNS; FACIT; FACT; FACT-CNS; FACT-CNS - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868980	FACT; FACT-Cx; FACT-Cx - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868981	FACT; FACT-E; FACT-E - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868983	FACT; FACT-Ga; FACT-Ga - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868986	FACIT; FACT; FACT-L; FACT-L - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868988	FACIT; FACT; FACT-Lym; FACT-Lym - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868991	FACIT; FACT; FACT-NP; FACT-NP - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868993	FACIT; FACT; FACT-V; FACT-V - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868994	FACIT; FACT; FACT-GP; FACT-GP - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42868996	Finding; Findings; Fullness heaviness stomach area past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868997	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868998	Bothered by chills past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42868999	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Get tired easily past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869004	FACIT; FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN - FBlSI-18; NCCN-FACT FBlSI; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869006	FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT - FBrSI-24; NCCN-FACT FBrSI; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869007	FACIT; FACT; FBSI; FBSI-8; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869010	Functional Assessment of Chronic Illness Therapy; NCCN - FCSI-19; NCCN-FACT FCSI-19; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869012	FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT - FHNSI-22; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869013	FACIT; FACIT - FHSI-8; FACT; FHSI; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869014	FACIT; FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT - FHSI-18; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869015	FACIT; FACIT - FKSI-15; FKSI-15; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869016	FACIT; FACIT - FKSI-10; FKSI-10; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869017	Dis; Diseases; Dz; FACIT; FACIT - FKSI-DRS 9; FACT; FKSI-DRS 9; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869021	FACIT; FACIT - FACT-LCS-version 4; FACT-LCS; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869022	FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT - FLSI-17; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869023	FACT; Functional Assessment of Chronic Illness Therapy; NCCN; NCCN-FACT - FLymSI-18; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869024	FACIT; FACIT - FOSI 8; FACT; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Sx	4180186
42869029	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Problems with urinating limit activities past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869030	Feel light-headed, dizzy past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869034	Blood in urine past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869037	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble moving bowels past 7D	4180186
42869038	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malaria; Malarial; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P knowlesi; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
42869038	P knowlesi DNA Bld Ql NAA+probe	4180186
42869038	诺氏疟原虫 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
42869039	Antigen; Antigens; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Identity or presence; Infectious Disease; InfectiousDisease; Malaria; Malarial; MEIA; Microbiology; Nominal; Point in time; Random; species; spp; SUDS; WB; Whole blood	4180186
42869039	Plasmodium Ag Bld IA.rapid	4180186
42869039	疟原虫亚属单个未知种 抗原:存在与否或特征标识:时间点:全血:名义型:免疫测定法.快速	4182948
42869043	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Tx; Tx for bone disease will take up family's time	4180186
42869047	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx bone disease not be effective	4180186
42869048	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx bone disease harmful to me	4180186
42869049	Dis; Diseases; Dz; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx bone disease stressful to me	4180186
42869052	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Waiting 60M before breakfast inconvenient	4180186
42869053	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Infusion bone tx cause pain; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42869056	Feeling of fullness tube feeding past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869060	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tube feeding limits do inside the house past 7D	4180186
42869061	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tube feeding limits do outside of the house past 7D	4180186
42869065	Desire to eat past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869069	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry infection fr feeding tube past 7D	4180186
42869073	Feel left out when others eating past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; L; Last; LT; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869075	Feeding tube right decision past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.GNHLTH	4180186
42869076	FACT; FACT-EGFRI-18; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869077	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin scalp feels irritated past 7D; Survey; SURVEY.GNHLTH	4180186
42869078	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin scalp dry flaky past 7D; Survey; SURVEY.GNHLTH	4180186
42869080	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin bleeds easily past 7D; Survey; SURVEY.GNHLTH	4180186
42869081	Bothered change skins sensitivity to sun past 7D; Exchange; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
42869082	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin condition interferes sleep past 7D; Survey; SURVEY.GNHLTH	4180186
42869083	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin condition affects mood past 7D; Survey; SURVEY.GNHLTH	4180186
42869088	Changes skin make life difficult past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869091	Bothered sensitivity fingernails past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869094	FACT; FACT&GOG-NTX; FACT-GOG-NTX - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869095	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Numbness tingling feet past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869096	Discomfort in hands past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869098	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Joint pain muscle cramps past 7D; Last; Musc; Muscl; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869100	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble buttoning buttons past 7D	4180186
42869101	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble feeling shape small objects past 7D; Upper extremity	4180186
42869105	FACT; FACT&GOG-NTX-13; FACT-GOG-NTX-13 - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869110	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry transplant will not work past 7D	4180186
42869112	Confidence in my nurse-s past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; nursing; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42869113	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Regret having bone marrow transplant past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42869116	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tremors in past 7D	4180186
42869118	Cost tx burden past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42869120	Bothered by sweating past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869121	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble remembering things past 7D	4180186
42869123	Annoyed easily past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869127	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hands swollen past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869132	Chemistry; Exchange; Intact Parathormone; intact parathyroid hormone; iPTH; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; PTH-Intact; PTH-Intact IO % Dif; QNT; Quan; Quant; Quantitative; Random; Replace; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
42869132	PTH-Intact IO % Dif SerPl	4180186
42869132	甲状旁腺素.完整型 术中百分比变化组套:质量浓度百分数差:时间点:血清/血浆:定量型	4182948
42869133	CA Ser Ql 18 deg C inc	4180186
42869133	Agglut; Agglutination; Agglutinins; Agglutins; AGT; CA; Cold agglutinin titration; degree; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
42869133	冷凝集素:存在情况或阈值:时间点:血清:序数型:18℃孵育	4182948
42869135	CA Ser Ql 28 deg C inc	4180186
42869135	Agglut; Agglutination; Agglutinins; Agglutins; AGT; CA; Cold agglutinin titration; degree; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
42869135	冷凝集素:存在情况或阈值:时间点:血清:序数型:28℃孵育	4182948
42869136	Bothered by way food tastes past 7D; Exchange; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
42869140	FACIT; FACIT - tx specific measures panel; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Spec; Survey; SURVEY.GNHLTH; Tx	4180186
42869141	FACIT; FACIT - non CA specific measures pnl; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Spec; Survey; SURVEY.GNHLTH	4180186
42869142	FACIT; FACIT - symp specific measures; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Spec; Survey; SURVEY.GNHLTH; Sx	4180186
42869143	FACIT; FACIT pediatric measures panel; Pan; PANEL.SURVEY.GNHLTH; Panl; PEDS; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869144	FAACT; FAACT - version 4; FACIT; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Tx	4180186
42869147	Finding; Findings; Food tastes unpleasant past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869148	Concerned about how thin past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869152	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Seem to get full quickly past 7D; Survey; SURVEY.GNHLTH	4180186
42869156	FACIT; FACIT - ascites index; FACIT-AI; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869158	Cerv; FACIT; FACIT-CD; FACIT-CD - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869159	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Tx	4180186
42869161	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869162	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit sexual activity b/c infection past 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869164	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hopeful about future past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869165	Find comfort in faith past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869167	Accepted that I have infection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869168	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry infection will get worse past 7D	4180186
42869174	Careful who I told about infection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; World Heatlth Organization	4180186
42869178	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Told partner about infection past 7D	4180186
42869180	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Told family members about infection past 7D	4180186
42869181	Emotional support from family past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869182	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have people help me past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869183	FACIT; FACIT-D; FACIT-D - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869184	Bove bowels more frequently past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869185	Afraid to be far from toilet past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869186	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit social activity b/c diarrhea past 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869188	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit sexual activity b/c diarrhea past 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869191	Diarrhea keeps wakes up at night past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869192	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Move bowels frequently to avoid accidents past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869193	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Wear protection for stool past 7D	4180186
42869198	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have energy past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869199	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Need to sleep during day past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869200	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Too tired to eat past 7D	4180186
42869205	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain in my chest past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869208	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Which side was breast operation	4180186
42869209	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Movement of arm this side painful past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Upper extremity	4180186
42869212	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Stiffness of arm this side past 7D; Survey; SURVEY.GNHLTH; Upper extremity	4180186
42869213	FACIT; FACT; FACT-BP; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869214	bod; Bodies; Finding; Findings; Functional Assessment of Chronic Illness Therapy; How many places in body felt bone pain; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42869215	Bone pain past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hurts when wt pressure where bone pain past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Wt	4180186
42869217	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Need help usual activities b/c bone pain past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869218	Finding; Findings; Forced rest during day b/c bone pain past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869223	Finding; Findings; Frustrated by bone pain past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869224	Depressed about bone pain past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869226	Activ; Actvty; Family trouble understanding past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869227	Cogn func; cognition; cognitive status; FACIT; FACT; FACT-Cog; FACT-Cog - v3; FCN; Func; Funct; Functional Assessment of Chronic Illness Therapy; III; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869230	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have had trouble concentrating past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869232	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble remembering where put things past 7D	4180186
42869233	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Had trouble remembering new information past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869235	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Had trouble finding the right words past 7D; Last; Ordinal; Ql; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.GNHLTH	4180186
42869237	Average; Avg; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Had trouble saying what I mean past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869238	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Walked into room forgot what meant get past 7D	4180186
42869242	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869245	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Thinking slower than usual past 7D	4180186
42869246	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work harder express myself clearly past 7D	4180186
42869249	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble shifting between thinking activities past 7D	4180186
42869250	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Others told trouble speaking cleary past 7D; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869252	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Others told seemed confused past 7D; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869253	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869255	Able to bring to mind words past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869257	Been able to remember to do things past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869258	Able to pay attention W/O extra effort past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869262	Able to keep track if interrupted past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869265	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Problems interfered w ability work past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869267	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Problems interfered w quality of life past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869269	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have vaginal itching past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869270	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have vaginal dryness past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869276	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about getting sick d/t low blood counts past 7D	4180186
42869278	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Get aches pains bother me past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869280	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Partner worries when blood counts low past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869284	FACT; FACT-Th11; FACT-Th11 - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869285	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about bruising bleeding past 7D	4180186
42869286	Bothered by nosebleeds past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869289	Activ; Actvty; Avoid phys activity b/c bleeding bruising past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869290	Finding; Findings; Frustrated by not able do usual activities past 7D; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869292	FACT; FACT-Th18; FACT-Th18 - version 4; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869294	Bothered by bleeding gums mouth past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869295	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Inconvenienced by platelet transfusions past 7D; Last; Ordinal; Pl; Platelets; Platelt; Plt; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Thrombocyte; Thrombocytes	4180186
42869296	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Limit social activity b/c concern bleeding past 7D; Movements; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869297	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tx; Worry tx dose reduced b/c low blood counts past 7D	4180186
42869298	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Women - bothered vaginal bleeding past 7D	4180186
42869300	Comfortable discussing condition past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869302	Bmbarrassed by condition past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869304	Far from home w/o fearing soilage past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869306	Condition wakes me up at night past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869308	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Wear protection for leakage urine past 7D	4180186
42869309	Discomfort in pelvic area past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869310	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pain in pelvic area past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869312	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sexually active or like to be sexually active; Survey; SURVEY.GNHLTH	4180186
42869314	Feel received tx right for me past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42869319	B pseudomal; B pseudomallei; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Melioidosis; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Pseudomonas pseudomallei; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
42869319	B pseudomal Spec Ql Cult	4180186
42869319	类鼻疽伯克霍尔德氏菌:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
42869321	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B mallei; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Equinia; Farcy; Glanders; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pseudomonas mallei; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42869321	B mallei DNA Spec Ql NAA+probe	4180186
42869321	鼻疽伯克霍尔德氏菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42869324	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lyssavirus; MEIA; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Rabies; RABV; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
42869324	RABV Ab CSF IA-aCnc	4180186
42869324	狂犬病病毒 抗体:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
42869327	狂犬病病毒 抗体.中和:存在情况或阈值:时间点:脑脊液:序数型:中和试验	4182948
42869327	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Conventional virus neutralization test; cVNT; ID; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; NAb; Neuro; Neurology; NEUTRALIZATION; Neutralization test; NT; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Serum virus neutralization; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SVN; Virus neutralization test; VNT	4180186
42869327	RABV NAb CSF Ql Nt	4180186
42869328	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Rabies; RABV; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
42869328	RABV IgG CSF IF-aCnc	4180186
42869328	狂犬病病毒 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫荧光法	4182948
42869331	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
42869331	RABV IgM Ser Ql IF	4180186
42869331	狂犬病病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
42869332	RABV IgM Titr Ser IF	4180186
42869332	狂犬病病毒 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42869332	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Point in time; Rabies; RABV; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42869333	RABV IgM Titr CSF IF	4180186
42869333	狂犬病病毒 抗体.IgM:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
42869333	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Neuro; Neurology; Point in time; Rabies; RABV; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42869334	ACIF; Anticomplement Immunofluorescence; FA; Fluorescent antibody; Fluoresent; ID; Identity or presence; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Isolated; Lyssavirus; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Rabies; RABV; RABV strain; Random; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
42869334	RABV strain Spec IF	4180186
42869334	狂犬病病毒株 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:免疫荧光法	4182948
42869335	high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lyssavirus; Microbiology; Misc; Miscellaneous; Next generation sequencing; NGS; Nominal; Other; Point in time; Rabies; RABV; RABV strain; Random; Spec; To be specified in another part of the message; Unspecified	4180186
42869335	RABV strain Spec Seq	4180186
42869335	狂犬病病毒株 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:序列测定	4182948
42869337	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869338	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869340	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869341	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869342	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869345	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869346	Add; Additional concerns - FACT-H+N; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869349	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869350	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869353	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869354	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869358	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869359	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869362	Add; Dextro; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869363	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869364	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869365	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869366	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869367	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869368	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869371	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869374	Cluster of differentiation; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869375	Crypt; Crypt sp rRNA gene; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Next generation sequencing; NGS; Nominal; Other; Point in time; Random; rDNA; ribosomal RNA; Spec; species; spp; To be specified in another part of the message; Unspecified	4180186
42869375	Crypt sp rRNA gene Spec Seq	4180186
42869375	隐球菌属 rRNA 基因:存在与否或特征标识:时间点:XXX:名义型:序列测定	4182948
42869379	Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; SUDS	4180186
42869379	Cryptoc Ag CSF Ql IA.rapid	4180186
42869379	隐球菌属单个未知种 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法.快速	4182948
42869383	Asp; C/sp; Cerebral spinal fluid; Cerebrospinal Fl; Cerv; CSF asp; C-spine; Document; Echography; Finding; Findings; Guid; Guide; Guided; Imaging; Neuro; Neurology; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spinal; Spinal Cord; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; ULS; Ultrasound	4180186
42869383	US Guided C-spine CSF asp	4180186
42869383	旨在抽吸脑脊液的引导:发现:时间点:颈部>脊椎.颈段:文档型:超声	4182948
42869386	C/sp; Cerv; C-spine; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Inj; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
42869386	RF Guided C-spine Inj	4180186
42869386	旨在注射的引导:发现:时间点:颈部>脊椎.颈段:文档型:放射荧光透视法	4182948
42869387	Abd; Abdo; Abdomen+; Abdominal; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Inj; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
42869387	RF Guided L-spine Inj	4180186
42869387	旨在注射的引导:发现:时间点:腹部>脊椎.腰段:文档型:放射荧光透视法	4182948
42869388	Document; Dorsal spine; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Inj; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
42869388	RF Guided T-spine Inj	4180186
42869388	旨在注射的引导:发现:时间点:胸部>脊椎.胸段:文档型:放射荧光透视法	4182948
42869392	Abd; Abdo; Abdomen+; Abdominal; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; L/sp; L-spine; Lumbar; Lumbo; PC Vertebroplasty; Perc; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
42869392	RF Guided L-spine PC Vertebroplasty	4180186
42869392	旨在经皮椎体成形术的引导:发现:时间点:腹部>脊椎.腰段:文档型:放射荧光透视法	4182948
42869397	C/sp; CAT scan; Cerv; Computed tomography; Computerized tomography; C-spine; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Stereo	4180186
42869397	Deprecated C-spine CT Stereo	4180186
42869401	c; Contr; Contra; Contrst; Discogram; Discography; Diskogram; Document; Dorsal spine; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; View; VWS; W contr ID; WC	4180186
42869401	RF T-spine Views W contr ID	4180186
42869401	多重视图^采用椎间盘内对比剂:发现:时间点:胸部>脊椎.胸段:文档型:放射荧光透视法	4182948
42869403	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869403	Ophthalmic medications	4180186
42869403	眼科药物:发现:时间点:^患者:叙述型	4182948
42869404	Vision testing	4180186
42869404	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869404	视力测试:发现:时间点:^患者:叙述型	4182948
42869407	Lensometry measurements	4180186
42869407	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869407	焦度测定法测定结果:发现:时间点:^患者:叙述型	4182948
42869408	Finding; Findings; In your life - needed less sleep than usual; My Mood Monitor Checklist; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42869411	Alc; alcoholic; Finding; Findings; My Mood Monitor Checklist; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx; These symptoms led to using alcohol to get by	4180186
42869412	Drug; Finding; Findings; My Mood Monitor Checklist; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx; These symptoms led to using drugs	4180186
42869413	My Mood Monitor Checklist; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869416	Can't concentrate or focus last 2W; Cnc; Conc; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; T prime	4180186
42869418	在其中确认放置情况的气道装置:发现:时间点:^患者:名义型	4182948
42869418	Finding; Findings; Nominal; Point in time; Random; TRAUMA	4180186
42869418	Airway device being confirmed NEMSIS	4180186
42869420	气道装置置入确认:发现:时间点:^患者:名义型	4182948
42869420	Airway placement confirm method	4180186
42869420	Airway placement confirm method; Finding; Findings; Meth; Method of; NEMSIS; Nominal; Point in time; Random	4180186
42869422	Emergency Medical Service(s); EMS destination; National EMS Information Services; Nominal; Point in time; Random; Typ	4180186
42869422	EMS destination NEMSIS	4180186
42869422	急救医疗服务运输目的地:类型:时间点:^设施:名义型:NEMSIS	4182948
42869424	National EMS Information Services; Nominal; Point in time; Random; Typ	4180186
42869424	认证:类型:时间点:^患者:名义型:NEMSIS	4182948
42869427	Emergency Medical Service(s); Nominal; Point in time; Random; TRAUMA; Typ	4180186
42869427	Service requested of EMS	4180186
42869427	所申请的服务:类型:时间点:急救医疗服务单元:名义型	4182948
42869432	Location; National EMS Information Services; Nominal; Point in time; Random	4180186
42869432	Chief complaint NEMSIS	4180186
42869432	主诉:位置:时间点:^患者:名义型:NEMSIS	4182948
42869433	Finding; Findings; National EMS Information Services; Nominal; Point in time; Random; Spinal; Spinal Cord	4180186
42869433	检查发现位置:发现:时间点:背部+脊椎:名义型:NEMSIS	4182948
42869439	FDA insert PMI-Get emerg medical help	4180186
42869439	DOCUMENT.REF; FDA insert; Narrative; PMI-Get emerg medical help; Report; SPL; Structured Product Labelling	4180186
42869439	PMI - 获得急救医疗协助小节:-:-:^FDA 包装说明书:叙述型	4182948
42869440	FDA insert PMI-Stop taking+call your doc	4180186
42869440	DOCUMENT.REF; FDA insert; Narrative; PMI-Stop taking+call your doc; Report; SPL; Structured Product Labelling	4180186
42869440	PMI - 停止服用并电话联系医生小节:-:-:^FDA 包装说明书:叙述型	4182948
42869441	DOCUMENT.REF; FDA insert; Narrative; PMI-Directions for use; Report; SPL; Structured Product Labelling	4180186
42869441	FDA insert PMI-Directions for use	4180186
42869441	PMI - 用法说明小节:-:-:^FDA 包装说明书:叙述型	4182948
42869443	DOCUMENT.REF; FDA insert; Narrative; PMI-Do not take; Report; SPL; Structured Product Labelling	4180186
42869443	FDA insert PMI-Do not take	4180186
42869443	PMI - 禁忌小节:-:-:^FDA 包装说明书:叙述型	4182948
42869447	#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42869447	Nuc cell # Fld Auto	4180186
42869447	有核细胞类:计数型浓度:时间点:体液:定量型:自动化计数方法	4182948
42869449	#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Immature platelets; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RP; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood; Young platelets	4180186
42869449	Platelets.reticulated # Bld Auto	4180186
42869449	血小板.网织:计数型浓度:时间点:全血:定量型:自动化计数方法	4182948
42869451	Hgb Retic Qn Auto	4180186
42869451	Auto; Automated detection; CHr; Elec; Elect; Electr; Entitic mass; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Reticulocyte hemoglobin content	4180186
42869451	血红蛋白:实体质量:时间点:网织红细胞:定量型:自动化计数方法	4182948
42869455	Polys # Fld Auto	4180186
42869455	#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC	4180186
42869455	分叶核白细胞:计数型浓度:时间点:体液:定量型:自动化计数方法	4182948
42869456	Antigen; Antigens; Flavi virus; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified	4180186
42869456	Flavivirus Ag Spec Ql ImStn	4180186
42869456	黄病毒 抗原:存在情况或阈值:时间点:XXX:序数型:免疫染色法	4182948
42869459	double stranded RNA; double-stranded RNA; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Polyacrylamide gel electrophoresis; Random; RNA; Rota virus; ROTAV; Rotaviral; Rotavirus ds; Rotavirus little(ds); Rotaviurs; RV	4180186
42869459	RV dsRNA Islt PAGE	4180186
42869459	轮状病毒 dsRNA:存在与否或特征标识:时间点:分离株:名义型:聚丙稀酰胺凝胶电泳法	4182948
42869461	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Serum; SR; SUDS	4180186
42869461	RV IgA Ser IA-aCnc	4180186
42869461	轮状病毒 抗体.IgA:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
42869462	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Serum; SR; SUDS	4180186
42869462	RV Ab Ser IA-aCnc	4180186
42869462	轮状病毒 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
42869463	MARV IgM Titr Ser IA	4180186
42869463	马尔堡病毒 抗体.IgM:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869463	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MARV; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869464	MARV IgG Titr Ser IA	4180186
42869464	马尔堡病毒 抗体.IgG:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869464	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MARV; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869466	LASV IgM Titr Ser IA	4180186
42869466	拉沙病毒 抗体.IgM:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869466	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LASV; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869467	LASV IgG Titr Ser IA	4180186
42869467	拉沙病毒 抗体.IgG:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869467	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LASV; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869472	Abort; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; IgG 1; IgG subgroup 1; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Undulant fever	4180186
42869472	B abortus IgG1+IgG2 Ser Ql IA	4180186
42869472	牛种布鲁氏菌 抗体.IgG1+IgG2:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869473	B suis Ab Titr Ser Tube aggl	4180186
42869473	猪种布鲁氏菌 抗体:滴定度:时间点:血清:定量型:凝集试验法.标准试管	4182948
42869473	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B suis; Bruc; Brucellosis; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; TA; Titer; Titered; Titre; Ttr; Tube aggl	4180186
42869474	B suis Ab Titr Ser Plate aggl	4180186
42869474	猪种布鲁氏菌 抗体:滴定度:时间点:血清:定量型:凝集法.平板	4182948
42869474	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B suis; Bruc; Brucellosis; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Plate aggl; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
42869477	Address; ADMIN; Nominal; Point in time; Random	4180186
42869477	地址:地址:时间点:工作人员:名义型	4182948
42869478	AD8 Dementia Screening Interview; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
42869481	ADMIN; Business phone #; Business phone # ext; EXT; No; Nominal; Num; Phone #; Phone # ext; Point in time; Random; Telecommunication number; Telephone number	4180186
42869481	Personnel Business phone # ext	4180186
42869481	办公电话号码分机:电话号码:时间点:工作人员:名义型	4182948
42869482	ADMIN; Business phone #; No; Nominal; Num; Phone #; Point in time; Random; Telecommunication number; Telephone number	4180186
42869482	Personnel Business phone #	4180186
42869482	办公电话号码:电话号码:时间点:工作人员:名义型	4182948
42869483	ADMIN; No; Nominal; Num; Point in time; Random; Telecommunication number; Telephone number	4180186
42869483	Personnel Fax #	4180186
42869483	传真号码:电话号码:时间点:工作人员:名义型	4182948
42869486	Personnel 5-digit postal code	4180186
42869486	5-digit postal code; ADMIN; Location; Nominal; Point in time; Random; ZIP code	4180186
42869486	5 位邮政编码:位置:时间点:工作人员:名义型	4182948
42869487	Address; ADMIN; Nominal; Point in time; Random	4180186
42869487	状态:地址:时间点:工作人员:名义型	4182948
42869488	Address; ADMIN; Nominal; Point in time; Random	4180186
42869488	城市:地址:时间点:工作人员:名义型	4182948
42869489	Address; ADMIN; II; Nominal; Point in time; Random	4180186
42869489	地址 2:地址:时间点:工作人员:名义型	4182948
42869491	ADMIN; Nominal; Point in time; Random; Typ	4180186
42869491	证书:类型:时间点:工作人员:名义型	4182948
42869493	ADMIN; Nominal; Person name; Point in time; Random	4180186
42869493	姓名后缀:人员姓名:时间点:工作人员:名义型	4182948
42869496	Personnel Last name	4180186
42869496	ADMIN; Nominal; Past; Person name; Point in time; Random	4180186
42869496	姓氏:人员姓名:时间点:工作人员:名义型	4182948
42869497	Admin; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869498	DOCUMENT.REF; Drugs; FDA label; Generic facility ID sub; Narrative; Report	4180186
42869498	FDA label Generic facility ID sub	4180186
42869498	仿制药设施身份标识提交情况:-:-:^FDA 产品标签:叙述型	4182948
42869504	ADMIN; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
42869504	Personnel unique ID	4180186
42869504	人员 唯一性标识符:标识符:时间点:工作人员:名义型	4182948
42869505	Admin; ESRD; ESRD survey; EXT; No; Nominal; Num; Phone #; Phone # ext; Point in time; Primary contact phone #; Primary contact phone # ext; Random; Survey; Telecommunication number; Telephone number	4180186
42869506	Admin; ESRD; ESRD survey; No; Nominal; Num; Phone #; Point in time; Primary contact phone #; Random; Survey; Telecommunication number; Telephone number	4180186
42869507	Admin; ESRD; ESRD survey; Given name; Nominal; Person name; Point in time; Random; Survey	4180186
42869508	Admin; ESRD; ESRD survey; Nominal; Past; Person name; Point in time; Random; Survey	4180186
42869509	My Mood Monitor Checklist; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH	4180186
42869511	Finding; Findings; My Mood Monitor Checklist; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen; Survey; SURVEY.MTLHLTH	4180186
42869512	My Mood Monitor Checklist; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH	4180186
42869513	My Mood Monitor Checklist; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH	4180186
42869515	Bowel movement; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Stl; Stool = Fecal	4180186
42869515	RV Stl Seq	4180186
42869515	轮状病毒 已鉴定的:存在与否或特征标识:时间点:大便:名义型:序列测定	4182948
42869516	high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV	4180186
42869516	RV Islt Seq	4180186
42869516	轮状病毒 已鉴定的:存在与否或特征标识:时间点:分离株:名义型:序列测定	4182948
42869517	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Screen; Serum; SR; SUDS	4180186
42869517	RV IgA Ser Ql IA	4180186
42869517	轮状病毒 抗体.IgA:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869521	Admin; ESRD; ESRD survey; Nominal; Point in time; Random; Survey	4180186
42869522	EBOV IgG Titr Ser IA	4180186
42869522	埃博拉病毒 抗体.IgG:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869522	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EBO; EBOV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869524	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MARV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
42869524	MARV IgG Ser Ql IA	4180186
42869524	马尔堡病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869526	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MARV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
42869526	MARV IgM Ser Ql IA	4180186
42869526	马尔堡病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869527	Arbitrary concentration; Blood; ID; IFN; IGRA; Infectious Disease; InfectiousDisease; Lung; Microbiology; Mitogen IGNF; Point in time; Pulmonary; Pulmonology; QFT; QNT; Quan; Quant; Quantiferon; Quantitative; Random; Respiratory; WB; Whole blood	4180186
42869527	Mitogen IGNF Bld-aCnc	4180186
42869527	丝裂原刺激型 gamma 干扰素:任意型浓度:时间点:全血:定量型	4182948
42869528	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Blood; ID; IFN; IGRA; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; M tb; M TB IFN-g; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TB; Tuberculosis; WB; Whole blood	4180186
42869528	M TB IFN-g Bld-Imp	4180186
42869528	结核分枝杆菌刺激型 gamma 干扰素:印象:时间点:全血:序数型	4182948
42869530	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Blood; ID; IFN; IGRA; Infectious Disease; InfectiousDisease; M tb; M TB IFN-g; M TB IFN-g Pnl; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; TB; Tuberculosis; WB; Whole blood	4180186
42869530	M TB IFN-g Pnl Bld	4180186
42869530	结核分枝杆菌刺激型 gamma 干扰素组套:-:时间点:全血:-	4182948
42869531	Arbitrary concentration; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; IFN; Infectious Disease; InfectiousDisease; Lung; MEIA; Microbiology; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SUDS; WB; Whole blood	4180186
42869531	Gamma interferon background Bld IA-aCnc	4180186
42869531	Gamma 干扰素本底:任意型浓度:时间点:全血:定量型:免疫测定法	4182948
42869532	My Mood Monitor Checklist; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
42869534	RVFV IgM Titr Ser IA	4180186
42869534	裂谷热病毒 抗体.IgM:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869534	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bunyavirus; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Rift valley fever; RVFV; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869535	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bunyavirus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rift valley fever; RVFV; Screen; Serum; SR; SUDS	4180186
42869535	RVFV IgG Ser Ql IA	4180186
42869535	裂谷热病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
42869537	ABS; Aby; American plague; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; yellow jack; YFV	4180186
42869537	YFV IgM CSF Ql IA	4180186
42869537	黄热病病毒 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
42869539	RVFV IgG Titr Ser IA	4180186
42869539	裂谷热病毒 抗体.IgG:滴定度:时间点:血清:定量型:免疫测定法	4182948
42869539	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bunyavirus; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Rift valley fever; RVFV; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
42869543	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42869543	N men DNA Spec NAA+probe	4180186
42869543	脑膜炎奈瑟菌 DNA:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
42869544	BP; Chg in sys B/P; Exchange; Point in time; QNT; Quan; Quant; Quantitative; Random; Replace; Survey; SURVEY.GNHLTH	4180186
42869547	Procollagen III.N-term propep Ser-mCnc	4180186
42869547	3; Chemistry; Level; Mass concentration; P3NP; PIIINP; Point in time; Procollagen III; Procollagen III.N-term propep; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
42869547	前胶原肽.III 型 N-末端:质量浓度:时间点:血清:定量型	4182948
42869550	Before; Breathing; Dynamic; Flow; Gases; Largest; Lung; Lungs; Maximal; Maximum; Peak; Peak expiratory flow; PEF; PFM; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
42869550	PEF pre therapy Airway PFM	4180186
42869550	呼气气体流量.最大值^在治疗之前:体积速率:时间点:呼吸系统.气道:定量型:最大呼吸流量测定仪	4182948
42869551	PML protein pattern Bld/T IF-Imp	4180186
42869551	ACIF; Anticomplement Immunofluorescence; Blood; Chemistry; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; PML protein; PML protein pattern; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; WB; Whole blood; Whole blood or Tissue	4180186
42869551	早幼粒细胞白血病蛋白分布模式:印象:时间点:全血/组织:序数型:免疫荧光法	4182948
42869552	Chemistry; Dicarboxyl porphyrin; Dicarboxylporphyrin; Erythrocytes; Level; Point in time; Protoporph; Protoporphrn; Protoporphyrins; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; Zinc protoporphyrin; Zn; Zn-PP; ZPP	4180186
42869552	ZPP RBC-sCnc	4180186
42869552	原卟啉.锌:物质的量浓度:时间点:红细胞:定量型	4182948
42869553	Finding; Findings; Gvn; Immunization status; Nominal; Point in time; Random; Reason immuniz not given; Survey; SURVEY.GNHLTH; Vaccination; Vaccinations; Vaccine	4180186
42869554	Adher to med instructions; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42869556	Finding; Findings; Nominal; Point in time; Random; Reason intervent refusal; Survey; SURVEY.GNHLTH	4180186
42869560	11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; 17-Hydroxycorticosterone; c155; Chemistry; Compound E; Compound F; Coritsol; Cort; Cortis F; Cortisone free; F; FR; hydrocortisone; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UR; Urn	4180186
42869560	Cortis F/Cortisone Free Ur-sRto	4180186
42869560	皮质醇.游离型/可的松.游离型:物质的量比率:时间点:尿液:定量型	4182948
42869562	Finding; Findings; My Mood Monitor Checklist; No pleasure since last screen; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869563	Finding; Findings; My Mood Monitor Checklist; No energy since last screen; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869568	Eaten more since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869570	Feel worried since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869574	Finding; Findings; My Mood Monitor Checklist; Nightmares since last screen; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869576	Avoid bad experiences since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869577	Feel dull numb since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869578	Can't get things out of mind since last screen; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH; T prime	4180186
42869580	Check recheck since last screen; Finding; Findings; Inspection; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Survey; SURVEY.MTLHLTH	4180186
42869583	Hct VFr.DF Fld	4180186
42869583	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Hct; HEMATOLOGY/CELL COUNTS; PCV; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42869583	血细胞压积:体积分数.小数型:时间点:体液:定量型	4182948
42869584	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Hct; HEMATOLOGY/CELL COUNTS; PCV; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous	4180186
42869584	Hct VFr.DF BldV	4180186
42869584	血细胞压积:体积分数.小数型:时间点:静脉全血:定量型	4182948
42869587	Hct VFr.DF BldA	4180186
42869587	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Hct; HEMATOLOGY/CELL COUNTS; PCV; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42869587	血细胞压积:体积分数.小数型:时间点:动脉全血:定量型	4182948
42869588	Hct VFr.DF Bld Auto	4180186
42869588	Auto; Automated detection; Blood; Elec; Elect; Electr; Hct; HEMATOLOGY/CELL COUNTS; PCV; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
42869588	血细胞压积:体积分数.小数型:时间点:全血:定量型:自动化计数方法	4182948
42869589	Centrifugation; Centrifuged; Chemistry; Cryo; Cryoglobulins; Cryoprecipitate; Point in time; Post centrifugation; QNT; Quan; Quant; Quantitative; Random; Ser; Serum; SR; Tot; Totl; Westerg; Westrgrn	4180186
42869589	Cryoglob VFr.DF Ser Spun Westergren	4180186
42869589	冷球蛋白/血清.总计:体积分数.小数型:时间点:血清:定量型:离心魏氏法	4182948
42869590	CLIN; Gases; IhG; Inhaled Gas; Inspired; O2; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Tot; Totl	4180186
42869590	FIO2	4180186
42869590	氧/气体.总计:体积分数.小数型:时间点:吸入的气体:定量型	4182948
42869592	OxyHgb MFr.DF BldMV	4180186
42869592	Bld mixed venous; Blood - mixed venous; Chemistry; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Point in time; QNT; Quan; Quant; Quantitative; Random; SO2; Tot; Totl	4180186
42869592	氧合血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:混合静脉全血:定量型	4182948
42869601	Bld mixed venous; Blood - mixed venous; Chemistry; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2	4180186
42869601	SaO2 DF BldMV	4180186
42869601	氧饱和度:质量分数.小数型:时间点:混合静脉全血:定量型	4182948
42869606	Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; Lung; O2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2	4180186
42869606	SaO2 DF BldC	4180186
42869606	氧饱和度:质量分数.小数型:时间点:毛细血管全血:定量型	4182948
42869609	DO-Hgb MFr.DF BldA	4180186
42869609	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Deoxygenated hemoglobin; Deoxyhaemoglobin; DO-Hgb; Ferrohaemoglobin; Ferrohemoglobin; Haemoglobin; Hb; Hgb; HHb; Point in time; QNT; Quan; Quant; Quantitative; Random; Reduced hemoglobin; RHB; Tot; Totl	4180186
42869609	还原血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:动脉全血:定量型	4182948
42869616	Hgb Lepore MFr.DF Bld	4180186
42869616	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Lepore; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869616	血红蛋白 Lepore/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869619	Blood; Fetal hemoglobin; Haemoglobin; Hb; HbF; HEMATOLOGY/CELL COUNTS; Hgb; Hgb F; High performance liquid chromatography; High pressure liquid chromatography; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869619	Hgb F MFr.DF Bld HPLC	4180186
42869619	血红蛋白 F/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:高效液相色谱分析法	4182948
42869620	Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Fetal hemoglobin; Haemoglobin; Hb; HbF; HEMATOLOGY/CELL COUNTS; Hgb; Hgb F; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869620	Hgb F MFr.DF Bld Elph	4180186
42869620	血红蛋白 F/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:电泳	4182948
42869621	Hgb E MFr.DF Bld HPLC	4180186
42869621	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb E; High performance liquid chromatography; High pressure liquid chromatography; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869621	血红蛋白 E/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:高效液相色谱分析法	4182948
42869622	Blood; Dextro; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb D; High performance liquid chromatography; High pressure liquid chromatography; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869622	Hgb D MFr.DF Bld HPLC	4180186
42869622	血红蛋白 D/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:高效液相色谱分析法	4182948
42869623	Blood; Dextro; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb D; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869623	Hgb D MFr.DF Bld	4180186
42869623	血红蛋白 D/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869624	Hgb C MFr.DF Bld HPLC	4180186
42869624	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb C; High performance liquid chromatography; High pressure liquid chromatography; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869624	血红蛋白 C/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:高效液相色谱分析法	4182948
42869625	Hgb C MFr.DF Bld	4180186
42869625	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb C; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869625	血红蛋白 C/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869626	Bart; Bart's; Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Barts; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869626	Hgb Barts MFr.DF Bld	4180186
42869626	血红蛋白 Barts/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869627	Hgb A2 MFr.DF Bld	4180186
42869627	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A2; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869627	血红蛋白 A2/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869628	Hgb A2 MFr.DF Bld HPLC	4180186
42869628	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A2; High performance liquid chromatography; High pressure liquid chromatography; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869628	血红蛋白 A2/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:高效液相色谱分析法	4182948
42869629	Hgb A2 MFr.DF Bld Elph	4180186
42869629	Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A2; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869629	血红蛋白 A2/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:电泳	4182948
42869632	Hgb A MFr.DF Bld HPLC	4180186
42869632	Blood; Haemoglobin; Hb; HbA; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A; High performance liquid chromatography; High pressure liquid chromatography; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869632	血红蛋白 A/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型:高效液相色谱分析法	4182948
42869636	MetHgb MFr.DF BldC	4180186
42869636	Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Methaemoglobin; MetHb; Methgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
42869636	高铁血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:毛细血管全血:定量型	4182948
42869637	MetHgb MFr.DF BldA	4180186
42869637	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Methaemoglobin; MetHb; Methgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
42869637	高铁血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:动脉全血:定量型	4182948
42869638	Blood; Chemistry; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Methaemoglobin; MetHb; Methgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
42869638	MetHgb MFr.DF Bld	4180186
42869638	高铁血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869639	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl; Venous	4180186
42869639	COHgb MFr.DF BldV	4180186
42869639	碳氧血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:静脉全血:定量型	4182948
42869642	Bld cord; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Cord arterial blood; Cord BldA; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
42869642	COHgb MFr.DF BldCoA	4180186
42869642	碳氧血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:脐带动脉全血:定量型	4182948
42869643	Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Finger stick; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl	4180186
42869643	COHgb MFr.DF BldC	4180186
42869643	碳氧血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:毛细血管全血:定量型	4182948
42869645	Blood; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl; WB; Whole blood	4180186
42869645	COHgb MFr.DF Bld	4180186
42869645	碳氧血红蛋白/血红蛋白.总计:质量分数.小数型:时间点:全血:定量型	4182948
42869646	My Mood Monitor Checklist; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869654	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869658	4 weeks; Emot probs interfere past 4W; Emot probs interferedw soc act past 4W; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869660	4 weeks; Finding; Findings; Happy person past 4W; Last; Ordinal; Persons; QL; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869661	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND; Worn out past 4W	4180186
42869662	4 weeks; Downhearted blue past 4W; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869665	4 weeks; Down in dumps past 4W; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869667	4 weeks; Finding; Findings; Full of pep past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869672	4 weeks; Accomplished less than like past 4W; Arterial Stenosis; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869675	4 weeks; Arterial Stenosis; Finding; Findings; Job; Last; Limited in kind of work past 4W; LMTED; LTD; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869676	4 weeks; Accomplished less than you like past 4W; Arterial Stenosis; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869678	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869680	Finding; Findings; Limit walking several blocks; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869681	Finding; Findings; Limit walking &gt; mile; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869682	Finding; Findings; Limit bending kneeling stooping; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869683	Finding; Findings; Limit climbing 1 flight stairs; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869685	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869686	Arterial Stenosis; Finding; Findings; Limit in moderate activities; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869687	Arterial Stenosis; Finding; Findings; Limit in vigorous activities; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869689	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; SF-12; SF-36; SURVEY.GNHLTH; Veterans RAND; VR-12	4180186
42869691	Assessment; Dextro; Eval; H&P; History and physical; P prime; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Pnl; Point in time; Random; S prime; Survey; SURVEY.GNHLTH	4180186
42869693	Minnesota Living with Heart Failure Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Tot; Totl	4180186
42869695	Kansas City Cardiomyopathy Questionnaire; KCCQ; Overall KCCQ; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869700	AD8; AD8 Dementia Screening Interview; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869701	IQCODE; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
42869702	Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; SLUMS; Survey; SURVEY.MTLHLTH	4180186
42869705	HAQ; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
42869706	IDI; Infant Devleopment Inventory; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869707	CDI; Child Devleopment Inventory; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869710	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869711	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869713	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869717	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869718	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869720	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; T-score	4180186
42869721	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869732	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869733	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869734	Meth; Method of; Obl; Phys score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869738	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869739	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869742	Meth; Method of; Obl; Phys score; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869743	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869746	Emotional stability; Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869747	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869748	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869749	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869750	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869752	Meth; Method of; Phys score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869754	Emotional stability; Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869755	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869756	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869757	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869758	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869760	Meth; Method of; Phys score; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869761	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869763	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869764	Emotional stability; Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869765	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869766	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869770	Meth; Method of; Obl; Phys score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869771	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SF-12; SF-36; Survey; SURVEY.GNHLTH; Veterans RAND	4180186
42869772	Emotional stability; Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869773	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869775	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869778	Meth; Method of; Obl; Phys score; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869779	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869781	Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869782	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869783	Meth; Method of; Point in time; QNT; Quan; Quant; Quantitative; Random; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
42869786	Dextro; End Stage Renal Disease; ESRD survey; Finding; Findings; Oral vit D analog prescribed; Ordinal; Osteoporosis; Point in time; QL; Qual; Qualitative; Random; Rickets; Screen; Survey; Vitamin D deficiency	4180186
42869787	Dextro; End Stage Renal Disease; ESRD survey; Nominal; Non-oral vit D analog prescribed; Oral vit D analog prescribed; Osteoporosis; Point in time; Random; Rickets; Survey; Typ; Vitamin D deficiency	4180186
42869788	Dextro; End Stage Renal Disease; ESRD survey; Finding; Findings; Non-oral vit D analog prescribed; Oral vit D analog prescribed; Ordinal; Osteoporosis; Point in time; QL; Qual; Qualitative; Random; Rickets; Screen; Survey; Vitamin D deficiency	4180186
42869789	Dextro; End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Osteoporosis; Pan; Panl; Pnl; Point in time; Random; Rickets; Survey; Vitamin D deficiency	4180186
42869793	AV graft assessed using doppler; DOP; DUPLEX; Echography; ESRD; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; ULS; Ultrasound	4180186
42869794	ESRD; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869796	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Testing of AV graft for access dysfunc	4180186
42869797	Before; Count/time; End Stage Renal Disease; ESRD survey; nRate; Number rate; Number Rate = Count/Time; Often arterial pre-pump press measured; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869799	Count/time; Dialy; Dialysis access phys exam freq; ESRD; ESRD survey; nRate; Number rate; Number Rate = Count/Time; Ordinal; PE; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869800	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; PEA; Phys exam dialysis access performed; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869802	End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42869803	ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869804	Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869805	Dialy; ESRD; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
42869806	Cath; ESRD; ESRD survey; Extraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Remove; Survey	4180186
42869807	Cath; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869813	ESRD; ESRD survey; Finding; Findings; FLUV; ID; Immunizations; Infectious Disease; InfectiousDisease; Influ; Influenza vacc received; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Vaccine	4180186
42869814	ESRD; ESRD survey; Immunizations; Nominal; Point in time; Random; Survey; Typ; Vaccine	4180186
42869815	ESRD; ESRD survey; Location; Nominal; Point in time; Random; Survey; Where vaccine received	4180186
42869816	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Immunizations; Pan; Panl; Pnl; Point in time; Random; Survey; Vaccine	4180186
42869817	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42869824	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; month; Na; Na+; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sodium profil-model prescrib report Mo; Survey	4180186
42869825	ESRD; ESRD survey; Finding; Findings; L; LT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869830	BP; Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869834	Dry wt order present; End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Wt	4180186
42869836	Date sodium education; End Stage Renal Disease; ESRD survey; Na; Na+; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42869838	End Stage Renal Disease; ESRD survey; Exchange; Finding; Findings; L; Left ventric hypertrophy change; LT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey	4180186
42869841	2; Brigance II Screen; BS II; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869845	FDA label ID of CBER-reg GDF	4180186
42869845	Center for Biologics Evaluation and Research; DOCUMENT.REF; Drugs; FDA label; ID of CBER-reg GDF; Narrative; Report	4180186
42869845	CBER 所监管的普通药品设施的标识:-:-:^FDA 产品标签:叙述型	4182948
42869848	Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Point in time; QNT; QoL score; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869849	Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869852	Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869855	ADL score; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869856	Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Sx	4180186
42869857	Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
42869858	Acute + chron leuk; Acute+chron leuk Pnl; Blood; Molecular genetics; Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42869858	Acute+chron leuk Pnl Bld/T	4180186
42869858	急性与慢性白血病融合转录物组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
42869862	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42869862	Sapovirus RNA Spec Ql NAA+probe	4180186
42869862	札如病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42869863	Finding; Findings; National EMS Information Services; Nominal; Point in time; Random; Reason proced not performed	4180186
42869863	Reason proced not performed NEMSIS	4180186
42869863	关于没有执行操作的原因:发现:时间点:^患者:名义型:NEMSIS	4182948
42869864	Reason medication not Gvn NEMSIS	4180186
42869864	Finding; Findings; Gvn; National EMS Information Services; Nominal; Point in time; Random; Reason med not given	4180186
42869864	关于没有药物的原因 给予的:发现:时间点:^患者:名义型:NEMSIS	4182948
42869865	National EMS Information Services; Nominal; Point in time; Random; Typ	4180186
42869865	抱怨:类型:时间点:^患者:名义型:NEMSIS	4182948
42869867	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 36 Mo; Totl	4180186
42869868	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 33 Mo; Totl	4180186
42869869	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 30 Mo; Totl	4180186
42869870	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 27 Mo; Totl	4180186
42869872	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 22 Mo; Totl	4180186
42869874	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 18 Mo; Totl	4180186
42869875	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 16 Mo; Totl	4180186
42869877	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 12 Mo; Totl	4180186
42869878	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 10 Mo; Totl	4180186
42869879	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 9 Mo; Totl	4180186
42869880	ASQ; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Total score - ASQ 8 Mo; Totl	4180186
42869884	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869884	Confrontation visual field	4180186
42869884	面对面视野:发现:时间点:^患者:叙述型	4182948
42869887	Ant seg; DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869887	Eye anterior segment	4180186
42869887	眼前段:发现:时间点:^患者:叙述型	4182948
42869889	Lacrimal	4180186
42869889	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
42869889	泪腺:发现:时间点:^患者:叙述型	4182948
42869891	Assessment; Eval; H&P; History and physical; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
42869891	总体眼睛评价:-:时间点:^患者:-	4182948
42869892	DOC.MISC; Finding; Findings; MISC; Narrative; PE; Point in time; Random; Report	4180186
42869892	Ocular physical exam	4180186
42869892	眼部体格检查:发现:时间点:^患者:叙述型	4182948
42869894	End Stage Renal Disease; ESRD survey; FCN; Finding; Findings; Func; Funct; Kidney; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42869901	Bdy surface; bod; Bodies; BSA; Cl; Clear; Clearanc; Clearances; Clr; CR; Crea; Creat; Creat clear; Creat clear corrected for BSA using std mthd; End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Surf; Survey	4180186
42869902	Dialy; End Stage Renal Disease; ESRD survey; Meth; Method of; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; Survey; To be specified in another part of the message; Typ; Unspecified	4180186
42869903	?Tm; adj; Bdy weight; bod; Bodies; Calc; Calculation; ESRD; ESRD survey; Mass Rate; mRate; Pl; Plasma; Plsm; PR; Prot; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Survey; Wt	4180186
42869904	Dialy; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Survey; V.Peritnl Dialysis	4180186
42869905	ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Survey	4180186
42869906	@ PD adequacy measure; Bdy weight; bod; Bodies; Dialy; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Wt	4180186
42869907	Dialy; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Survey; V.Peritnl Dialysis	4180186
42869908	Dialy; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Survey; V.Peritnl Dialysis	4180186
42869909	2; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Survey	4180186
42869910	ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Survey	4180186
42869914	Cryoglob Ser Ql Hypotonic dilution	4180186
42869914	Cryo; Cryoglobulins; Cryoprecipitate; Dil; Dilut; HYPO; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
42869914	冷球蛋白:存在情况或阈值:时间点:血清:序数型:低渗稀释	4182948
42869915	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB dressing past 7D; Survey; SURVEY.GNHLTH	4180186
42869917	Finding; Findings; Functional Assessment of Chronic Illness Therapy; II; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking up 20 stairs w/o stopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869919	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB washing dishes past 7D; Survey; SURVEY.GNHLTH	4180186
42869920	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB sweeping or mopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869922	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB lifting 10-20 lbs past 7D; Survey; SURVEY.GNHLTH	4180186
42869924	Finding; Findings; Functional Assessment of Chronic Illness Therapy; i; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking faster than usual .5 mile w/o stopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869925	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869927	FACIT; FACIT-Dyspnea; FACIT-Dyspnea - 33 item bank; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869929	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB taking a shower past 7D; Survey; SURVEY.GNHLTH	4180186
42869933	Control; Finding; Findings; Functional Assessment of Chronic Illness Therapy; i; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking .5 mile normal speed w/o stopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869934	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking up 5 stairs w/o stopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869935	Finding; Findings; Functional Assessment of Chronic Illness Therapy; i; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking up 10 stairs w/o stopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869936	Finding; Findings; Functional Assessment of Chronic Illness Therapy; III; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking up 30 stairs w/o stopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869938	Finding; Findings; Functional Assessment of Chronic Illness Therapy; II; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB lifting 5-10 lbs past 7D; Survey; SURVEY.GNHLTH	4180186
42869939	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB lifting more than 20 lbs past 7D; Survey; SURVEY.GNHLTH	4180186
42869940	Finding; Findings; Functional Assessment of Chronic Illness Therapy; II; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB carrying &lt; 5 lbs one room to another past 7D; Survey; SURVEY.GNHLTH	4180186
42869941	Finding; Findings; Functional Assessment of Chronic Illness Therapy; II; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB carrying 5-10 lbs one room to another past 7D; Survey; SURVEY.GNHLTH	4180186
42869945	Activ; Actvty; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Levels; Levl; LV; LVL; Movements; Ordinal; Ql; Qual; Qualitative; Screen; SOB moderate-intensity leisure activity past 7D; Survey; SURVEY.GNHLTH	4180186
42869947	Finding; Findings; Functional Assessment of Chronic Illness Therapy; i; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB walking, faster than usual at least 1 mi. w/o stopping past 7D; Survey; SURVEY.GNHLTH	4180186
42869951	FACIT; FACIT-Pal; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869952	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869953	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Maintain contact with friends past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869954	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have family members take responsibilities past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; World Heatlth Organization	4180186
42869955	Feel family appreciates me past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869956	Feel like burden to family past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869957	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I am constipated past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869958	bod; Bodies; Finding; Findings; Functional Assessment of Chronic Illness Therapy; I have swelling parts of body past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869959	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My mouth throat are dry past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869964	Able to make decisions past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869965	Able to reconcile with other people; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869966	Able to discuss concerns w/ people closest to me past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869971	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869974	Feel sense of harmony within myself past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869977	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My illness strengthened faith past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869979	FACIT; FACIT-Sp-Ex; FACIT-Sp-Ex - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869984	Able to forgive others past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869986	Feel a sense of thankfulness for my life past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869988	Feel sense of appreciation for nature past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869989	Feel compassion for others past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869990	FACIT; FACIT-Sp - non-illness; FACIT-Sp - non-illness - version 4; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42869993	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Pharmacist advises adverse effects medicines past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42869999	FACIT; FACIT-TS-G - version 1; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Tx	4180186
42870000	Finding; Findings; Functional Assessment of Chronic Illness Therapy; How do you rate effectiveness of tx so far; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870003	Feel you received tx that right for you; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870006	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870009	FACIT; FACIT-TS-PS - version 1; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Tx	4180186
42870013	Drs explain the possible benefits of tx; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870014	Drs explain side effects risks of tx; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870016	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870017	Did you get to say things that were important; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
42870018	Drs understand what was important to you; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870020	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870021	Drs understand your needs; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870022	Feel tx staff worked together to same goal; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870024	Control; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx staff discuss how tx may affect work	4180186
42870026	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx staff discuss how tx may affect relationships	4180186
42870031	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx staff thorough in examining treating you	4180186
42870032	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870037	Drs seem to respect your opinions; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870038	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870041	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Nurse-s understand your needs; nursing; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870042	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870043	Feel tx staff answered questions honestly; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx	4180186
42870044	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Tx staff respect your privacy	4180186
42870048	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Would you recommend clinic office to others	4180186
42870051	FAMS; FAMS - version 4; Functional Assessment of Chronic Illness Therapy; MS; Mult; Multi; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870052	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870053	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have trouble getting around public places past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870057	Feel trapped by condition past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870058	Depressed about condition past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870063	Family trouble understanding when condition worse past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870064	Feel left out of things past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; L; Last; LT; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870066	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Heat worsens symptoms past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Sx	4180186
42870068	Difficult times strengthened faith past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870070	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Physical well-being; Physical well-being - FAHI; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870071	AIDS; Emotional well-being - living with HIV; Functional Assessment of Chronic Illness Therapy; Human immunodeficiency virus; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870073	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social well-being; Survey; SURVEY.GNHLTH	4180186
42870074	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870081	Concerned what future holds past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870082	Embarrassed by my illness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870087	Functional Assessment of Chronic Illness Therapy; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FAACT; Peds-FAACT - child - v1; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870088	Functional Assessment of Chronic Illness Therapy; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FAACT; Peds-FAACT - adoles v1; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870090	Functional Assessment of Chronic Illness Therapy; II; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FAACT; Peds-FAACT 10 v2; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870091	FACIT; FACT; Functional Assessment of Chronic Illness Therapy; II; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FAACT; Peds-FACT-Br - adoles - v2; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870094	FACIT; FACT; Functional Assessment of Chronic Illness Therapy; i; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; PEDS; Peds-FACT-Br; Peds-FACT-Br parent_child v1; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870096	Arterial Stenosis; Eat as much as I want past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870098	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Most food tastes bad past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870100	Afraid to eat may make me sick past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870101	Family friends try to get me to eat more past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870105	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have energy or strength past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870107	Bal; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Lose balance or fall down easily past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870108	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have trouble getting myself dressed past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870113	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I feel happy past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870115	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Persons; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; The cancer exp makes me stronger past 7D	4180186
42870116	Cancer exp taught to appreciate life past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870117	Feel other people better than me past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870119	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Switch from good to bad moods past 7D	4180186
42870122	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about having good life in future past 7D	4180186
42870123	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about have girl or boyfriend b/c of illness past 7D	4180186
42870125	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work; Worry about getting job b/c of illness past 7D	4180186
42870126	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; People pick on - tease me past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870127	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I have fewer friends than others past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870128	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; People avoid me b/c I am different past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870129	Finding; Findings; Functional Assessment of Chronic Illness Therapy; I feel lonely past 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870131	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Parents worry too much about me past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870132	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My parents spoil me past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870135	4 weeks; Feel other children are better than me past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870136	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have fewer friends than other children past 7D; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870138	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Rather play alone than with children past 7D; Screen; Survey; SURVEY.GNHLTH	4180186
42870139	4 weeks; Bal; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child loses balance falls down easily past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870141	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child trouble running like other people past 4W; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870142	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child gets tired easily past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870143	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child's arms legs weak past 4W; Ordinal; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870145	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child trouble writing past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870146	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child has pain past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870148	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child tries to do something, believes will do it well past 4W; Ordinal; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870150	Cancer exp taught child appreciate life past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870153	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child is moody irritable past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870155	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child gets nervous easily past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870156	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child worries about good life in future past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870157	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child worries about girl or boyfriend b/c of illness past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870159	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child worries getting job b/c of illness past 4W; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work	4180186
42870160	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Physical well-being; Physical well-being - FACIT-peds; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870162	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social - family well-being; Social - family well-being - FAACT-peds; Survey; SURVEY.GNHLTH	4180186
42870163	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; People pick on my child past 4W; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870165	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; People avoid my child because different past 4W; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870166	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child seems lonely past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870167	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child prefers alone past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870168	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child thinks I worry too much past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870172	Add; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870177	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Physical well being FAACTpeds parent; Physical well-being; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870179	Child seems happy past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870182	Child worries about getting another cancer past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870185	Child gets nervous easily past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870187	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child worries about girl or boyfriend b/c of illness past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870188	Child worries about go to college b/c of illness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870189	Child worries about getting job b/c of illness past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work	4180186
42870190	Child has fewer friends past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870191	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; People avoid my child because is different past 7D; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870192	Child seems lonely past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870196	Child eats enough to do whatever needs to do past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870199	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child is worried about how thin s-he is past 7D; Ordinal; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870200	Arterial Stenosis; As soon as child starts eating, feels like stopping past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870202	Child has been throwing up past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870203	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH; When child eats get full quickly past 7D	4180186
42870204	Child has pain in stomach past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870206	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social - family well-being; Social/family well-being FAACTparent_adoles; Survey; SURVEY.GNHLTH	4180186
42870213	Child has trouble writing past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870214	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; People pick on child past 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870215	Family try to get child to eat more past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870218	Children avoid playing with child b/c different past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870220	4 weeks; Bal; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Lose balance easily past 4W; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870221	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble getting dressed past 4W	4180186
42870222	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble running past 4W	4180186
42870223	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Get tired easily past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870224	4 weeks; Arms or legs weak past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870226	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble writing past 4W	4180186
42870228	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Try to do something will do it well past 4W	4180186
42870229	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Illness experience makes me stronger past 4W; Last; Ordinal; Persons; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870231	4 weeks; Feel that others are better than me past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870232	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about being sick again past 4W	4180186
42870234	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hosp; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry when go back to hospital past 4W	4180186
42870235	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; I get nervous easily past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870236	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about having good life past 4W	4180186
42870237	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hx; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about being able to date b/c illness past 4W	4180186
42870238	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hx; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Worry about able to go college b/c illness past 4W	4180186
42870239	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hx; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Work; Worry about getting job b/c illness past 4W	4180186
42870241	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Have fewer friends past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870242	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hx; Last; Ordinal; Othr; People avoid me b/c illness past 4W; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870244	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Would rather do something by myself past 4W	4180186
42870245	4 weeks; Bothered by being shorter than others past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870248	4 weeks; Bothered by headaches past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870249	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; People have trouble understanding me past 4W; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870251	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Grades are worse than before I was sick past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870253	4 weeks; Cnc; Conc; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hard for me to concentrate in school past 4W; Hard to concentrate in school; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870255	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; When play, react slowly than most my age past 4W	4180186
42870256	4 weeks; Average; Avg; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hard to find the right words; Hard to find the right words past 4W; Last; Ordinal; Ql; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.GNHLTH	4180186
42870258	Emotional well-beingFACT-Br -peds-child; Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
42870263	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social well-being FACT-Br -peds-parent_child; Survey; SURVEY.GNHLTH	4180186
42870264	Functional Assessment of Chronic Illness Therapy; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Social well-being - FACT-Br -peds-parent_adoles; Survey; SURVEY.GNHLTH	4180186
42870265	4 weeks; Child bothered by being shorter than peers past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870266	4 weeks; Child bothered by poor vision past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870268	4 weeks; Child bothered by headaches past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870269	4 weeks; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; My child's speech hard to understand past 4W; Ordinal; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870270	4 weeks; Child work harder get school work done past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870271	4 weeks; Child's school performance worse than before diagnosed past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
42870272	4 weeks; Child forgets things easily past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870273	4 weeks; Cnc; Conc; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Hard for child concentrate in school past 4W; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870276	4 weeks; Child has difficulty using right words past 4W; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.GNHLTH	4180186
42870278	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870280	Being tired made me mad-angry past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870281	BSA; Cl; Clear; Clearanc; Clearances; Clr; End Stage Renal Disease; ESRD survey; HD; Kidney; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Square Meter; SR; Survey; UA; UR; Ur+SerPl; Urn; Volume rate/area; Volume Rate/Ratio	4180186
42870282	End Stage Renal Disease; ESRD survey; Interdialytic interval; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870287	Edinburgh Postnatal Depression Scale; Finding; Findings; Last; Looked forward to things past 7D; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.EPDS	4180186
42870288	Blamed myself unnecessarily past 7D; Edinburgh Postnatal Depression Scale; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.EPDS	4180186
42870289	Been anxious for no good reason past 7D; Edinburgh Postnatal Depression Scale; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.EPDS	4180186
42870290	Edinburgh Postnatal Depression Scale; Felt scared for no reason past 7D; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.EPDS	4180186
42870292	Edinburgh Postnatal Depression Scale; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; So unhappy difficulty sleeping past 7D; Survey; SURVEY.EPDS	4180186
42870294	Edinburgh Postnatal Depression Scale; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; So unhappy been crying past 7D; Survey; SURVEY.EPDS	4180186
42870296	Pan; Panel; PANEL.SURVEY.EPDS; Panl; Pnl; Point in time; Random; Survey; SURVEY.EPDS	4180186
42870298	Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Narrative; PCR; Point in time; Random; Report; thiopurine S-methyltransferase; Thiopurine S-methyltransferase gene; Tissue; Tissue, unspecified; TPMT c.238G&gt;C; TPMT c.238G&gt;C+460G&gt;A+719A&gt;G; WB; Whole blood; Whole blood or Tissue	4180186
42870298	TPMT c.238G>C+460G>A+719A>G Bld/T	4180186
42870298	TPMT 基因.c.238G>C+460G>A+719A>G:存在与否或特征标识:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
42870300	Blood; CX31; DFNA2; DFNA2B; Document; EKV; Finding; Findings; gap junction protein, beta 3, 31kDa; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42870300	GJB3 gene Mut Anl Bld/T	4180186
42870300	GJB3 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870301	Y chr AZFa region Del Bld/T	4180186
42870301	Blood; Chromosom; Chromosomes; Del; Deletions; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; Y chr AZFa region; Y chromosome microdeletion	4180186
42870301	Y 染色体 AZFa 区 缺失:存在与否或特征标识:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
42870302	Blood; Chromosom; Chromosomes; Del; Deletions; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; Y chr AZFb region; Y chromosome microdeletion	4180186
42870302	Y chr AZFb region Del Bld/T	4180186
42870302	Y 染色体 AZFb 区 缺失:存在与否或特征标识:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
42870304	ALP Plac 2 CFr SerPl	4180186
42870304	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Plac; ALP Plac 2; AP; Catalytic Fraction; Chemistry; II; Percent; Phos; Phosphtase; Pl; Placent; Placenta; Placntl; PLAP; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
42870304	碱性磷酸酶.胎盘型 2/碱性磷酸酶.总计:催化分数:时间点:血清/血浆:定量型	4182948
42870306	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.GI; Alkaline phosphatase.total; ALKP; ALP; ALP Intest; ALP Intest 3; ALP-3; ALPI; AP; Catalytic Concentration; Chemistry; IAP; III; Intest; Intestine; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870306	ALP Intest 3 SerPl-cCnc	4180186
42870306	碱性磷酸酶.小肠型 3:催化浓度:时间点:血清/血浆:定量型	4182948
42870308	Desmosome IgG Titr Ser IF	4180186
42870308	桥粒 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42870308	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; macula adherens; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42870311	(灰桤木+白桦+榛子+白栎+黄花柳) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42870311	Tree Allerg Mix 9 IgE Qn	4180186
42870311	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; Common silver birch; European alder; f017; f17; Filbert; Gray alder; Grey alder; Hazel nut; Hazelnut; IFR; Immune globulin E; Immunoglobulin E; Isoflavone reductase; Oak; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Silver Birch; Speckled alder; SR; t007; t12; t2; t3; t7; TP9; TP9M; Tree Allerg Mix 9; Tree Allerg Mix 9 IgE; tx9; White oak; Willow	4180186
42870313	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brassica/Sinapis spp; Carrot; f031; f035; f047; f089; f25; f31; f35; f47; f89; Food Allerg Mix 51; Food Allerg Mix 51 IgE; fp51; Garlic; Immune globulin E; Immunoglobulin E; Lycopersicon esculatum; Lycopersicon lycopersicon; Point in time; Potato; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tomato; White potato	4180186
42870313	Food Allerg Mix 51 IgE Qn	4180186
42870313	(胡萝卜+番茄+芥菜+马铃薯+大蒜) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42870315	Inhalant Allerg Mix 7 IgE Qn	4180186
42870315	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Canine; Cat epithelium; Cat hair; D pteronyss; D pteronyssinus; d001; d1; Dog hair; e003; e005; e082; e1; e3; e5; e82; Epithelia; Equus spp; European house dust mite; f213; Feline; Felis domesticus; HDM; House dust mite; Immune globulin E; Immunoglobulin E; Inhalant Allerg Mix 7; Inhalant Allerg Mix 7 IgE; ip7; ix7; Oryctalagus spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
42870315	(屋尘螨+猫毛屑+猫上皮细胞+马毛屑+狗毛屑+家兔上皮细胞) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
42870316	Agg; Agglut; Agglutination; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Legion; Legionela; Microbiology; Nominal; Point in time; Random; species; spp	4180186
42870316	Legionella Islt Aggl	4180186
42870316	军团菌属单个未知种:存在与否或特征标识:时间点:分离株:名义型:凝集试验法	4182948
42870317	Agg; Agglut; Agglutination; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Leptospirosis; Microbiology; Nominal; Point in time; Random; species; spp	4180186
42870317	Leptospira Islt Aggl	4180186
42870317	钩端螺旋体属单个未知种:存在与否或特征标识:时间点:分离株:名义型:凝集试验法	4182948
42870320	Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Past 7D needed sleep during day; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870322	Arterial Stenosis; Dextro; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Tired made hard to play past 7D	4180186
42870325	Hepcidin-25 SerPl-sCnc	4180186
42870325	Chemistry; Hepcidin-25; Level; Pept; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870325	铁调素 25 肽:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870331	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870333	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870336	CMS - gastrointestinal - abdomen - exam pnl; GI; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870337	GU; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870343	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870346	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey; Sx	4180186
42870349	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870350	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870351	GI; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870352	GU; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870353	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870354	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870355	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870357	Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870358	Hemato; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870359	Immunol; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870360	Document; Hx; Last; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Social Hx; Survey	4180186
42870361	Hx; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Social Hx; Survey	4180186
42870362	Hx; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Survey	4180186
42870363	Hx; Last; Narrative; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Report; Surg; Survey	4180186
42870364	Beta Natriuretic Peptide; Blood; BNP; Brain Natriuretic Peptide; B-type natriuretic peptide; Cardio; Cardiology; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Heart Disease; IAA; Level; Mass concentration; MEIA; Natriutietic peptide.B; NTproBNP; NT-proBNP; Pept; Point in time; proBNP; Pro-brain natriuretic peptide; QNT; Quan; Quant; Quantitative; Random; SUDS; WB; Whole blood	4180186
42870364	NT-proBNP Bld IA-mCnc	4180186
42870364	利钠肽.B 激素原 N-末端:质量浓度:时间点:全血:定量型:免疫测定法	4182948
42870370	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HPV; HPV H Risk 12 DNA; HPV HR 12; HPV31; HPV31+33; HPV31+33+35; Human papilloma virus; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Papilloma virus intermediate/high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders	4180186
42870370	HPV HR 12 DNA Cvx Ql NAA+probe	4180186
42870370	人乳头瘤病毒 31+33+35+39+45+51+52+56+58+59+66+68 型 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
42870371	Cervix; Deoxyribonucleic acid; Genital tract; Genital warts; Gyn; Gynecology; HPV; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; HPV16+18+H Risk 12 DNA Pnl; HPV16+18+HRisk12DNA; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; Papilloma virus high risk; Pnl; Point in time; Random; UniversalLabOrders	4180186
42870371	HPV16+18+H Risk 12 DNA Pnl Cvx	4180186
42870371	人乳头瘤病毒 16 与 18 与 31+33+35+39+45+51+52+56+58+59+66+68 型 DNA 组套:-:时间点:子宫颈:-	4182948
42870376	Able to feel like a man past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870377	Able to have maintain erection past 7D; Finding; Findings; Functional Assessment of Chronic Illness Therapy; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
42870379	Centers for Medicare and Medicaid Assessment; Disch; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Typ	4180186
42870381	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Wt; Wt gain	4180186
42870383	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Past; Survey	4180186
42870384	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Past; Survey	4180186
42870386	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Received sched pain meds; Report period; Screen; Survey	4180186
42870387	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Received PRN pain meds; Report period; Screen; Survey	4180186
42870388	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Received non-med pain intervention; Report period; Screen; Survey	4180186
42870391	Finding; Findings; ID/DD with organic condition; MDS version 3; Ordinal; Pan; Panel; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
42870392	Finding; Findings; ID/DD with no organic condition; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
42870395	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
42870395	Deprecated Nitrofural Susc Islt	4180186
42870396	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; Erythropoiesis-stimulating agent Pnl; ESRD; ESRD survey; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42870397	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870398	End Stage Renal Disease; End Stage Renal Disease (ESDR) pnl; ESRD; ESRD survey; Pan; Panl; Pnl; Point in time; Random; Survey	4180186
42870401	End Stage Renal Disease; ESRD survey; Finding; Findings; Meth; Method of ID vasc access infection; Nominal; Point in time; Random; Survey	4180186
42870402	End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870404	Date and time; ESRD; ESRD survey; Med; Point in time; QNT; Quan; Quant; Quantitative; Random; Rx; Survey; Time stamp; Timestamp	4180186
42870406	ESRD; ESRD survey; Finding; Findings; Med; Nominal; Point in time; Random; Survey	4180186
42870408	End Stage Renal Disease; ESRD survey; Finding; Findings; Med; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870410	ESRD; ESRD survey; Med; Nominal; Point in time; Random; Survey; Typ	4180186
42870412	Dialy; End Stage Renal Disease; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
42870414	End Stage Renal Disease; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870418	End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870419	End Stage Renal Disease; ESRD survey; Location; Nominal; Point in time; Random; Survey	4180186
42870420	Death involve injury; Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC; Ulcer	4180186
42870421	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
42870421	Risk assessment Doc	4180186
42870421	风险评估:发现:时间点:{环境}:文档型:{角色}	4182948
42870422	Hip and Knee Outcomes Instrument - American Academy of Orthopaedic Surgeons; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.AAOS; Tot; Totl	4180186
42870426	Eye; EYE.PX; Eyeball; Fibers; Finding; Findings; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Opt disc ret nerv abnor; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; R; R eye; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RT; Screen; Vision; Visual; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
42870426	Opt disc ret nerv abnor Eye-R Ophthal	4180186
42870426	视乳头或者视网膜神经纤维层结构异常:发现:时间点:眼睛.右侧:序数型:检眼镜检查法	4182948
42870428	Eye; EYE.PX; Eyeball; Finding; Findings; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; R; R eye; Random; RT; Screen; Vision; Visual	4180186
42870428	R eye Macular edema Ophthalmoscopy	4180186
42870428	黄斑水肿:发现:时间点:眼睛.右侧:序数型:检眼镜检查法	4182948
42870432	Informant Questionnaire on Cognitive Decline in the Elderly; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
42870433	Dialy; End Stage Renal Disease; ESRD; ESRD survey; Ident; Identifier; Nominal; Point in time; Random; Survey	4180186
42870434	Dialy; End Stage Renal Disease; ESRD survey; Ident; Identifier; Nominal; Point in time; Random; Survey	4180186
42870435	Dialy; End Stage Renal Disease; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
42870437	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870439	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870442	Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870443	Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870444	Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870446	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870449	Cnt; Count; Dialy; End Stage Renal Disease; ESRD survey; Isol; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
42870450	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870451	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870453	Date and time; Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Time stamp; Timestamp	4180186
42870457	Dx; End Stage Renal Disease; ESRD survey; Finding; Findings; Hospitalized due to presumptive Dx; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870462	End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870463	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
42870472	Dialy; End Stage Renal Disease; ESRD survey; Finding; Findings; Hosp; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; To hospital direct fr dialysis	4180186
42870474	Date and time; Dialy; End Stage Renal Disease; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Time stamp; Timestamp	4180186
42870476	Finding; Findings; My Mood Monitor Checklist; Nothing give me pleasure last 2W; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870477	Finding; Findings; I feel tired no energy last 2W; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870480	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Sleeping too much last 2W; Survey; SURVEY.MTLHLTH	4180186
42870482	Eating more last 2W; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870483	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; T prime; Tense, anxious can't sit still last 2W	4180186
42870484	Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Worried fearful last 2W	4180186
42870485	Attacks of anxiety panic last 2W; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870487	Finding; Findings; My Mood Monitor Checklist; Nervous shaky social situations last 2W; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870488	Finding; Findings; My Mood Monitor Checklist; Nightmares flashbacks last 2W; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870491	Dull numb detached last 2W; Finding; Findings; My Mood Monitor Checklist; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
42870495	Finding; Findings; In your life - more energy than usual; My Mood Monitor Checklist; Ordinal; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
42870500	Act/Nor; Atroxin time; Clot; Clottable; Coag; Coagulation assay; Control; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Reptilase time; RlTm; Tilt tube	4180186
42870500	Reptilase time/normal	4180186
42870500	蛇毒素诱导型凝血过程 实际的/正常的:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
42870501	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ENA; ENA RNP; ENA RNP 63kD; Nuc; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Ribonuclear protein; RNP; Ro; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870501	ENA RNP 63kD Ab SerPl Ql	4180186
42870501	核蛋白可提取核 63kD 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
42870502	History; Hx; International Classification of Diseases; Med - surg hx ICD code; NEMSIS; Nominal; Point in time; Random; Surg	4180186
42870502	Med - surg hx ICD code	4180186
42870502	内科 - 外科手术史 - ICD-9 和 ICD-10 代码:历史记录:时间点:^患者:名义型	4182948
42870504	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M hominis; Metamycoplasma hominis; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42870504	M hominis DNA Spec Ql NAA+probe	4180186
42870504	人型支原体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42870505	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42870505	Ureaplasma DNA Spec Ql NAA+probe	4180186
42870505	脲原体属单个未知种 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42870507	C albicans Ab Titr Ser IF	4180186
42870507	白色假丝酵母 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42870507	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C albicans; Cand; Candidiasis; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; m005; m5; Microbiology; Monilia; Point in time; Random; Serum; SmQn; SR; Thrush; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42870508	E chaffeensis Ab Titr Ser IF	4180186
42870508	查菲埃立克体 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
42870508	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); E chaffeensis; FA; Fluorescent antibody; Fluoresent; HME; Human monocytic ehrlichiosis; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
42870514	Arbitrary concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
42870514	Argatroban PPP Chro-aCnc	4180186
42870514	阿加曲班:任意型浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
42870517	Bact; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random	4180186
42870517	Bacteria antigenic formula Islt	4180186
42870517	细菌抗原结构公式:标识符:时间点:分离株:名义型	4182948
42870518	ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; PH; Point in time; Public Health; PublicHealth; Random	4180186
42870518	Local PFGE pattern Islt	4180186
42870518	本地 PFGE 模式:标识符:时间点:分离株:名义型	4182948
42870520	B220; Blood; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Dynamic; FC; LCA; Leukocyte common antigen; LPA; LPT; LPT PW; LST; Ly5; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Number fraction; Percent; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Stim; T200; WB; Whole blood	4180186
42870520	LPT PW/CD45 NFr Bld FC	4180186
42870520	淋巴细胞增殖.美洲商陆丝裂原刺激/CD45:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
42870523	Gestation; Gestations; Gravida; History; NEMSIS; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
42870523	Hx of Pregnancy	4180186
42870523	妊娠:历史记录:时间点:^患者:序数型	4182948
42870528	C&S; Cult; Cultures; H flu; H influenza; H influenzae; Haem influ; Haemoph; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
42870528	Haem influ Spec Cult	4180186
42870528	流感嗜血杆菌:存在与否或特征标识:时间点:XXX:名义型:微生物特异性培养	4182948
42870535	Ca; Cal; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
42870535	Calcium Smn-mCnc	4180186
42870535	钙:质量浓度:时间点:精液:定量型	4182948
42870536	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
42870536	Medical director review	4180186
42870536	医学总监审核:印象:时间点:XXX:叙述型	4182948
42870537	Supervisor review	4180186
42870537	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
42870537	监督者审核:印象:时间点:XXX:名义型	4182948
42870539	2q37.3; AGT; AGT1; AGXT1; alanine-glyoxylate aminotransferase; Amplification; Blood; Del; Del+Dup; Deletions; Document; Dp; Finding; Findings; Genetics; Heredity; Heritable; Inherited; L-alanine: glyoxylate aminotransferase 1; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; oxalosis I; PH1; Point in time; primary hyperoxaluria type 1; Random; serine:pyruvate aminotransferase; SPAT; SPT; Tissue; Tissue, unspecified; TLH6; WB; Whole blood; Whole blood or Tissue	4180186
42870539	AGXT gene Del+Dup Bld/T MLPA	4180186
42870539	AGXT 基因 缺失+重复:发现:时间点:全血/组织:文档型:多重连接探针扩增技术	4182948
42870540	Agammaglobulinaemia tyrosine kinase gene; AGMX1; AT; ATK; B cell progenitor kinase gene; Blood; BPK; Bruton agammaglobulinemia tyrosine kinase; Bruton agammaglobulinemia tyrosine kinase gene; Bruton's tyrosine kinase gene; Document; Fam Mut Anl; Finding; Findings; Genetics; Heredity; Heritable; IMD1; Inherited; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; PCR; Point in time; PSCTK1; Random; Tissue; Tissue, unspecified; Tyrosine-protein kinase gene; WB; Whole blood; Whole blood or Tissue; XLA	4180186
42870540	BTK gene Fam Mut Anl Bld/T	4180186
42870540	BTK 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870541	ABC35; ABCC7; Amplification; Blood; CBAVD; CF; CFA; CFTR/MRP; Cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7); Del; Del+Dup; Deletions; dJ760C5.1; Document; Dp; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MRP7; Point in time; Random; Tissue; Tissue, unspecified; TNR-CFTR; WB; Whole blood; Whole blood or Tissue	4180186
42870541	CFTR Del+Dup Bld/T MLPA	4180186
42870541	CFTR 基因 缺失+重复:发现:时间点:全血/组织:文档型:多重连接探针扩增技术	4182948
42870542	activin A receptor type II-like 1; Activin receptor-like kinase 1; ACVRL1+ENG gene; ACVRLK1; ALK1; ALK-1; Amplification; Blood; CD105; CD105 Ag; Del; Del+Dup; Deletions; Document; Dp; END; Endoglin; Finding; Findings; Genetics; Heredity; Heritable; HHT; HHT1; HHT2; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; ORW; ORW1; ORW2; Osler-Rendu-Weber syndrome 1; Osler-Rendu-Weber syndrome 2; Point in time; Random; Serine/threonine-protein kinase receptor R3 precursor; SKR3; TGF-B superfamily receptor type I; Tissue; Tissue, unspecified; TSR-I; WB; Whole blood; Whole blood or Tissue	4180186
42870542	ACVRL1+ENG gene Del+Dup Bld/T MLPA	4180186
42870542	ACVRL1 基因+ENG 基因 缺失+重复:发现:时间点:全血/组织:文档型:多重连接探针扩增技术	4182948
42870545	ACMICD; Blood; Document; ECTOL1; Fam Mut Anl; FBN; fibrillin 1; Fibrillin 1 (Marfan syndrome); Finding; Findings; Genetics; GPHYSD2; Heredity; Heritable; Inherited; LMTED; LTD; MASS; MFS1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; OCTD; PCR; Point in time; Random; SGS; SSKS; Tissue; Tissue, unspecified; WB; Weill-Marchesani syndrome; Whole blood; Whole blood or Tissue; WMS; WMS2	4180186
42870545	FBN1 gene Fam Mut Anl Bld/T	4180186
42870545	FB1 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870547	Amplification; Blood; Del; Del+Dup; Deletions; Document; Dp; FH; FHC; Finding; Findings; Genetics; Heredity; Heritable; Inherited; LDLCQ2; Low Density Lipoprotein Receptor; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
42870547	LDLR gene Del+Dup Bld/T MLPA	4180186
42870547	LDLR 基因 缺失+重复:发现:时间点:全血/组织:文档型:多重连接探针扩增技术	4182948
42870548	BAFF; Blood; BLYS; CD267; CVID; CVID2; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; IGAD2; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; RYZN; sequencing of entire coding region; TACI; TALL1; THANK; Tissue; Tissue, unspecified; TNFRSF14B; TNFSF20; Tumor necrosis factor (ligand) superfamily, member 13b; tumor necrosis factor receptor superfamily, member 13B; WB; Whole blood; Whole blood or Tissue; ZTNF4	4180186
42870548	TNFRSF13B gene Full Mut Anl Bld/T Seq	4180186
42870548	TNFRSF13B 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
42870549	BAFF; Blood; BLYS; CD267; CVID; CVID2; Document; Fam Mut Anl; Finding; Findings; Genetics; Heredity; Heritable; IGAD2; Inherited; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; PCR; Point in time; Random; RYZN; TACI; TALL1; THANK; Tissue; Tissue, unspecified; TNFRSF14B; TNFSF20; Tumor necrosis factor (ligand) superfamily, member 13b; tumor necrosis factor receptor superfamily, member 13B; WB; Whole blood; Whole blood or Tissue; ZTNF4	4180186
42870549	TNFRSF13B gene Fam Mut Anl Bld/T	4180186
42870549	TNFRSF13B 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870550	Blood; Document; Fam Mut Anl; Finding; Findings; Genetics; Heredity; Heritable; HRCA1; Inherited; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; PCR; Point in time; pVHL; Random; RCA1; Tissue; Tissue, unspecified; VHL1; von Hippel-Lindau syndrome; von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase; WB; Whole blood; Whole blood or Tissue	4180186
42870550	VHL gene Fam Mut Anl Bld/T	4180186
42870550	VHL 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
42870552	CHEMISTRY.CHALLENGE TESTING; Gastro; Gastroenterology; GI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LTT; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870552	Lactose tolerance SerPl-Imp	4180186
42870552	乳糖耐量:印象:时间点:血清/血浆:叙述型	4182948
42870555	Ku Ab Ser Ql IB	4180186
42870555	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
42870555	Ku 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
42870556	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; CADM; Clinically amyopathic DM; Dermatomyositis, Adult Type; ILD; Immune blot; Immunobl; Immunoblot; Interstitial Lung Disease; Isoleucyl tRNA Synthetase; Ordinal; Point in time; Polymyositis, Idiopathic; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
42870556	OJ Ab Ser Ql IB	4180186
42870556	OJ 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
42870560	Arbitrary concentration; Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Endocrine; Endocrinology; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Thyroid stimulating hormone; Thyrotropic hormone; TSH	4180186
42870560	TSH BldCo-aCnc	4180186
42870560	促甲状腺激素:任意型浓度:时间点:脐带全血:定量型	4182948
42870562	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
42870562	C glabrata DNA Vag Ql NAA+probe	4180186
42870562	光滑假丝酵母 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
42870571	Antigen; Antigens; Excision repair cross-complementation group 1; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
42870571	ERCC1 Ag Tiss Ql ImStn	4180186
42870571	ERCC1 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
42870572	(C5:1); C5:1; Chemistry; i; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tgly+Mthyl (C5:1)	4180186
42870572	Tgly+Mthyl (C5:1) SerPl-sCnc	4180186
42870572	甲基巴豆酰肉碱+甲基巴豆酰肉碱 (C5:1):物质的量浓度:时间点:血清/血浆:定量型	4182948
42870575	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bovine genital campylobacteriosis; C fetus; Campy; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vibriosis	4180186
42870575	C fetus Ab Ser Ql	4180186
42870575	胎儿弯曲菌 抗体:存在情况或阈值:时间点:血清:序数型	4182948
42870577	(Diff cap; adj; ALV; Alv vol; Breathing; CO; Diff cap; Diff cap.CO; DL; DLCO; Haemoglobin; Hb; Hgb; Hgb adj; Lung; Lungs; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; VA; Vol	4180186
42870577	Diff cap.CO/Alv vol Hgb adj	4180186
42870577	弥散量.一氧化碳/肺泡容积^^经过针对血红蛋白而调整的:通气指数之倒数:时间点:呼吸系统:定量型	4182948
42870578	ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; PH; Point in time; Public Health; PublicHealth; Random	4180186
42870578	Local PFGE event Islt	4180186
42870578	本地 PFGE 事件描述:标识符:时间点:分离株:名义型	4182948
42870581	Enz; Enzymes; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; PH; Point in time; Public Health; PublicHealth; Random	4180186
42870581	PFGE restriction enzyme Islt	4180186
42870581	脉冲场凝胶电泳限制性内切酶:标识符:时间点:分离株:名义型	4182948
42870582	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
42870586	Agf98; Celiac; Celiac disease; Dermatitis Herpetiformis; DGP; DH; F98; Fibrin stabilizing factor; Gliadine; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Protein-glutamine gamma glutamyltransferase; Random; Serology; Serum; SR; TG2; tTG; tTG antibodies; tTG IgA+DGP IgA+IgG; tTG IgA+DGP IgA+IgG pnl; tTg/DGP	4180186
42870586	tTG IgA+DGP IgA+IgG pnl Ser	4180186
42870586	组织谷氨酰胺转移酶抗体.IgA+麦醇溶蛋白肽抗体.IgA 与 IgG 组套:-:时间点:血清:-	4182948
42870588	Diff pnl,unspecified Bld	4180186
42870588	Blood; Diff; Diff Pnl; Diff pnl,unspecified; Differl; Differn; HEMATOLOGY/CELL COUNTS; Meth; Method of; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
42870588	方法未加说明且细胞分类组套:-:时间点:全血:定量型	4182948
42870591	Diff Pnl Pcar	4180186
42870591	Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; PCAR; Pericardial Fluid; Pnl; Point in time; Random	4180186
42870591	细胞分类组套:-:时间点:心包液:-	4182948
42870592	Blood; CBC W Diff Pnl; CBC W Diff pnl,unspecified; Diff; Diff Pnl; Diff pnl,unspecified; Differl; Differn; HEMATOLOGY/CELL COUNTS; Meth; Method of; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood	4180186
42870592	CBC W Diff pnl,unspecified Bld	4180186
42870592	方法未加说明且带有细胞分类的全血细胞计数组套:-:时间点:全血:定量型	4182948
42870599	DOC.MISC; Ident; Identifier; MISC; Nominal; Point in time; Random	4180186
42870599	文档类型标识符:标识符:时间点:表单:名义型	4182948
42870602	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; California Encephalitis Virus; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Lacrosse virus; LACV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
42870602	LACV RNA Spec Ql NAA+probe	4180186
42870602	拉克罗斯病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
42870603	2-oxoadipic acid; alpha Ketoadipate; alpha Ketoadipic acid; Chemistry; II; Level; Oxoadipate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870603	2-Oxoadipate SerPl-sCnc	4180186
42870603	2-氧代己二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870604	C18:1DC; C18:1-DC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Dicarboxyoleoylcarnitine; i; Octadecenediolcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
42870604	Dicarboxyoleylcarn/Creat Ur-sRto	4180186
42870604	二羧基油酰肉碱 (C18:1-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
42870605	Dicarboxyoleylcarn CSF-sCnc	4180186
42870605	C18:1DC; C18:1-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; Dicarboxyoleoylcarnitine; i; Level; Octadecenediolcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42870605	二羧基油酰肉碱 (C18:1-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
42870609	C3; C3-carntitine; Chemistry; Level; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
42870609	Propionylcarn Ur-sCnc	4180186
42870609	丙酰肉碱 (C3):物质的量浓度:时间点:尿液:定量型	4182948
42870610	C18; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Steroylcarnitine; Substance concentration; UA; UR; Urn	4180186
42870610	Stearoylcarn Ur-sCnc	4180186
42870610	硬脂酰肉碱 (C18):物质的量浓度:时间点:尿液:定量型	4182948
42870611	C8DC; C8-DC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
42870611	Suberylcarn/Creat Ur-sRto	4180186
42870611	环庚基肉碱 (C8-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
42870613	Suberylcarn Amn-sCnc	4180186
42870613	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C8DC; C8-DC; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
42870613	环庚基肉碱 (C8-DC):物质的量浓度:时间点:羊水:定量型	4182948
42870614	C8DC; C8-DC; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
42870614	Suberylcarn Ur-sCnc	4180186
42870614	环庚基肉碱 (C8-DC):物质的量浓度:时间点:尿液:定量型	4182948
42870616	2-HIA; 2-hydroxy-isovalerate; 2-hydroxyisovaleric acid; 2OH-isovalerate; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870616	2OH-isovalerate SerPl-sCnc	4180186
42870616	2-羟基异戊酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870617	2HPA; 2-hydroxy-phenylacetate; 2-hydroxyphenylacetic acid; 2OH-phenylacetate; Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Hydroxyphenylacetic acid; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42870617	2OH-phenylacetate CSF-sCnc	4180186
42870617	2-羟基苯乙酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42870619	2OH-sebacate CSF-sCnc	4180186
42870619	2OH-sebacate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42870619	2-羟基癸二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
42870621	2-Methylacetoacetic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
42870621	2-Methylacetoacetate CSF-sCnc	4180186
42870621	2-甲基乙酰乙酸乙酯:物质的量浓度:时间点:脑脊液:定量型	4182948
42870622	2-Methylacetoacetate SerPl-sCnc	4180186
42870622	2-Methylacetoacetic acid; Chemistry; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870622	2-甲基乙酰乙酸乙酯:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870624	2Me3OH-butyrate; 2-Methyl,3-Hydroxy butyrate; 2-methyl,3-hydroxybutyric acid; 2-Methyl-3-Hydroxybutyrate; 3-Hydroxy-2-Methylbutanoate; 3-Hydroxy-2-Methylbutanoic acid; 3-Hydroxy-2-Methylbutyrate; 3-Hydroxy-2-Methyl-butyrate; 3-hydroxy-2-methylbutyric acid; 3-Hydroxy-2-Methyl-butyric acid; alpha-methyl-beta-hydroxybutyrate; alpha-methyl-beta-hydroxybutyric acid; C5OH; C5-OH; Chemistry; HMBA; Hydroxybutyric acid; II; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
42870624	2Me3OH-butyrate SerPl-sCnc	4180186
42870624	2-甲基-3-羟基丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
42870626	C14:2; Chemistry; CR; Crea; Creat; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tdecadienoylcarn; UA; UCr; UR; Urn	4180186
42870626	Tdecadienoylcarn/Creat Ur-sRto	4180186
42870626	十四烷二烯酰肉碱 (C14:2)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
42870629	C14:2; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tdecadienoylcarn; UA; UR; Urn	4180186
42870629	Tdecadienoylcarn Ur-sCnc	4180186
42870629	十四烷二烯酰肉碱 (C14:2):物质的量浓度:时间点:尿液:定量型	4182948
42870631	17OHP Amn-sCnc	4180186
42870631	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Hydroxyproges; Hydroxyprogstron; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
42870631	17-羟孕酮:物质的量浓度:时间点:羊水:定量型	4182948
42870632	1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
42870632	1OH-midazolam SerPl-mCnc	4180186
42870632	1-羟基咪达唑仑:质量浓度:时间点:血清/血浆:定量型	4182948
42870635	B-HCG Plr-aCnc	4180186
42870635	Arbitrary concentration; B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; Tumor marker	4180186
42870635	绒毛膜促性腺激素.Beta 亚单位:任意型浓度:时间点:胸膜液:定量型	4182948
42870636	Arbitrary concentration; Ascites; Ascitic fluid; Ascitis; B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
42870636	B-HCG Prt-aCnc	4180186
42870636	绒毛膜促性腺激素.Beta 亚单位:任意型浓度:时间点:腹膜液:定量型	4182948
42870687	FSHB gene.c.-211G>T	4180186
42870710	Enterovirus Ab.IgG	4180186
42870803	CCR2 gene.p.Val64Ile	4180186
42870805	GALT gene.p.Gln188Arg	4180186
42870865	TPMT gene.c.238G>C+460G>A+719A>G	4180186
42870872	Myrica spp	4180186
42870962	Mycoplasma sp & Ureaplasma sp	4180186
42871050	2-Methyl-3-Hydroxybutyrate	4180186
42871087	Yellow fever virus Ab.IgM	4180186
42871098	Juglans california	4180186
42871102	Enterovirus Ab.IgM	4180186
42871104	European tick borne encephalitis virus Ab.IgG	4180186
42871109	Mycobacterium avium subspecies paratuberculosis Ab	4180186
42872380	Peripherally inserted central venous catheter in situ (finding)	4180186
42872380	PICC (peripherally inserted central catheter) in situ	4180186
42872383	Insufficient prenatal care (finding)	4180186
42872385	Abdominal panniculus	4180186
42872385	Panniculus of abdomen	4180186
42872385	Excess panniculus of abdomen (finding)	4180186
42872388	Obstructive sleep apnea of child (disorder)	4180186
42872388	Obstructive sleep apnoea of child	4180186
42872389	Obstructive sleep apnea of adult (disorder)	4180186
42872389	Obstructive sleep apnoea of adult	4180186
42872390	Nonischemic congestive cardiomyopathy (disorder)	4180186
42872393	Inappropriate diet and eating habits (finding)	4180186
42872394	Daytime somnolence (finding)	4180186
42872396	Primary adenocarcinoma of colon (disorder)	4180186
42872397	Awaiting renal transplant	4180186
42872397	Patient awaiting renal transplant (finding)	4180186
42872402	Coronary arteriosclerosis in native artery (disorder)	4180186
42872404	Moderate dehydration (disorder)	4180186
42872407	Arthritis of wrist (disorder)	4180186
42872408	Nontuberculous mycobacterial lung disease	4180186
42872408	Atypical mycobacterial infection of lung (disorder)	4180186
42872410	Never smoked any substance (finding)	4180186
42872411	Severe major depression, single episode (disorder)	4180186
42872414	Muscle spasm of cervical muscle of neck (disorder)	4180186
42872415	Tendinitis of elbow or forearm (disorder)	4180186
42872417	Childhood failure to gain weight (finding)	4180186
42872418	Tattoo of skin (finding)	4180186
42872418	Tattoo	4180186
42872420	Strain of foot (disorder)	4180186
42872421	Pseudomonas toyotomiensis (organism)	4180186
42872423	Lysinibacillus xylanilyticus (organism)	4180186
42872425	Serratia ureilytica (organism)	4180186
42872428	Ignatzschineria ureiclastica (organism)	4180186
42872431	Neisseria shayeganii (organism)	4180186
42872436	Perinatal cutaneous ecchymoses (disorder)	4180186
42872441	Verification of organ donation status (procedure)	4180186
42872442	Destruction of lesion of oral cavity (procedure)	4180186
42872443	Excision of squamous cell carcinoma (procedure)	4180186
42872444	Laparoscopy with peritoneal washout	4180186
42872444	Laparoscopy and peritoneal lavage (procedure)	4180186
42872446	Revision of anterior excision of lumbar disc (procedure)	4180186
42872450	Exploration of burnt skin of neck (procedure)	4180186
42872452	Streptomyces colombiensis (organism)	4180186
42872453	Genus Ornithinibacillus	4180186
42872453	Genus Ornithinibacillus (organism)	4180186
42872456	Genus Robinsoniella	4180186
42872456	Genus Robinsoniella (organism)	4180186
42872457	Robinsoniella peoriensis (organism)	4180186
42872459	Patient ventilator dyssynchrony (finding)	4180186
42872460	Overweight in childhood (finding)	4180186
42872460	Childhood overweight BMI greater than 85 percentile	4180186
42872461	Empedobacter falsenii	4180186
42872461	Wautersiella falsenii (organism)	4180186
42872464	Arabo-Friesian horse breed (organism)	4180186
42872464	Arabo-Friesian horse breed	4180186
42872467	Genus Rummeliibacillus (organism)	4180186
42872467	Genus Rummeliibacillus	4180186
42872470	Subtotal excision of colon and creation of colonic pouch (procedure)	4180186
42872471	Subtotal excision of colon and rectum and creation of colonic pouch (procedure)	4180186
42872472	Removal of artificial sphincter of anus (procedure)	4180186
42872472	Removal of artificial anal sphincter	4180186
42872476	Nocardia mikamii (organism)	4180186
42872477	Nocardia kruczakiae (organism)	4180186
42872478	Mycobacterium salmoniphilum (organism)	4180186
42872479	Paraburkholderia ferrariae (organism)	4180186
42872479	Burkholderia ferrariae	4180186
42872480	Mycobacterium conceptionense (organism)	4180186
42872482	Aratinga erythrogenys	4180186
42872482	Aratinga erythrogenys (organism)	4180186
42872483	Family Cyclobacteriaceae	4180186
42872483	Family Cyclobacteriaceae (organism)	4180186
42872484	For cardiopulmonary resuscitation (finding)	4180186
42872484	For attempted cardiopulmonary resuscitation	4180186
42872489	Influenza virus H3N2v	4180186
42872489	Influenza A virus subtype H3N2v (organism)	4180186
42872490	Partial excision of esophagus and interposition of colon (procedure)	4180186
42872490	Partial excision of oesophagus and interposition of colon	4180186
42872490	Partial oesophagectomy and interposition of colon	4180186
42872491	Bypass of oesophagus by interposition of jejunum	4180186
42872491	Bypass of esophagus by interposition of jejunum (procedure)	4180186
42872493	Cesarean section through J shaped incision of uterus (procedure)	4180186
42872493	Caesarean section through J shaped incision of uterus	4180186
42872494	Electrodesiccation of lesion of skin (procedure)	4180186
42872495	Antegrade colonic enema through appendicostomy (procedure)	4180186
42872495	ACE - antegrade colonic enema	4180186
42872497	Excision and retrograde filling of root of tooth (procedure)	4180186
42872497	Apicectomy and retrograde root filling	4180186
42872499	Sialendoscopic removal of calculus from parotid gland using grasping forceps (procedure)	4180186
42872500	Sialendoscopic dilation of stenosis of parotid duct (procedure)	4180186
42872503	Sialendoscopic dilation of stenosis of submandibular duct (procedure)	4180186
42872504	Sialendoscopically assisted removal of calculus from parotid duct by extraoral approach (procedure)	4180186
42872511	Laparoscopic biopsy of lesion of omentum (procedure)	4180186
42872512	Obliteration of aneurysm of cerebral artery (procedure)	4180186
42872513	Obliteration of aneurysm of circle of Willis (procedure)	4180186
42872514	Angulation osteotomy (procedure)	4180186
42872519	Conversion to fusion of joint (procedure)	4180186
42872521	Endarterectomy of axillary artery (procedure)	4180186
42872524	Endoscopic destruction of lesion of uterus (procedure)	4180186
42872525	Endoscopic extraction of calculus of kidney (procedure)	4180186
42872526	Photodestruction of lesion of skin of neck (procedure)	4180186
42872528	Exploration of burnt skin of head (procedure)	4180186
42872529	Exploration of inguinal region (procedure)	4180186
42872529	Exploration of groin	4180186
42872532	Conversion from hybrid total replacement of joint (procedure)	4180186
42872533	Conversion to hybrid total replacement of joint (procedure)	4180186
42872534	Drainage of dental abscess by extraoral approach (procedure)	4180186
42872537	Magnetic resonance imaging of thoracic aorta with contrast	4180186
42872537	Magnetic resonance imaging of thoracic aorta with contrast (procedure)	4180186
42872541	Ligation of short saphenous vein and multiple avulsions of varicose veins (procedure)	4180186
42872546	Listeria monocytogenes serotype 1/2b (organism)	4180186
42872547	Listeria monocytogenes serotype 1/2c (organism)	4180186
42872548	Listeria monocytogenes serotype 4b (organism)	4180186
42872549	Listeria monocytogenes serotype 3a (organism)	4180186
42872551	Listeria monocytogenes serotype 3c (organism)	4180186
42872553	Listeria monocytogenes serotype 4c (organism)	4180186
42872557	Listeria monocytogenes serotype 7 (organism)	4180186
42872560	Traumatic brain injury with prolonged loss of consciousness (more than 24 hours) and return to pre-existing conscious level (disorder)	4180186
42872563	Sutured laceration (morphologic abnormality)	4180186
42872566	Embolization of circle of Willis (procedure)	4180186
42872566	Embolisation of circle of Willis	4180186
42872568	Laparoscopic excision of uterine fibroid	4180186
42872568	Laparoscopic excision of leiomyoma of uterus	4180186
42872568	Laparoscopic excision of leiomyoma of uterus (procedure)	4180186
42872569	Laparoscopic removal of ovarian cyst (procedure)	4180186
42872570	Conversion from hemiarthroplasty of shoulder (procedure)	4180186
42872571	Laparoscopic excision of ruptured ectopic tubal pregnancy (procedure)	4180186
42872572	Laparoscopic excision of ectopic ovarian pregnancy (procedure)	4180186
42872573	Ligation of superior mesenteric artery (procedure)	4180186
42872574	Ligation of coeliac artery	4180186
42872574	Ligation of celiac artery (procedure)	4180186
42872577	Endoscopic excision of articular cartilage (procedure)	4180186
42872578	Traumatic brain injury with loss of consciousness one hour or more (disorder)	4180186
42872579	Conversion to fusion of joint with articular bone graft (procedure)	4180186
42872580	Conversion to fusion of joint and internal fixation (procedure)	4180186
42872581	Conversion to fusion of joint and external fixation (procedure)	4180186
42872582	Restoration of part of tooth using filling (procedure)	4180186
42872585	Microsurgical graft to facial nerve (procedure)	4180186
42872585	Microsurgical graft to cranial nerve VII	4180186
42872587	Removal of foreign body from pouch of Douglas	4180186
42872587	Removal of foreign body from rectouterine pouch (procedure)	4180186
42872589	Removal of foreign body from skin of neck (procedure)	4180186
42872591	Removal of slough from skin of head (procedure)	4180186
42872592	Removal of slough from skin of neck (procedure)	4180186
42872594	Removal of intermaxillary fixation wire (procedure)	4180186
42872596	Curettage of lesion of skin of neck (procedure)	4180186
42872597	Curettage of lesion of skin of head (procedure)	4180186
42872598	Excision of recurrent sebaceous cyst (procedure)	4180186
42872599	Excision of recurrent lipoma of subcutaneous tissue (procedure)	4180186
42872601	Excision of lesion of wall of heart	4180186
42872601	Excision of lesion of cardiac wall (procedure)	4180186
42872603	Primary malignant adenomatous neoplasm (morphologic abnormality)	4180186
42872604	Squamous intraepithelial neoplasia, low grade (morphologic abnormality)	4180186
42872607	Vibrio cholerae O75	4180186
42872607	Vibrio cholerae serogroup O75 (organism)	4180186
42872608	Borreliella spielmanii	4180186
42872608	Borrelia spielmanii (organism)	4180186
42872610	Biopsy of lesion of brainstem (procedure)	4180186
42872611	Bacteroides ureolyticus	4180186
42872611	Campylobacter ureolyticus (organism)	4180186
42872613	Biopsy of lesion of occipital lobe (procedure)	4180186
42872615	Biopsy of lesion of spinal cord (procedure)	4180186
42872617	Destruction of lesion of lung (procedure)	4180186
42872618	Campylobacter volucris (organism)	4180186
42872619	Insertion of orthodontic appliance (procedure)	4180186
42872620	Fluoribacter bozemanae	4180186
42872620	Legionella bozemanae (organism)	4180186
42872623	Ljungan virus (organism)	4180186
42872624	HPeV1 - Human parechovirus 1	4180186
42872624	Human parechovirus 1 (organism)	4180186
42872625	Human parechovirus 2 (organism)	4180186
42872625	HPeV2 - Human parechovirus 2	4180186
42872626	West caucasian bat virus (organism)	4180186
42872628	Khujand virus (organism)	4180186
42872629	Aravan virus (organism)	4180186
42872630	Chapare virus (organism)	4180186
42872633	Biopsy of lesion of skin of neck (procedure)	4180186
42872634	Biopsy of lesion of skin of head (procedure)	4180186
42872636	Punch biopsy of vulva (procedure)	4180186
42872638	Dressing of skin of head (procedure)	4180186
42872641	Application of vacuum assisted closure device to burnt skin (procedure)	4180186
42872641	Application of negative pressure wound dressing to burn of skin	4180186
42872642	Application of vacuum assisted closure device to skin of neck (procedure)	4180186
42872642	Application of negative pressure wound dressing to skin of neck	4180186
42872643	Dressing of ulcer of lower limb (procedure)	4180186
42872646	Open clipping of fallopian tube (procedure)	4180186
42872647	Open ringing of fallopian tube (procedure)	4180186
42872649	Open removal of products of conception from uterus (procedure)	4180186
42872652	Open cannulation of artery (procedure)	4180186
42872654	Open embolectomy of coeliac artery	4180186
42872654	Open embolectomy of celiac artery (procedure)	4180186
42872659	Open embolization of celiac artery (procedure)	4180186
42872659	Open embolisation of coeliac artery	4180186
42872660	Open embolization of superior mesenteric artery (procedure)	4180186
42872660	Open embolisation of superior mesenteric artery	4180186
42872661	Open embolization of inferior mesenteric artery (procedure)	4180186
42872661	Open embolisation of inferior mesenteric artery	4180186
42872662	Open embolisation of suprarenal artery	4180186
42872662	Open embolization of suprarenal artery (procedure)	4180186
42872665	Closed reduction of injury to epiphyseal growth plate (procedure)	4180186
42872669	Therapeutic endoscopic operation on structure of joint (procedure)	4180186
42872671	Therapeutic endoscopic operation on articular cartilage (procedure)	4180186
42872673	Excision of mass of neck (procedure)	4180186
42872675	Excision of lesion of skin of neck (procedure)	4180186
42872676	Excision of lipoma of subcutaneous tissue of neck (procedure)	4180186
42872678	Excision of adnexa of uterus (procedure)	4180186
42872679	Debridement of skin of head (procedure)	4180186
42872680	Debridement of soft tissue (procedure)	4180186
42872681	Debridement of skin of neck (procedure)	4180186
42872682	Application of gauze support bandage (procedure)	4180186
42872683	Fusion of joint with articular bone graft (procedure)	4180186
42872686	Injection of botulinum toxin into anal sphincter (procedure)	4180186
42872687	Intraamniotic injection of abortifacient (procedure)	4180186
42872689	Aspiration of intervertebral disc (procedure)	4180186
42872690	Aspiration of lesion of liver (procedure)	4180186
42872691	Bypass of segment of aorta (procedure)	4180186
42872693	Bypass of brachial artery (procedure)	4180186
42872694	Bypass of coeliac artery	4180186
42872694	Bypass of celiac artery (procedure)	4180186
42872695	Bypass of subclavian artery (procedure)	4180186
42872698	Bypass of vertebral artery (procedure)	4180186
42872700	Bypass of inferior mesenteric artery (procedure)	4180186
42872702	Skin structure over greater trochanter of hip (body structure)	4180186
42872704	Endarterectomy and patch repair of artery (procedure)	4180186
42872706	Repair of retina (procedure)	4180186
42872707	Repair of artery using prosthetic graft (procedure)	4180186
42872709	Repair of axillary artery (procedure)	4180186
42872711	Repair of iliac artery (procedure)	4180186
42872714	Repair of subclavian artery (procedure)	4180186
42872715	Repair of wall of heart	4180186
42872715	Repair of cardiac wall (procedure)	4180186
42872716	Repair of vault of vagina by abdominal approach (procedure)	4180186
42872717	Repair of vault of vagina by vaginal approach (procedure)	4180186
42872718	Open repair of extraarticular ligament (procedure)	4180186
42872719	Plastic repair of extraarticular ligament (procedure)	4180186
42872720	Plastic repair of intraarticular ligament (procedure)	4180186
42872721	Joint structure of forearm or wrist (body structure)	4180186
42872726	Temple region structure (body structure)	4180186
42872731	Entire lamina dura of tooth socket (body structure)	4180186
42872734	Impact of event scale revised (assessment scale)	4180186
42872736	Impact of event scale revised score (observable entity)	4180186
42872738	Assessment using World Health Organisation surgical safety checklist first edition	4180186
42872738	Assessment using World Health Organization surgical safety checklist first edition (procedure)	4180186
42872741	Rockall score (observable entity)	4180186
42872742	Coronary artery calcium score (assessment scale)	4180186
42872745	Assessment using thirty second chair stand test (procedure)	4180186
42872746	Thirty second chair stand test score (observable entity)	4180186
42872747	Strengths and difficulties questionnaire (assessment scale)	4180186
42872747	SDQ - strengths and difficulties questionnaire	4180186
42872749	National Institutes of Health stroke scale (assessment scale)	4180186
42872749	NIHSS - National Institutes of Health stroke scale	4180186
42872750	Assessment using National Institutes of Health stroke scale (procedure)	4180186
42872750	Assessment using NIHSS (National Institutes of Health stroke scale)	4180186
42872751	National Institutes of Health stroke scale score (observable entity)	4180186
42872751	NIHSS (National Institutes of Health stroke scale) score	4180186
42872752	Action for dysphasic adults comprehension battery (assessment scale)	4180186
42872752	ADA (action for dysphasic adults) comprehension battery	4180186
42872755	Saint George's respiratory questionnaire score (observable entity)	4180186
42872755	St. George's respiratory questionnaire score	4180186
42872756	Assessment using St. George's respiratory questionnaire	4180186
42872756	Assessment using Saint George's respiratory questionnaire (procedure)	4180186
42872757	Sexual health inventory for men (assessment scale)	4180186
42872757	International index of erectile function - 5 items	4180186
42872758	Conversation analysis profile for people with cognitive impairment (assessment scale)	4180186
42872762	Assessment using mobility inventory for agoraphobia (procedure)	4180186
42872763	Medical Research Council breathlessness scale score	4180186
42872763	Medical Research Council Dyspnoea scale score (observable entity)	4180186
42872763	MRC (Medical Research Council) breathlessness scale score	4180186
42872764	Voice handicap index (assessment scale)	4180186
42872764	VHI - voice handicap index	4180186
42872766	Voice handicap index score (observable entity)	4180186
42872766	VHI (voice handicap index) score	4180186
42872768	Assessment using alcohol use disorders identification test (procedure)	4180186
42872768	Assessment using AUDIT (alcohol use disorders identification test)	4180186
42872773	Lymphocyte antigen CD154 (substance)	4180186
42872779	Issuing of certificate of incapacity (procedure)	4180186
42872780	Application of cosmetic camouflage (procedure)	4180186
42872780	Cosmetic camouflage	4180186
42872782	Emptying of ureterostomy bag (procedure)	4180186
42872783	Prosthetic replacement of ligament (procedure)	4180186
42872784	Prosthetic replacement of intraarticular ligament (procedure)	4180186
42872788	Primary fusion of joint and external fixation (procedure)	4180186
42872792	Primary fusion of joint with articular bone graft (procedure)	4180186
42872794	Revision of cemented total replacement of joint (procedure)	4180186
42872795	Revision of closed reduction of dislocation (procedure)	4180186
42872796	Revision of cardiac conduit (procedure)	4180186
42872799	Revision of fusion of lumbar spine (procedure)	4180186
42872800	Revision of hybrid total replacement of joint (procedure)	4180186
42872802	Revision of fusion of joint with articular bone graft (procedure)	4180186
42872808	Infrared photocoagulation of lesion of skin (procedure)	4180186
42872809	Photodestruction of lesion of skin of head (procedure)	4180186
42872812	European bat lyssavirus 1 (organism)	4180186
42872813	European bat lyssavirus 2 (organism)	4180186
42872815	Bathrocephaly (disorder)	4180186
42872819	Primary uncemented total replacement of joint (procedure)	4180186
42872820	Primary total prosthetic replacement of hip (procedure)	4180186
42872821	Revision of hybrid total knee replacement (procedure)	4180186
42872823	Revision of transplantation of heart (procedure)	4180186
42872825	Primary hybrid total knee replacement (procedure)	4180186
42872826	On NPO - nil per os	4180186
42872826	Taking nil by mouth	4180186
42872826	On nothing by mouth status (finding)	4180186
42872827	Replacement of pulse generator of permanent cardiac pacemaker using fluoroscopic guidance (procedure)	4180186
42872827	Fluoroscopy guided replacement of pulse generator of permanent cardiac pacemaker	4180186
42872829	Reexcision of ganglion of hand (procedure)	4180186
42872830	Postpartum exploration of uterus using instrument (procedure)	4180186
42872830	Instrumental exploration of delivered uterus	4180186
42872830	Instrumental postpartum exploration of uterus	4180186
42872835	Excision of orbital fat herniation (procedure)	4180186
42872837	Cleansing and sterilisation of skin	4180186
42872837	Cleansing and sterilization of skin (procedure)	4180186
42872838	Cleansing and sterilization of burnt skin (procedure)	4180186
42872838	Cleansing and sterilisation of burnt skin	4180186
42872839	Assessment of ureterostomy tube (procedure)	4180186
42872840	Child visual perception assessment (procedure)	4180186
42872845	Human leukocyte antigen B5701 (substance)	4180186
42872845	HLA-B5701 antigen	4180186
42872848	Non-organic secondary nocturnal enuresis (finding)	4180186
42872849	Non-organic nocturnal enuresis (finding)	4180186
42872851	Secondary nocturnal enuresis (finding)	4180186
42872853	Thickening of skin of breast (disorder)	4180186
42872854	Congenital monosaccharide malabsorption (disorder)	4180186
42872856	Uses contraceptive diaphragm (finding)	4180186
42872858	Engages in homosexual sexual activity (finding)	4180186
42872859	Engages in heterosexual sexual activity (finding)	4180186
42872861	Kobuvirus	4180186
42872861	Genus Kobuvirus (organism)	4180186
42872862	Sapelovirus	4180186
42872862	Genus Sapelovirus (organism)	4180186
42872865	Tremovirus	4180186
42872865	Genus Tremovirus (organism)	4180186
42872867	Cryptococcus gattii (organism)	4180186
42872867	Cryptococcus bacillisporus	4180186
42872869	Nontunneled haemodialysis catheter	4180186
42872869	Nontunneled hemodialysis catheter (physical object)	4180186
42872871	Haemodialysis catheter	4180186
42872871	Hemodialysis catheter (physical object)	4180186
42872872	Bovine rhinovirus 1	4180186
42872872	BRV-3 Bovine rhinovirus 3	4180186
42872872	BRV-1 Bovine rhinovirus 1	4180186
42872872	Bovine rhinovirus A (organism)	4180186
42872872	Bovine rhinovirus 3	4180186
42872873	BRV-2 Bovine rhinovirus 2	4180186
42872873	Bovine rhinovirus 2	4180186
42872873	Bovine rhinovirus B (organism)	4180186
42872874	Human rhinovirus B (organism)	4180186
42872876	Attention to colostomy (procedure)	4180186
42872878	Plication of emphysematous bleb of lung (procedure)	4180186
42872881	Hindlimb lameness	4180186
42872881	Limping on hindlimb (finding)	4180186
42872888	Aspergillus westerdijkiae (organism)	4180186
42872889	American English coonhound dog breed (organism)	4180186
42872889	American English coonhound dog breed	4180186
42872892	Differentiation syndrome	4180186
42872892	Retinoic acid syndrome (disorder)	4180186
42872895	Glandular intraepithelial neoplasia, low grade (morphologic abnormality)	4180186
42872896	Functioning endocrine tumor (morphologic abnormality)	4180186
42872896	Functioning endocrine tumour	4180186
42872897	Non-invasive pancreatobiliary neoplasm (morphologic abnormality)	4180186
42872898	Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality)	4180186
42872901	Low grade appendiceal mucinous neoplasm (morphologic abnormality)	4180186
42872903	Calcifying nested epithelial stromal tumour	4180186
42872903	Calcifying nested epithelial stromal tumor (morphologic abnormality)	4180186
42872904	Papillary tumor of the pineal region (morphologic abnormality)	4180186
42872904	Papillary tumour of the pineal region	4180186
42872907	Papillary glioneuronal tumor (morphologic abnormality)	4180186
42872907	Papillary glioneuronal tumour	4180186
42872913	Primary cutaneous gamma-delta T-cell lymphoma (morphologic abnormality)	4180186
42872915	Anaplastic lymphoma kinase positive large B-cell lymphoma (morphologic abnormality)	4180186
42872915	Anaplastic lymphoma kinase positive large B-cell lymphoma	4180186
42872919	Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)	4180186
42872919	Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1	4180186
42872921	Mixed phenotype acute leukaemia with myeloid and B-cell lymphoid phenotypes	4180186
42872921	Mixed phenotype acute leukemia with myeloid and B-cell lymphoid phenotypes (morphologic abnormality)	4180186
42872921	Mixed phenotype acute leukemia with myeloid and B-cell lymphoid phenotypes	4180186
42872921	Mixed phenotype acute leukaemia B/myeloid	4180186
42872922	Mixed phenotype acute leukemia with myeloid and T-cell lymphoid phenotypes	4180186
42872922	Mixed phenotype acute leukaemia with myeloid and T-cell lymphoid pheotypes	4180186
42872922	Mixed phenotype acute leukemia with myeloid and T-cell lymphoid phenotypes (morphologic abnormality)	4180186
42872922	Mixed phenotype acute leukaemia T/myeloid	4180186
42872923	Nasopharyngolaryngoscopy (procedure)	4180186
42872926	Pseudomonas japonica (organism)	4180186
42872929	Shewanella haliotis (organism)	4180186
42872932	Wilsonia canadensis	4180186
42872932	Wilsonia canadensis (organism)	4180186
42872935	Amycolatopsis regifaucium (organism)	4180186
42872937	Aeromicrobium flavum (organism)	4180186
42872939	Transient abnormal myelopoiesis (morphologic abnormality)	4180186
42872940	Myeloid leukaemia associated with Down Syndrome	4180186
42872940	Myeloid leukemia associated with Down Syndrome (morphologic abnormality)	4180186
42872942	Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 (morphologic abnormality)	4180186
42872942	Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1	4180186
42872943	Commissurotomy of heart valve (procedure)	4180186
42872944	Negativicoccus succinicivorans (organism)	4180186
42872951	Refractory neutropaenia	4180186
42872951	Refractory neutropenia (morphologic abnormality)	4180186
42872952	Refractory thrombocytopenia (morphologic abnormality)	4180186
42872952	Refractory thrombocytopaenia	4180186
42872957	B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (morphologic abnormality)	4180186
42872957	B lymphoblastic leukaemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)	4180186
42872960	B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH (morphologic abnormality)	4180186
42872960	B lymphoblastic leukaemia lymphoma with t(5;14)(q31;q32); IL3-IGH	4180186
42872961	B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) (morphologic abnormality)	4180186
42872961	B lymphoblastic leukaemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)	4180186
42872962	Phocaeicola dorei	4180186
42872962	Phocaeicola dorei (organism)	4180186
42872962	Bacteroides dorei (organism)	4180186
42872965	Structure of mid portion of right coronary artery (body structure)	4180186
42872966	Entire mid portion of right coronary artery (body structure)	4180186
42872969	Primary dressing (physical object)	4180186
42872971	Moist saline gauze (physical object)	4180186
42872975	General Practice / Family Practice reference set (foundation metadata concept)	4180186
42872976	GP/FP reason for encounter reference set (foundation metadata concept)	4180186
42872978	GP/FP health issue reference set (foundation metadata concept)	4180186
42872979	Symptoms and signs reference set for GP/FP reason for encounter (foundation metadata concept)	4180186
42872980	Assessment using sensory modality assessment and rehabilitation technique (procedure)	4180186
42872981	Disorders and diseases reference set for GP/FP reason for encounter (foundation metadata concept)	4180186
42872983	Family history reference set for GP/FP reason for encounter (foundation metadata concept)	4180186
42872987	Processes and procedures reference set for GP/FP reason for encounter (foundation metadata concept)	4180186
42872989	Symptoms and signs reference set for GP/FP health issue (foundation metadata concept)	4180186
42872990	Sacroiliac joint somatic dysfunction	4180186
42872990	Somatic dysfunction of sacroiliac joint (finding)	4180186
42872991	Disorders and diseases reference set for GP/FP health issue (foundation metadata concept)	4180186
42872994	Family history reference set for GP/FP health issue (foundation metadata concept)	4180186
42872995	Allergies reference set for GP/FP health issue (foundation metadata concept)	4180186
42872996	Adverse drug reactions reference set for GP/FP health issue (foundation metadata concept)	4180186
42872997	Processes and procedures reference set for GP/FP health issue (foundation metadata concept)	4180186
42872999	SNOMED CT to International Classification of Primary Care, Second edition complex map reference set (foundation metadata concept)	4180186
42872999	SNOMED CT to International Classification of Primary Care, Second edition complex map reference set	4180186
42872999	SNOMED CT to ICPC-2 complex map	4180186
42872999	SNOMED CT to International Classification of Primary Care, Second edition complex map	4180186
42872999	International Classification of Primary Care, Second edition complex map reference set (foundation metadata concept)	4180186
42873000	ICPC-2 map category reference set (foundation metadata concept)	4180186
42873001	ICPC-2 map category value (foundation metadata concept)	4180186
42873003	Map source concept is properly classified in ICPC-2 (foundation metadata concept)	4180186
42873004	Map source concept cannot be classified in ICPC-2 with available data (foundation metadata concept)	4180186
42873006	Source SNOMED CT concept is ambiguous in the context of mapping to ICPC-2 (foundation metadata concept)	4180186
42873007	Closed injury of head (disorder)	4180186
42873007	Closed head injury	4180186
42873008	Source SNOMED CT concept is incompletely modeled in the context of mapping to ICPC-2 (foundation metadata concept)	4180186
42873016	Enucleation of radicular cyst of lower jaw (procedure)	4180186
42873020	Enucleation of odontogenic keratocyst of lower jaw (procedure)	4180186
42873025	Western Ontario and McMaster Universities osteoarthritis index (assessment scale)	4180186
42873025	WOMAC scale	4180186
42873025	WOMAC index	4180186
42873026	Metamizole sodium	4180186
42873026	Metamizole sodium product	4180186
42873026	Product containing metamizole sodium	4180186
42873026	Product containing metamizole sodium (medicinal product)	4180186
42873027	Family APGAR	4180186
42873027	Family adaptation, partnership, growth, affection, and resolve (assessment scale)	4180186
42873028	ESAS	4180186
42873028	Edmonton symptom assessment system (assessment scale)	4180186
42873031	Inspection of vagina using vaginal speculum (procedure)	4180186
42873032	Open commissurotomy of mitral valve (procedure)	4180186
42873034	Commissurotomy of atrioventricular valve (procedure)	4180186
42873035	Commissurotomy of mitral valve (procedure)	4180186
42873036	Commissurotomy of tricuspid valve (procedure)	4180186
42873037	Urachal sinus (disorder)	4180186
42873039	Structure of subpial space of brain (body structure)	4180186
42873042	Subpial intracranial hemorrhage (disorder)	4180186
42873042	Subpial intracranial haemorrhage	4180186
42873043	Hemorrhage into subpial space of spinal cord (disorder)	4180186
42873043	Haemorrhage into subpial space of spinal cord	4180186
42873044	Pallidal haemorrhage	4180186
42873044	Haemorrhage in globus pallidus	4180186
42873044	Hemorrhage in globus pallidus (disorder)	4180186
42873044	Pallidal hemorrhage	4180186
42873045	Haemorrhage in caudate nucleus	4180186
42873045	Hemorrhage in caudate nucleus (disorder)	4180186
42873050	Anomalous origin of right coronary artery from pulmonary artery (disorder)	4180186
42873052	Anomalous origin of left anterior descending coronary artery from pulmonary artery (disorder)	4180186
42873053	Congenital pericardial effusion (disorder)	4180186
42873055	Coarctation of infrarenal abdominal aorta (disorder)	4180186
42873057	Major systemic to pulmonary collateral artery supplying entire right lung (disorder)	4180186
42873058	Major systemic to pulmonary collateral artery supplying entire left lung (disorder)	4180186
42873059	Major systemic to pulmonary collateral artery supplying part of right lung (disorder)	4180186
42873060	Major systemic to pulmonary collateral artery supplying part of left lung (disorder)	4180186
42873061	Major systemic to pulmonary collateral artery supplying unknown zone of distribution (disorder)	4180186
42873062	Coarctation of aorta between subclavian artery and common carotid artery (disorder)	4180186
42873064	Vascular ring with right aortic arch and left patent ductus arteriosus	4180186
42873064	Vascular ring with right aortic arch and left patent ductus arteriosus (disorder)	4180186
42873066	Severe dehydration (disorder)	4180186
42873067	Strengths and difficulties questionnaire score (observable entity)	4180186
42873067	SDQ (Strengths and difficulties questionnaire) score	4180186
42873073	Factor VIII specific immunoglobulin E (substance)	4180186
42873073	Factor VIII specific IgE	4180186
42873074	Obsessive compulsive inventory score (observable entity)	4180186
42873075	Assessment using obsessive compulsive inventory (procedure)	4180186
42873079	Removal of tunneled central venous catheter (procedure)	4180186
42873079	Removal of tunnelled central venous catheter	4180186
42873082	Attention to ventriculopleural shunt (procedure)	4180186
42873086	Primary decompression of peripheral nerve (procedure)	4180186
42873086	Primary release of peripheral nerve	4180186
42873087	Secondary decompression of peripheral nerve (procedure)	4180186
42873087	Secondary release of peripheral nerve	4180186
42873090	Destruction of sympathetic nerve (procedure)	4180186
42873094	Aspiration of bronchus (procedure)	4180186
42873096	Reconstruction of lip with skin flap (procedure)	4180186
42873097	Primary repair of cleft palate (procedure)	4180186
42873100	Reduction of prolapse of rectum (procedure)	4180186
42873102	Obsessive compulsive inventory (assessment scale)	4180186
42873104	Benign prostatic hyperplasia impact index (assessment scale)	4180186
42873104	BPHII - benign prostatic hyperplasia impact index	4180186
42873105	Assessment using benign prostatic hyperplasia impact index (procedure)	4180186
42873105	Assessment using BPHII (benign prostatic hyperplasia impact index)	4180186
42873106	Benign prostatic hyperplasia impact index score (observable entity)	4180186
42873106	BPHII (benign prostatic hyperplasia impact index) score	4180186
42873107	Coronary artery calcium score (observable entity)	4180186
42873108	Clinical opiate withdrawal scale (assessment scale)	4180186
42873112	Oceanobacillus sojae (organism)	4180186
42873113	Paenibacillus ginsengarvi (organism)	4180186
42873114	Paenibacillus taichungensis (organism)	4180186
42873115	Paenibacillus tundrae (organism)	4180186
42873118	Pseudomonas moorei (organism)	4180186
42873121	Prevotella timonensis (organism)	4180186
42873122	Traumatic haemorrhage into subarachnoid space of neuraxis	4180186
42873122	Traumatic hemorrhage into subarachnoid space of neuraxis (disorder)	4180186
42873123	Hemorrhage of intracranial meningeal space (disorder)	4180186
42873123	Haemorrhage of intracranial meningeal space	4180186
42873125	Haemorrhage into extradural space of neuraxis	4180186
42873125	Hemorrhage into extradural space of neuraxis (disorder)	4180186
42873126	Haemorrhage into extradural space of spine	4180186
42873126	Hemorrhage into extradural space of spine	4180186
42873126	Hemorrhage into extradural space of spine (disorder)	4180186
42873126	Haemorrhage into epidural space of spine	4180186
42873128	Chryseobacterium arthrosphaerae (organism)	4180186
42873129	Pediococcus lolii (organism)	4180186
42873130	Corynebacterium pyruviciproducens (organism)	4180186
42873134	Bacillus foraminis	4180186
42873134	Mesobacillus foraminis (organism)	4180186
42873136	Bacillus herbersteinensis (organism)	4180186
42873137	Bacillus niabensis (organism)	4180186
42873138	Yersinia aleksiciae (organism)	4180186
42873140	Lactobacillus plantarum subspecies plantarum (organism)	4180186
42873140	Lactobacillus plantarum subspecies plantarum	4180186
42873140	Lactiplantibacillus plantarum subsp. plantarum	4180186
42873140	Lactobacillus plantarum subsp. plantarum	4180186
42873140	Lactiplantibacillus plantarum subspecies plantarum (organism)	4180186
42873140	Lactiplantibacillus plantarum subspecies plantarum	4180186
42873145	Aeromonas sanarellii (organism)	4180186
42873146	Methylorubrum salsuginis	4180186
42873146	Methylorubrum salsuginis (organism)	4180186
42873146	Methylobacterium salsuginis (organism)	4180186
42873153	Bacillus methylotrophicus (organism)	4180186
42873154	Bacillus siamensis (organism)	4180186
42873157	Intracranial hemorrhage following injury (disorder)	4180186
42873157	Traumatic intracranial haemorrhage	4180186
42873157	Intracranial haemorrhage following injury	4180186
42873157	Traumatic intracranial hemorrhage	4180186
42873159	Irritant rhinitis (disorder)	4180186
42873160	Sibling relationship problem (finding)	4180186
42873160	Sibling relation problem	4180186
42873162	Long term methotrexate user (finding)	4180186
42873164	Acute cystitis in pregnancy, antepartum (disorder)	4180186
42873166	Telangiectasia of limb (disorder)	4180186
42873168	Reactive airway disease (disorder)	4180186
42873170	Dependence on supplemental oxygen (finding)	4180186
43020392	Hepatitis C virus subtype 2b (organism)	4180186
43020394	Hepatitis C virus subtype 4b (organism)	4180186
43020395	Educated to senior high school level (finding)	4180186
43020396	Hepatitis C virus subtype 1a (organism)	4180186
43020397	Hepatitis C virus subtype 1b (organism)	4180186
43020400	Hepatitis C virus subtype 3b (organism)	4180186
43020402	Hepatitis C virus subtype 6a (organism)	4180186
43020413	Hepatitis C virus subtype 4e (organism)	4180186
43020415	Primary hyposomnia (disorder)	4180186
43020416	Problem with aged spouse or partner (finding)	4180186
43020417	Interpersonal problem, codependency	4180186
43020417	Codependency (finding)	4180186
43020420	Permanent cardiac pacemaker (finding)	4180186
43020422	Dementia due to Rett's syndrome (disorder)	4180186
43020424	Hypertensive emergency (disorder)	4180186
43020425	Childhood onset stammering	4180186
43020425	Childhood onset stuttering (finding)	4180186
43020427	Childhood onset stuttering and stammering (finding)	4180186
43020430	Intravenous cocaine abuse (disorder)	4180186
43020433	Psychogenic inhibited male orgasm (finding)	4180186
43020433	Psychosexual dysfunction with inhibited male orgasm	4180186
43020435	Visceral ischemia (disorder)	4180186
43020435	Visceral ischaemia	4180186
43020436	Cares for sick or handicapped family member (finding)	4180186
43020436	Care of sick or handicapped person in family	4180186
43020441	Psychological disorder in pregnancy	4180186
43020441	Psychological disorder during pregnancy (disorder)	4180186
43020443	Limb ischemia (disorder)	4180186
43020443	Limb ischaemia	4180186
43020445	Psychosis in early childhood (disorder)	4180186
43020445	Psychosis, early childhood	4180186
43020447	Child victim of nutritional neglect (finding)	4180186
43020448	Adult abuse, nutritional neglect	4180186
43020448	Adult victim of nutritional neglect (finding)	4180186
43020454	Left anterior hemiblock (disorder)	4180186
43020455	Malignant hypertensive end stage renal disease (disorder)	4180186
43020458	Mechanical breakdown of coronary artery bypass graft (disorder)	4180186
43020459	Mechanical breakdown of prosthetic heart valve (disorder)	4180186
43020459	Mechanical breakdown of heart valve prosthesis	4180186
43020462	Discord with neighbors, lodgers and landlord (finding)	4180186
43020464	Behavioral insomnia of childhood, limit setting type (disorder)	4180186
43020464	Behavioural insomnia of childhood, limit setting type	4180186
43020467	Behavioural insomnia of childhood, sleep onset association type	4180186
43020467	Behavioral insomnia of childhood, sleep onset type	4180186
43020467	Behavioral insomnia of childhood, sleep onset association type (disorder)	4180186
43020469	Dependent relative needing care at home	4180186
43020469	Cares for dependent relative at home (finding)	4180186
43020470	Fear of bridges (finding)	4180186
43020472	Childhood onset fluency disorder (disorder)	4180186
43020476	High risk homosexual behaviour	4180186
43020476	High risk homosexual behavior (finding)	4180186
43020478	Total anomalous pulmonary venous connection to right atrium (disorder)	4180186
43020480	Acquired coronary artery fistula (disorder)	4180186
43020482	Adult physical abuse by female partner	4180186
43020482	Adult victim of physical abuse by female partner (finding)	4180186
43020484	Parent child estrangement (finding)	4180186
43020485	Problem related to life management difficulty (finding)	4180186
43020486	Problem related to upbringing (finding)	4180186
43020487	Problem in relationship with in laws	4180186
43020487	Problem in relationship with in-laws (finding)	4180186
43020489	Psychosocial problems related to multiparity (finding)	4180186
43020490	Aneurysm of extracranial portion of internal carotid artery (disorder)	4180186
43020493	Right carotid artery atherosclerosis	4180186
43020493	Atherosclerosis of right carotid artery (disorder)	4180186
43020494	High-grade second degree AV block	4180186
43020494	High degree second degree atrioventricular block (disorder)	4180186
43020495	Postoperative atrioventricular block (disorder)	4180186
43020496	Occlusion of left carotid artery (disorder)	4180186
43020496	Occlusion of left carotid artery	4180186
43020503	Pervasive developmental disorder of residual state (disorder)	4180186
43020504	Shone complex (disorder)	4180186
43020504	Shone syndrome	4180186
43020505	Salter-Harris type VI (morphologic abnormality)	4180186
43020505	Epiphyseal fracture, Salter-Harris type VI	4180186
43020507	Epiphyseal fracture, Salter-Harris type VIII	4180186
43020507	Salter-Harris type VIII (morphologic abnormality)	4180186
43020508	Acquired abnormality of inferior vena cava (disorder)	4180186
43020508	Acquired abnormality of inferior caval vein	4180186
43020511	Progression of foetal left ventricular outflow tract obstruction	4180186
43020511	Progression of fetal left ventricular outflow tract obstruction (disorder)	4180186
43020512	Poor feather condition (finding)	4180186
43020515	Eastern fox squirrel	4180186
43020515	Sciurus niger subspecies cinereus (organism)	4180186
43020515	Sciurus niger subspecies cinereus	4180186
43020516	Mycoplasma haemolamae (organism)	4180186
43020516	Mycoplasma hemolama	4180186
43020517	Lochia serosa (substance)	4180186
43020518	Fluorocholine (18-F) (substance)	4180186
43020518	Fluorocholine F^18^	4180186
43020519	Florbetapir [F-18]	4180186
43020519	Product containing florbetapir (18-F) (medicinal product)	4180186
43020522	Fluciclatide (18-F) (substance)	4180186
43020522	Fluciclatide F^18^	4180186
43020523	Fluciclovine (18-F) (substance)	4180186
43020523	Fluciclovine F^18^	4180186
43020525	Escherichia coli serotype Orough:H8 (organism)	4180186
43020525	E. coli Orough:H8	4180186
43020527	Escherichia coli serotype Orough:H49 (organism)	4180186
43020527	E. coli Orough:H49	4180186
43020528	E. coli Orough:H45	4180186
43020528	Escherichia coli serotype Orough:H45 (organism)	4180186
43020529	E. coli Orough:H34	4180186
43020529	Escherichia coli serotype Orough:H34 (organism)	4180186
43020530	E. coli Orough:H28	4180186
43020530	Escherichia coli serotype Orough:H28 (organism)	4180186
43020532	Escherichia coli serotype Orough:H2 (organism)	4180186
43020532	E. coli Orough:H2	4180186
43020534	E. coli Orough:H18	4180186
43020534	Escherichia coli serotype Orough:H18 (organism)	4180186
43020535	E. coli Orough:H14	4180186
43020535	Escherichia coli serotype Orough:H14 (organism)	4180186
43020536	E. coli Orough:H10	4180186
43020536	Escherichia coli serotype Orough:H10 (organism)	4180186
43020537	Escherichia coli serotype Orough:H11 (organism)	4180186
43020537	E. coli Orough:H11	4180186
43020538	Escherichia coli serotype O181:H28 (organism)	4180186
43020538	E. coli serotype O181:H28	4180186
43020542	Escherichia coli serotype O177:nonmotile (organism)	4180186
43020542	E. coli serotype O177:nonmotile	4180186
43020544	E. coli serotype O175:H16	4180186
43020544	Escherichia coli serotype O175:H16 (organism)	4180186
43020545	E. coli serotype O175:H21	4180186
43020545	Escherichia coli serotype O175:H21 (organism)	4180186
43020547	Tumor of fetal heart	4180186
43020547	Neoplasm of foetal heart	4180186
43020547	Tumour of fetal heart	4180186
43020547	Tumour of foetal heart	4180186
43020547	Neoplasm of fetal heart (disorder)	4180186
43020548	Magnetic resonance imaging of fetal cardiovascular system (procedure)	4180186
43020548	Magnetic resonance imaging of foetal cardiovascular system	4180186
43020548	Magnetic resonance imaging of fetal cardiovascular system	4180186
43020548	MRI of foetal cardiovascular system	4180186
43020550	Tense ascites (disorder)	4180186
43020552	Occlusion of superior vena cava (disorder)	4180186
43020553	Occlusion of inferior vena cava (disorder)	4180186
43020554	Normal nonintramural course of coronary artery (finding)	4180186
43020555	Middle aortic syndrome (disorder)	4180186
43020557	Excessive curve of Spee	4180186
43020557	Deep curve of Spee (finding)	4180186
43020558	Cavitary pneumonia (disorder)	4180186
43020561	Single left coronary artery supplying all of heart with usual distribution of right coronary artery derived from distal left coronary artery (disorder)	4180186
43020563	Recurrent atrial component of atrioventricular septal defect after prior cardiovascular surgical procedure (disorder)	4180186
43020564	Recurrent ventricular component of atrioventricular septal defect after prior cardiovascular surgical procedure (disorder)	4180186
43020566	Chromosome microdeletion (finding)	4180186
43020567	Air leak from lung	4180186
43020567	Pulmonary air leakage	4180186
43020567	Air leaking from lung (disorder)	4180186
43020568	Loss of lamina dura (disorder)	4180186
43020569	Anomalous origin of coronary artery from sinus 2	4180186
43020569	Anomalous origin of coronary artery from aortic sinus of Valsalva to left of nonfacing aortic sinus of Valsalva	4180186
43020569	Anomalous origin of coronary artery from aortic sinus to left of nonfacing aortic sinus (disorder)	4180186
43020570	Anomalous origin of left coronary artery and right coronary artery with dual orifices from sinus 2	4180186
43020570	Anomalous origin of left coronary artery and right coronary artery with dual orifices from aortic sinus to left of nonfacing aortic sinus (disorder)	4180186
43020570	Anomalous origin of left coronary artery and right coronary artery with dual ostia from aortic sinus of Valsalva to left of nonfacing aortic sinus of Valsalva	4180186
43020571	Anomalous origin of left coronary artery and right coronary artery with dual orifices from sinus 1	4180186
43020571	Anomalous origin of left coronary artery and right coronary artery with dual ostia from aortic sinus of Valsalva to right of nonfacing aortic sinus of Valsalva	4180186
43020571	Anomalous origin of left coronary artery and right coronary artery with dual orifices from aortic sinus to right of nonfacing aortic sinus (disorder)	4180186
43020572	Anomalous origin of circumflex artery from aortic sinus to right of nonfacing aortic sinus and anomalous origin of left anterior descending coronary artery and right coronary artery from aortic sinus to left of nonfacing aortic sinus (disorder)	4180186
43020572	Anomalous origin of circumflex artery from sinus 1 and anomalous origin of left anterior descending coronary artery and right coronary artery from sinus 2	4180186
43020573	Anomalous origin of left anterior descending artery from aortic sinus to right of nonfacing aortic sinus and anomalous origin of circumflex artery and right coronary artery from aortic sinus to left of nonfacing aortic sinus (disorder)	4180186
43020573	Anomalous origin of left anterior descending artery from sinus 1 and anomalous origin of circumflex artery and right coronary artery from sinus 2	4180186
43020574	Anomalous origin of right coronary artery from aortic sinus of Valsalva to right of nonfacing aortic sinus of Valsalva and anomalous origin of left coronary artery from aortic sinus of Valsalva to left of nonfacing aortic sinus of Valsalva	4180186
43020574	Anomalous origin of right coronary artery from aortic sinus to right of nonfacing aortic sinus and anomalous origin of left coronary artery from aortic sinus to left of nonfacing aortic sinus (disorder)	4180186
43020574	Anomalous origin of right coronary artery from sinus 1 and anomalous origin of left coronary artery from sinus 2	4180186
43020579	Anomalous origin of single coronary artery from sinus 2	4180186
43020579	Anomalous origin of single coronary artery from aortic sinus of Valsalva to left of nonfacing aortic sinus of Valsalva	4180186
43020579	Anomalous origin of single coronary artery from aortic sinus to left of nonfacing aortic sinus (disorder)	4180186
43020580	Anomalous origin of single coronary artery from aortic sinus of Valsalva to right of nonfacing aortic sinus of Valsalva	4180186
43020580	Anomalous origin of single coronary artery from aortic sinus to right of nonfacing aortic sinus (disorder)	4180186
43020580	Anomalous origin of single coronary artery from sinus 1	4180186
43020581	On waiting list for organ transplant (finding)	4180186
43020582	Acquired excessive restriction of interatrial communication (disorder)	4180186
43020583	Escherichia coli serotype O153:nonmotile (organism)	4180186
43020583	E. coli serotype O153:nonmotile	4180186
43020585	Escherichia coli serotype O153:H25 (organism)	4180186
43020585	E. coli serotype O153:H25	4180186
43020586	E. coli serotype O153:H2	4180186
43020586	Escherichia coli serotype O153:H2 (organism)	4180186
43020587	E. coli serotype O153:H45	4180186
43020587	Escherichia coli serotype O153:H45 (organism)	4180186
43020589	E. coli O150	4180186
43020589	E. coli serogroup O150	4180186
43020589	Escherichia coli O150	4180186
43020589	Escherichia coli serogroup O150 (organism)	4180186
43020589	Escherichia coli serotype O150	4180186
43020590	E. coli serotype O150:H11	4180186
43020590	Escherichia coli serotype O150:H11 (organism)	4180186
43020594	Escherichia coli serotype O146:nonmotile (organism)	4180186
43020594	E. coli serotype O146:nonmotile	4180186
43020597	Escherichia coli serotype O146:H11 (organism)	4180186
43020597	E. coli serotype O146:H11	4180186
43020598	Escherichia coli serotype O145:nonmotile (organism)	4180186
43020598	E. coli serotype O145:nonmotile	4180186
43020602	Escherichia coli serotype O145:H16 (organism)	4180186
43020602	E. coli serotype O145:H16	4180186
43020606	E. coli O172:nonmotile	4180186
43020606	Escherichia coli O172:nonmotile (organism)	4180186
43020610	Escherichia coli serotype O168	4180186
43020610	Escherichia coli serogroup O168 (organism)	4180186
43020611	Abscess of right ventricular wall (disorder)	4180186
43020611	Abscess in right ventricular wall	4180186
43020612	Abscess of left ventricular wall (disorder)	4180186
43020612	Abscess in left ventricular wall	4180186
43020614	Occlusion of iliac vein (disorder)	4180186
43020615	Occlusion of femoral vein (disorder)	4180186
43020616	Obstruction of tricuspid valve due to tumor	4180186
43020616	Obstruction of tricuspid valve due to neoplasm (disorder)	4180186
43020616	Obstruction of tricuspid valve due to tumour	4180186
43020618	Obstruction of mitral valve due to tumor	4180186
43020618	Obstruction of mitral valve due to tumour	4180186
43020618	Obstruction of mitral valve due to neoplasm (disorder)	4180186
43020621	Thrombosis of pulmonary valve (disorder)	4180186
43020623	Rupture of pulmonary valve cusp (disorder)	4180186
43020623	Rupture of pulmonary cusp	4180186
43020625	Calcification of pulmonary valve annulus (disorder)	4180186
43020628	Disruption of aortic valve annulus (disorder)	4180186
43020629	Dehiscence of aortic valve annulus as complication of procedure (disorder)	4180186
43020630	Disorder of aortic valve prosthesis (disorder)	4180186
43020631	Calcification of truncal valve (disorder)	4180186
43020632	Rupture of truncal valve leaflet	4180186
43020632	Rupture of truncal valve cusp (disorder)	4180186
43020633	Thrombosis of common atrioventricular valve (disorder)	4180186
43020635	Calcification of right atrioventricular (not morphologically tricuspid) valve (disorder)	4180186
43020635	Calcification of right atrioventricular (nontricuspid) valve	4180186
43020636	Rupture of right atrioventricular (nontricuspid) valve chordae tendinae	4180186
43020636	Rupture of right atrioventricular (not morphologically tricuspid) valve chordae tendinae (disorder)	4180186
43020638	Thrombosis of left atrioventricular (not morphologically mitral) valve (disorder)	4180186
43020638	Thrombosis of left atrioventricular (nonmitral) valve	4180186
43020640	Calcification of left atrioventricular (not morphologically mitral) valve (disorder)	4180186
43020640	Calcification of left atrioventricular (nonmitral) valve	4180186
43020641	Rupture of left atrioventricular (not morphologically mitral) valve papillary muscle (disorder)	4180186
43020641	Rupture of left atrioventricular (nonmitral) valve papillary muscle	4180186
43020643	Escherichia coli serotype O165:nonmotile (organism)	4180186
43020643	E. coli serotype O165:nonmotile	4180186
43020644	Escherichia coli serotype O165:H7 (organism)	4180186
43020644	E. coli serotype O165:H7	4180186
43020645	E. coli O162	4180186
43020645	Escherichia coli O162	4180186
43020645	Escherichia coli serotype O162	4180186
43020645	E. coli serogroup O162	4180186
43020645	Escherichia coli serogroup O162 (organism)	4180186
43020646	Escherichia coli serotype O163:H19 (organism)	4180186
43020646	E. coli serotype O163:H19	4180186
43020647	Escherichia coli serotype O162:H6 (organism)	4180186
43020647	E. coli serotype O162:H6	4180186
43020648	Escherichia coli O160	4180186
43020648	E. coli O160	4180186
43020648	Escherichia coli serogroup O160 (organism)	4180186
43020648	E. coli serogroup O160	4180186
43020648	Escherichia coli serotype O160	4180186
43020650	Long lower third of face (finding)	4180186
43020654	Cardiomyopathy due to disorder of heart valve	4180186
43020654	Valvular cardiomyopathy (disorder)	4180186
43020660	Ischaemic congestive cardiomyopathy due to coronary artery disease	4180186
43020660	Ischemic dilated cardiomyopathy due to coronary artery disease (disorder)	4180186
43020660	Ischemic congestive cardiomyopathy due to coronary artery disease	4180186
43020660	Ischaemic dilated cardiomyopathy due to coronary artery disease	4180186
43020663	Tortuosity of branch of aortic arch (disorder)	4180186
43020664	Congenital tortuosity of branch of aortic arch (disorder)	4180186
43020666	Mitochondrial cardiomyopathy (disorder)	4180186
43020667	Histiocytoid mitochondrial cardiomyopathy (disorder)	4180186
43020668	Hypertrophic mitochondrial cardiomyopathy associated with cataracts and lactic acidosis (disorder)	4180186
43020671	E. coli serotype O160:nonmotile	4180186
43020671	Escherichia coli serotype O160:nonmotile (organism)	4180186
43020672	Escherichia coli serotype O160:H18 (organism)	4180186
43020672	E. coli serotype O160:H18	4180186
43020673	Escherichia coli O157:H-	4180186
43020673	Escherichia coli serotype O157:nonmotile (organism)	4180186
43020673	E. coli serotype O157:H-	4180186
43020673	E. coli serotype O157:nonmotile	4180186
43020674	E. coli serotype O157:H7	4180186
43020674	Escherichia coli serotype O157:H7 (organism)	4180186
43020675	E. coli serotype O157:H45	4180186
43020675	Escherichia coli serotype O157:H45 (organism)	4180186
43020678	E. coli serogroup O156	4180186
43020678	Escherichia coli serogroup O156 (organism)	4180186
43020678	Escherichia coli O156	4180186
43020678	E. coli O156	4180186
43020678	Escherichia coli serotype O156	4180186
43020679	Escherichia coli serotype O156:nonmotile (organism)	4180186
43020679	E. coli serotype O156:nonmotile	4180186
43020680	E. coli serotype O156:H8	4180186
43020680	Escherichia coli serotype O156:H8 (organism)	4180186
43020681	E. coli serotype O156:H25	4180186
43020681	Escherichia coli serotype O156:H25 (organism)	4180186
43020682	Escherichia coli serotype O156:H23 (organism)	4180186
43020682	E. coli serotype O156:H23	4180186
43020683	E. coli O141	4180186
43020683	Escherichia coli serotype O141	4180186
43020683	E. coli serogroup O141	4180186
43020683	Escherichia coli O141	4180186
43020683	Escherichia coli serogroup O141 (organism)	4180186
43020684	Escherichia coli serotype O141:nonmotile (organism)	4180186
43020684	E. coli serotype O141:nonmotile	4180186
43020689	Anomalous origin of left circumflex coronary artery from pulmonary artery (disorder)	4180186
43020691	Thoracopagus with separate hearts and common pericardial sac (disorder)	4180186
43020692	Thoracopagus with conjoined atria (disorder)	4180186
43020692	Thoracopagus with conjoined atriums	4180186
43020693	Thoracopagus with conjoined atria and ventricles (disorder)	4180186
43020693	Thoracopagus with conjoined atriums and ventricles	4180186
43020694	Rachipagus (disorder)	4180186
43020696	Escherichia coli serotype O2:H6 (organism)	4180186
43020696	E. coli serotype O2:H6	4180186
43020697	Escherichia coli serotype O140:H32 (organism)	4180186
43020697	E. coli serotype O140:H32	4180186
43020699	E. coli serotype O136:H16	4180186
43020699	Escherichia coli serotype O136:H16 (organism)	4180186
43020700	E. coli serotype O136:H12	4180186
43020700	Escherichia coli serotype O136:H12 (organism)	4180186
43020701	E. coli serogroup O132	4180186
43020701	Escherichia coli serotype O132	4180186
43020701	Escherichia coli serogroup O132 (organism)	4180186
43020701	Escherichia coli O132	4180186
43020701	E. coli O132	4180186
43020703	Escherichia coli serotype O130:H11 (organism)	4180186
43020703	E. coli serotype O130:H11	4180186
43020704	Escherichia coli serotype O128:nonmotile (organism)	4180186
43020704	E. coli serotype O128:nonmotile	4180186
43020711	E. coli serotype O126:nonmotile	4180186
43020711	Escherichia coli serotype O126:nonmotile (organism)	4180186
43020713	E. coli serotype O14:nonmotile	4180186
43020713	Escherichia coli serotype O14:nonmotile (organism)	4180186
43020717	E. coli serotype O125:H21	4180186
43020717	Escherichia coli serotype O125:H21 (organism)	4180186
43020718	Escherichia coli serotype O124:nonmotile (organism)	4180186
43020718	E. coli serotype O124:nonmotile	4180186
43020720	E. coli serotype O124:H7	4180186
43020720	Escherichia coli serotype O124:H7 (organism)	4180186
43020727	E. coli serotype O119:nonmotile	4180186
43020727	Escherichia coli serotype O119:nonmotile (organism)	4180186
43020730	E. coli serotype O118:nonmotile	4180186
43020730	Escherichia coli serotype O118:nonmotile (organism)	4180186
43020731	Interventricular dyssynchrony (disorder)	4180186
43020732	Dithoracic parapagus (disorder)	4180186
43020733	Dicephalic parapagus (disorder)	4180186
43020735	E. coli O7	4180186
43020735	Escherichia coli O7	4180186
43020735	Escherichia coli serotype O7	4180186
43020735	Escherichia coli serogroup O7 (organism)	4180186
43020735	E. coli serogroup O7	4180186
43020736	Escherichia coli serotype O11	4180186
43020736	Escherichia coli O11	4180186
43020736	E. coli serogroup O11	4180186
43020736	E. coli O11	4180186
43020736	Escherichia coli serogroup O11 (organism)	4180186
43020740	Escherichia coli serotype O6:H34 (organism)	4180186
43020740	E. coli serotype O6:H34	4180186
43020742	E. coli serotype O7:H157	4180186
43020742	Escherichia coli serotype O7:H157 (organism)	4180186
43020743	E. coli serotype O7:H15	4180186
43020743	Escherichia coli serotype O7:H15 (organism)	4180186
43020745	Escherichia coli serotype O8:H16 (organism)	4180186
43020745	E. coli serotype O8:H16	4180186
43020747	Escherichia coli serotype O8:H28 (organism)	4180186
43020747	E. coli serotype O8:H28	4180186
43020748	Escherichia coli serotype O8:H8 (organism)	4180186
43020748	E. coli serotype O8:H8	4180186
43020751	Escherichia coli serotype O18	4180186
43020751	E. coli O18	4180186
43020751	Escherichia coli O18	4180186
43020751	Escherichia coli serogroup O18 (organism)	4180186
43020751	E. coli serogroup O18	4180186
43020752	Escherichia coli serotype O14:H28 (organism)	4180186
43020752	E. coli serotype O14:H28	4180186
43020754	Escherichia coli serotype O18:H7 (organism)	4180186
43020754	E. coli serotype O18:H7	4180186
43020755	Escherichia coli serogroup O21 (organism)	4180186
43020755	Escherichia coli serotype O21	4180186
43020755	E. coli O21	4180186
43020755	E. coli serogroup O21	4180186
43020755	Escherichia coli O21	4180186
43020758	E. coli O24	4180186
43020758	Escherichia coli O24	4180186
43020758	Escherichia coli serotype O24	4180186
43020758	Escherichia coli serogroup O24 (organism)	4180186
43020758	E. coli serogroup O24	4180186
43020761	E. coli serotype O25:nonmotile	4180186
43020761	Escherichia coli serotype O25:nonmotile (organism)	4180186
43020763	E. coli serotype O25:H1	4180186
43020763	Escherichia coli serotype O25:H1 (organism)	4180186
43020766	Escherichia coli serotype O26:H2 (organism)	4180186
43020766	E. coli serotype O26:H2	4180186
43020768	Escherichia coli serotype O27:nonmotile (organism)	4180186
43020768	E. coli serotype O27:nonmotile	4180186
43020770	Escherichia coli serotype O28:nonmotile (organism)	4180186
43020770	E. coli serotype O28:nonmotile	4180186
43020771	E. coli serotype O29:nonmotile	4180186
43020771	Escherichia coli serotype O29:nonmotile (organism)	4180186
43020774	E. coli serotype O42:H25	4180186
43020774	Escherichia coli serotype O42:H25 (organism)	4180186
43020781	Foetal cardiomyopathy	4180186
43020781	Fetal cardiomyopathy (disorder)	4180186
43020782	Foetal hypertrophic cardiomyopathy	4180186
43020782	Fetal hypertrophic cardiomyopathy (disorder)	4180186
43020783	Fetal hypertrophic cardiomyopathy due to twin to twin transfusion syndrome (disorder)	4180186
43020783	Foetal hypertrophic cardiomyopathy due to twin to twin transfusion syndrome	4180186
43020785	Fetal dilated cardiomyopathy (disorder)	4180186
43020785	Fetal congestive cardiomyopathy	4180186
43020785	Foetal dilated cardiomyopathy	4180186
43020785	Foetal congestive cardiomyopathy	4180186
43020787	Loose suture of cornea (finding)	4180186
43020790	Type II Raeder paratrigeminal syndrome	4180186
43020790	Type II paratrigeminal syndrome (disorder)	4180186
43020790	Type II Raeder's paratrigeminal syndrome	4180186
43020792	Foetal right heart dominance	4180186
43020792	Fetal right heart dominance (disorder)	4180186
43020793	Fetal left heart dominance (disorder)	4180186
43020793	Foetal left heart dominance	4180186
43020794	Fetal pulmonary outflow tract obstruction due to twin to twin transfusion syndrome (disorder)	4180186
43020794	Foetal pulmonary outflow tract obstruction due to twin to twin transfusion syndrome	4180186
43020797	Closure of fetal ductus arteriosus (disorder)	4180186
43020797	Closure of foetal ductus arteriosus	4180186
43020797	Closure of fetal ductus arteriosus	4180186
43020797	Closure of foetal arterial duct	4180186
43020798	Foetal myocarditis	4180186
43020798	Fetal myocarditis (disorder)	4180186
43020800	Quercus phellos pollen allergen (substance)	4180186
43020800	Willow oak pollen allergen	4180186
43020802	Turkey oak pollen	4180186
43020802	Quercus laevis pollen (substance)	4180186
43020803	Live oak pollen	4180186
43020803	Quercus virginiana pollen (substance)	4180186
43020804	Quercus lyrata pollen allergen (substance)	4180186
43020804	Overcup oak pollen allergen	4180186
43020806	Blackjack oak pollen allergen	4180186
43020806	Quercus marilandica pollen allergen (substance)	4180186
43020807	Blackjack oak pollen	4180186
43020807	Quercus marilandica pollen (substance)	4180186
43020811	Red oak pollen	4180186
43020811	Quercus rubra pollen (substance)	4180186
43020812	Quercus rubra pollen allergen (substance)	4180186
43020812	Red oak pollen allergen	4180186
43020816	False acacia pollen	4180186
43020816	Robinia pseudoacacia pollen (substance)	4180186
43020816	Black locust pollen	4180186
43020817	White mulberry pollen	4180186
43020817	Morus alba pollen (substance)	4180186
43020819	Ficus pollen (substance)	4180186
43020821	Pepper tree pollen	4180186
43020821	Schinus pollen (substance)	4180186
43020822	Pepper tree pollen allergen	4180186
43020822	Schinus pollen allergen (substance)	4180186
43020825	Ligustrum pollen allergen (substance)	4180186
43020825	Privet tree pollen allergen	4180186
43020826	Carya pollen (substance)	4180186
43020826	Hickory pollen	4180186
43020834	Stenosis of superior vena cava as complication of procedure (disorder)	4180186
43020834	Stenosis of superior caval vein as complication of procedure	4180186
43020836	Stenosis of inferior vena cava as complication of procedure (disorder)	4180186
43020836	Stenosis of inferior caval vein as complication of procedure	4180186
43020838	Obstruction of inferior vena cava due to neoplasm	4180186
43020838	Inferior caval vein obstruction due to neoplasm	4180186
43020838	Occlusion of inferior vena cava due to tumor	4180186
43020838	Occlusion of inferior vena cava due to tumour	4180186
43020838	Occlusion of inferior vena cava due to neoplasm (disorder)	4180186
43020839	Narrowing of anastomosis between pulmonary venous confluence and left atrium after prior repair of anomalous pulmonary venous connection	4180186
43020839	Stenosis of anastomosis between pulmonary venous confluence and left atrium after prior repair of anomalous pulmonary venous connection (disorder)	4180186
43020840	Pulmonary venous hypertension due to compression of pulmonary great vein (disorder)	4180186
43020841	Pulmonary venous hypertension due to compression of pulmonary great vein by fibrosing mediastinitis	4180186
43020841	Pulmonary venous hypertension due to compression of pulmonary great vein by sclerosing mediastinitis (disorder)	4180186
43020842	Pulmonary venous hypertension due to compression of pulmonary great vein by lymphadenopathy (disorder)	4180186
43020844	Disorder of left atrium (disorder)	4180186
43020845	Disorder of right atrium as complication of procedure (disorder)	4180186
43020846	Thrombus of physiologic right atrium as complication of procedure (disorder)	4180186
43020850	E. coli serotype O49:H19	4180186
43020850	Escherichia coli serotype O49:H19 (organism)	4180186
43020853	E. coli serotype O50:H8	4180186
43020853	Escherichia coli serotype O50:H8 (organism)	4180186
43020855	Escherichia coli serotype O52:H45 (organism)	4180186
43020855	E. coli serotype O52:H45	4180186
43020859	Escherichia coli serotype O55:H7 (organism)	4180186
43020859	E. coli serotype O55:H7	4180186
43020860	Escherichia coli serotype O55:H6 (organism)	4180186
43020860	E. coli serotype O55:H6	4180186
43020863	E. coli serotype O60:H19	4180186
43020863	Escherichia coli serotype O60:H19 (organism)	4180186
43020864	Escherichia coli serotype O63:H12 (organism)	4180186
43020864	E. coli serotype O63:H12	4180186
43020866	E. coli serotype O69:H11	4180186
43020866	Escherichia coli serotype O69:H11 (organism)	4180186
43020867	E. coli serotype O69:nonmotile	4180186
43020867	Escherichia coli serotype O69:nonmotile (organism)	4180186
43020871	Increased fetal nuchal thickness (finding)	4180186
43020871	Increased foetal nuchal thickness	4180186
43020872	Vegetation of heart (disorder)	4180186
43020872	Cardiac vegetation	4180186
43020875	Infective endocarditis of homograft (disorder)	4180186
43020875	Infectious endocarditis of homograft	4180186
43020878	Congenital disorder of glycosylation type Ia (disorder)	4180186
43020880	Congenital atresia of left main stem coronary artery (disorder)	4180186
43020881	Infective endocarditis of cardiac valve (disorder)	4180186
43020881	Infectious endocarditis of cardiac valve	4180186
43020882	Infective endocarditis of aortic valve (disorder)	4180186
43020882	Infectious endocarditis of aortic valve	4180186
43020883	Escherichia coli serotype O118:H16 (organism)	4180186
43020883	Escherichia coli O118:H16	4180186
43020890	Acquired excessive restriction of ventricular septal defect (disorder)	4180186
43020892	Fetal right atrial dilatation (disorder)	4180186
43020892	Foetal right atrial dilatation	4180186
43020893	Foetal ventricular dysfunction	4180186
43020893	Fetal ventricular dysfunction (disorder)	4180186
43020894	Fetal right ventricular dysfunction (disorder)	4180186
43020894	Foetal right ventricular dysfunction	4180186
43020895	Foetal left ventricular dysfunction	4180186
43020895	Fetal left ventricular dysfunction (disorder)	4180186
43020899	Acquired abnormality of brachiocephalic vein (disorder)	4180186
43020899	Acquired abnormality of innominate vein	4180186
43020900	Acquired occlusion of inferior caval vein	4180186
43020900	Acquired occlusion of inferior vena cava (disorder)	4180186
43020905	Right ventricular outflow tract obstruction due to tumor	4180186
43020905	Right ventricular outflow tract obstruction due to neoplasm (disorder)	4180186
43020905	Right ventricular outflow tract obstruction due to tumour	4180186
43020907	Left ventricular outflow tract obstruction due to tumour	4180186
43020907	Left ventricular outflow tract obstruction due to neoplasm (disorder)	4180186
43020907	Left ventricular outflow tract obstruction due to tumor	4180186
43020908	Obstruction of surgically constructed systemic venous pathway as complication of procedure (disorder)	4180186
43020909	Obstruction of surgically constructed pulmonary venous pathway as complication of procedure (disorder)	4180186
43020912	Congenital abnormality of branch of aortic arch	4180186
43020912	Congenital abnormality of supraaortic branch of thoracic aorta (disorder)	4180186
43020916	Congenital subaortic stenosis due to restrictive ventricular septal defect associated with functionally univentricular heart (disorder)	4180186
43020917	Subaortic stenosis associated with functionally univentricular heart as complication of procedure (disorder)	4180186
43020919	Acquired subpulmonary stenosis associated with functionally univentricular heart (disorder)	4180186
43020920	Acquired subpulmonary stenosis due to restrictive ventricular defect associated with functionally univentricular heart (disorder)	4180186
43020923	Acquired abnormality of atrioventricular (nonmitral, nontricuspid) valve associated with atrioventricular septal defect	4180186
43020923	Acquired abnormality of atrioventricular (not morphologically mitral or tricuspid) valve associated with atrioventricular septal defect (disorder)	4180186
43020927	Ventricular septal defect due to endocarditis	4180186
43020927	Ventricular septal defect due to and following infective endocarditis (disorder)	4180186
43020928	Cardiovascular fistula due to endocarditis (disorder)	4180186
43020929	Atrioventricular block due to endocarditis (disorder)	4180186
43020933	Spontaneous closure of surgically created fenestration of interatrial septum after prior atrial fenestration operation (disorder)	4180186
43020936	Pleuroscope (physical object)	4180186
43020938	Adjustment insomnia (disorder)	4180186
43020939	Abnormal ventriculoarterial connection with usual origin of left coronary artery from aortic sinus to right of nonfacing aortic sinus and usual origin of right coronary artery from aortic sinus to left of nonfacing aortic sinus (disorder)	4180186
43020939	Abnormal ventriculoarterial connection with usual origin of left coronary artery from sinus 1 and usual origin of right coronary artery from sinus 2	4180186
43020940	Rickettsia heilongjiangensis (organism)	4180186
43020944	Foetal kinetocardiography	4180186
43020944	Fetal kinetocardiography (procedure)	4180186
43020945	Disorder of atrioventricular (nonmitral, nontricuspid) valve	4180186
43020945	Disorder of atrioventricular (not morphologically mitral or tricuspid) valve (disorder)	4180186
43020950	Disorder of truncal valve prosthesis (disorder)	4180186
43020951	Calcification of tricuspid valve (disorder)	4180186
43020954	Termination of pregnancy after first twelve weeks of pregnancy	4180186
43020954	Termination of pregnancy after first trimester (procedure)	4180186
43020956	Stenosis of foetal mitral valve	4180186
43020956	Stenosis of fetal mitral valve (disorder)	4180186
43020958	Stenosis of fetal pulmonary valve (disorder)	4180186
43020958	Stenosis of foetal pulmonary valve	4180186
43020959	Stenosis of fetal aortic valve (disorder)	4180186
43020959	Stenosis of foetal aortic valve	4180186
43020960	Regurgitation of foetal right atrioventricular (not morphologically tricuspid) valve	4180186
43020960	Regurgitation of fetal right atrioventricular (not morphologically tricuspid) valve (disorder)	4180186
43020960	Regurgitation of fetal right atrioventricular (nontricuspid) valve	4180186
43020960	Regurgitation of foetal right atrioventricular (nontricuspid) valve	4180186
43020965	Escherichia coli O117:H4	4180186
43020965	Escherichia coli serotype O117:H4 (organism)	4180186
43020967	Escherichia coli O116:nonmotile	4180186
43020967	Escherichia coli serotype O116:nonmotile (organism)	4180186
43020970	Escherichia coli serotype O115:H25 (organism)	4180186
43020970	Escherichia coli O115:H25	4180186
43020971	Escherichia coli O114:H2	4180186
43020971	Escherichia coli serotype O114:H2 (organism)	4180186
43020972	Escherichia coli O114:nonmotile	4180186
43020972	Escherichia coli serotype O114:nonmotile (organism)	4180186
43020973	Escherichia coli serotype O113:H21 (organism)	4180186
43020973	Escherichia coli O113:H21	4180186
43020974	Escherichia coli serotype O113:H8 (organism)	4180186
43020974	Escherichia coli O113:H8	4180186
43020975	Escherichia coli O113:nonmotile	4180186
43020975	Escherichia coli serotype O113:nonmotile (organism)	4180186
43020977	Escherichia coli serotype O112:H19 (organism)	4180186
43020977	Escherichia coli O112:H19	4180186
43020978	Escherichia coli serotype O111:H2 (organism)	4180186
43020978	Escherichia coli O111:H2	4180186
43020982	Escherichia coli serotype O111:H11 (organism)	4180186
43020982	Escherichia coli O111:H11	4180186
43020983	Escherichia coli O111:H21	4180186
43020983	Escherichia coli serotype O111:H21 (organism)	4180186
43020985	Escherichia coli serotype O110:H28 (organism)	4180186
43020985	Escherichia coli O110:H28	4180186
43020986	Escherichia coli serotype O110:H2 (organism)	4180186
43020986	Escherichia coli O110:H2	4180186
43020988	E. coli serogroup O109	4180186
43020988	Escherichia coli serotype O109	4180186
43020988	Escherichia coli O109	4180186
43020988	Escherichia coli serogroup O109 (organism)	4180186
43020988	E. coli O109	4180186
43020994	Escherichia coli serotype O103:nonmotile (organism)	4180186
43020994	Escherichia coli O103:nonmotile	4180186
43020995	Escherichia coli serotype O103:H4 (organism)	4180186
43020995	Escherichia coli O103:H4	4180186
43020996	Escherichia coli O103:H25	4180186
43020996	Escherichia coli serotype O103:H25 (organism)	4180186
43020999	Escherichia coli serotype O100	4180186
43020999	E. coli O100	4180186
43020999	Escherichia coli O100	4180186
43020999	E. coli serogroup O100	4180186
43020999	Escherichia coli serogroup O100 (organism)	4180186
43021003	Escherichia coli O98:nonmotile	4180186
43021003	Escherichia coli serotype O98:nonmotile (organism)	4180186
43021007	Escherichia coli O91:H49	4180186
43021007	Escherichia coli serotype O91:H49 (organism)	4180186
43021014	Escherichia coli O85:H43	4180186
43021014	Escherichia coli serotype O85:H43 (organism)	4180186
43021015	Escherichia coli serotype O85:H1 (organism)	4180186
43021015	Escherichia coli O85:H1	4180186
43021016	Escherichia coli serotype O84:nonmotile (organism)	4180186
43021016	Escherichia coli O84:nonmotile	4180186
43021019	Escherichia coli O83:H1	4180186
43021019	Escherichia coli serotype O83:H1 (organism)	4180186
43021020	E. coli O82	4180186
43021020	Escherichia coli serogroup O82 (organism)	4180186
43021020	Escherichia coli serotype O82	4180186
43021020	E. coli serogroup O82	4180186
43021020	Escherichia coli O82	4180186
43021022	Escherichia coli O80	4180186
43021022	Escherichia coli serotype O80	4180186
43021022	Escherichia coli serogroup O80 (organism)	4180186
43021022	E. coli serogroup O80	4180186
43021022	E. coli O80	4180186
43021024	Escherichia coli serotype O79:H7 (organism)	4180186
43021024	Escherichia coli O79:H7	4180186
43021026	Escherichia coli O78:H11	4180186
43021026	Escherichia coli serotype O78:H11 (organism)	4180186
43021028	Escherichia coli O76	4180186
43021028	E. coli serogroup O76	4180186
43021028	Escherichia coli serogroup O76 (organism)	4180186
43021028	E. coli O76	4180186
43021028	Escherichia coli serotype O76	4180186
43021029	Escherichia coli serotype O76:H7 (organism)	4180186
43021029	Escherichia coli O76:H7	4180186
43021031	Escherichia coli serotype O76:H2 (organism)	4180186
43021031	Escherichia coli O76:H2	4180186
43021034	Escherichia coli serotype O74:H25 (organism)	4180186
43021034	Escherichia coli O74:H25	4180186
43021038	Escherichia coli serogroup O71 (organism)	4180186
43021038	Escherichia coli O71	4180186
43021038	Escherichia coli serotype O71	4180186
43021038	E. coli serogroup O71	4180186
43021038	E. coli O71	4180186
43021039	Escherichia coli serotype O71:nonmotile (organism)	4180186
43021039	Escherichia coli O71:nonmotile	4180186
43021040	Escherichia coli serotype O71:H28 (organism)	4180186
43021040	Escherichia coli O71:H28	4180186
43021042	Escherichia coli serotype O70:H11 (organism)	4180186
43021042	Escherichia coli O70:H11	4180186
43021044	Infective endocarditis of pulmonary valve (disorder)	4180186
43021044	Infectious endocarditis of pulmonary valve	4180186
43021045	Infectious endocarditis of truncal valve	4180186
43021045	Infective endocarditis of truncal valve (disorder)	4180186
43021046	Abscess of cardiovascular structure of trunk (disorder)	4180186
43021048	Infective endocarditis of left atrioventricular (nonmitral) valve	4180186
43021048	Infective endocarditis of left atrioventricular (not morphologically mitral) valve (disorder)	4180186
43021048	Infectious endocarditis of left atrioventricular (not morphologically mitral) valve	4180186
43021050	Abscess at site of ventricular septal defect (disorder)	4180186
43021056	Monochorionic diamniotic twin pregnancy with similar amniotic fluid volumes (disorder)	4180186
43021057	Monochorionic diamniotic twin pregnancy with dissimilar amniotic fluid volumes (disorder)	4180186
43021062	Abscess at site of interatrial communication (disorder)	4180186
43021063	Infectious endocarditis of common atrioventricular valve	4180186
43021063	Infective endocarditis of common atrioventricular valve (disorder)	4180186
43021065	Aneurysm of patch of ventricular septal defect (disorder)	4180186
43021069	Spontaneous closure of residual interatrial communication (finding)	4180186
43021073	Perinatal pulmonary hemorrhage (disorder)	4180186
43021073	Perinatal pulmonary haemorrhage	4180186
43021074	Fluid containing adipose derived stem cells	4180186
43021074	Fluid containing fat derived stem cells	4180186
43021074	Fluid containing adipose tissue derived mesenchymal stem cells (substance)	4180186
43021076	Taking anal swab for gonorrhoea	4180186
43021076	Taking anal swab for gonorrhoea (procedure)	4180186
43021077	Swab from testis	4180186
43021077	Swab from testicle (specimen)	4180186
43021077	Testicular swab	4180186
43021080	Swab from lower limb (specimen)	4180186
43021081	Swab from toe (specimen)	4180186
43021086	Swab from tracheostomy wound (specimen)	4180186
43021088	Swab from ultrasonic nebulizer (specimen)	4180186
43021088	Swab from ultrasonic nebuliser	4180186
43021089	Swab from urethral meatus (specimen)	4180186
43021096	Swab from catheter (specimen)	4180186
43021098	Swab from superficial wound (specimen)	4180186
43021099	Swab from surgical wound (specimen)	4180186
43021100	Swab from deep wound (specimen)	4180186
43021102	Swab from gastrostomy stoma (specimen)	4180186
43021103	Labial swab	4180186
43021103	Swab from labia (specimen)	4180186
43021105	Swab from pelvis (specimen)	4180186
43021108	Swab from finger and/or thumb	4180186
43021108	Swab from digit of hand (specimen)	4180186
43021110	Corneal swab	4180186
43021110	Swab from cornea (specimen)	4180186
43021111	Swab from buttock (specimen)	4180186
43021115	Swab from vaginal introitus (specimen)	4180186
43021117	Swab from nasal sinus (specimen)	4180186
43021121	Usual hyperplasia of lactiferous duct (disorder)	4180186
43021121	Usual hyperplasia of lactiferous duct	4180186
43021122	Usual ductal hyperplasia (morphologic abnormality)	4180186
43021126	Structure of terminal lactiferous ductule (body structure)	4180186
43021127	Entire terminal lactiferous ductule (body structure)	4180186
43021130	Entire extralobular part of terminal lactiferous ductule (body structure)	4180186
43021136	Umbilical catheter submitted as specimen (specimen)	4180186
43021137	Umbilical catheter tip submitted as specimen (specimen)	4180186
43021138	Intracranial catheter submitted as specimen (specimen)	4180186
43021142	Contact lens case submitted as specimen (specimen)	4180186
43021144	Central venous catheter tip submitted as specimen (specimen)	4180186
43021145	Bottle submitted as specimen (specimen)	4180186
43021146	Arterial line tip submitted as specimen (specimen)	4180186
43021147	Shunt tip submitted as specimen (specimen)	4180186
43021148	Stent submitted as specimen (specimen)	4180186
43021149	Central venous catheter tip from subclavian vein submitted as specimen (specimen)	4180186
43021150	Tenckhoff catheter tip submitted as specimen (specimen)	4180186
43021154	Intracranial ventricular catheter tip submitted as specimen (specimen)	4180186
43021155	Ventriculoperitoneal shunt submitted as specimen (specimen)	4180186
43021156	Peritoneal catheter submitted as specimen (specimen)	4180186
43021160	Primary transvestism (finding)	4180186
43021162	Engages in sexual activity before marriage (finding)	4180186
43021162	Engages in premarital sexual activity	4180186
43021164	History of chlamydial infection (situation)	4180186
43021168	History of connective tissue disease	4180186
43021168	History of disorder of connective tissue (situation)	4180186
43021169	History of cellulitis (situation)	4180186
43021170	Allergic process (qualifier value)	4180186
43021172	History of cervical dysplasia	4180186
43021172	History of dysplasia of cervix (situation)	4180186
43021176	History of immunodeficiency disorder (situation)	4180186
43021176	H/O immunodeficiency disorder	4180186
43021178	Type B behavior pattern (finding)	4180186
43021178	Type B behaviour pattern	4180186
43021179	Orocutaneous fistula (disorder)	4180186
43021179	Fistula between oral cavity and cutaneous surface of face	4180186
43021180	Systemic to pulmonary collateral artery from right carotid artery (disorder)	4180186
43021182	Dissection of iliofemoral vein as complication of femoral vein catheterisation	4180186
43021182	Dissection of iliofemoral vein as complication of femoral vein catheterization (disorder)	4180186
43021183	Myocarditis caused by Genus Candida (disorder)	4180186
43021183	Candidal myocarditis	4180186
43021183	Myocarditis caused by Genus Candida	4180186
43021186	Spirochaetal myocarditis	4180186
43021186	Myocarditis caused by Order Spirochaetales	4180186
43021186	Myocarditis caused by Order Spirochaetales (disorder)	4180186
43021186	Spirochetal myocarditis	4180186
43021189	Systemic to pulmonary collateral artery connecting with artery (disorder)	4180186
43021191	Systemic to pulmonary collateral artery from left brachiocephalic artery (disorder)	4180186
43021191	Systemic to pulmonary collateral artery from left innominate artery	4180186
43021194	Pericarditis caused by Genus Haemophilus	4180186
43021194	Pericarditis caused by Genus Hemophilus	4180186
43021194	Pericarditis caused by Genus Haemophilus (disorder)	4180186
43021194	Haemophilus pericarditis	4180186
43021194	Pericarditis due to Genus Haemophilus	4180186
43021196	Focal intervertebral disc protrusion (disorder)	4180186
43021197	Fetishistic transvestism (disorder)	4180186
43021197	Fetishistic cross-dressing	4180186
43021199	Gynephilic sexual orientation	4180186
43021199	Sexually attracted to female gender (finding)	4180186
43021199	Sexually attracted to women	4180186
43021200	Sexually attracted to male and female genders (finding)	4180186
43021200	Sexually attracted to men and women	4180186
43021201	No sexual attraction to either male or female gender	4180186
43021201	Not sexually attracted to either gender	4180186
43021201	Sexually attracted to neither gender (finding)	4180186
43021203	Sexually active with women (finding)	4180186
43021205	Dual-role transvestism (finding)	4180186
43021206	Normal development of sexuality (finding)	4180186
43021213	Diminished erotic interest (finding)	4180186
43021215	Multiple historical sexual partners (finding)	4180186
43021216	Single historical sexual partner (finding)	4180186
43021219	Voice broken	4180186
43021219	Virilised pitch of voice	4180186
43021219	Virilized pitch of voice (finding)	4180186
43021221	Anomalous origin of ligamentum arteriosum from retroesophageal aortic diverticulum	4180186
43021221	Anomalous origin of ligamentum arteriosum from retroesophageal aortic diverticulum (disorder)	4180186
43021222	Vagal autonomic bradycardia of prematurity (disorder)	4180186
43021222	Vagal sinus bradycardia of prematurity	4180186
43021223	Cervical discogenic pain (disorder)	4180186
43021225	Palatal pain	4180186
43021225	Pain in roof of mouth	4180186
43021225	Pain in palate (finding)	4180186
43021227	Allergic condition (finding)	4180186
43021228	PHQ-9	4180186
43021228	Patient health questionnaire-nine item (procedure)	4180186
43021230	Foot rot (disorder)	4180186
43021231	milliampere	4180186
43021231	Milliampere	4180186
43021231	Milliampere (qualifier value)	4180186
43021231	milliamp	4180186
43021232	kV - kilovolt	4180186
43021232	kilovolt (qualifier value)	4180186
43021233	millivolt (qualifier value)	4180186
43021233	mV - millivolt	4180186
43021235	volt (qualifier value)	4180186
43021235	V - volt	4180186
43021237	Secondary erectile dysfunction (disorder)	4180186
43021237	Secondary impotence	4180186
43021239	Mechanical complication of cardiac implant (disorder)	4180186
43021243	Complication associated with silicone gel breast implant	4180186
43021243	Complication associated with silicone gel-filled breast implant (disorder)	4180186
43021244	Complication associated with saline breast implant (disorder)	4180186
43021246	Complication associated with insulin pump (disorder)	4180186
43021247	Complication associated with dialysis catheter (disorder)	4180186
43021249	Complication associated with neurological device (disorder)	4180186
43021250	Complication associated with orthopedic device (disorder)	4180186
43021250	Complication associated with orthopaedic device	4180186
43021254	Mechanical complication of internal fixation device (disorder)	4180186
43021255	Mechanical complication of vascular implant (disorder)	4180186
43021256	Complication associated with nervous system implant (disorder)	4180186
43021257	Device colonization	4180186
43021257	Infection associated with device (disorder)	4180186
43021257	Device colonisation	4180186
43021260	Infection associated with indwelling urinary catheter (disorder)	4180186
43021262	Infection of central venous catheter tunnel	4180186
43021262	Infection of tunnel site of tunnelled central venous catheter	4180186
43021262	Infection of tunnel site of tunneled central venous catheter (disorder)	4180186
43021263	Infection of pacemaker pulse generator site (disorder)	4180186
43021263	Infection of pacemaker pulse generator pocket	4180186
43021266	History of malignant tumor of brain	4180186
43021266	History of malignant tumour of brain	4180186
43021266	History of malignant neoplasm of brain (situation)	4180186
43021270	History of malignant tumour of larynx	4180186
43021270	History of malignant neoplasm of larynx (situation)	4180186
43021270	History of malignant tumor of larynx	4180186
43021270	H/O carcinoma of larynx	4180186
43021272	History of malignant neoplasm of liver (situation)	4180186
43021272	History of malignant tumor of liver	4180186
43021272	History of malignant tumour of liver	4180186
43021273	History of Hodgkin lymphoma (situation)	4180186
43021273	History of Hodgkin's disease	4180186
43021273	History of Hodgkins lymphoma	4180186
43021273	History of Hodgkin's lymphoma	4180186
43021274	Family history of mitochondrial disease (situation)	4180186
43021275	Family history of oedema of lower extremity	4180186
43021275	Family history of edema of lower extremity (situation)	4180186
43021275	Family history of lower limb oedema	4180186
43021275	Family history of lower limb edema	4180186
43021277	No history of dizziness (situation)	4180186
43021277	No H/O dizziness	4180186
43021279	Allergy to teriparatide (finding)	4180186
43021280	Allergy to raloxifene (finding)	4180186
43021281	Inflammation associated with retained intrauterine contraceptive device (disorder)	4180186
43021286	Inflammation associated with cardiac implant (disorder)	4180186
43021286	Inflammatory reaction associated with cardiac implant	4180186
43021291	Constrictive pericarditis caused by virus (disorder)	4180186
43021291	Viral constrictive pericarditis	4180186
43021291	Constrictive pericarditis caused by virus	4180186
43021292	Bacterial constrictive pericarditis	4180186
43021292	Constrictive pericarditis caused by bacteria (disorder)	4180186
43021292	Constrictive pericarditis caused by bacteria	4180186
43021294	Anomalous origin of conus artery from separate aortic sinus orifice (disorder)	4180186
43021294	Anomalous origin of conus artery from separate aortic sinus of Valsalva orifice	4180186
43021299	Histiocytoid mitochondrial cardiomyopathy due to cytochrome aa3 deficiency (disorder)	4180186
43021301	Anomalous origin of coronary arteries from anterior aortic sinus (disorder)	4180186
43021301	Anomalous origin of coronary arteries from anterior aortic sinus of Valsalva	4180186
43021304	Anomalous origin of right coronary artery from left circumflex coronary artery (disorder)	4180186
43021304	Abnormal origin of right coronary artery from circumflex artery	4180186
43021306	Congenital atresia of right coronary artery ostium	4180186
43021306	Congenital atresia of right coronary artery orifice (disorder)	4180186
43021307	Anomalous origin of accessory coronary artery from aortic sinus (disorder)	4180186
43021307	Anomalous origin of accessory coronary artery from aortic sinus of Valsalva	4180186
43021309	Anomalous origin of sinus node coronary artery from separate aortic sinus orifice (disorder)	4180186
43021309	Anomalous origin of sinus node coronary artery from separate aortic sinus of Valsalva orifice	4180186
43021311	Anomalous course of coronary artery posterior to aorta (disorder)	4180186
43021313	Anomalous origin of single coronary artery from left coronary artery aortic sinus (disorder)	4180186
43021313	Abnormal origin of single coronary artery from left coronary artery aortic sinus of Valsalva	4180186
43021314	Abnormal origin of left circumflex coronary artery from right coronary aortic sinus of Valsalva	4180186
43021314	Anomalous origin of left circumflex coronary artery from right coronary aortic sinus (disorder)	4180186
43021315	Vascular ring with right aortic arch and left ligamentum arteriosum between left subclavian artery and left common carotid artery (disorder)	4180186
43021315	Vascular ring with right aortic arch and left ligamentum arteriosum between left subclavian artery and left common carotid artery	4180186
43021317	Vascular ring with right aortic arch and left arterial duct from aberrant retroesophageal left subclavian artery	4180186
43021317	Vascular ring with right aortic arch and left ductus arteriosus from anomalous retroesophageal left subclavian artery (disorder)	4180186
43021317	Vascular ring with right aortic arch and left ductus arteriosus from anomalous retroesophageal left subclavian artery	4180186
43021321	Systemic to pulmonary collateral artery connecting with central pulmonary arteries (disorder)	4180186
43021322	Systemic to pulmonary collateral artery connecting with isolated intraparenchymal pulmonary arteries (disorder)	4180186
43021324	Dysfunction of tricuspid valve papillary muscle (disorder)	4180186
43021327	Dilatation of right atrioventricular (not morphologically tricuspid) valve in double inlet ventricle (disorder)	4180186
43021327	Dilation of right atrioventricular (not morphologically tricuspid) valve in double inlet ventricle	4180186
43021327	Dilatation of right atrioventricular (nontricuspid) valve in double inlet ventricle	4180186
43021330	Anomalous origin of ductus arteriosus from aortic arch	4180186
43021330	Anomalous origin of ductus arteriosus from aortic arch (disorder)	4180186
43021332	Anomalous insertion of ductus arteriosus (disorder)	4180186
43021332	Anomalous insertion of ductus arteriosus	4180186
43021332	Abnormal insertion of arterial duct	4180186
43021333	Anomalous insertion of ductus arteriosus into pulmonary trunk (disorder)	4180186
43021333	Anomalous insertion of ductus arteriosus into pulmonary trunk	4180186
43021335	Arterial duct dependent systemic circulation	4180186
43021335	Ductus arteriosus dependent systemic circulation (disorder)	4180186
43021336	Dilatation of left atrioventricular (not morphologically mitral) valve in double inlet ventricle (disorder)	4180186
43021336	Dilation of left atrioventricular (not morphologically mitral) valve in double inlet ventricle	4180186
43021336	Dilatation of left atrioventricular (nonmitral) valve in double inlet ventricle	4180186
43021337	Education with explicit context (situation)	4180186
43021337	Context-dependent education	4180186
43021338	Carer education	4180186
43021338	Caregiver education	4180186
43021338	Education of caregiver (situation)	4180186
43021339	Abscess in wall of truncus arteriosus	4180186
43021339	Abscess of wall of truncus arteriosus (disorder)	4180186
43021339	Abscess in wall of common arterial trunk	4180186
43021341	Inflammatory reaction associated with implant	4180186
43021341	Inflammation associated with implant (disorder)	4180186
43021342	Inflammatory reaction associated with indwelling urinary catheter	4180186
43021342	Inflammation associated with indwelling urinary catheter (disorder)	4180186
43021343	Infection and inflammatory reaction associated with indwelling urinary catheter	4180186
43021343	Infection and inflammation associated with indwelling urinary catheter (disorder)	4180186
43021344	History of use of depot contraception (situation)	4180186
43021346	Inflammation associated with musculoskeletal implant (disorder)	4180186
43021346	Inflammatory reaction associated with musculoskeletal implant	4180186
43021347	History of use of symptothermal method of contraception (situation)	4180186
43021348	History of use of withdrawal method of contraception (situation)	4180186
43021351	Inflammation associated with vascular device (disorder)	4180186
43021351	Inflammatory reaction associated with vascular device	4180186
43021353	History of use of progestogen only oral contraceptive (situation)	4180186
43021354	History of use of postcoital contraception (situation)	4180186
43021359	History of osteomyelitis (situation)	4180186
43021359	H/O osteomyelitis	4180186
43021363	Leakage from Tenckhoff catheter (disorder)	4180186
43021364	History of polymyalgia rheumatica (situation)	4180186
43021364	H/O polymyalgia rheumatica	4180186
43021369	History of ventricular septal defect (situation)	4180186
43021373	History of palpitations (situation)	4180186
43021378	Suspected infectious disease (situation)	4180186
43021380	Migration of percutaneous transhepatic biliary drain catheter (disorder)	4180186
43021382	Lipodystrophy absent (situation)	4180186
43021382	No lipodystrophy	4180186
43021385	Protrusion of musculoskeletal implant (disorder)	4180186
43021388	Coronary arteriosclerosis excluded (situation)	4180186
43021390	Long acting reversible contraception declined (situation)	4180186
43021391	Not on psychotropic medication (finding)	4180186
43021392	Superficial ulcer of skin of pacemaker pulse generator site (disorder)	4180186
43021392	Skin erosion at pacemaker pulse generator site	4180186
43021394	Retained fragment of ureteric catheter (disorder)	4180186
43021394	Retained fragment of ureteral catheter	4180186
43021400	Embolisation of vascular device fragment during cardiac catheterisation	4180186
43021400	Embolization of vascular device fragment during cardiac catheterization (disorder)	4180186
43021402	History of measles, mumps and rubella vaccination (situation)	4180186
43021402	History of MMR (measles, mumps and rubella) vaccination	4180186
43021403	History of yellow fever vaccination (situation)	4180186
43021407	Displacement of musculoskeletal implant (disorder)	4180186
43021409	Obstruction of nasogastric tube (disorder)	4180186
43021409	Blockage of nasogastric tube	4180186
43021410	Breakage of internal fixation device (disorder)	4180186
43021413	Blockage of suprapubic catheter	4180186
43021413	Obstruction of suprapubic catheter (disorder)	4180186
43021416	Discussion about vaginal bleeding (procedure)	4180186
43021417	Drug-induced dizziness	4180186
43021417	Dizziness due to drug (disorder)	4180186
43021419	Wheelchair in need of repair (finding)	4180186
43021421	Loosening of orthopaedic device	4180186
43021421	Loosening of orthopedic device (disorder)	4180186
43021422	Normal renal function of transplanted kidney (finding)	4180186
43021424	Gated computed tomography of heart with contrast for congenital heart disease (procedure)	4180186
43021425	Telehealth monitoring for chronic disease (regime/therapy)	4180186
43021426	Genetic screening for disorder (procedure)	4180186
43021427	Arteriovenous fistula of great cerebral vein of Galen (disorder)	4180186
43021430	Anomalous origin of left common carotid artery from brachiocephalic artery (disorder)	4180186
43021430	Anomalous origin of left common carotid artery from innominate artery	4180186
43021431	Vascular ring with mirror image branching of right aortic arch and left ligamentum arteriosum	4180186
43021431	Vascular ring with mirror image branching of right aortic arch and left ligamentum arteriosum (disorder)	4180186
43021434	Abnormal origin of right coronary artery from left coronary artery aortic sinus of Valsalva	4180186
43021434	Anomalous origin of right coronary artery from left coronary artery aortic sinus (disorder)	4180186
43021437	Abnormal origin of right coronary artery from left coronary artery aortic sinus of Valsalva and abnormal origin of left coronary artery from right coronary artery aortic sinus of Valsalva	4180186
43021437	Anomalous origin of right coronary artery from left coronary artery aortic sinus and anomalous origin of left coronary artery from right coronary artery aortic sinus (disorder)	4180186
43021438	Cowper syringocele	4180186
43021438	Cowper duct cyst	4180186
43021438	Cystic dilatation of duct of bulbourethral gland (disorder)	4180186
43021438	Cowper's syringocele	4180186
43021439	Abnormality of ligamentum arteriosum	4180186
43021439	Abnormality of ligamentum arteriosum (disorder)	4180186
43021441	Anomalous insertion of ligamentum arteriosum into distal left pulmonary artery	4180186
43021441	Anomalous insertion of ligamentum arteriosum into distal left pulmonary artery (disorder)	4180186
43021442	Anomalous insertion of ligamentum arteriosum into pulmonary trunk	4180186
43021442	Anomalous insertion of ligamentum arteriosum into pulmonary trunk (disorder)	4180186
43021444	Anomalous origin of ligamentum arteriosum (disorder)	4180186
43021444	Abnormal origin of arterial ligament	4180186
43021444	Anomalous origin of ligamentum arteriosum	4180186
43021445	Anomalous origin of ligamentum arteriosum from aortic arch (disorder)	4180186
43021445	Anomalous origin of ligamentum arteriosum from aortic arch	4180186
43021447	Anomalous origin of ligamentum arteriosum from distal descending aorta (disorder)	4180186
43021447	Anomalous origin of ligamentum arteriosum from distal descending aorta	4180186
43021449	Anomalous origin of ligamentum arteriosum from left brachiocephalic artery	4180186
43021449	Anomalous origin of ligamentum arteriosum from left brachiocephalic artery (disorder)	4180186
43021451	Anomalous origin of ligamentum arteriosum from left subclavian artery	4180186
43021451	Anomalous origin of ligamentum arteriosum from left subclavian artery (disorder)	4180186
43021452	Anomalous origin of ligamentum arteriosum from right carotid artery (disorder)	4180186
43021452	Anomalous origin of ligamentum arteriosum from right carotid artery	4180186
43021453	Anomalous origin of ligamentum arteriosum from left carotid artery (disorder)	4180186
43021453	Anomalous origin of ligamentum arteriosum from left carotid artery	4180186
43021457	Cardiac abnormality due to heart abscess (disorder)	4180186
43021458	Right ductus arteriosus (disorder)	4180186
43021458	Right ductus arteriosus	4180186
43021459	Patent right ductus arteriosus (disorder)	4180186
43021459	Patent right ductus arteriosus	4180186
43021463	Bilateral patent ductus arteriosus	4180186
43021463	Bilateral patent ductus arteriosus (disorder)	4180186
43021466	Cardiovascular abnormality due to patent ductus arteriosus	4180186
43021466	Cardiovascular abnormality due to patent ductus arteriosus (disorder)	4180186
43021470	Interruption of coronary artery (disorder)	4180186
43021472	Single coronary artery dividing into right coronary artery and left coronary artery (disorder)	4180186
43021473	Disorder of left atrioventricular (not morphologically mitral) valve prosthesis (disorder)	4180186
43021473	Disorder of left atrioventricular (nonmitral) valve prosthesis	4180186
43021476	Anomalous course of coronary artery anterior to pulmonary trunk (disorder)	4180186
43021477	Acquired abnormality of superior vena cava (disorder)	4180186
43021477	Acquired abnormality of superior caval vein	4180186
43021478	Acquired abnormality of jugular vein (disorder)	4180186
43021482	Optimisation of medication for chronic obstructive pulmonary disease	4180186
43021482	Optimisation of medication for chronic obstructive lung disease	4180186
43021482	Optimization of medication for chronic obstructive lung disease	4180186
43021482	Optimization of medication for chronic obstructive lung disease (procedure)	4180186
43021483	Assessment of dementia (procedure)	4180186
43021483	Dementia assessment	4180186
43021484	Assessment of raised intracranial pressure (procedure)	4180186
43021485	Assessment of effectiveness of bowel preparation (procedure)	4180186
43021486	Assessment of stoma self care (procedure)	4180186
43021486	Assessment of stoma self-care	4180186
43021486	Assessment of self-care of stoma	4180186
43021486	Assessment of self-care of stoma (procedure)	4180186
43021487	Assessment of need for interpreter (procedure)	4180186
43021487	Assessment of need for translator	4180186
43021488	Assessment of diabetic erectile dysfunction (procedure)	4180186
43021489	Diabetic erectile dysfunction review (regime/therapy)	4180186
43021493	Celiac disease annual review (regime/therapy)	4180186
43021493	Coeliac disease annual review	4180186
43021502	Injection of thrombin for femoral artery pseudoaneurysm using imaging guidance (procedure)	4180186
43021503	Chronic obstructive pulmonary disease medication review	4180186
43021503	Chronic obstructive lung disorder medication review (procedure)	4180186
43021504	Gout medication review (procedure)	4180186
43021507	Metabolic disorder medication review (procedure)	4180186
43021507	Metabolic disease medication review	4180186
43021508	Neurological disorder medication review (procedure)	4180186
43021509	Catheter ablation of arrhythmogenic focus (procedure)	4180186
43021509	Catheter ablation for cardiac arrhythmia	4180186
43021510	Gastrointestinal disorder medication review (procedure)	4180186
43021513	Human immunodeficiency virus medication review (procedure)	4180186
43021514	Dyslipidemia medication review (procedure)	4180186
43021524	Burn of eye region with superficial burn of face	4180186
43021524	Burn of eye region with first degree burn of face	4180186
43021524	Burn of eye region with epidermal burn of face (disorder)	4180186
43021526	Burn of eye region with third degree burn of face	4180186
43021526	Burn of eye region with full thickness burn of face (disorder)	4180186
43021529	Burn of eye region with second degree burn of head and/or neck	4180186
43021529	Burn of eye region with partial thickness burn of head and/or neck (disorder)	4180186
43021536	Burn of multiple sites of head without involvement of eye proper (disorder)	4180186
43021537	Epidermal burn of multiple sites of head without involvement of eye proper (disorder)	4180186
43021537	Burn erythema of multiple sites of head without involvement of eye proper	4180186
43021537	Superficial burn of multiple sites of head without involvement of eye proper	4180186
43021537	First degree burn of multiple sites of head without involvement of eye proper	4180186
43021539	Full thickness burn of multiple sites of head without involvement of eye proper (disorder)	4180186
43021539	Third degree burn of multiple sites of head without involvement of eye proper	4180186
43021540	Burn of multiple sites of neck (disorder)	4180186
43021541	Second degree burn of multiple sites of neck	4180186
43021541	Partial thickness burn of multiple sites of neck (disorder)	4180186
43021544	Third degree burn of multiple sites of hand	4180186
43021544	Full thickness burn of multiple sites of hand (disorder)	4180186
43021551	Endoscopic control of haemorrhage of pharynx	4180186
43021551	Endoscopic control of hemorrhage of pharynx (procedure)	4180186
43021552	Suture plication of artery for control of rectal haemorrhage	4180186
43021552	Suture plication of artery for control of rectal hemorrhage (procedure)	4180186
43021553	Laparoscopic excision of hydrosalpinx (procedure)	4180186
43021558	HPeV3 - Human parechovirus 3	4180186
43021558	Human parechovirus 3 (organism)	4180186
43021560	Human parechovirus 5 (organism)	4180186
43021560	HPeV5 - Human parechovirus 5	4180186
43021562	Human parechovirus 8 (organism)	4180186
43021562	HPeV8 - Human parechovirus 8	4180186
43021563	Human parechovirus 14 (organism)	4180186
43021563	HPeV14 - Human parechovirus 14	4180186
43021565	Psychotic symptom rating scales auditory hallucination subscale physical characteristics score (observable entity)	4180186
43021565	PSYRATS (psychotic symptom rating scales) auditory hallucination subscale physical characteristics score	4180186
43021567	Psychotic symptom rating scales auditory hallucination subscale score (observable entity)	4180186
43021567	PSYRATS (psychotic symptom rating scales) auditory hallucination subscale score	4180186
43021569	Anomalous separate origins of internal carotid arteries and external carotid arteries from single aortic arch (disorder)	4180186
43021570	Malposition of coronary artery orifice (disorder)	4180186
43021570	Abnormal position of coronary artery ostium	4180186
43021571	Cardiovascular abnormality due to anomalous origin of coronary artery ostium	4180186
43021571	Cardiovascular abnormality due to anomalous origin of coronary artery orifice (disorder)	4180186
43021572	Coronary artery ostium abnormally low	4180186
43021572	Coronary artery orifice abnormally low (disorder)	4180186
43021573	Slit-like coronary artery orifice (disorder)	4180186
43021573	Slit-like coronary artery ostium	4180186
43021574	Common coronary artery ostium	4180186
43021574	Common coronary artery orifice (disorder)	4180186
43021576	Congenital hypoplasia of abdominal aorta (disorder)	4180186
43021577	Congenital hypoplasia of thoracoabdominal aorta (disorder)	4180186
43021580	Anomalous intramural course of proximal portion of coronary artery above aortic sinus (disorder)	4180186
43021580	Anomalous intramural course of proximal portion of coronary artery above aortic sinus of Valsalva	4180186
43021581	Aberrant course of coronary artery across right ventricular outflow tract	4180186
43021581	Anomalous course of coronary artery across right ventricular outflow tract (disorder)	4180186
43021583	Patent ductus arteriosus with normal origin and insertion (disorder)	4180186
43021583	Patent ductus arteriosus with normal origin and insertion	4180186
43021585	Anomalous origin of right ductus arteriosus from right aortic arch (disorder)	4180186
43021585	Anomalous origin of right ductus arteriosus from right aortic arch	4180186
43021592	Normal insertion of ductus arteriosus into proximal left pulmonary artery	4180186
43021592	Normal insertion of ductus arteriosus into proximal left pulmonary artery (finding)	4180186
43021595	Normal left aortic arch branching pattern (finding)	4180186
43021597	Anomalous origin of ligamentum arteriosum from aortic diverticulum	4180186
43021597	Anomalous origin of ligamentum arteriosum from aortic diverticulum (disorder)	4180186
43021598	Anomalous origin of ligamentum arteriosum from unknown site (disorder)	4180186
43021598	Anomalous origin of ligamentum arteriosum from unknown site	4180186
43021602	Normal origin of ligamentum arteriosum from left aortic arch (finding)	4180186
43021602	Normal origin of ligamentum arteriosum from left aortic arch	4180186
43021603	Normal origin of ligamentum arteriosum from proximal descending aorta (finding)	4180186
43021603	Normal origin of ligamentum arteriosum from proximal descending aorta	4180186
43021605	Acquired abnormality of pulmonary venous structure (disorder)	4180186
43021608	Acquired abnormality of right iliac vein (disorder)	4180186
43021609	Acquired abnormality of left iliac vein (disorder)	4180186
43021610	Acquired subaortic aneurysm of left ventricle (disorder)	4180186
43021612	Infective endocarditis at site of implanted vascular shunt (disorder)	4180186
43021612	Infectious endocarditis at site of implanted vascular shunt	4180186
43021613	Acquired occlusion of coronary sinus (disorder)	4180186
43021614	Acquired occlusion of femoral vein (disorder)	4180186
43021615	Anomalous coronary artery with acute angulation of less than 45 degrees relative to aorta (disorder)	4180186
43021616	Arteriovenous fistula of coronary artery to superior caval vein	4180186
43021616	Arteriovenous fistula of coronary artery to superior vena cava (disorder)	4180186
43021622	Infective endocarditis of vascular cardiac conduit (disorder)	4180186
43021622	Infectious endocarditis of vascular cardiac conduit	4180186
43021627	Anomalous origin of left anterior descending coronary artery from right coronary artery aortic sinus (disorder)	4180186
43021627	Abnormal origin of left anterior descending coronary artery from right coronary artery aortic sinus of Valsalva	4180186
43021633	Congenital atresia of aortic arch (disorder)	4180186
43021635	Atresia of aortic arch with fibrous cord between subclavian artery and common carotid artery (disorder)	4180186
43021635	Type B atresia of aortic arch with fibrous cord between subclavian artery and common carotid artery	4180186
43021636	Type C atresia of aortic arch with fibrous cord between left common carotid artery and right common carotid artery	4180186
43021636	Atresia of aortic arch with fibrous cord between left common carotid artery and right common carotid artery (disorder)	4180186
43021638	Psychotic symptom rating scales delusions subscale emotional characteristics score (observable entity)	4180186
43021638	PSYRATS (psychotic symptom rating scales) delusions subscale emotional characteristics score	4180186
43021639	Psychotic symptom rating scales auditory hallucination subscale (assessment scale)	4180186
43021639	PSYRATS (psychotic symptom rating scales) auditory hallucination subscale	4180186
43021640	Psychotic symptom rating scales delusions subscale (assessment scale)	4180186
43021640	PSYRATS (psychotic symptom rating scales) delusions subscale	4180186
43021641	Assessment using psychotic symptom rating scales auditory hallucination subscale (procedure)	4180186
43021641	Assessment using PSYRATS (psychotic symptom rating scales) auditory hallucination subscale	4180186
43021642	Assessment using psychotic symptom rating scales delusions subscale (procedure)	4180186
43021642	Assessment using PSYRATS (psychotic symptom rating scales) delusions subscale	4180186
43021643	Carer aware of prognosis	4180186
43021643	Caregiver aware of prognosis (situation)	4180186
43021646	Caregiver unaware of diagnosis (situation)	4180186
43021646	Carer unaware of diagnosis	4180186
43021647	Assessment using Addenbrooke's cognitive examination revised language subscale (procedure)	4180186
43021647	Assessment using ACE-R (Addenbrooke's cognitive examination revised) language subscale	4180186
43021648	Assessment using Addenbrooke's cognitive examination revised attention and orientation subscale (procedure)	4180186
43021648	Assessment using ACE-R (Addenbrooke's cognitive examination revised) attention and orientation subscale	4180186
43021651	Assessment using Addenbrooke's cognitive examination revised visuospatial subscale (procedure)	4180186
43021651	Assessment using ACE-R (Addenbrooke's cognitive examination revised) visuospatial subscale	4180186
43021653	Addenbrooke's cognitive examination revised language subscale (assessment scale)	4180186
43021653	ACE-R (Addenbrooke's cognitive examination revised) language subscale	4180186
43021656	Addenbrooke's cognitive examination revised visuospatial subscale (assessment scale)	4180186
43021656	ACE-R (Addenbrooke's cognitive examination revised) visuospatial subscale	4180186
43021658	Relative aware of prognosis (situation)	4180186
43021664	Ages and Stages Questionnaires Third Edition communication subscale (assessment scale)	4180186
43021664	ASQ-3 (ages and stages questionnaires third edition) communication subscale	4180186
43021665	Ages and Stages Questionnaires Third Edition fine motor subscale (assessment scale)	4180186
43021665	ASQ-3 (ages and stages questionnaires third edition) fine motor subscale	4180186
43021666	Ages and Stages Questionnaires Third Edition gross motor subscale (assessment scale)	4180186
43021666	ASQ-3 (ages and stages questionnaires third edition) gross motor subscale	4180186
43021674	Chronic respiratory disease questionnaire fatigue subscale score (observable entity)	4180186
43021675	Chronic respiratory disease questionnaire mastery subscale score (observable entity)	4180186
43021679	History of osteopenia resolved (situation)	4180186
43021680	Assessment using chronic respiratory disease questionnaire mastery subscale (procedure)	4180186
43021681	Chronic respiratory disease questionnaire dyspnea subscale (assessment scale)	4180186
43021681	Chronic respiratory disease questionnaire dyspnoea subscale	4180186
43021683	Chronic respiratory disease questionnaire fatigue subscale (assessment scale)	4180186
43021684	Chronic respiratory disease questionnaire mastery subscale (assessment scale)	4180186
43021687	Eating disorder examination questionnaire weight concern subscale score (observable entity)	4180186
43021687	EDE-Q (eating disorder examination questionnaire) weight concern subscale score	4180186
43021688	Eating disorder examination questionnaire restraint subscale score (observable entity)	4180186
43021688	EDE-Q (eating disorder examination questionnaire) restraint subscale score	4180186
43021689	Eating disorder examination questionnaire eating concern subscale (assessment scale)	4180186
43021689	EDE-Q (eating disorder examination questionnaire) eating concern subscale	4180186
43021690	Eating disorder examination questionnaire shape concern subscale (assessment scale)	4180186
43021690	EDE-Q (eating disorder examination questionnaire) shape concern subscale	4180186
43021692	Eating disorder examination questionnaire restraint subscale (assessment scale)	4180186
43021692	EDE-Q (eating disorder examination questionnaire) restraint subscale	4180186
43021699	Not tolerating normal diet (situation)	4180186
43021701	Acquired stenosis of inferior vena cava (disorder)	4180186
43021701	Acquired stenosis of inferior caval vein	4180186
43021702	Dysfunction of right cardiac ventricle (disorder)	4180186
43021702	Right ventricular cardiac dysfunction	4180186
43021703	Laparoscopy for undescended testicle (procedure)	4180186
43021703	Laparoscopy for undescended testis	4180186
43021704	Pericardial cyst along left cardiophrenic angle (disorder)	4180186
43021708	Calcification of aortic valve annulus (disorder)	4180186
43021709	Perforated mitral valve leaflet	4180186
43021709	Perforation of mitral valve leaflet (disorder)	4180186
43021710	Rupture of right atrioventricular (nontricuspid) valve leaflet	4180186
43021710	Rupture of right atrioventricular (not morphologically tricuspid) valve leaflet (disorder)	4180186
43021711	Perforation of right atrioventricular (not morphologically tricuspid) valve leaflet (disorder)	4180186
43021711	Perforation of right atrioventricular (nontricuspid) valve leaflet	4180186
43021713	Perforation of left atrioventricular (not morphologically mitral) valve leaflet (disorder)	4180186
43021713	Perforation of left atrioventricular (nonmitral) valve leaflet	4180186
43021716	Congenital luminal atresia of aortic arch between subclavian artery and common carotid artery (disorder)	4180186
43021716	Type B congenital luminal atresia of aortic arch between subclavian artery and common carotid artery	4180186
43021718	Acquired atresia of aortic arch	4180186
43021718	Acquired complete obstruction of aortic arch (disorder)	4180186
43021719	Acquired luminal obstruction of aortic arch (disorder)	4180186
43021721	Acquired luminal obstruction of aortic arch between subclavian artery and common carotid artery (disorder)	4180186
43021721	Type B acquired luminal obstruction of aortic arch between subclavian artery and common carotid artery	4180186
43021724	Abnormality within thorax due to interruption of aortic arch (disorder)	4180186
43021725	Dysplasia of glottis (disorder)	4180186
43021729	Foetal pericardial effusion	4180186
43021729	Fetal pericardial effusion (disorder)	4180186
43021730	Foetal choroid plexus cyst	4180186
43021730	Fetal choroid plexus cyst (disorder)	4180186
43021731	Foetal mediastinal shift to right	4180186
43021731	Fetal mediastinal shift to right (disorder)	4180186
43021733	Fetal supraventricular tachycardia with long ventriculoatrial interval (disorder)	4180186
43021733	Foetal supraventricular tachycardia with long RP interval	4180186
43021733	Foetal supraventricular tachycardia with long ventriculoatrial interval	4180186
43021733	Fetal supraventricular tachycardia with long RP interval	4180186
43021734	Foetal cardiomegaly	4180186
43021734	Fetal cardiomegaly (disorder)	4180186
43021735	Fetal heart failure (disorder)	4180186
43021735	Foetal heart failure	4180186
43021736	Fetal heart failure with redistribution of cardiac output (disorder)	4180186
43021736	Foetal heart failure with redistribution of cardiac output	4180186
43021737	Transthoracic echocardiography for congenital heart disease (procedure)	4180186
43021738	Administration of prophylactic antiviral after potential sexual exposure to human immunodeficiency virus	4180186
43021738	Administration of prophylactic antiviral after potential sexual exposure to human immunodeficiency virus (procedure)	4180186
43021738	Post exposure prophylaxis with antiviral therapy for potential sexual exposure to human immunodeficiency virus (procedure)	4180186
43021739	Abnormality of foetal heart	4180186
43021739	Abnormality of fetal heart (disorder)	4180186
43021739	Fetal cardiac abnormality	4180186
43021740	Not trying to conceive (situation)	4180186
43021743	Never used contraception (situation)	4180186
43021744	Born at home (situation)	4180186
43021745	Born in ambulance (situation)	4180186
43021746	History of attempted weight loss (situation)	4180186
43021746	H/O attempted weight loss	4180186
43021747	Asthma never causes night symptoms (situation)	4180186
43021750	Congenital occlusion of iliac vein (disorder)	4180186
43021751	Congenital occlusion of femoral vein (disorder)	4180186
43021753	Dialysis catheter in situ usable (finding)	4180186
43021755	Swab from Tenckhoff catheter exit site (specimen)	4180186
43021761	Shunt submitted as specimen (specimen)	4180186
43021762	Peripherally inserted central catheter submitted as specimen (specimen)	4180186
43021764	Central venous catheter submitted as specimen (specimen)	4180186
43021766	External ventricular drain tip submitted as specimen (specimen)	4180186
43021768	Central venous catheter from internal jugular vein submitted as specimen (specimen)	4180186
43021769	Intracranial pressure catheter submitted as specimen (specimen)	4180186
43021771	Nephrostomy tube submitted as specimen (specimen)	4180186
43021771	Nephrostomy catheter submitted as specimen	4180186
43021772	Cardiac pacemaker lead submitted as specimen (specimen)	4180186
43021776	Deafness of right ear (disorder)	4180186
43021778	Hearing loss of right ear (disorder)	4180186
43021779	Hearing loss of left ear (disorder)	4180186
43021780	Fluorinated hydrocarbon poisoning (disorder)	4180186
43021781	Primary tuberculous complex confirmed by culture (disorder)	4180186
43021785	Primary tuberculous complex confirmed (disorder)	4180186
43021786	Primary tuberculous complex with bacteriological or histological examination results unknown (disorder)	4180186
43021789	Pain in chin (finding)	4180186
43021793	Central venous catheter related bloodstream infection (disorder)	4180186
43021793	CRBSI - catheter related bloodstream infection	4180186
43021794	History of osteopenia (situation)	4180186
43021797	Acquired abnormality of femoral vein (disorder)	4180186
43021798	Exerting inappropriate parental pressure (finding)	4180186
43021800	Non-coronary non-aorta systemic artery structure (body structure)	4180186
43021803	Disorder of left atrioventricular (not morphologically mitral) valve (disorder)	4180186
43021803	Disorder of left atrioventricular (nonmitral) valve	4180186
43021807	Allergic conjunctivitis (disorder)	4180186
43021811	Sleep related hypoventilation or hypoxaemia	4180186
43021811	Sleep related hypoventilation or hypoxemia (disorder)	4180186
43021812	Behavioural insomnia of childhood	4180186
43021812	Behavioral insomnia of childhood (disorder)	4180186
43021812	Behavioral sleep problem	4180186
43021812	Behavioural sleep problem	4180186
43021813	Moderate receptive language delay (disorder)	4180186
43021815	Anterior pleuritic pain (finding)	4180186
43021821	Coronary arteriosclerosis in native artery of transplanted heart (disorder)	4180186
43021824	Mild expressive language delay (disorder)	4180186
43021825	Congestive heart failure stage D (disorder)	4180186
43021827	Hypertrophy or dilatation of right ventricle (disorder)	4180186
43021828	Right atrial enlargement (disorder)	4180186
43021829	Caffeine user (finding)	4180186
43021830	Postoperative hypertension (disorder)	4180186
43021834	Adjustment to life threatening illness (finding)	4180186
43021835	Hypertensive heart AND chronic kidney disease stage 3 (disorder)	4180186
43021838	Adult child of alcoholic (ACA)	4180186
43021838	Adult child of alcoholic (situation)	4180186
43021839	Positive screening for depression on Patient Health Questionnaire 9 (finding)	4180186
43021839	Positive screening for depression on Patient Health Questionnaire 9	4180186
43021840	Systolic heart failure, stage D	4180186
43021840	Systolic heart failure stage D (disorder)	4180186
43021845	Psychosocial problems related to unwanted pregnancy (finding)	4180186
43021847	Rapid cycling bipolar I disorder (disorder)	4180186
43021850	Sleep related hypoxemia (disorder)	4180186
43021850	Sleep related hypoxaemia	4180186
43021851	Left carotid artery atherosclerosis	4180186
43021851	Atherosclerosis of left carotid artery (disorder)	4180186
43021853	Malignant hypertensive chronic kidney disease stage 1 (disorder)	4180186
43021857	Arteriosclerosis of autologous arterial coronary artery bypass graft (disorder)	4180186
43021858	Arteriosclerosis of autologous coronary artery bypass graft (disorder)	4180186
43021859	Stenosis of right carotid artery	4180186
43021859	Stenosis of right carotid artery (disorder)	4180186
43021860	Behavioural insomnia of childhood, combined type	4180186
43021860	Behavioral insomnia of childhood, combined type (disorder)	4180186
43021861	Congenital peripheral pulmonary artery stenosis (disorder)	4180186
43021864	Malignant hypertensive end stage renal disease on dialysis (disorder)	4180186
43021865	Inappropriate parental pressure (finding)	4180186
43021866	Adult victim of physical abuse by male partner (finding)	4180186
43021866	Adult physical abuse by male partner	4180186
43021868	Aneurysm of peripheral artery (disorder)	4180186
43021869	Measurement of 17-hydroxycorticosteroid in 24 hour urine specimen (procedure)	4180186
43021874	Fluorocholine F^18^	4180186
43021874	Product containing fluorocholine (18-F) (medicinal product)	4180186
43021877	Fluciclovine F^18^	4180186
43021877	Product containing fluciclovine (18-F) (medicinal product)	4180186
43021878	E. coli Orough:H9	4180186
43021878	Escherichia coli serotype Orough:H9 (organism)	4180186
43021880	Escherichia coli O181	4180186
43021880	E. coli serogroup O181	4180186
43021880	E. coli O181	4180186
43021880	Escherichia coli serotype O181	4180186
43021880	Escherichia coli serogroup O181 (organism)	4180186
43021881	Escherichia coli serotype O179:H8 (organism)	4180186
43021881	E. coli serotype O179:H8	4180186
43021882	Escherichia coli serotype O175:H27 (organism)	4180186
43021882	E. coli serotype O175:H27	4180186
43021884	Spontaneous recanalization of systemic vein (finding)	4180186
43021884	Spontaneous recanalisation of systemic vein	4180186
43021885	Single right coronary artery supplying all of heart with usual distribution of left coronary artery derived from distal right coronary artery (disorder)	4180186
43021886	Anomalous origin of coronary artery from sinus 1	4180186
43021886	Anomalous origin of coronary artery from aortic sinus of Valsalva to right of nonfacing aortic sinus of Valsalva	4180186
43021886	Anomalous origin of coronary artery from aortic sinus to right of nonfacing aortic sinus (disorder)	4180186
43021887	Congenital pericardial cyst (disorder)	4180186
43021889	Government midwife (occupation)	4180186
43021890	Thrombosis of tricuspid valve (disorder)	4180186
43021892	Perforation of pulmonary cusp	4180186
43021892	Perforation of pulmonary valve cusp (disorder)	4180186
43021895	Perforation of truncal valve cusp (disorder)	4180186
43021895	Perforation of truncal valve leaflet	4180186
43021902	Cardiomyopathy due to neuromuscular disorder (disorder)	4180186
43021904	Interruption of aortic arch between left common carotid artery and right common carotid artery (disorder)	4180186
43021904	Type C interruption of aortic arch between left common carotid artery and right common carotid artery	4180186
43021905	Hypertrophic mitochondrial cardiomyopathy (disorder)	4180186
43021906	Maternally inherited mitochondrial cardiomyopathy and myopathy (disorder)	4180186
43021908	E. coli serotype O119:H6	4180186
43021908	Escherichia coli serotype O119:H6 (organism)	4180186
43021909	Escherichia coli serotype O118:H12 (organism)	4180186
43021909	E. coli serotype O118:H12	4180186
43021910	Parapagus (disorder)	4180186
43021911	Major systemic to pulmonary collateral artery (disorder)	4180186
43021912	Escherichia coli serotype O5:nonmotile (organism)	4180186
43021912	E. coli serotype O5:nonmotile	4180186
43021913	Escherichia coli serotype O7:H18 (organism)	4180186
43021913	E. coli serotype O7:H18	4180186
43021914	E. coli serotype O7:nonmotile	4180186
43021914	Escherichia coli serotype O7:nonmotile (organism)	4180186
43021916	Escherichia coli serotype O14:H23 (organism)	4180186
43021916	E. coli serotype O14:H23	4180186
43021917	E. coli serotype O21:nonmotile	4180186
43021917	Escherichia coli serotype O21:nonmotile (organism)	4180186
43021919	E. coli serotype O27:H7	4180186
43021919	Escherichia coli serotype O27:H7 (organism)	4180186
43021921	Escherichia coli serotype O38:H26 (organism)	4180186
43021921	E. coli serotype O38:H26	4180186
43021922	Escherchia coli serotype O45:nonmotile (organism)	4180186
43021922	E. coli serotype O45:nonmotile	4180186
43021923	Pseudoacardia (disorder)	4180186
43021923	Nonfunctional recipient heart in twin reversal arterial perfusion syndrome	4180186
43021928	Ligustrum pollen (substance)	4180186
43021928	Privet tree pollen	4180186
43021929	Celtis pollen allergen (substance)	4180186
43021929	Hackberry pollen allergen	4180186
43021931	Occlusion of superior vena cava due to neoplasm (disorder)	4180186
43021931	Occlusion of superior vena cava due to tumour	4180186
43021931	Occlusion of superior vena cava due to tumor	4180186
43021932	Pulmonary venous hypertension as complication of procedure (disorder)	4180186
43021934	Malrotation of intestine with internal herniation (disorder)	4180186
43021936	Fatal congenital nonlysosomal heart glycogenosis (disorder)	4180186
43021937	Anomalous origin of accessory coronary artery from pulmonary artery (disorder)	4180186
43021938	Spontaneous closure of surgically created fenestration of atrial tunnel after prior atrial fenestration operation (disorder)	4180186
43021942	Yolk sac absent (finding)	4180186
43021946	Stenosis of fetal common atrioventricular valve (disorder)	4180186
43021946	Stenosis of foetal common atrioventricular valve	4180186
43021947	Infective endocarditis of mitral valve (disorder)	4180186
43021947	Infectious endocarditis of mitral valve	4180186
43021948	Abscess of cardiovascular homograft (disorder)	4180186
43021950	Infectious endarteritis at site of aortic coarctation	4180186
43021950	Infective endarteritis at site of aortic coarctation (disorder)	4180186
43021952	Monochorionic monoamniotic twin pregnancy (disorder)	4180186
43021954	Abscess at site of ductus arteriosus (disorder)	4180186
43021954	Abscess at site of ductus arteriosus	4180186
43021955	Aneurysm of patch of left ventricular outflow tract (disorder)	4180186
43021956	Umbilical vein catheter tip submitted as specimen (specimen)	4180186
43021958	Tracheal tube submitted as specimen (specimen)	4180186
43021959	Heyer-Pudenz valve submitted as specimen (specimen)	4180186
43021961	History of chronic kidney disease	4180186
43021961	History of chronic renal impairment (situation)	4180186
43021961	H/O chronic kidney disease	4180186
43021964	History of abnormally low blood pressure	4180186
43021964	History of hypotension (situation)	4180186
43021965	Hypersensitivity process (qualifier value)	4180186
43021966	History of cutaneous cellulitis	4180186
43021966	History of cellulitis of skin (situation)	4180186
43021967	History of autoimmune endocrine disease	4180186
43021967	History of autoimmune disorder of endocrine system (situation)	4180186
43021967	H/O autoimmune endocrine disease	4180186
43021970	Previously bisexual transsexual (finding)	4180186
43021971	Myocarditis caused by Genus Rickettsia (disorder)	4180186
43021971	Rickettsial myocarditis	4180186
43021971	Myocarditis caused by Genus Rickettsia	4180186
43021972	Systemic to pulmonary collateral artery from left renal artery (disorder)	4180186
43021973	Anomalous origin of large conus artery from right coronary artery (disorder)	4180186
43021973	Abnormal origin of large conus artery from right coronary artery	4180186
43021974	Complication associated with device (disorder)	4180186
43021977	Complication associated with cardiac implant (disorder)	4180186
43021978	Complication associated with cardiac pacemaker lead (disorder)	4180186
43021979	Mechanical complication of nervous system implant (disorder)	4180186
43021982	History of noncompliance with medication regimen (situation)	4180186
43021987	Inflammatory reaction associated with neurological device	4180186
43021987	Inflammation associated with neurological device (disorder)	4180186
43021990	Inflammation associated with device (disorder)	4180186
43021990	Inflammatory reaction associated with device	4180186
43021992	Abnormality of ductus arteriosus (disorder)	4180186
43021992	Abnormality of ductus arteriosus	4180186
43021993	Anomalous origin of ductus arteriosus from ascending aorta (disorder)	4180186
43021993	Anomalous origin of ductus arteriosus from ascending aorta	4180186
43021995	Education of family (situation)	4180186
43021995	Education of family member	4180186
43021995	Family education	4180186
43021996	Chlamydial endocarditis	4180186
43021996	Endocarditis caused by Genus Chlamydia (disorder)	4180186
43021996	Endocarditis caused by Genus Chlamydia	4180186
43021997	Lipomatous hypertrophy of interatrial groove (disorder)	4180186
43021997	Lipomatous hypertrophy of interatrial septum	4180186
43022001	Sickling disorder due to hemoglobin S not suspected	4180186
43022001	Sickle cell disease not suspected (situation)	4180186
43022001	Sickling disorder due to haemoglobin S not suspected	4180186
43022002	Migration of suprapubic catheter (disorder)	4180186
43022003	No known disability	4180186
43022003	Disability absent (situation)	4180186
43022004	Bruising absent	4180186
43022004	No contusion	4180186
43022004	Contusion absent (situation)	4180186
43022004	No bruising	4180186
43022007	Advised to maintain supply of blood ketone test strips	4180186
43022007	Recommended to maintain supply of blood ketone test strips (situation)	4180186
43022009	History of angioplasty (situation)	4180186
43022011	Accidental removal of nasogastric tube (finding)	4180186
43022013	Hemorrhage associated with implant (disorder)	4180186
43022013	Haemorrhage associated with implant	4180186
43022014	History of influenza vaccination (situation)	4180186
43022017	Discussion about diabetic ketoacidosis in pregnancy (procedure)	4180186
43022022	Cardiovascular abnormality due to anomalous origin of coronary artery from pulmonary artery (disorder)	4180186
43022025	Anomalous origin of coronary artery from aorta (disorder)	4180186
43022025	Abnormal origin of coronary artery from aorta	4180186
43022029	Epidermal burn of multiple sites of neck (disorder)	4180186
43022029	Burn erythema of multiple sites of neck	4180186
43022029	Superficial burn of multiple sites of neck	4180186
43022029	First degree burn of multiple sites of neck	4180186
43022034	Psychotic symptom rating scales auditory hallucination subscale cognitive interpretation score (observable entity)	4180186
43022034	PSYRATS (psychotic symptom rating scales) auditory hallucination subscale cognitive interpretation score	4180186
43022035	Acquired submitral aneurysm of left ventricle (disorder)	4180186
43022036	Acquired occlusion of iliac vein (disorder)	4180186
43022036	Acquired obstruction of iliac vein	4180186
43022037	Anomalous coronary artery without acute angulation of less than 45 degrees relative to aorta (disorder)	4180186
43022038	Restriction of coronary artery ostium due to valve cusp tissue	4180186
43022038	Restriction of coronary artery orifice due to valve cusp tissue (disorder)	4180186
43022039	Major systemic to pulmonary collateral artery with absent pulmonary arteries proximal to hilar bifurcation (disorder)	4180186
43022042	Eating disorder examination questionnaire shape concern subscale score (observable entity)	4180186
43022042	EDE-Q (eating disorder examination questionnaire) shape concern subscale score	4180186
43022044	Tolerating oral fluids	4180186
43022044	Tolerating oral fluid (finding)	4180186
43022046	Pericardial cyst along right cardiophrenic angle (disorder)	4180186
43022048	Torn tricuspid valve leaflet	4180186
43022048	Rupture of tricuspid valve leaflet (disorder)	4180186
43022049	Rupture of left atrioventricular (not morphologically mitral) valve leaflet (disorder)	4180186
43022049	Rupture of left atrioventricular (nonmitral) valve leaflet	4180186
43022050	Foetal fluid retention	4180186
43022050	Fetal fluid retention (disorder)	4180186
43022051	Fetal fluid retention restricted to two fetal compartments (disorder)	4180186
43022051	Foetal fluid retention restricted to two foetal compartments	4180186
43022052	Foetal anaemia	4180186
43022052	Fetal anemia (disorder)	4180186
43022052	Fetal anaemia	4180186
43022055	Two column burst fracture of vertebra	4180186
43022055	Two column classification system burst fracture of vertebra (disorder)	4180186
43022056	Chondroradionecrosis of larynx (disorder)	4180186
43022057	CABSI - catheter associated bloodstream infection	4180186
43022057	Central venous catheter associated bloodstream infection (disorder)	4180186
43022057	CLABSI - Central line associated bloodstream infection	4180186
43022062	Cardiovascular system complication of procedure (disorder)	4180186
43022063	Received elementary school education (finding)	4180186
43022064	Atherosclerosis aortoiliac bypass graft	4180186
43022064	Atherosclerosis of aortoiliac bypass graft (disorder)	4180186
43022067	Organic sleep-wake cycle disorder (disorder)	4180186
43022069	Primary central sleep apnoea	4180186
43022069	Primary central sleep apnea (disorder)	4180186
43054873	Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Count/time; Finger stick; Lung; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Respiratory rate	4180186
43054873	Breaths BldC	4180186
43054873	呼吸:计数型速率:时间点:毛细血管全血:定量型	4182948
43054874	Cells # Fld	4180186
43054874	#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43054874	细胞:计数型浓度:时间点:体液:定量型	4182948
43054875	Leuk FTperCT Pnl Bld/T	4180186
43054875	Acute + chron leuk; Blood; Leuk FTperCT Pnl; Molecular genetics; Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43054875	基于对照转录的急性与慢性白血病融合转录物组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
43054876	MoCA; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
43054881	Brst; Brst-L; CorePlaybook; DBT; Document; Dx; Finding; Findings; Imaging; L; LT; Mammography tomo; Mammography tomosynthesis; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
43054881	DBT Brst-L Dx	4180186
43054881	诊断类多层:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术.断层合成	4182948
43054882	Bil; Bilat; Both; Breast-Bl; Breasts; Brst; Brst-Bl; CorePlaybook; DBT; Document; Dx; Finding; Findings; Imaging; Mammography tomo; Mammography tomosynthesis; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
43054882	DBT Brst-Bl Dx	4180186
43054882	诊断类多层:发现:时间点:乳腺.双侧:文档型:乳房X线摄影术.断层合成	4182948
43054883	Asympt; Asymptomatic; Brst; Brst-R; DBT; Document; Finding; Findings; Imaging; Mammography tomo; Mammography tomosynthesis; Point in time; R; Rad; Radiology; Random; RT; Scn	4180186
43054883	DBT Brst-R Screening	4180186
43054883	筛查类多层:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术.断层合成	4182948
43054884	Asympt; Asymptomatic; Brst; Brst-L; DBT; Document; Finding; Findings; Imaging; L; LT; Mammography tomo; Mammography tomosynthesis; Point in time; Rad; Radiology; Random; Scn	4180186
43054884	DBT Brst-L Screening	4180186
43054884	筛查类多层:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术.断层合成	4182948
43054886	Gender; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Typ	4180186
43054887	After; Birth status; Finding; Findings; Ordinal; Point in time; PST; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054889	Birth status; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054890	@ birth; Finding; Findings; GA; GA at birth; Gest; Gestation; New born; Newborn; Ordinal; Point in time; Prenatal; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054891	Finding; Findings; Nominal; Persons; Point in time; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH	4180186
43054892	Finding; Findings; Meth; Method of; Nominal; Point in time; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH	4180186
43054893	Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Typ	4180186
43054894	Arrived at clinic w partner; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054897	Finding; Findings; Gestation; Gestations; Gravida; Nominal; Point in time; Pregnancies; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH	4180186
43054899	Asympt; Asymptomatic; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Rwanda Health Enterprise Architecture; Scn; Survey; SURVEY.GNHLTH	4180186
43054902	BSA; Cl; Clear; Clearanc; Clearances; Clr; DRUG/TOXICOLOGY; Drugs; Kidney; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; Square Meter; SR; Studies; Study; Sutdies; UA; UR; Ur+SerPl; Urn; Volume rate/area; Volume Rate/Ratio	4180186
43054902	Inulin Cl/1.73 sq M Ur+SerPl-ArVRat	4180186
43054902	菊糖 肾脏清除率/1.73 平方米:单位面积体积速率:检查过程持续时间:尿液+血清/血浆:定量型	4182948
43054903	Holo-TC-II Ser-sCnc	4180186
43054903	2; Active B12; Active vitamin B12; Chemistry; Cobalamin; haptocorrin; holo-haptocorrin; holo-TC; Holo-TC-II; Holotranscobalamin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration; TC; TC-2; TCII; TC-II; Transcobalamin; Transcobalamin 2; Vit B12; Vitamin B12	4180186
43054903	Holo-运钴胺素蛋白 II:物质的量浓度:时间点:血清:定量型	4182948
43054904	Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Gram Stn; HEMATOLOGY/CELL COUNTS; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified	4180186
43054904	Epi Cells Spec Ql Gram Stn	4180186
43054904	上皮细胞:存在情况或阈值:时间点:XXX:序数型:革兰氏染色法	4182948
43054905	RBC Spec Ql Gram Stn	4180186
43054905	Discocytes; Erthrocyte; Erythrocyte; Gram Stn; HEMATOLOGY/CELL COUNTS; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified	4180186
43054905	红细胞:存在情况或阈值:时间点:XXX:序数型:革兰氏染色法	4182948
43054912	DOC.MISC; Finding; Findings; Immunization status; MISC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vaccination; Vaccinations; Vaccine	4180186
43054912	Permission to release immunization data	4180186
43054912	允许发布来自学校档案的疫苗接种数据:发现:时间点:^患者:序数型	4182948
43054914	GTT 2h Pnl SerPl	4180186
43054914	120 min; 120 minutes; 120min; 2 hours; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; GTT 2h Pnl; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43054914	2小时葡萄糖耐量组套:-:-:血清/血浆:定量型	4182948
43054917	Antigen; Antigens; Bowel movement; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Screen; Stl; Stool = Fecal; SUDS	4180186
43054917	RV Ag Stl Ql IA.rapid	4180186
43054917	轮状病毒 抗原:存在情况或阈值:时间点:大便:序数型:免疫测定法.快速	4182948
43054918	Finding; Findings; Ordinal; Physician assess necessary; Point in time; QL; Qual; Qualitative; Random; Rwanda Health Enterprise Architecture; Screen; Survey; SURVEY.GNHLTH	4180186
43054919	Finding; Findings; Nominal; Point in time; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH	4180186
43054920	Finding; Findings; Nominal; Point in time; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH	4180186
43054928	Finding; Findings; Hx; Nominal; Point in time; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH	4180186
43054930	Gvn; Point in time; QNT; Quan; Quant; Quantitative; Random; Rwanda Health Enterprise Architecture; Survey; SURVEY.GNHLTH	4180186
43054931	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
43054932	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; QoL score; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
43054933	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
43054934	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Sx; Tot; Totl	4180186
43054935	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Sx	4180186
43054936	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Sx; Symptom freq score	4180186
43054938	Kansas City Cardiomyopathy Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
43054940	Dextro; HEDIS 2013 CWP-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Strep; Strept	4180186
43054940	HEDIS 2013 CWP-D	4180186
43054940	用于标识 A 组链球菌试验的 HEDIS 2013 代码 (CWP-D):-:时间点:^患者:-	4182948
43054941	HEDIS 2013 CHL-B	4180186
43054941	HEDIS 2013 CHL-B; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
43054941	用于标识性活跃妇女的 HEDIS 2013 代码 (CHL-B):-:时间点:^患者:-	4182948
43054943	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV NA; FLUAV NA seg sequence ID; FLUV; Fowl plague; high-throughput sequencing; HTS; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; NA; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
43054943	FLUAV NA seg sequence ID Islt Seq	4180186
43054943	流感病毒 A 型神经氨酸酶片段序列标识符:标识符:时间点:分离株:名义型:序列测定	4182948
43054944	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV MP; FLUAV MP seg seqence ID; FLUV; Fowl plague; high-throughput sequencing; HTS; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; PR; Prot; Random	4180186
43054944	FLUAV MP seg seqence ID Islt Seq	4180186
43054944	流感病毒 A 型基质蛋白片段序列标识符:标识符:时间点:分离株:名义型:序列测定	4182948
43054947	Follow-up; My Mood Monitor Checklist; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
43054948	Chgs sleeping patterns - follow up; Follow-up; My Mood Monitor Checklist; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
43054950	21q22.3; ABL; ABL1; ABL1 transcript; Acute myelogenous leukemia 1 translocation 1, cyclin-D related; Acute myeloid leukemia; Acute myeloid leukemia 1; AML; AML1; AML1T1L myeloid translocation gene on 8q22; Blood; CBFA2; CBFA2T1; CDR; control gene; Core binding factor runt domain alpha subunit 2; DNA; ETO; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; MGC2796; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; MTG8; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(8,21)(RUNX1T1,RUNX1) gene translocation; t(8;21)(RUNX1T1,RUNX1); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue; ZMYND2	4180186
43054950	t(8;21)(RUNX1T1,RUNX1)/control Bld/T	4180186
43054950	t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43054951	21q22.3; ABL; ABL1; ABL1 transcript; Acute myelogenous leukemia 1 translocation 1, cyclin-D related; Acute myeloid leukemia; Acute myeloid leukemia 1; AML; AML1; AML1T1L myeloid translocation gene on 8q22; BM; BON; Bone marrow; CBFA2; CBFA2T1; CDR; control gene; Core binding factor runt domain alpha subunit 2; DNA; ETO; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); MGC2796; minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; MTG8; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(8,21)(RUNX1T1,RUNX1) gene translocation; t(8;21)(RUNX1T1,RUNX1); translocation; ZMYND2	4180186
43054951	t(8;21)(RUNX1T1,RUNX1)/control Mar	4180186
43054951	t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) 融合转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43054954	ABL; ABL1; ABL1 transcript; Acute promyelocytic leukemia; APL; BM; BON; Bone marrow; breakpoint cluster region 2; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Number ratio; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(PML,RARA) gene translocation breakpoint cluster region 2; t(15,17)(q22,q11.2-q12); t(15;17) BCR2; t(15;17)(PML,RARA); translocation	4180186
43054954	t(15;17) BCR2/control Mar	4180186
43054954	t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 融合转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43054957	HLA-DP+DQ+DR IgG Ser Ql FC	4180186
43054957	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; HLA ANTIGEN; HLA class II; Human Leukocyte Antigen; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
43054957	HLA-DP+DQ+DR 抗体.IgG:存在情况或阈值:时间点:血清:序数型:流式细胞测量术	4182948
43054959	BldA Fshunt vol temp adj VFr	4180186
43054959	ABG; adj; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Fshunt; Fshunt vol; Hemodynamics; HEMODYNAMICS.MOLEC; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Temp; temp adj; Vol; Volfr; Volume fraction	4180186
43054959	功能分流体积^^调整至病人实际体温的:体积分数:时间点:动脉全血:定量型	4182948
43054962	A,B; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; HLA ANTIGEN; HLA class I; Human Leukocyte Antigen; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; Serum; SR	4180186
43054962	HLA-A+B+C IgG Ser Ql FC	4180186
43054962	HLA-A+B+C 抗体.IgG:存在情况或阈值:时间点:血清:序数型:流式细胞测量术	4182948
43054963	100 rnd; Anuc bdy; bod; Body; Cell; Cellularity; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnd Cells; Sem; Seminal fluid; Smn; SMPLS; Unnucleated; URO; Urology	4180186
43054963	Anuc bdy/100 rnd NFr Smn Manual	4180186
43054963	无核小体/100 个圆形细胞:计数型分数:时间点:精液:定量型:手工计数方法	4182948
43054964	100 rnd; Cell; Cellularity; Ejaculate; Genitourinary; GU; HEMATOLOGY/CELL COUNTS; Manl; Nuc; Nuc cell; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnd Cells; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
43054964	Nuc cell/100 rnd NFr Smn Manual	4180186
43054964	有核细胞类/100 个圆形细胞:计数型分数:时间点:精液:定量型:手工计数方法	4182948
43054966	100 rnd; Cell; Cellularity; EPS; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; Manl; Nuc; Nuc cell; Number Fraction; Percent; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; Rnd Cells	4180186
43054966	Nuc cell/100 rnd NFr Prost fld Manual	4180186
43054966	有核细胞类/100 个圆形细胞:计数型分数:时间点:前列腺液:定量型:手工计数方法	4182948
43054969	ABL; ABL1; ABL1 transcript; B23; BM; BON; Bone marrow; control gene; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NPM; NPM1 gene mut A; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43054969	NPM1 gene mut A/control Mar	4180186
43054969	NPM1 基因.c.956dupTCTG 转录物/对照转录物:计数型比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
43054972	RBC Prost fld Ql Micro	4180186
43054972	Discocytes; EPS; Erthrocyte; Erythrocyte; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen	4180186
43054972	红细胞:存在情况或阈值:时间点:前列腺液:序数型:显微镜检查.光学	4182948
43054974	Bact; EPS; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QL; Qual; Qualitative; Random; Screen	4180186
43054974	Bacteria Prost fld Ql Micro	4180186
43054974	细菌:存在情况或阈值:时间点:前列腺液:序数型:显微镜检查.光学	4182948
43054977	100 rnd; Cell; Cellularity; Ejaculate; Genitourinary; GU; HEMATOLOGY/CELL COUNTS; Manl; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnd Cells; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
43054977	Monocytes/100 rnd NFr Smn Manual	4180186
43054977	单核细胞/100 个圆形细胞:计数型分数:时间点:精液:定量型:手工计数方法	4182948
43054979	Neutrophils/100 rnd NFr Prost fld Manual	4180186
43054979	100 rnd; Cell; Cellularity; EPS; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; Manl; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; Rnd Cells	4180186
43054979	嗜中性粒细胞/100 个圆形细胞:计数型分数:时间点:前列腺液:定量型:手工计数方法	4182948
43054980	Rnd Cells # Prost fld Manual	4180186
43054980	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; EPS; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; Rnd Cells	4180186
43054980	圆形细胞:计数型浓度:时间点:前列腺液:定量型:手工计数方法	4182948
43054982	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; EPS; expressed prostatic secretion; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43054982	WBC # Prost fld Manual	4180186
43054982	白细胞:计数型浓度:时间点:前列腺液:定量型:手工计数方法	4182948
43054983	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; Levels; Levl; LV; LVL; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
43054984	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Pain past 1Mo; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
43054987	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Physical well-being; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
43054988	1 month; 1 month (30 days); 30 days; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
43054990	A,B; Antigen; Antigens; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; IAA; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
43054990	FLUAV + FLUBV Ag Spec IA.rapid	4180186
43054990	流感病毒 A 型与 B 型 抗原:存在与否或特征标识:时间点:XXX:名义型:免疫测定法.快速	4182948
43054992	MetHgb MFr BldCoV	4180186
43054992	Bld cord; Cord BldV; Cord venous blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hemiglobin; Hgb; Hi; Mass fraction; Methaemoglobin; MetHb; Methgb; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
43054992	高铁血红蛋白/血红蛋白.总计:质量分数:时间点:脐带静脉全血:定量型	4182948
43054993	MetHgb MFr BldCoA	4180186
43054993	Bld cord; Cord arterial blood; Cord BldA; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hemiglobin; Hgb; Hi; Mass fraction; Methaemoglobin; MetHb; Methgb; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
43054993	高铁血红蛋白/血红蛋白.总计:质量分数:时间点:脐带动脉全血:定量型	4182948
43054994	#/area; Granule; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
43054994	Starch Granules #/area UrnS LPF	4180186
43054994	淀粉颗粒:单位面积数量或计数:时间点:尿沉渣:定量型:显微镜检查.光学.低倍视野	4182948
43054997	A,B; Antigen; Antigens; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; IAA; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Nasal; Nominal; Nos; Nose (nasal passage); Point in time; Random; Smell; SUDS; UniversalLabOrders	4180186
43054997	FLUAV + FLUBV Ag Nose IA.rapid	4180186
43054997	流感病毒 A 型与 B 型 抗原:存在与否或特征标识:时间点:鼻:名义型:免疫测定法.快速	4182948
43054999	BM; BON; Bone marrow; Chronic lymphocytic leukemia; CLL; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; mantle cell lymphoma; MAR; Marrow (bone); MCL; minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Multiple myeloma; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(11,14)(CLL,IGH) gene translocation; t(11,14)(q13,q32); t(11;14)(CCND1,IGH); translocation	4180186
43054999	t(11;14)(CCND1,IGH) Mar Ql	4180186
43054999	t(11;14)(q13;q32)(CCND1,IGH) 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
43055001	Wound bed appear % Area of Wnd base	4180186
43055001	Appear; Appr; Ar wnd bd; Ar wnd bd appr; H+P; H+P.PX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Wnd; Wnd base; wound bed	4180186
43055001	已识别的创面外观的面积/创面面积:面积比:时间点:伤口.基底部:定量型	4182948
43055002	Appearance Wnd base	4180186
43055002	Appear; Appearance; Appr; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Wnd; Wnd base; wound bed	4180186
43055002	外观:外观:时间点:伤口.基底部:名义型	4182948
43055003	Wnd bed+edge pnl	4180186
43055003	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd; Wnd bed+edge pnl	4180186
43055003	创面与创缘组套:-:时间点:伤口:-	4182948
43055005	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Tissue; Tissue lung; Tissue, unspecified; Tlng	4180186
43055005	Virus Lung tiss Cult	4180186
43055005	病毒 已鉴定的:存在与否或特征标识:时间点:肺组织:名义型:培养	4182948
43055006	Meth; Method of; Micro mthd; Nominal; Point in time; Random; Typ; UA; UR; URINALYSIS; Urn	4180186
43055006	Micro mthd Ur	4180186
43055006	显微镜检查方法:类型:时间点:尿液:名义型	4182948
43055007	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; HCV; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood	4180186
43055007	HCV Ab SerPlBld Ql IA.rapid	4180186
43055007	丙型肝炎病毒 抗体:存在情况或阈值:时间点:血清/血浆/全血:序数型:免疫测定法.快速	4182948
43055010	Addiction; Cannabinoid; Cannabinoids synthetic; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Misc; Miscellaneous; Ordinal; Other; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Spec; THC; To be specified in another part of the message; Unspecified	4180186
43055010	Cannabinoids synthetic Spec Ql Scn	4180186
43055010	大麻类.合成型:存在情况或阈值:时间点:XXX:序数型:毒理学筛查试验	4182948
43055012	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Niravam; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Xanax	4180186
43055012	Alpraz Sal-mCnc	4180186
43055012	阿普唑仑:质量浓度:时间点:唾液:定量型	4182948
43055013	Arbitrary concentration; C-ERBB-2; EIA; ELFA; ELISA; Enzyme immunoassay; erb; ERB2; ERB-2; erbB2; HER-2; HER-2/neu; IAA; MEIA; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; Tissue; Tissue, unspecified	4180186
43055013	Her2 Tiss IA-aCnc	4180186
43055013	Her2:任意型浓度:时间点:组织与涂片:定量型:免疫测定法	4182948
43055014	C-ERBB-2; EIA; ELFA; ELISA; Enzyme immunoassay; erb; ERB2; ERB-2; erbB2; HER-2; HER-2/neu; IAA; MEIA; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; Tissue; Tissue, unspecified	4180186
43055014	Her2 Tiss Ql IA	4180186
43055014	Her2:存在情况或阈值:时间点:组织与涂片:序数型:免疫测定法	4182948
43055016	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; GCMS; i; II; III; Illicit; Level; Mass concentration; Methadone metabolite; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055016	EDDP Sal Cfm-mCnc	4180186
43055016	2-亚乙基-1,5-二甲基-3,3-四氢吡咯:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055018	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; METD; Methadose; MTD; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055018	Methadone Sal Ql Cfm	4180186
43055018	美沙酮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055025	Cell Cnt Pnl Vitf Manual	4180186
43055025	Cell Cnt Pnl; HEMATOLOGY/CELL COUNTS; Manl; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour	4180186
43055025	细胞计数组套:-:时间点:玻璃体液:-:手工计数方法	4182948
43055027	Barbiturate; Blood; c417; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Luminal; Mass concentration; Nirvonal; PHBR; Phenobarb; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43055027	Phenobarb Bld Cfm-mCnc	4180186
43055027	苯巴比妥:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
43055031	Addiction; Blood; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; WB; Whole blood	4180186
43055031	Methadone Bld Ql Scn	4180186
43055031	美沙酮:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
43055032	Addiction; Algaphan; Blood; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Napsalgesic; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; WB; Whole blood	4180186
43055032	Propoxyph Bld Ql Scn	4180186
43055032	丙氧氨酚:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
43055033	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Vicodin; WB; Whole blood	4180186
43055033	oxyCODONE Bld Ql Scn	4180186
43055033	羟考酮:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
43055035	3-epi-25(OH)D2; 3-epi-25-Hydroxy vitamin D2; C-3 epimer of 25OHD2; Chemistry; III; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055035	3-epi-25(OH)D2 SerPl-mCnc	4180186
43055035	3-表-25-羟维生素 D2:质量浓度:时间点:血清/血浆:定量型	4182948
43055036	Addiction; Benzoylmethylecgonine; Blood; Cfm; CNFR; CNFRM; Coke; Conf; Confirmation; Confirmatory; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Snow; WB; Whole blood	4180186
43055036	Cocaine Bld Cfm-mCnc	4180186
43055036	可卡因:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
43055037	Norchlordiazep Bld Cfm-mCnc	4180186
43055037	Blood; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; Desmethylchlordiazepoxide; Dmchlord; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43055037	去甲基甲氨二氮卓:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
43055043	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; BKV subtyp; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Typ; UA; UR; Urn	4180186
43055043	BKV subtyp Ur NAA+probe	4180186
43055043	BK 病毒亚型:类型:时间点:尿液:名义型:探针法.基因扩增.靶向	4182948
43055044	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; BKV subtyp; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Typ; Unspecified	4180186
43055044	BKV subtyp Spec NAA+probe	4180186
43055044	BK 病毒亚型:类型:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
43055048	3-hydroxybutyrate; 3-hydroxybutyric acid; B; Before; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; Blood; BOHB; B-OH-Butyr; CHEMISTRY.CHALLENGE TESTING; Hydroxybutyric acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055048	B-OH-Butyr pre-meal Bld-sCnc	4180186
43055048	Beta 羟基丁酸^在进餐之前:物质的量浓度:时间点:全血:定量型	4182948
43055051	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminobutric; Aminobutyric; Amino-n-butyrate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; FR; GABA; GABA. free; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Level; Non-protein bound; Piperidic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055051	GABA. free CSF-sCnc	4180186
43055051	Gamma 氨基丁酸.游离型:物质的量浓度:时间点:脑脊液:定量型	4182948
43055052	ANTIBIOTIC SUSCEPTIBILITIES; Bact; c162; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; VANC; Vancocin; Vancomycin resistance gene; Vancor	4180186
43055052	vanB Islt/Spm Ql	4180186
43055052	细菌万古霉素耐药 vanB 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43055053	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminobutric; Aminobutyric; Amino-n-butyrate; Blood; Chemistry; Fetal; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Piperidic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055053	GABA Bld Fetus-sCnc	4180186
43055053	Gamma 氨基丁酸:物质的量浓度:时间点:全血^胎儿:定量型	4182948
43055054	3Me-histidine; 3-MH; Blood; Ch3hist; Chemistry; Fetal; Gyn; Gynecology; III; Level; methyl-histidine; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055054	3Me-histidine Bld Fetus-sCnc	4180186
43055054	3-甲基组氨酸:物质的量浓度:时间点:全血^胎儿:定量型	4182948
43055055	3Me-histidine; 3-MH; AA; Acd; Acid; Amino acid; Amino acids.total; Ch3hist; Chemistry; III; methyl-histidine; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Tot; Totl	4180186
43055055	3Me-histidine SFr SerPl	4180186
43055055	3-甲基组氨酸/氨基酸类.总计:物质的量分数:时间点:血清/血浆:定量型	4182948
43055056	7OH-octanoate SerPl-sCnc	4180186
43055056	7OH-octanoate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055056	7-羟基辛酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055058	4HPP; 4-Hydroxy phenylpyruvate; 4-hydroxyphenylpyruvic acid; 4OH-phenylpyruvate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055058	4OH-phenylpyruvate CSF-sCnc	4180186
43055058	4-羟基苯丙酮酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055061	4HPLA; 4-Hydroxy phenyllactate; 4-hydroxyphenyllactic acid; 4OH-phenyllactate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055061	4OH-phenyllactate SerPl-sCnc	4180186
43055061	4-羟基苯乳酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055063	4HPA; 4-Hydroxy phenylacetate; 4-hydroxyphenylacetic acid; 4OH-phenylacetate; Chemistry; Hydroxyphenylacetic acid; Level; p-hydroxyphenylacetate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055063	4OH-phenylacetate SerPl-sCnc	4180186
43055063	4-羟基苯乙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055064	G-OH-Butyr CSF-sCnc	4180186
43055064	4-hydroxybutyrate; 4-hydroxybutyric acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Level; Liquidx; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055064	Gamma 羟基丁酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055065	4,5-DiOH-hexanolactone SerPl-sCnc	4180186
43055065	4,5-DHL; 4,5-dihydroxy-hexanoic acid lactone; 4,5-DiOH-hexanolactone; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055065	4,5-二羟基已内酯:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055066	4,5-DHHA; 4,5-dihydroxyhexanoic acid; 4,5-DiOH-hexanoate; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solerol; SR; Substance concentration	4180186
43055066	4,5-DiOH-hexanoate SerPl-sCnc	4180186
43055066	4,5-二羟基已酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055067	Chemistry; Level; Phenylpyruvic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055067	Phenylpyruvate SerPl-sCnc	4180186
43055067	苯丙酮酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055070	3Me-glutarate SerPl-sCnc	4180186
43055070	3Me-glutarate; 3-methylglutaric acid; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055070	3-甲基戊二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055071	3Me-glutaconate; 3-methylglutaconic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055071	3Me-glutaconate CSF-sCnc	4180186
43055071	3-甲基戊烯二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055074	3-Methyladipate SerPl-sCnc	4180186
43055074	Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055074	3-甲基己二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055080	3-HIA; 3-hydroxy-isovalerate; 3-hydroxyisovaleric acid; 3OH-Isovalerate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055080	3OH-Isovalerate CSF-sCnc	4180186
43055080	3-羟基异戊酸:物质的量浓度:时间点:脑脊液:定量型	4182948
43055085	Addiction; Allylbarbital; Allylbarbituric acid; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fiorinal; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055085	Butalbital Sal Cfm-mCnc	4180186
43055085	布他比妥:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055086	Addiction; Amobarb; Amylobarbitone; Amytal; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055086	Amobarbital Sal Cfm-mCnc	4180186
43055086	异戊巴比妥:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055088	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
43055088	Desmin Ab SerPl Ql IB	4180186
43055088	肌间线蛋白 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫印迹法	4182948
43055089	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
43055089	Myosin Ab SerPl Ql IB	4180186
43055089	肌球蛋白 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫印迹法	4182948
43055090	1-pentyl-3-(1-naphthoyl)indole; Addiction; AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-018 4/5OH-pentyl; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055090	JWH-018 4/5OH-pentyl Ur Ql Cfm	4180186
43055090	JWH-018 4+5-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055091	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; III; Illicit; JWH-073 3OH-butyl; JWH-073 N-(3-hydroxybutyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055091	JWH-073 3OH-butyl Ur Ql Cfm	4180186
43055091	JWH-073 3-羟丁基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055092	Addiction; AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-018 N-pentanoate metabolite; JWH-018 N-pentanoic acid metabolite; JWH-018 N-valeric metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055092	JWH-018 pentanoate Ur Ql Cfm	4180186
43055092	JWH-018 戊酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055093	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-200 4OH-indole; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055093	JWH-200 4OH-indole Ur Ql Cfm	4180186
43055093	JWH-200 4-羟基吲哚:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055094	Addiction; AM-2201 4OH-pentyl; AM-2201 N-(4-hydroxypentyl) metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; Synthetic marijuana; UA; UR; Urn; Yucatan Fire	4180186
43055094	AM-2201 4OH-pentyl Ur Ql Cfm	4180186
43055094	AM-2201 4-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055096	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-073 N-Butanoic acid metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055096	JWH-073 butanoate Ur Ql Cfm	4180186
43055096	JWH-073 丁酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055097	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-250 5OH-pentyl; JWH-250 N-(5-hydroxypentyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055097	JWH-250 5OH-pentyl Ur Ql Cfm	4180186
43055097	JWH-250 5-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055099	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; RCS-4 5OH-pentyl; RCS-4 N-(5-hydroxypentyl) metabolite; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055099	RCS-4 5OH-pentyl Ur Ql Cfm	4180186
43055099	RCS-4 5-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055100	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; RCS-4 N-(5-carboxypentyl) metabolite; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055100	RCS-4 5-carboxypentyl Ur Ql Cfm	4180186
43055100	RCS-4 5-羧戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055102	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; UR-144 4/5OH-pentyl; UR-144 N-(4/5-hydroxypentyl) metabolites; UR-144 N-pentanoic acid metabolite; Urn; Yucatan Fire	4180186
43055102	UR-144 4/5OH-pentyl Ur Ql Cfm	4180186
43055102	UR-144 4+5-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055105	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-122 5OH-pentyl; JWH-122 N-(5-hydroxypentyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055105	JWH-122 5OH-pentyl Ur Ql Cfm	4180186
43055105	JWH-122 5-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43055110	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; BKV subtyp; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Typ	4180186
43055110	BKV subtyp SerPl NAA+probe	4180186
43055110	BK 病毒亚型:类型:时间点:血清/血浆:名义型:探针法.基因扩增.靶向	4182948
43055114	Blood; CD142; coagulation factor III (thromboplastin, tissue factor); Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; TF; TFA; Tissue; Tissue, unspecified; transferrin; WB; Whole blood; Whole blood or Tissue	4180186
43055114	TF gene Full Mut Anl Bld/T Seq	4180186
43055114	TF 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
43055116	Chemistry; gamma-4-Androstenedione; Level; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
43055116	Androst Sal-sCnc	4180186
43055116	雄烯二酮:物质的量浓度:时间点:唾液:定量型	4182948
43055121	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
43055121	CMV DNA SerPl NAA+probe-Log IU	4180186
43055121	巨细胞病毒 DNA:对数型任意浓度:时间点:血清/血浆:定量型:探针法.基因扩增.靶向	4182948
43055122	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C parap; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
43055122	C parap DNA Vag Ql NAA+probe	4180186
43055122	近平滑假丝酵母 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
43055125	Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43055125	Tripeptidyl peptidase I DBS-cCnc	4180186
43055125	三肽基肽酶 I:催化浓度:时间点:全血.斑点:定量型	4182948
43055126	#/area; bod; Body; Bowel movement; Chemistry; Faecal; Faeces; Fat bodies.oval; Fat droplets; Fecal; Feces; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
43055126	Oval fat bodies #/area Stl LPF	4180186
43055126	脂肪小体.卵圆形:单位面积数量或计数:时间点:大便:定量型:显微镜检查.光学.低倍视野	4182948
43055127	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; HCY; Hcys; Hcyst; homocysteine; homocystine; Level; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055127	Hcys p fast SerPl-sCnc	4180186
43055127	同型半胱氨酸或同型胱氨酸^在热量型禁食之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055128	Hcys 6h p Met SerPl-sCnc	4180186
43055128	&gt;6h; 6h p Met; After; CHEMISTRY.CHALLENGE TESTING; HCY; Hcys; Hcyst; homocysteine; homocystine; Level; Met; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43055128	同型半胱氨酸或同型胱氨酸^在给予剂量蛋氨酸之后6小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
43055130	ABL; ABL1; ABL1 transcript; AWT1; Blood; control gene; EWS-WT1; Genetics; GUD; Heredity; Heritable; i; II; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NPHS4; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WAGR; WB; Whole blood; Whole blood or Tissue; Wilms tumor 1; WIT-2; WT1 ex 1+2; WT33	4180186
43055130	WT1 ex 1+2/control Bld/T	4180186
43055130	WT1 基因外显子 1+2 转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055132	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E rostratum; E rostratum DNA; H halodes; H rostratum; Helminthosporium halodes; Helminthosporium rostratum; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
43055132	E rostratum DNA Spec Ql NAA+probe	4180186
43055132	嘴突突脐蠕孢 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
43055133	3435C-T; ABC20; ABCB1 c.3435C&gt;T; ATP-binding cassette, sub-family B (MDR/TAP), member 1; Blood; CD243; CLCS; Genetics; GP170; Heredity; Heritable; Inherited; MDR1; MDR-1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; multidrug resistance protein 1; Ordinal; PCR; P-GLYCOPROTEIN 1; P-GP; PGY1; Point in time; PR; QL; Qual; Qualitative; Random; rs1045642; Screen; T prime; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055133	ABCB1 c.3435C>T Bld/T Ql	4180186
43055133	ABCB1 基因.c.3435C>T:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
43055134	Blood; EDTP308; Genetics; Heredity; Heritable; IMAGE3455200; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; MST134; MST576; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; Tissue; Tissue, unspecified; vitamin K epoxide reductase complex, subunit 1; VKCFD2; VKOR; VKORC1 c.1173C&gt;T; WB; Whole blood; Whole blood or Tissue	4180186
43055134	VKORC1 c.1173C>T Bld/T Ql	4180186
43055134	VKORC1 基因.c.1173C>T:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
43055135	BILIQTL1; Blood; Crigler-Najjar syndrome, type I; Genetics; Gilbert Syndrome; GNT1; Heredity; Heritable; HUG-BR1; Inherited; Ma2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs8175347; Screen; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 1 family, polypeptide A1; UDP glycosyltransferase 1 family, polypeptide A1 gene; UDPGT; UDPGT 1-1; UGT1; UGT1A; UGT1A1*28; UGT1A5; WB; Whole blood; Whole blood or Tissue	4180186
43055135	UGT1A1*28 Bld/T Ql	4180186
43055135	UGT1A1 基因.c.A(TA)7TAA(*28):存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
43055138	Blood; CPB6; CYP2B; CYP2B7; CYP2B7P; CYPIIB6; cytochrome P450, family 2, subfamily B, polypeptide 6; Document; EFVM; Finding; Findings; Genetics; Heredity; Heritable; IIB1; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; P450; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055138	CYP2B6 Mut Anl Bld/T	4180186
43055138	CYP2B6 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
43055139	Blood; Document; EDTP308; Finding; Findings; Genetics; Heredity; Heritable; IMAGE3455200; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; MST134; MST576; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; vitamin K epoxide reductase complex, subunit 1; VKCFD2; VKOR; WB; Whole blood; Whole blood or Tissue	4180186
43055139	VKORC1 gene Mut Anl Bld/T	4180186
43055139	VKORC1 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
43055140	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
43055141	疼痛严重程度 - 0-10 口述描绘数字型评级:评分:时间点:^患者:定量型:报告法	4182948
43055141	H+P; H+P.HX; P prime; Pain severity 0-10; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
43055141	Pain severity 0-10 Score Reported	4180186
43055142	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; MPO; MPO - ANCA; Myeloperoxidase ANCA; Ordinal; p-ANCA; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF; Vasculitis	4180186
43055142	Myeloperoxidase IgG SerPl Ql IF	4180186
43055142	髓过氧化物酶 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
43055143	Glucose Bld Strip.auto-sCnc	4180186
43055143	葡萄糖:物质的量浓度:时间点:全血:定量型:试纸条.自动化法	4182948
43055143	Auto; Automated detection; Blood; Chemistry; Dip stick; Dipstick; Elec; Elect; Electr; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; Point in time; Random; SmQn; Substance Concentration; WB; Whole blood	4180186
43055146	Echography; Gestation; Gestations; Gravida; Identity or presence; Nominal; Point in time; Pregnancies; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43055148	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; P prime; pANCA; p-ANCA frmln sens; Perinuclear ANCA; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
43055148	p-ANCA frmln sens IgG SerPl Ql IF	4180186
43055148	p-ANCA 福尔马林敏感型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
43055149	p-ANCA frmln resist IgG SerPl Ql IF	4180186
43055149	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; P prime; pANCA; p-ANCA frmln resist; Perinuclear ANCA; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
43055149	p-ANCA 福尔马林耐受型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
43055151	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
43055151	Myelin Ab SerPl Ql IF	4180186
43055151	髓磷脂 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
43055152	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Isentress; Islt; Isol; MK-0518; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43055152	Raltegravir Islt Genotyp	4180186
43055152	雷特拉韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43055153	ANTIBIOTIC SUSCEPTIBILITIES; AST; EVG; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43055153	Elvitegravir Islt Genotyp	4180186
43055153	埃替格韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43055156	US Axilla-L	4180186
43055156	Ax; Axilla-L; Document; Echography; Finding; Findings; Imaging; L; LT; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Thorax; ULS; Ultrasound; Upper extremity	4180186
43055156	多层:发现:时间点:胸部>腋窝.左侧:文档型:超声	4182948
43055157	Document; Echography; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Jnt; Misc; Miscellaneous; Other; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
43055157	US Guided Joint Inj	4180186
43055157	旨在注射的引导:发现:时间点:XXX>关节:文档型:超声	4182948
43055159	Amb phleb; Cardio; Cardiology; Document; Echography; EXT; Extr v; Extr v-R; Extr-R; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Phlebectomy; Point in time; R; Radiology; Random; RT; Sonogram; Sonograph; Sonography; Stab avulsion; ULS; Ultrasound; Ven; Venous	4180186
43055159	US Guided Extr v-R Amb phleb	4180186
43055159	旨在门诊静脉切除术的引导:发现:时间点:肢体.右侧>肢体静脉:文档型:超声	4182948
43055160	Amb phleb; Cardio; Cardiology; Document; Echography; EXT; Extr v; Extr v-L; Extr-L; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; L; LT; Phlebectomy; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Stab avulsion; ULS; Ultrasound; Ven; Venous	4180186
43055160	US Guided Extr v-L Amb phleb	4180186
43055160	旨在门诊静脉切除术的引导:发现:时间点:肢体.左侧>肢体静脉:文档型:超声	4182948
43055161	US Guided Extr v-R Laser ablation	4180186
43055161	Document; Echography; EXT; Extr v; Extr v-R; Extr-R; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; R; Radiology; Random; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ven; Venous	4180186
43055161	旨在激光消融术的引导:发现:时间点:肢体.右侧>肢体静脉:文档型:超声	4182948
43055163	US Guided Extr vv-Bl Vasc sclerotherapy	4180186
43055163	Bil; Bilat; Both; Document; Echography; EXT; Extr vv-Bl; Extr-Bl; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vasc sclerotherapy	4180186
43055163	旨在血管硬化疗法的引导:发现:时间点:肢体.双侧>肢体静脉类:文档型:超声	4182948
43055164	US Guided Extr v-Bl Vasc sclerotherapy	4180186
43055164	Bil; Bilat; Both; Document; Echography; EXT; Extr v; Extr v-Bl; Extr-Bl; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vasc sclerotherapy; Ven; Venous	4180186
43055164	旨在血管硬化疗法的引导:发现:时间点:肢体.双侧>肢体静脉:文档型:超声	4182948
43055166	Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Periph; PN; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
43055166	RF Guided PN Denerv	4180186
43055166	旨在去神经的引导:发现:时间点:XXX>周围神经:文档型:放射荧光透视法	4182948
43055167	Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Jnt; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Spinal; Spinal Cord; Spine FJ; To be specified in another part of the message; Unspecified; Zygapophysial Joint	4180186
43055167	RF Guided Spine FJ Denerv	4180186
43055167	旨在去神经的引导:发现:时间点:XXX>脊椎小面关节:文档型:放射荧光透视法	4182948
43055168	C/sp; Cerv; C-spine; C-Spine facet joint; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Jnt; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Zygapophysial Joint	4180186
43055168	RF Guided C-Spine facet joint Denerv	4180186
43055168	旨在去神经的引导:发现:时间点:颈部>脊椎.颈段小面关节:文档型:放射荧光透视法	4182948
43055176	Cardio; Cardiology; Cath; Document; Extraction; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; Remove; Spec; To be specified in another part of the message; Tunneled CVC rem; Unspecified; Ven; Venous	4180186
43055176	RF Guided Tunneled CVC rem	4180186
43055176	旨在去除隧道式中心静脉导管的引导:发现:时间点:XXX>静脉:文档型:放射荧光透视法	4182948
43055177	Cardio; Cardiology; Cath; CVC w port repair; CVC W pump repair; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
43055177	RFA Guided Vein CVC W pump repair	4180186
43055177	旨在修复带有输液港或输液泵的中心静脉导管的引导:发现:时间点:XXX>静脉:文档型:放射荧光透视法.血管造影术	4182948
43055179	Abd; Abdo; Abdomen+; Abdominal; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
43055179	RF Guided L-spine Kyphoplasty	4180186
43055179	旨在椎体后凸成形术的引导:发现:时间点:腹部>脊椎.腰段:文档型:放射荧光透视法	4182948
43055180	Document; Dorsal spine; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
43055180	RF Guided T-spine Kyphoplasty	4180186
43055180	旨在椎体后凸成形术的引导:发现:时间点:胸部>脊椎.胸段:文档型:放射荧光透视法	4182948
43055183	IR Prog note	4180186
43055183	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
43055183	病程记录:发现:时间点:{环境}:文档型:介入放射医学	4182948
43055184	ABL; ABL1; ABL1 transcript; Acute promyelocytic leukemia; APL; Blood; breakpoint cluster region 3; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Number ratio; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(q22,q11.2-q12); t(15;17) BCR3; t(15;17)(PML,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
43055184	t(15;17) BCR3/control Bld/T	4180186
43055184	t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055186	ABL; ABL1; ABL1 transcript; Acute promyelocytic leukemia; APL; Blood; breakpoint cluster region 1; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; long form; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Number ratio; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(PML,RARA) gene translocation breakpoint cluster region 1; t(15,17)(q22,q11.2-q12); t(15;17) BCR1; t(15;17)(PML,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
43055186	t(15;17) BCR1/control Bld/T	4180186
43055186	t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055188	21q22.3; ABL; ABL1; ABL1 transcript; Acute lymphoblastic leukaemia; Acute lymphocytic leukemia; Acute myeloid leukemia 1; ALL; AML1; B-cell ALL; B-cell precursor acute lymphoblastic leukemia; BCP ALL; Blood; CBFA2; control gene; DNA; ets variant gene 6; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(12,21)(ETV6,RUNX1) gene translocation; t(12;21)(ETV6,RUNX1); TEL; Tel oncogene; TEL1; Tissue; Tissue, unspecified; translocation; Translocation ets leukemia; WB; Whole blood; Whole blood or Tissue	4180186
43055188	t(12;21)(ETV6,RUNX1)/control Bld/T	4180186
43055188	t(12;21)(p13;q22.3)(ETV6,RUNX1) 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055189	#/area; HEMATOLOGY/CELL COUNTS; Kidney; LM; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urine sediment; Urn; UrnS	4180186
43055189	Lymphocytes #/area UrnS HPF	4180186
43055189	淋巴细胞:单位面积数量或计数:时间点:尿沉渣:定量型:显微镜检查.光学.高倍视野	4182948
43055190	#/area; HEMATOLOGY/CELL COUNTS; Kidney; LM; Macrop; Macrophage; Macros; Macrphg; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urine sediment; Urn; UrnS	4180186
43055190	Macrophages #/area UrnS HPF	4180186
43055190	巨噬细胞:单位面积数量或计数:时间点:尿沉渣:定量型:显微镜检查.光学.高倍视野	4182948
43055194	Congenital dyserythropoietic anaemia; Encounter; Evaluation and management; Evaluation and management note; notes; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Prog note; Progress Nte C-CDA R1.1 Sections; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
43055194	Progress Nte C-CDA R1.1 Sections	4180186
43055194	病程记录 - 推荐 CDA 小节:-:时间点:{环境}:-	4182948
43055198	DIR C-CDA R1.1 Sections	4180186
43055198	Congenital dyserythropoietic anaemia; DIR C-CDA R1.1 Sections; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
43055198	影像学诊断报告 - 推荐 CDA 小节:-:时间点:{环境}:-	4182948
43055199	Consult note C-CDA R1.1 sections	4180186
43055199	Congenital dyserythropoietic anaemia; Consult note; Consult note C-CDA R1.1 sections; Encounter; Evaluation and management; Evaluation and management note; notes; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random; Visit note	4180186
43055199	会诊记录 - 推荐 CDA 小节:-:时间点:{环境}:-	4182948
43055200	CCD C-CDA R1.1 Sections; Congenital dyserythropoietic anaemia; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
43055200	CCD C-CDA R1.1 Sections	4180186
43055200	连续性医疗护理文档 - 推荐 CDA 小节:-:时间点:{环境}:-	4182948
43055201	Mini-Cog Dementia Screen; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
43055203	c; Contr; Contra; Contrst; Distal metatarsals; Document; EXT; Extr-R; Finding; Findings; Imaging; Interphalangeal joints; LE; Leg; LE-R; Low; Metatarsophalangeal Joints; Mitral regurgitation maximum velocity; MRI; Phalanges; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT; Toe; Toes-R; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
43055203	MR Toes-R WO+W contr IV	4180186
43055203	多层^不采用 & 采用静脉注射对比剂:发现:时间点:下肢.右侧>脚趾类:文档型:MR	4182948
43055204	c; Contr; Contra; Contrst; Distal metatarsals; Document; EXT; Extr-R; Finding; Findings; Imaging; Interphalangeal joints; LE; Leg; LE-R; Low; Metatarsophalangeal Joints; Mitral regurgitation maximum velocity; MRI; Phalanges; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT; Toe; Toes-R; without contrast	4180186
43055204	MR Toes-R WO contr	4180186
43055204	多层^不采用对比剂:发现:时间点:下肢.右侧>脚趾类:文档型:MR	4182948
43055206	c; Contr; Contra; Contrst; Distal metatarsals; Document; EXT; Extr-L; Finding; Findings; Imaging; Interphalangeal joints; L; LE; Leg; LE-L; LLE; Low; LT; Metatarsophalangeal Joints; Mitral regurgitation maximum velocity; MRI; Phalanges; Point in time; Rad; RADIOLOGY; Random; Toe; Toes-L; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
43055206	MR Toes-L WO+W contr IV	4180186
43055206	多层^不采用 & 采用静脉注射对比剂:发现:时间点:下肢.左侧>脚趾类:文档型:MR	4182948
43055207	c; Contr; Contra; Contrst; Distal metatarsals; Document; EXT; Extr-L; Finding; Findings; Imaging; Interphalangeal joints; L; LE; Leg; LE-L; LLE; Low; LT; Metatarsophalangeal Joints; Mitral regurgitation maximum velocity; MRI; Phalanges; Point in time; Rad; RADIOLOGY; Random; Toe; Toes-L; without contrast	4180186
43055207	MR Toes-L WO contr	4180186
43055207	多层^不采用对比剂:发现:时间点:下肢.左侧>脚趾类:文档型:MR	4182948
43055208	c; Contr; Contra; Contrst; Distal metatarsals; Document; EXT; Extr-L; Finding; Findings; Imaging; Interphalangeal joints; L; LE; Leg; LE-L; LLE; Low; LT; Metatarsophalangeal Joints; Mitral regurgitation maximum velocity; MRI; Phalanges; Point in time; Rad; RADIOLOGY; Random; Toe; Toes-L; W contr IV; WC	4180186
43055208	MR Toes-L W contr IV	4180186
43055208	多层^采用静脉注射对比剂:发现:时间点:下肢.左侧>脚趾类:文档型:MR	4182948
43055211	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; Document; Enterography; Finding; Findings; Imaging; Mitral regurgitation maximum velocity; MRI; Pelvic; Point in time; Rad; RADIOLOGY; Random; W contr IV; W contr PO; W contr PO+WO+W IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
43055211	MR Abd+Pelvis W contr PO+WO+W IV	4180186
43055211	多层^采用口服对比剂+不采用 & 采用静脉注射对比剂:发现:时间点:腹部+盆腔:文档型:MR	4182948
43055212	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; Document; Enterography; Finding; Findings; Imaging; Mitral regurgitation maximum velocity; MRI; Pelvic; Point in time; Rad; RADIOLOGY; Random; W contr PO; W contr PO+WO IV; WC; without contrast	4180186
43055212	MR Abd+Pelvis W contr PO+WO IV	4180186
43055212	多层^采用口服对比剂+不采用静脉注射对比剂:发现:时间点:腹部+盆腔:文档型:MR	4182948
43055214	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Face; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast	4180186
43055214	CT Face WO contr	4180186
43055214	多层^不采用对比剂:发现:时间点:头部>面骨类:文档型:CT	4182948
43055215	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; SB; Small Intestine; W contr IV; W contr PO; W contrast PO+IV; WC	4180186
43055215	CT SB W contrast PO+IV	4180186
43055215	多层^采用口服对比剂+采用静脉注射对比剂:发现:时间点:腹部>小肠:文档型:CT	4182948
43055221	Abd; Abdo; Abdomen+; Abdominal; Colon transit study; Document; Films; Finding; Findings; Imaging; Mot; Plain Films; Point in time; Rad; RADIOLOGY; Random; View; VWS; W ROMS; Xray; X-ray	4180186
43055221	XR Abd Views for motility W ROMS	4180186
43055221	针对运动功能的多重视图^采用放射线不透性标记:发现:时间点:腹部:文档型:X射线摄影术	4182948
43055223	Malondialdehyde EntSub Plts	4180186
43055223	Chemistry; Entitic substance; MDA; Platelet; Plt; Plts; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes	4180186
43055223	丙二醛:实体物质的量:时间点:血小板:定量型	4182948
43055225	181P; Alzheimer disease; Alzheimer's disease; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Neuro; Neurology; phospho T181; Point in time; PR; Prot; p-tau181; pThr181; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Thr181; threonine 181	4180186
43055225	p-tau181 CSF IA-mCnc	4180186
43055225	Tau 蛋白.磷酸化 181:质量浓度:时间点:脑脊液:定量型:免疫测定法	4182948
43055227	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hemiglobin; Hi; Level; Methaemoglobin; MetHb; Methgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055227	MetHgb CSF-sCnc	4180186
43055227	高铁血红蛋白:物质的量浓度:时间点:脑脊液:定量型	4182948
43055228	OxyHgb CSF-sCnc	4180186
43055228	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Haemoglobin oxygenated; HbO2; Hemoglobin oxygenated; Level; O2Hb; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
43055228	氧合血红蛋白:物质的量浓度:时间点:脑脊液:定量型	4182948
43055233	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; S pyogenes speB; Screen; SDA; Spec; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; streptococcal pyrogenic exotoxin B; Streptococci group A; Streptococcus group A; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
43055233	S pyogenes speB Spec Ql NAA+probe	4180186
43055233	化脓性链球菌外毒素 B speB 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
43055236	Before; c; Chemistry; Contr; Contra; Contrst; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055236	Creat pre contrast SerPl-mCnc	4180186
43055236	肌酐^在对比剂之前:质量浓度:时间点:血清/血浆:定量型	4182948
43055237	Alpha amylase; Ams; Amyl; Amylase+lipase Pnl; Chemistry; Diastase; k87; LIPA; Lipase; LPS; Pan; Pancreatic lipase; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Steapsin; Tributyrase; Tributyrinase	4180186
43055237	Amylase+lipase Pnl SerPl	4180186
43055237	淀粉酶与三酰基甘油脂肪酶组套:-:时间点:血清/血浆:定量型	4182948
43055238	Blood prod order Vol BPU	4180186
43055238	BLOOD BANK; Blood prod order; Blood product unit; Blood Product Unit (Pack); Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
43055238	医嘱所规定的血液制品:体积型属性:时间点:^血液制品单位:定量型	4182948
43055239	ABL; ABL1; ABL1 transcript; Acute promyelocytic leukemia; APL; Blood; control gene; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Number ratio; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(q22,q11.2-q12); t(15;17)(PML,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
43055239	t(15;17)(PML,RARA)/control Bld/T	4180186
43055239	t(15;17)(q24.1;q21.1)(PML,RARA) 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055241	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; FLQ; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M tb; M tuberculosis; Molecular genetics; Mtb; MTB gyrA fluoroquin res mut; Mut; Mutations; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; TB; Tuberculosis	4180186
43055241	MTB gyrA fluoroquin res mut Islt/Spm Ql	4180186
43055241	结核分枝杆菌 gyrA 基因氟喹诺酮耐药性突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43055242	EPS; expressed prostatic secretion; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QL; Qual; Qualitative; Random; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis	4180186
43055242	T vaginalis Prost fld Ql Micro	4180186
43055242	阴道毛滴虫:存在情况或阈值:时间点:前列腺液:序数型:显微镜检查.光学	4182948
43055246	Ds INR range/Ds INR det Patient-Rto	4180186
43055246	Ds INR det; Ds INR range; H&P.HX.LAB; H+P; H+P.HX; Internat norm ratio; International normal ratio; International normalization ratio; International normalized ratio; Lab; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rnge; Rto; Ther	4180186
43055246	INR 治疗窗内天数/已确定 INR 结果的天数:比率:时间点:^患者:定量型	4182948
43055248	Nail assess pnl	4180186
43055248	H+P; Nail assess pnl; Nails; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Ungal nail	4180186
43055248	指甲或趾甲评估组套:-:时间点:甲:-	4182948
43055249	Dermatologic; Epidermis; H+P; Integument; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Skin Assessment Pnl; Skn	4180186
43055249	Skin Assessment Pnl	4180186
43055249	皮肤评估组套:-:时间点:皮肤:-	4182948
43055256	Drain amt device Wnd.exdte	4180186
43055256	Drain; Drain amt device; Drainage Amt; Exud; Exudate; H+P; H+P.PX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Removal of fluid; Volume; Wnd; Wnd.exdte	4180186
43055256	来自装置的引流量:体积型属性:时间点:伤口.渗出物:定量型	4182948
43055257	Wnd Exudate pnl	4180186
43055257	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd; Wnd Exudate pnl	4180186
43055257	伤口渗出物组套:-:时间点:伤口:-	4182948
43055259	Undermining clck Wnd	4180186
43055259	Finding; Findings; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Undermining clck; Wnd	4180186
43055259	潜行钟点位置:发现:时间点:伤口:名义型	4182948
43055262	Finding; Findings; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Tunneling clck; Wnd	4180186
43055262	Tunneling clck Wnd	4180186
43055262	窦道钟点位置:发现:时间点:伤口:名义型	4182948
43055266	Periwnd desc	4180186
43055266	Finding; Findings; H+P; H+P.PX; Nominal; P prime; Periwnd; Periwnd desc; Point in time; Random; Wnd; wound	4180186
43055266	创周描述:发现:时间点:创周:名义型	4182948
43055269	Edge wnd descrp Wnd edge	4180186
43055269	Edge wnd descrp; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Typ; Wnd; Wnd edge	4180186
43055269	创缘描述:类型:时间点:伤口.边缘部位:名义型	4182948
43055271	Nicotinurate SerPl-mCnc	4180186
43055271	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055271	烟碱尿酸:质量浓度:时间点:血清/血浆:定量型	4182948
43055272	Brucella IgG sp2 Titr Ser	4180186
43055272	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; Convalescent; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; Random; Second; Serum; SmQn; sp2; Spec; species; spp; SR; Titer; Titered; Titre; Ttr	4180186
43055272	布鲁氏菌属单个未知种 抗体.IgG^第2个标本:滴定度:时间点:血清:定量型	4182948
43055274	ABL; ABL1; ABL1 transcript; B23; Blood; control gene; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NPM; NPM1 gene mut D; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055274	NPM1 gene mut D/control Bld/T	4180186
43055274	NPM1 基因.c.960insCCTG 转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055275	ABL; ABL1; ABL1 transcript; B23; Blood; control gene; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NPM; NPM1 gene mut B; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055275	NPM1 gene mut B/control Bld/T	4180186
43055275	NPM1 基因.c.960insCATG 转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055276	ABL; ABL1; ABL1 transcript; B23; Blood; control gene; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NPM; NPM1 gene mut A; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055276	NPM1 gene mut A/control Bld/T	4180186
43055276	NPM1 基因.c.956dupTCTG 转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055277	ABL; ABL1; ABL1 transcript; Acute lymphoblastic leukaemia; Acute lymphoblastic leukemia; Acute myeloid leukemia; ALL; AML; Blood; control gene; DNA; E2A Immunoglobulin enhancer binding factors E12/E47; gene fusion; gene translocation; Genetics; Heredity; Heritable; i; Immunoglobulin transcription factor 1; Inherited; ITF1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Non-Hodgkin lymphoma; Number ratio; PBXP1; PCR; Point in time; Pre-B cell leukemia transcription factor-1; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(1;19)(PBX1,TCF3); Tissue; Tissue, unspecified; Transcription factor 3; translocation; WB; Whole blood; Whole blood or Tissue	4180186
43055277	t(1;19)(PBX1,TCF3)/control Bld/T	4180186
43055277	t(1;19)(q23.3;p13.3)(PBX1,TCF3) 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
43055279	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Thallium	4180186
43055279	Th-To IgG SerPl Ql IA	4180186
43055279	Th-To 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
43055281	RNAp III RP155 IgG SerPl Ql IA	4180186
43055281	3; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; Pol III; POL3RA gene; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; RNAp III; RNAp III RP155; RNAp III RP155 Ab; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
43055281	RNA 聚合酶 III RP155 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
43055283	CENP A IgG SerPl Ql IA	4180186
43055283	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cen; CENP A; CENPA; Centromere A Ab; CRST syndrome; EIA; ELFA; ELISA; Enzyme immunoassay; Histone H3-like centromeric protein A; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
43055283	着丝粒蛋白 A 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
43055284	M2-3E IgG Ser Ql IA	4180186
43055284	线粒体 M2-3E 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43055284	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BPO; EIA; ELFA; ELISA; Enzyme immunoassay; Hepatology; IAA; Immune globulin G; Immunoglobulin G; Liver; MEIA; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
43055285	HLA-DP+DQ+DR IgG Ser Ql IA	4180186
43055285	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HLA ANTIGEN; HLA class II; Human Leukocyte Antigen; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43055285	HLA-DP+DQ+DR 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43055289	Eosinophil NFr.DF Bronch Manual	4180186
43055289	Bro; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055289	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:支气管来源的标本:定量型:手工计数方法	4182948
43055290	Bro; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lung; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; WBC; WBCs; White blood cell; White blood cells	4180186
43055290	Lymphocytes NFr.DF Bronch Manual	4180186
43055290	淋巴细胞/白细胞:计数型分数.小数型:时间点:支气管来源的标本:定量型:手工计数方法	4182948
43055291	Bro; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lung; Manl; Neut; Neutr; Neutrophil; Number fraction; PMN; PNM; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; WBC; WBCs; White blood cell; White blood cells	4180186
43055291	Neutrophils NFr.DF Bronch Manual	4180186
43055291	嗜中性粒细胞/白细胞:计数型分数.小数型:时间点:支气管来源的标本:定量型:手工计数方法	4182948
43055292	Mesothl Cell NFr.DF Pcar Manual	4180186
43055292	Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number fraction; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055292	间皮细胞/白细胞:计数型分数.小数型:时间点:心包液:定量型:手工计数方法	4182948
43055293	Macrophages NFr.DF Pcar Manual	4180186
43055293	HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055293	巨噬细胞/白细胞:计数型分数.小数型:时间点:心包液:定量型:手工计数方法	4182948
43055301	Polys NFr.DF Plr Manual	4180186
43055301	Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Pleural; Pleural fluid; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055301	分叶核白细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055302	HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055302	Macrophages NFr.DF Plr Manual	4180186
43055302	巨噬细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055303	Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mononuc; Mononuc Cells; Number fraction; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055303	Mononuc Cells NFr.DF Plr Manual	4180186
43055303	单个核细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055305	Basophils NFr.DF Plr Manual	4180186
43055305	Baso; Basophil; Basos; Bph; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055305	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055306	Eosinophil NFr.DF Plr Manual	4180186
43055306	Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055306	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055307	HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055307	Monocytes NFr.DF Plr Manual	4180186
43055307	单核细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055308	HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lung; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055308	Lymphocytes NFr.DF Plr Manual	4180186
43055308	淋巴细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055309	HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lung; Manl; Neut; Neutr; Neutrophil; Number fraction; Pleural; Pleural fluid; PMN; PNM; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055309	Neutrophils NFr.DF Plr Manual	4180186
43055309	嗜中性粒细胞/白细胞:计数型分数.小数型:时间点:胸膜液:定量型:手工计数方法	4182948
43055310	Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Segmented WBC; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055310	Polys NFr.DF Snv Manual	4180186
43055310	分叶核白细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055311	Macrophages NFr.DF Snv Manual	4180186
43055311	HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055311	巨噬细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055313	HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBC Other; WBCs; White blood cell; White blood cells	4180186
43055313	WBC Other NFr.DF Snv Manual	4180186
43055313	其他白细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055314	Basophils NFr.DF Snv Manual	4180186
43055314	Baso; Basophil; Basos; Bph; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055314	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055318	HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055318	Neutrophils NFr.DF Snv Manual	4180186
43055318	嗜中性粒细胞/白细胞:计数型分数.小数型:时间点:滑液:定量型:手工计数方法	4182948
43055319	Mesothl Cell NFr.DF Prt Manual	4180186
43055319	Ascites; Ascitic fluid; Ascitis; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number fraction; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055319	间皮细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055320	Ascites; Ascitic fluid; Ascitis; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Peritoneal fluid; PMN; Point in time; Poly; Polys; Prt; QNT; Quan; Quant; Quantitative; Random; Segmented WBC; WBC; WBCs; White blood cell; White blood cells	4180186
43055320	Polys NFr.DF Prt Manual	4180186
43055320	分叶核白细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055322	Mononuc Cells NFr.DF Prt Manual	4180186
43055322	Ascites; Ascitic fluid; Ascitis; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mononuc; Mononuc Cells; Number fraction; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055322	单个核细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055324	Ascites; Ascitic fluid; Ascitis; Baso; Basophil; Basos; Bph; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055324	Basophils NFr.DF Prt Manual	4180186
43055324	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055325	Eosinophil NFr.DF Prt Manual	4180186
43055325	Ascites; Ascitic fluid; Ascitis; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055325	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055327	Ascites; Ascitic fluid; Ascitis; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055327	Lymphocytes NFr.DF Prt Manual	4180186
43055327	淋巴细胞/白细胞:计数型分数.小数型:时间点:腹膜液:定量型:手工计数方法	4182948
43055330	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055330	Unspecified Cells NFr.DF Fld Manual	4180186
43055330	未详细说明的细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055331	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; NOS AB; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Unident Cells; WBC; WBCs; White blood cell; White blood cells	4180186
43055331	Unident Cells NFr.DF Fld Manual	4180186
43055331	未经确认的细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055334	Macrophages NFr.DF Fld Manual	4180186
43055334	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055334	巨噬细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055335	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055335	Promyelocytes NFr.DF Fld Manual	4180186
43055335	早幼粒细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055336	Metamyelocytes NFr.DF Fld Manual	4180186
43055336	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055336	晚幼粒细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055338	B/F; Bands; BF; bnd; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055338	Neuts Band NFr.DF Fld Manual	4180186
43055338	嗜中性粒细胞.带状核/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055341	Monocytes NFr.DF Fld Manual	4180186
43055341	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
43055341	单核细胞/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055343	Neuts Seg NFr.DF Fld Manual	4180186
43055343	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs; WBC; WBCs; White blood cell; White blood cells	4180186
43055343	嗜中性粒细胞.分叶型/白细胞:计数型分数.小数型:时间点:体液:定量型:手工计数方法	4182948
43055344	Macrophages NFr.DF CSF Manual	4180186
43055344	Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055344	巨噬细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055345	Plasma Cells NFr.DF CSF Manual	4180186
43055345	Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myeloma cells; Number fraction; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055345	浆细胞类/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055346	Promyelocytes NFr.DF CSF Manual	4180186
43055346	Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055346	早幼粒细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055348	Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055348	Metamyelocytes NFr.DF CSF Manual	4180186
43055348	晚幼粒细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055350	Neuts Band NFr.DF CSF Manual	4180186
43055350	Bands; bnd; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055350	嗜中性粒细胞.带状核/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055351	Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neuro; Neurology; Neut; Neutr; Neutrophil; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055351	Neutrophils NFr.DF CSF Manual	4180186
43055351	嗜中性粒细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055352	Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055352	Monocytes NFr.DF CSF Manual	4180186
43055352	单核细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055353	Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Neuro; Neurology; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055353	Lymphocytes NFr.DF CSF Manual	4180186
43055353	淋巴细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055354	Eosinophil NFr.DF CSF Manual	4180186
43055354	Cerebral spinal fluid; Cerebrospinal Fl; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055354	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055355	Baso; Basophil; Basos; Bph; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
43055355	Basophils NFr.DF CSF Manual	4180186
43055355	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:脑脊液:定量型:手工计数方法	4182948
43055357	Basket cells; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055357	Smudge Cells NFr.DF Bld Manual	4180186
43055357	涂抹细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055358	Atypical lymphocytes; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive lymphocytes; Variant lymphocytes; Variant Lymphs; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055358	Variant Lymphs NFr.DF Bld Manual	4180186
43055358	淋巴细胞.异型/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055359	Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055359	Promyelocytes NFr.DF Bld Manual	4180186
43055359	早幼粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055361	Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055361	Metamyelocytes NFr.DF Bld Manual	4180186
43055361	晚幼粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055362	Blast; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055362	Blasts NFr.DF Bld Manual	4180186
43055362	幼稚细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055366	Lymphocytes NFr.DF Bld Manual	4180186
43055366	Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055366	淋巴细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:手工计数方法	4182948
43055371	Lymphocytes NFr.DF Bld Auto	4180186
43055371	Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055371	淋巴细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:自动化计数方法	4182948
43055372	Eosinophil NFr.DF Bld Auto	4180186
43055372	Auto; Automated detection; Blood; Elec; Elect; Electr; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055372	嗜酸性粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:自动化计数方法	4182948
43055373	Basophils NFr.DF Bld Auto	4180186
43055373	Auto; Automated detection; Baso; Basophil; Basos; Blood; Bph; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43055373	嗜碱性粒细胞/白细胞:计数型分数.小数型:时间点:全血:定量型:自动化计数方法	4182948
43055381	Cannabinoids.synthetic	4180186
43055392	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Intelence; Islt; Isol; Pheno; Phenotype; Phenotypic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TMC125; Virtual Phenotype	4180186
43055392	Etravirine Islt Phenotyp	4180186
43055392	依曲韦林:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
43055394	HIV INI Susc Pnl Islt Genotyp	4180186
43055394	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HIV INI Susc Pnl; Human immunodeficiency virus; Inhib; Inhibit; INI; Islt; Isol; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pnl; Point in time; Random; Sus; Susc; Suscept; Susceptibilities; Susceptibilty	4180186
43055394	HIV 整合酶抑制剂敏感性组套:-:时间点:分离株:-:基因分型	4182948
43055396	Cardio; Cardiology; Chemistry; CK; CK 3; CK MM; CK-MM; CPK; Creatine phosphokinase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Heart Disease; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
43055396	CK MM CFr.DF SerPl Elph	4180186
43055396	肌酸激酶.MM 型/肌酸激酶总计:催化分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055397	Cardio; Cardiology; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Heart Disease; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
43055397	CK MB CFr.DF SerPl Elph	4180186
43055397	肌酸激酶.MB 型/肌酸激酶总计:催化分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055398	Calc; Calculation; Cardio; Cardiology; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Heart Disease; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
43055398	CK MB CFr.DF SerPl Calc	4180186
43055398	肌酸激酶.MB 型/肌酸激酶总计:催化分数.小数型:时间点:血清/血浆:定量型:计算法	4182948
43055399	Chemistry; CK; CK 1; CK BB; CK-BB; CPK; Creatine phosphokinase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Neuro; Neurology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
43055399	CK BB CFr.DF SerPl Elph	4180186
43055399	肌酸激酶.BB 型/肌酸激酶总计:催化分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055401	Acylcholine acylhydrolase; BChE; Benzoyl cholinesterase; Benzoylcholinesterase; Butyrylcholine esterase; Che; Chemistry; Choline esterase II; CHS; Pl; Plasma; Plsm; Point in time; Pseudocho; Pseudocholinesterase; QNT; Quan; Quant; Quantitative; Random; RO 020683 number; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055401	RO 020683 Inhib/CHe CFr.DF SerPl	4180186
43055401	胆碱酯酶.RO 020683 抑制型/胆碱酯酶:催化分数.小数型:时间点:血清/血浆:定量型	4182948
43055402	Acylcholine acylhydrolase; BChE; Benzoyl cholinesterase; Benzoylcholinesterase; Butyrylcholine esterase; Che; Chemistry; Choline esterase II; CHS; Fl; Fluoride number; Pl; Plasma; Plsm; Point in time; Pseudocho; Pseudocholinesterase; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055402	Fluoride Inhib/CHe CFr.DF SerPl	4180186
43055402	胆碱酯酶.氟化物抑制型/胆碱酯酶:催化分数.小数型:时间点:血清/血浆:定量型	4182948
43055408	1 day; 24 hours; 24HR; Chemistry; Copro; Coproporph; Coproporphyrins; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; Tot; Totl; UA; UR; Urn	4180186
43055408	Copro 24h SFr.DF Ur	4180186
43055408	粪卟啉/卟啉.总计:物质的量分数.小数型:24小时:尿液:定量型	4182948
43055409	bbPRL; Big-big prolactin; Chemistry; IgG-bound Prolactin; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055409	Macroprolactin/Prolactin MFr.DF SerPl	4180186
43055409	巨催乳素/催乳素:质量分数.小数型:时间点:血清/血浆:定量型	4182948
43055410	PSA Free MFr.DF SerPl	4180186
43055410	Chemistry; fPSA; FR; Kallikrein 3; Non-protein bound; P-30 antigen; Pl; Plasma; Plsm; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Tot; Totl; Tumor marker	4180186
43055410	前列腺特异性抗原.游离型/前列腺特异性抗原.总计:质量分数.小数型:时间点:血清/血浆:定量型	4182948
43055414	1 day; 24 hours; 24HR; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; PEUR; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055414	Gamma glob 24h MFr.DF Ur Elph	4180186
43055414	Gamma 球蛋白/蛋白质.总计:质量分数.小数型:24小时:尿液:定量型:电泳	4182948
43055415	Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; PEUR; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055415	Gamma glob MFr.DF Ur Elph	4180186
43055415	Gamma 球蛋白/蛋白质.总计:质量分数.小数型:时间点:尿液:定量型:电泳	4182948
43055418	1 day; 24 hours; 24HR; B; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; PEUR; PR; Prot; Protein beta globulin; QNT; Quan; Quant; Quantitative; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055418	B-Globulin 24h MFr.DF Ur Elph	4180186
43055418	Beta 球蛋白/蛋白质.总计:质量分数.小数型:24小时:尿液:定量型:电泳	4182948
43055419	B-Globulin MFr.DF Ur Elph	4180186
43055419	B; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; PEUR; Point in time; PR; Prot; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055419	Beta 球蛋白/蛋白质.总计:质量分数.小数型:时间点:尿液:定量型:电泳	4182948
43055422	1 day; 24 hours; 24HR; A2; Alfa; Alpha2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; PEUR; PR; Prot; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055422	Alpha2 Glob 24h MFr.DF Ur Elph	4180186
43055422	Alpha 2 球蛋白/蛋白质.总计:质量分数.小数型:24小时:尿液:定量型:电泳	4182948
43055423	Alpha2 Glob MFr.DF Ur Elph	4180186
43055423	A2; Alfa; Alpha2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; PEUR; Point in time; PR; Prot; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
43055423	Alpha 2 球蛋白/蛋白质.总计:质量分数.小数型:时间点:尿液:定量型:电泳	4182948
43055428	A1; Alfa; Alpha1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP	4180186
43055428	Alpha1 Glob MFr.DF SerPl Elph	4180186
43055428	Alpha 1 球蛋白/蛋白质.总计:质量分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055429	A1; Alfa; Alpha1 Glob; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Neuro; Neurology; Point in time; PR; Prot; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; TP	4180186
43055429	Alpha1 Glob MFr.DF CSF Elph	4180186
43055429	Alpha 1 球蛋白/蛋白质.总计:质量分数.小数型:时间点:脑脊液:定量型:电泳	4182948
43055432	Albumin MFr.DF SerPl Elph	4180186
43055432	Alb; Albumin fraction; Albumin%; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP	4180186
43055432	白蛋白/蛋白质.总计:质量分数.小数型:时间点:血清/血浆:定量型:电泳	4182948
43055433	Alb; Albumin fraction; Albumin%; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Neuro; Neurology; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; TP	4180186
43055433	Albumin MFr.DF CSF Elph	4180186
43055433	白蛋白/蛋白质.总计:质量分数.小数型:时间点:脑脊液:定量型:电泳	4182948
43055435	B-OH-Butyr+Acetoacet pre-meal Bld-sCnc	4180186
43055435	3-hydroxybutyrate; 3-hydroxybutyric acid; 3-ketobutyrate; 3-oxobutyric acid; AcAc; Acetoacetates; Acetoacetic acid; B; Before; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; Beta-ketobutyrate; BHB; Blood; BOHB; B-OH-Butyr; B-OH-Butyr+Acetoacet; CHEMISTRY.CHALLENGE TESTING; Diacetate; Diacetic acid; Hydroxybutyric acid; Ketone body ratio; Level; oxobutyrate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055435	Beta 羟基丁酸+乙酰乙酸^在进餐之前:物质的量浓度:时间点:全血:定量型	4182948
43055436	3-hydroxybutyrate; 3-hydroxybutyric acid; 3-ketobutyrate; 3-oxobutyric acid; AcAc; Acetoacetates; Acetoacetic acid; After; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; Beta-ketobutyrate; BHB; Blood; BOHB; B-OH-Butyr; B-OH-Butyr+Acetoacet; CHEMISTRY.CHALLENGE TESTING; Diacetate; Diacetic acid; Hydroxybutyric acid; Ketone body ratio; Level; oxobutyrate; p meal; PC; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055436	B-OH-Butyr+Acetoacet p meal Bld-sCnc	4180186
43055436	Beta 羟基丁酸+乙酰乙酸^在进餐之后:物质的量浓度:时间点:全血:定量型	4182948
43055437	3-hydroxybutyrate; 3-hydroxybutyric acid; 3-ketobutyrate; 3-oxobutyric acid; AcAc; Acetoacetates; Acetoacetic acid; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; Beta-ketobutyrate; BHB; Blood; BOHB; B-OH-Butyr; B-OH-Butyr+Acetoacet; Chemistry; Diacetate; Diacetic acid; Hydroxybutyric acid; Ketone body ratio; Level; oxobutyrate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43055437	B-OH-Butyr+Acetoacet Bld-sCnc	4180186
43055437	Beta 羟基丁酸+乙酰乙酸:物质的量浓度:时间点:全血:定量型	4182948
43055438	270 min; 4 1/2 hours; 4.5h p 75 g Glc PO; 75Gm; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
43055438	Insulin 4.5h p 75 g Glc PO SerPl-aCnc	4180186
43055438	胰岛素^在口服75 g葡萄糖之后4.5小时:任意型浓度:时间点:血清/血浆:定量型	4182948
43055441	C&S; Cult; Cultures; GBS; Genital vaginal; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rectal; S agalactiae; Screen; Spec; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
43055441	Gp B Strep Vag+Rectum Ql Cult	4180186
43055441	无乳链球菌:存在情况或阈值:时间点:阴道+直肠:序数型:微生物特异性培养	4182948
43055443	Addiction; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; NSAIDs; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055443	NSAIDs SerPl Ql Scn	4180186
43055443	非甾体抗炎药物:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
43055444	Addiction; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Stesolid; Valium	4180186
43055444	diazePAM Sal Cfm-mCnc	4180186
43055444	安定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055446	DRUG/TOXICOLOGY; Drugs; Niravam; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen; Xanax	4180186
43055446	Alpraz Sal Ql	4180186
43055446	阿普唑仑:存在情况或阈值:时间点:唾液:序数型	4182948
43055447	Oxazepam Sal Cfm-mCnc	4180186
43055447	Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Sal; Serax; Temazepam metabolite	4180186
43055447	去甲羟安定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055451	Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Napsalgesic; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn	4180186
43055451	Propoxyph Sal Ql Scn	4180186
43055451	丙氧氨酚:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
43055453	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; n-desmethylproproxyphene; Norpropoxyp; Oral fluid; Point in time; Propoxyphene metabolite; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055453	Norpropoxyph Sal-mCnc	4180186
43055453	去甲基丙氧氨酚:质量浓度:时间点:唾液:定量型	4182948
43055456	Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Napsalgesic; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055456	Propoxyph Sal Ql	4180186
43055456	丙氧氨酚:存在情况或阈值:时间点:唾液:序数型	4182948
43055458	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xarelto	4180186
43055458	Rivaroxaban SerPl-mCnc	4180186
43055458	利伐沙班:质量浓度:时间点:血清/血浆:定量型	4182948
43055459	Dabigatran SerPl-mCnc	4180186
43055459	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pradax; Pradaxa; Prazaxa; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055459	达比加群:质量浓度:时间点:血清/血浆:定量型	4182948
43055462	Barbiturate; c417; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Luminal; Nirvonal; Oral fluid; Ordinal; PHBR; Phenobarb; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055462	Phenobarb Sal Ql Cfm	4180186
43055462	苯巴比妥:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055464	Addiction; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Nembutal; Oral fluid; Ordinal; Pentobarb; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055464	Pentobarb Sal Ql Cfm	4180186
43055464	戊巴比妥:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055466	Addiction; Allylbarbital; Allylbarbituric acid; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fiorinal; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
43055466	Butalbital Sal Ql Cfm	4180186
43055466	布他比妥:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
43055467	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn	4180186
43055467	Benzodiaz Sal Ql Scn	4180186
43055467	苯并二氮:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
43055470	Borderline Symptom List - Supplement; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
43055473	1 week; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH; Took medication not prescribed	4180186
43055474	1 week; Borderline Symptom List - Supplement; Drug; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055476	US Guided Extr vv-R Vasc sclerotherapy	4180186
43055476	Document; Echography; EXT; Extr vv-R; Extr-R; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; R; Radiology; Random; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vasc sclerotherapy	4180186
43055476	旨在血管硬化疗法的引导:发现:时间点:肢体.右侧>肢体静脉类:文档型:超声	4182948
43055477	Document; Echography; EXT; Extr vv-L; Extr-L; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vasc sclerotherapy	4180186
43055477	US Guided Extr vv-L Vasc sclerotherapy	4180186
43055477	旨在血管硬化疗法的引导:发现:时间点:肢体.左侧>肢体静脉类:文档型:超声	4182948
43055480	Alb; Alb Pcar; Alb Ser; albumin gradient; Albumin ser-peric fld; Cardio; Cardiology; Chemistry; Heart Disease; MCDiff; Pcar; Pericard fld+SerPl; Pericardial Fluid; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055480	Albumin ser-peric fld-MCDiff	4180186
43055480	白蛋白.血清-白蛋白.心包液:质量浓度差:时间点:心包液+血清/血浆:定量型	4182948
43055481	Alb; Alb Ser; albumin gradient; Albumin ser-plr fld; Chemistry; MCDiff; Pl; Plasma; Pleural; Pleural fluid; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Ser; SerP; SerPl; SerPl+Plr; SerPlas; Serum; Serum or plasma; SR; thoracentesis fluid	4180186
43055481	Albumin ser-plr fld-MCDiff	4180186
43055481	白蛋白.血清-白蛋白.胸膜液:质量浓度差:时间点:血清/血浆+胸膜液:定量型	4182948
43055482	Chemistry; Glu; Gluc; Gluc.synv fld; glucose gradient; Glucose ser - synv fld; Glucoseur; Joint aspirate; Joint fld; Joint flu; Joint fluid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SCDiff; Ser; SerP; SerPl; SerPl+Synv; SerPlas; Serum; Serum or plasma; SF; SNV; SR; Syn; Syn fl; Synov; Synovial fluid	4180186
43055482	Glucose ser - synv fld-SCDiff	4180186
43055482	葡萄糖.血清-葡萄糖.滑液:物质的量浓度差:时间点:血清/血浆+滑液:定量型	4182948
43055486	Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Narrative; Point in time; Random; Report; Subtelomere.q arm; Tissue; Tissue, unspecified; Upper extremity; WB; Whole blood; Whole blood or Tissue	4180186
43055486	Subtelomere.q arm Bld/T FISH-Imp	4180186
43055486	亚端粒分析.长臂:印象:时间点:全血/组织:叙述型:FISH	4182948
43055488	Amplification; Blood; Del; Del+Dup; Deletions; Dp; Fluorescent in situ hybridization; Genetics; HCERN3; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Nominal; Point in time; Prader Willi syndrome; PWCR; PWS; Random; RT-LI; small nuclear ribonucleoprotein polypeptide N; SM-D; SMN; sm-N; SNRNP-N; SNRPN 15q11; SNRPN 15q11 del+dup; SNURF-SNRPN; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055488	SNRPN 15q11 Del+Dup Bld/T FISH	4180186
43055488	SNRPN 基因 15q11 缺失+重复:存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43055489	Aldolase RBC-cCnt	4180186
43055489	Catalytic Content; Chemistry; Erythrocytes; Fructose Aldolase; Fructose Biphosphate Aldolase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
43055489	醛缩酶:催化含量:时间点:红细胞:定量型	4182948
43055491	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PA; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Procan; Pronestyl; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055491	Procainamide Trough SerPl-mCnc	4180186
43055491	普鲁卡因胺^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055496	Extrnsc coag fctr act pnl PPP	4180186
43055496	Activ; Actvty; Coag; Extrnsc coag fctr act pnl; Fac; Fact; Movements; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; Random	4180186
43055496	外源性凝血因子活性 4 项组套:-:时间点:贫血小板血浆:-	4182948
43055497	BPGM RBC-cCnt	4180186
43055497	BPGM; Catalytic Content; Chemistry; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
43055497	二磷酸甘油酸变位酶:催化含量:时间点:红细胞:定量型	4182948
43055500	Alodorm; APODORM; AREM; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; Imeson; Insoma; Ipersed; Level; Mass concentration; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Remnos; Serenade; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somnibel n; Somniper; Somnite; SR; Surem	4180186
43055500	Nitrazepam Trough SerPl-mCnc	4180186
43055500	硝基安定^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055503	Antidepressant; Bolvidon; Depnon; DRUG/TOXICOLOGY; Drugs; Lantanon; Lerivon; Level; Lumin; Mass concentration; Norval; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tolvon	4180186
43055503	Mianserin Trough SerPl-mCnc	4180186
43055503	米安舍林^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055504	Mtnphs+3MT+Creat pnl Ur	4180186
43055504	3Me-tyramine; CR; Crea; Creat; Creat Pnl; Dopamine metabolite; DRUG/TOXICOLOGY; Drugs; III; Metaneph; Metaneph+Normetaneph; Metanephrine fractionated; Metanephrines panel; Metanephrne; Metenephrine; Mtnphs+3MT+Creat pnl; Normeta; Normetaneph; Normetanephrn; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UCr; UR; Urn	4180186
43055504	间甲肾上腺素, 去甲间肾上腺素, 3-甲氧酪氨酸和肌酐组套:-:时间点:尿液:-	4182948
43055506	Desyrel; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trazon; Trialodine	4180186
43055506	traZODone Trough SerPl-mCnc	4180186
43055506	曲唑酮^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055507	Aminophylline; Biophyllin; Continus; DRUG/TOXICOLOGY; Drugs; Lasma; Level; Mass concentration; Nuelin; Phyllocontin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Pro-vent; QNT; Quan; Quant; Quantitative; Random; Sabidal SR; SerP; SerPl; SerPlas; Serum; Serum or plasma; Slo-Phyllin; Somophyllin; Somophylline; SR; Theo; Theo-dur; Theolair; Uniphyllin	4180186
43055507	Theophylline Trough SerPl-mCnc	4180186
43055507	茶碱^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055509	Sotalol Trough SerPl-mCnc	4180186
43055509	Beta-cardone; Betapace; Betudes; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solalex; Sotacor; SR	4180186
43055509	索他洛尔^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055512	文拉法辛+O-去甲基文拉法辛^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43055512	Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; Level; Mass concentration; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Pristiq; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Venlafaxin; Venlafaxine metabolite; Vnlfxn+ODV	4180186
43055512	Vnlfxn+ODV Trough SerPl-mCnc	4180186
43055513	1 day; 24 hours; 24HR; Acd; Acids; Bile acid.total; Bile salt; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate	4180186
43055513	Bile Ac 24h Stl-sRate	4180186
43055513	胆汁酸:物质的量速率:24小时:大便:定量型	4182948
43055514	bbPRL; Big-big prolactin; Chemistry; IgG-bound Prolactin; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055514	Macroprolactin SerPl Ql	4180186
43055514	巨催乳素:存在情况或阈值:时间点:血清/血浆:序数型	4182948
43055515	1 week; Borderline Symptom List - Supplement; Finding; Findings; High risk behavior; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055519	1 week; Borderline Symptom List - Supplement; Finding; Findings; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH; Told people going to kill self	4180186
43055521	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055523	Borderline Symptom List - 23 item; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
43055525	1 week; Arterial Stenosis; Borderline Symptom List - 23 item; Felt far from self; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055527	Big IGF-II SerPl-mCnc	4180186
43055527	2; Big big IGF2; Big big IGF-2; Big IGF2; Big IGF-2; Big IGF-II; Chemistry; Fac; Fact; Factor 2; FII; HMW; HUM; Humulin; IGF; IGF2; IGF-II; IH7; Insul; Lente; Level; Mass concentration; NPH; Pl; Plasma; Plsm; Point in time; pro-IGF2-(E1-21); QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente; Wt	4180186
43055527	胰岛素样生长因子-II.高分子量:质量浓度:时间点:血清/血浆:定量型	4182948
43055528	Activ; Actvty; Acylcholine acylhydrolase; BChE; Benzoyl cholinesterase; Benzoylcholinesterase; Butyrylcholine esterase; Che; Chemistry; Choline esterase II; Cholinesterase actvty pnl; CHS; Movements; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Pseudocho; Pseudocholinesterase; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43055528	Cholinesterase actvty pnl SerPl	4180186
43055528	胆碱酯酶活性组套:-:时间点:血清/血浆:-	4182948
43055529	RBC enzy pnl RBC	4180186
43055529	Chemistry; Discocyte; Enz; Enzymes; Erc; Erythrocytes; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; RBC; RBC enzy pnl; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
43055529	红细胞酶组套:-:时间点:红细胞:-	4182948
43055530	Blood; FPN1; Genetics; Heredity; Heritable; HFE4; Identity or presence; Inherited; IREG1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MST079; MSTP079; MTP1; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; SLC11A3; solute carrier family 40 (iron-regulated transporter), member 1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055530	SLC40A1 Mut Anl Bld/T	4180186
43055530	SLC40A1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43055532	1 week; Afraid losing control; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055535	1 week; Borderline Symptom List - 23 item; Felt vulnerable 1W; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055537	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055538	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Rapidly cycled mood; Screen; Survey; SURVEY.MTLHLTH	4180186
43055539	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Suffered shame; Survey; SURVEY.MTLHLTH	4180186
43055540	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; Punish self; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055541	1 week; Borderline Symptom List - 23 item; Finding; Findings; Hated self; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055542	1 week; Afraid of images; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055544	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055546	1 week; Borderline Symptom List - 23 item; Didn't trust people; Finding; Findings; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH; T prime	4180186
43055547	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH; Thought of hurting self	4180186
43055549	1 week; Absent minded; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055550	1 week; Borderline Symptom List - 23 item; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
43055552	Borderline Symptom List - Supplement; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH; Sx	4180186
43055553	Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.MTLHLTH; Sx	4180186
43055554	Base ex; Base ex.oxy; BE; Blood - capillary; BSE; Calc; Calculation; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; EXS; Finger stick; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SBE; std; Substance Concentration	4180186
43055554	Base ex.oxy std BldC Calc-sCnc	4180186
43055554	碱剩余.100% 氧合^^标准:物质的量浓度:时间点:毛细血管全血:定量型:计算法	4182948
43055555	ABE; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Base ex; Base ex.oxy; BE; Blood arterial; BSE; Calc; Calculation; Chemistry; EXS; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SBE; std; Substance Concentration	4180186
43055555	Base ex.oxy std BldA Calc-sCnc	4180186
43055555	碱剩余.100% 氧合^^标准:物质的量浓度:时间点:动脉全血:定量型:计算法	4182948
43055558	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Evening; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; PM-SCL75; PM-SCL-75; Point in time; Polymyositis; PR; QL; Qual; Qualitative; Random; Scleroderma; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Systemic Sclerosis	4180186
43055558	PM-SCL75 IgG SerPl Ql IA	4180186
43055558	PM-SCL-75 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
43055559	Blood; DNA; Fluorescent in situ hybridization; gene fusion; gene translocation; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Nominal; Point in time; Random; RNA; T prime; t(11;14)(MYEOV,IGH); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
43055559	t(11;14)(MYEOV,IGH) Bld/T FISH	4180186
43055559	t(11;14)(q13.2;q32)(MYEOV,IGH) 融合转录物:存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43055560	Blood; DNA; Fluorescent in situ hybridization; gene fusion; gene translocation; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Nominal; Point in time; Random; RNA; T prime; t(4;14)(FGFR3,IGH); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
43055560	t(4;14)(FGFR3,IGH) Bld/T FISH	4180186
43055560	t(4;14)(p16;q32)(FGFR3,IGH) 融合转录物:存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43055561	Blood; Chronic lymphocytic leukemia; CLL; Del(13)(q14)+del(17)(p13); Molecular pathology; MOLPATH; Pan; Panel; Panel.molpath; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055561	Del(13)(q14)+del(17)(p13) Bld/T	4180186
43055561	Del(13)(q14) 与 del(17)(p13):-:时间点:全血/组织:-	4182948
43055562	Blood; Chronic lymphocytic leukemia; CLL; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055562	Del(13)(q14) Bld/T FISH	4180186
43055562	Del(13)(q14):存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43055563	7-OH-mitragynine/Creat Ur	4180186
43055563	7-hydroxy mitragynine; 7-OH-mitragynine; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Kratom; Mass concentration ratio; Mass ratio; MCRto; Mitragynine hydroxyindolenine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055563	7-羟基帽柱碱/肌酐:质量比率:时间点:尿液:定量型	4182948
43055564	Mitragynine/Creat Ur	4180186
43055564	7-hydroxymitragynine; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Kratom; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055564	帽柱碱/肌酐:质量比率:时间点:尿液:定量型	4182948
43055566	7-hydroxymitragynine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Kratom; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055566	Mitragynine Ur Cfm-mCnc	4180186
43055566	帽柱碱:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055568	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; METD; Methadose; MTD; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Scn; Scr; Scrn	4180186
43055568	Methadone Sal Scn-mCnc	4180186
43055568	美沙酮:质量浓度:时间点:唾液:定量型:毒理学筛查试验	4182948
43055573	Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Oral fluid; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Sal; Stilny; Tranxilium N; Vegesan	4180186
43055573	Nordiazepam Sal Cfm-mCnc	4180186
43055573	去甲基安定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055575	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Tramadol metabolite	4180186
43055575	Nortramadol Sal Cfm-mCnc	4180186
43055575	去甲基曲马多:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055577	Normeperidine Sal Cfm-mCnc	4180186
43055577	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Meperidine metabolite; Norpethidine; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055577	去甲基哌替啶:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055578	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydrocodone metabolite; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055578	Norhydrocodone Sal Cfm-mCnc	4180186
43055578	去甲基氢可酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055580	Addiction; Buprenorphine metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; NBU; norBUP; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055580	Norbuprenorphine Sal Cfm-mCnc	4180186
43055580	去甲基丁丙诺啡:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055581	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Tramadol metabolite	4180186
43055581	N-nortramadol Sal Cfm-mCnc	4180186
43055581	N-去甲基曲吗多:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055583	Addiction; Algil; Alodan; Centralgine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Pethidine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055583	Meperidine Sal Cfm-mCnc	4180186
43055583	哌替啶:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055584	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Lortab; Mass concentration; Oral fluid; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Vicodin	4180186
43055584	oxyCODONE Sal Cfm-mCnc	4180186
43055584	羟考酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055587	Addiction; Anexsia; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Vicodin	4180186
43055587	HYDROcodone Sal Cfm-mCnc	4180186
43055587	氢可酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055588	Addiction; Ativan; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055588	LORazepam Sal Cfm-mCnc	4180186
43055588	氯羟安定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055589	clonazePAM Sal Cfm-mCnc	4180186
43055589	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055589	氯硝安定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055590	Alpraz Sal Cfm-mCnc	4180186
43055590	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Niravam; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Xanax	4180186
43055590	阿普唑仑:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055592	Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Speed	4180186
43055592	Amphet Sal Cfm-mCnc	4180186
43055592	苯丙胺:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055593	Addiction; c260; C300; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Methylmorphine; Morphine methyl ether; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055593	Codeine Sal Cfm-mCnc	4180186
43055593	可待因:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055594	Actiq; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Sublimaze	4180186
43055594	fentaNYL Sal Cfm-mCnc	4180186
43055594	芬太尼:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055596	Addiction; BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; GCMS; Illicit; Level; Mass concentration; Norspan; Oral fluid; Point in time; PotentialForAbuse; Prefin; QNT; Quan; Quant; Quantitative; Random; Sal; Suboxone; Subutex; Temgesic	4180186
43055596	Buprenorphine Sal Cfm-mCnc	4180186
43055596	丁丙诺啡:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055597	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin metabolite; Illicit; Level; MAM; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055597	6MAM Sal Cfm-mCnc	4180186
43055597	6-单乙酰吗啡:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055599	Addiction; Angel dust; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; PCP; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Sernylan	4180186
43055599	PCP Sal Cfm-mCnc	4180186
43055599	苯环利定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055600	14-Hydroxydihydromorphinone; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Numorphan; Numorphone; Opana; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
43055600	oxyMORphone Sal Cfm-mCnc	4180186
43055600	羟吗啡酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
43055602	Zolpidem phenyl-4-carb Ur Cfm-mCnc	4180186
43055602	Adormix; Ambien; Ambien CR; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Damixan; DRUG/TOXICOLOGY; Drugs; Edluar; GCMS; Hypnogen; Ivedal; Level; Lioran; Mass concentration; Myslee; Nasen; Nytamel; Point in time; QNT; Quan; Quant; Quantitative; Random; Sanval; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist	4180186
43055602	唑吡坦 苯基-4-羧酸酯:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055605	Adormix; Ambien; Ambien CR; CR; Crea; Creat; Damixan; DRUG/TOXICOLOGY; Drugs; Edluar; Hypnogen; Ivedal; Lioran; Mass concentration ratio; Mass ratio; MCRto; Myslee; Nasen; Nytamel; Point in time; QNT; Quan; Quant; Quantitative; Random; Sanval; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UCr; UR; Urn; Zoldem; Zolpihexal; Zolpimist	4180186
43055605	Zolpidem/Creat Ur	4180186
43055605	唑吡坦/肌酐:质量比率:时间点:尿液:定量型	4182948
43055606	O-去甲基文拉法新:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055606	ODV Ur Cfm-mCnc	4180186
43055606	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Point in time; Pristiq; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Venlafaxine metabolite	4180186
43055607	O-去甲基文拉法新/肌酐:质量比率:时间点:尿液:定量型	4182948
43055607	CR; Crea; Creat; Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Point in time; Pristiq; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Venlafaxine metabolite	4180186
43055607	ODV/Creat Ur	4180186
43055609	Venlafaxine/Creat Ur	4180186
43055609	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Venlafaxin	4180186
43055609	文拉法辛/肌酐:质量比率:时间点:尿液:定量型	4182948
43055626	Human reference sequence assembly release number	4180186
43055638	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-073 N-Butanoic acid metabolite; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055638	JWH-073 butanoate Ur Cfm-mCnc	4180186
43055638	JWH-073 丁酸:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055639	JWH-073 butanoate/Creat Ur	4180186
43055639	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; JWH-073 N-Butanoic acid metabolite; K2; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UCr; UR; Urn; Yucatan Fire	4180186
43055639	JWH-073 丁酸/肌酐:质量比率:时间点:尿液:定量型	4182948
43055640	Addiction; AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-018 N-pentanol metabolite; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055640	JWH-018 pentanol Ur Cfm-mCnc	4180186
43055640	JWH-018 戊醇:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055641	AM-678; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; JWH-018 N-pentanol metabolite; K2; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UCr; UR; Urn; Yucatan Fire	4180186
43055641	JWH-018 pentanol/Creat Ur	4180186
43055641	JWH-018 戊醇/肌酐:质量比率:时间点:尿液:定量型	4182948
43055642	Addiction; AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-018 N-pentanoate metabolite; JWH-018 N-pentanoic acid metabolite; JWH-018 N-valeric metabolite; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055642	JWH-018 pentanoate Ur Cfm-mCnc	4180186
43055642	JWH-018 戊酸:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055644	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055644	PARoxetine Ur Cfm-mCnc	4180186
43055644	帕罗西汀:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055646	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nicotine metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
43055646	Cotinine Ur Scn-mCnc	4180186
43055646	可铁宁:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
43055647	6-Beta naltrexol; 6B-Naltrexone; Addiction; B; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Naltrexone metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Revia; UA; UR; Urn; Vivitrol	4180186
43055647	Deprecated 6B-Naltrexone Ur Cfm-mCnc	4180186
43055648	6-Beta naltrexol; 6B-Naltrexone; B; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Naltrexone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Revia; UA; UCr; UR; Urn; Vivitrol	4180186
43055648	Deprecated 6B-Naltrexone/Creat Ur	4180186
43055649	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Revia; UA; UCr; UR; Urn; Vivitrol	4180186
43055649	Naltrexone/Creat Ur	4180186
43055649	纳曲酮/肌酐:质量比率:时间点:尿液:定量型	4182948
43055653	3,4-Methylenedioxy-N-Methylcathinone; Addiction; Bath salts; bk-MDMA; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; M1; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055653	Methylone Ur Cfm-mCnc	4180186
43055653	亚甲基双氧甲基卡西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055654	3,4-Methylenedioxy-N-Methylcathinone; Bath salts; bk-MDMA; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; M1; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055654	Methylone/Creat Ur	4180186
43055654	亚甲基双氧甲基卡西酮/肌酐:质量比率:时间点:尿液:定量型	4182948
43055657	Addiction; Bath salts; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; MDPV; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055657	MDPV Ur Cfm-mCnc	4180186
43055657	亚甲基二氧吡咯戊酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055662	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-250 N-(5-carboxypentyl) metabolite; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43055662	JWH-250 5-carboxypentyl Ur Cfm-mCnc	4180186
43055662	JWH-250 5-羧戊基:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055664	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH-210 carboxypentyl; JWH-210 N-(5-carboxypentyl) metabolite; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055664	JWH-210 carboxypentyl Ur Cfm-mCnc	4180186
43055664	JWH-210 5-羧戊基:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055667	JWH-073 carboxylated/Creat Ur	4180186
43055667	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; K2; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UCr; UR; Urn; Yucatan Fire	4180186
43055667	JWH-073 羧基化/肌酐:质量比率:时间点:尿液:定量型	4182948
43055670	Gabapentin Ur Cfm-mCnc	4180186
43055670	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Horizant; Level; Mass concentration; Neurontin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055670	加巴喷丁:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055671	Gabapentin/Creat Ur	4180186
43055671	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Horizant; Mass concentration ratio; Mass ratio; MCRto; Neurontin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055671	加巴喷丁/肌酐:质量比率:时间点:尿液:定量型	4182948
43055672	(S)-Norfluoxetine; CR; Crea; Creat; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; Mass concentration ratio; Mass ratio; MCRto; Norfluoxetin; Point in time; QNT; Quan; Quant; Quantitative; Random; Seproxetine; UA; UCr; UR; Urn	4180186
43055672	Norfluoxetine/Creat Ur	4180186
43055672	去甲基氟西汀/肌酐:质量比率:时间点:尿液:定量型	4182948
43055673	FLUoxetine/Creat Ur	4180186
43055673	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
43055673	氟西汀/肌酐:质量比率:时间点:尿液:定量型	4182948
43055674	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Cymbalta; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Yentreve	4180186
43055674	DULoxetine Ur Cfm-mCnc	4180186
43055674	度洛西汀:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055675	DULoxetine/Creat Ur	4180186
43055675	CR; Crea; Creat; Cymbalta; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Yentreve	4180186
43055675	度洛西汀/肌酐:质量比率:时间点:尿液:定量型	4182948
43055676	DOPamine Ur Cfm-mCnc	4180186
43055676	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43055676	多巴胺:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055677	Addiction; AM-2201 4OH-pentyl; AM-2201 N-(4-hydroxypentyl) metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; Synthetic marijuana; UA; UR; Urn; Yucatan Fire	4180186
43055677	AM-2201 4OH-pentyl Ur Cfm-mCnc	4180186
43055677	AM-2201 4-羟戊基:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43055679	APAP/Creat Ur	4180186
43055679	ACET; Acetamidophenol; Acetaminoph; Acetominophen; APAP; c209; C55; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Hydroxyacetanilide; Mass concentration ratio; Mass ratio; MCRto; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; QNT; Quan; Quant; Quantitative; Random; Tylenol; u209; UA; UCr; UR; Urn	4180186
43055679	对乙酰氨基酚/肌酐:质量比率:时间点:尿液:定量型	4182948
43055682	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; Etx; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m224; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rm224; S aureus; S aureus Etx; S aureus Etx D; S aureus Etx D gene; Screen; SDA; Spec; St a SED; Staph; Staphylococcal enterotoxin; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
43055682	S aureus Etx D gene Spec Ql NAA+probe	4180186
43055682	金黄色葡萄球菌肠毒素 D sed 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
43055684	Blood; Chronic lymphocytic leukemia; CLL; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43055684	Del(17)(p13) Bld/T FISH	4180186
43055684	Del(17)(p13):存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43055685	Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; PCP; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Sernylan; UA; UR; Urn	4180186
43055685	PCP Ur Scn-mCnc	4180186
43055685	苯环利定:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
43055686	CLIN; Ethnicity; Nominal; Point in time; Random; Typ	4180186
43055686	种族:类型:时间点:^患者:名义型:OMB.1997	4182948
43055687	Acute lymphoblastic leukaemia; ALL; Blood; dic(9;20)(wcp9+,wcp20+); Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; whole chromosome paint	4180186
43055687	dic(9;20)(wcp9+,wcp20+) Bld/T FISH	4180186
43055687	dic(9;20)(p11-13;q11)(wcp9+,wcp20+):存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43055688	C trac; C trach; C trach+GC; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT + NG DNA; CT/GC; CT+NG DNA Pnl; Deoxyribonucleic acid; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; N gonorrhoea; N gonorrhoeae; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Trachoma; Unspecified	4180186
43055688	CT+NG DNA Pnl Spec	4180186
43055688	沙眼衣原体与淋病奈瑟菌 DNA 组套:-:时间点:XXX:-	4182948
43055690	Influenza virus A & B Ag	4180186
43055691	Axilla.left	4180186
43055717	ABCB1 gene.c.3435C>T	4180186
43055727	NPM1 gene.c.960insCATG transcript	4180186
43055728	NPM1 gene.c.956dupTCTG transcript	4180186
43055730	Glucose.serum-glucose.plr fld	4180186
43055731	Glucose.serum-glucose.perition fld	4180186
43055732	Glucose.serum-glucose.synv fld	4180186
43055733	Glucose.serum-glucose.pericard fld	4180186
43055790	VKORC1 gene.c.1173C>T	4180186
43055793	CYP3A5 gene.c.6986A>G(*3)	4180186
43055794	UGT1A1 gene.c.A(TA)7TAA(*28)	4180186
43055812	Del(13)(q14) & del(17)(p13)	4180186
43530606	Sequela of traumatic intracranial hemorrhage (disorder)	4180186
43530606	Sequela of traumatic intracranial haemorrhage	4180186
43530607	Musculocutaneous nerve paralysis	4180186
43530607	Musculocutaneous nerve palsy (disorder)	4180186
43530609	Postoperative neuroma of upper limb (disorder)	4180186
43530611	Paralytic syndrome of both lower limbs as sequela of stroke (disorder)	4180186
43530611	Paraplegia or paraparesis as sequela of stroke	4180186
43530614	Lipomyelomeningocele (disorder)	4180186
43530616	Drug induced central sleep apnoea	4180186
43530616	Drug induced central sleep apnea (disorder)	4180186
43530618	Common peroneal neuropathy at the fibular head (disorder)	4180186
43530620	Oral lesion (finding)	4180186
43530621	Acute postoperative pain (finding)	4180186
43530622	Chronic neck pain (finding)	4180186
43530624	Psychosocial dysfunction due to chronic pain (finding)	4180186
43530626	Simple partial seizure (disorder)	4180186
43530627	History of embolic stroke without deficits (situation)	4180186
43530628	Intractable simple partial epilepsy (disorder)	4180186
43530629	Chronic vertigo (finding)	4180186
43530630	Chronic sacral pain for greater than three months (finding)	4180186
43530631	Chronic pain in coccyx for more than three months (finding)	4180186
43530632	Non infant excessive crying (finding)	4180186
43530634	History of tobacco use (situation)	4180186
43530635	History of melanoma in situ of skin (situation)	4180186
43530636	Spontaneous caroticocavernous sinus fistula (disorder)	4180186
43530638	History of primary malignant neoplasm of testis (situation)	4180186
43530647	Lesion of skin of face (disorder)	4180186
43530648	New daily persistent headache (disorder)	4180186
43530653	Skin ulcer associated with type II diabetes mellitus	4180186
43530653	Skin ulcer associated with type II diabetes mellitus (disorder)	4180186
43530656	Nonproliferative retinopathy due to type 2 diabetes mellitus (disorder)	4180186
43530656	Nonproliferative diabetic retinopathy due to type II diabetes mellitus	4180186
43530656	Nonproliferative diabetic retinopathy due to type 2 diabetes mellitus	4180186
43530657	Diabetic peripheral neuropathy associated with Type 1 diabetes mellitus (disorder)	4180186
43530657	Diabetic peripheral neuropathy associated with type I diabetes mellitus	4180186
43530657	Diabetic peripheral neuropathy associated with type I diabetes mellitus (disorder)	4180186
43530658	History of primary malignant neoplasm of larynx (situation)	4180186
43530660	Mixed hyperlipidaemia due to type 1 diabetes mellitus	4180186
43530660	Mixed hyperlipidemia due to type 1 diabetes mellitus (disorder)	4180186
43530662	Epidural empyema (disorder)	4180186
43530664	Dementia of the Alzheimer type with behavioural disturbance	4180186
43530664	Dementia of the Alzheimer type with behavioral disturbance (disorder)	4180186
43530667	History of haemorrhagic stroke with hemiparesis	4180186
43530667	History of hemorrhagic stroke with hemiparesis (situation)	4180186
43530669	Ischemic stroke with coma (disorder)	4180186
43530669	Ischaemic stroke with coma	4180186
43530674	Spontaneous cerebellar hemorrhage (disorder)	4180186
43530674	Spontaneous cerebellar haemorrhage	4180186
43530675	Exposure to tuberculosis (event)	4180186
43530677	Exposure to streptococcal pharyngitis (event)	4180186
43530677	Exposure to Streptococcal pharyngitis (event)	4180186
43530678	History of bilateral breast implants (situation)	4180186
43530679	Apraxia as late effect of cerebrovascular disease (disorder)	4180186
43530680	Drug dependence in remission (disorder)	4180186
43530685	Proliferative diabetic retinopathy due to type II diabetes mellitus	4180186
43530685	Proliferative retinopathy due to type 2 diabetes mellitus (disorder)	4180186
43530685	Proliferative retinopathy with type 2 diabetes mellitus	4180186
43530689	Peripheral neuropathy with type 2 diabetes	4180186
43530689	Peripheral neuropathy due to type 2 diabetes mellitus (disorder)	4180186
43530690	Foot ulcer due to type II diabetes mellitus	4180186
43530690	Ulcer of foot due to type 2 diabetes mellitus (disorder)	4180186
43530690	Ulcer of foot due to type 2 diabetes mellitus	4180186
43530692	Nocturia due to benign prostatic hypertrophy (finding)	4180186
43530694	Metastasis to liver from adenocarcinoma (disorder)	4180186
43530697	Metastasis to lymph node from squamous cell carcinoma (disorder)	4180186
43530698	Sprain of ankle grade II (disorder)	4180186
43530698	Ankle sprain 2nd degree	4180186
43530698	Sprain of ankle, second degree	4180186
43530699	Sprain of ankle grade I (disorder)	4180186
43530699	Sprain of ankle, first degree	4180186
43530699	Ankle sprain 1st degree	4180186
43530700	Chronic obstructive airway disease with asthma (disorder)	4180186
43530701	Acute disseminated encephalomyelitis following infectious disease (disorder)	4180186
43530702	Monoplegia of leg dominant side as sequela of cerebrovascular disease (disorder)	4180186
43530707	Paraneoplastic peripheral neuropathy (disorder)	4180186
43530710	Hydrocephalus due to Arnold Chiari malformation type 2 (disorder)	4180186
43530711	Premature - gestation of 35-36 weeks (disorder)	4180186
43530714	Sensory disorder of smell and/or taste (disorder)	4180186
43530715	Sleep-wake schedule disorder, delayed phase	4180186
43530715	Sleepwake schedule disorder, delayed phase	4180186
43530715	Sleep-wake schedule disorder, delayed phase (disorder)	4180186
43530717	Meningeal adhesions (disorder)	4180186
43530719	Incomplete paraplegia (disorder)	4180186
43530720	Acquired pseudoporencephaly (disorder)	4180186
43530725	Intraspinal epidural granuloma (disorder)	4180186
43530728	Spontaneous subacute subdural haemorrhage	4180186
43530728	Subacute non-traumatic intracranial subdural hemorrhage (disorder)	4180186
43530728	Subacute non-traumatic intracranial subdural haemorrhage	4180186
43530728	Spontaneous subacute subdural hemorrhage	4180186
43530729	Sensation of burning or prickling of skin (finding)	4180186
43530730	Ataxic hemiparesis (disorder)	4180186
43530732	Sequela of lacunar stroke (disorder)	4180186
43530734	Refractory generalised convulsive epilepsy	4180186
43530734	Refractory generalized convulsive epilepsy (disorder)	4180186
43530735	History of malignant melanoma of the skin (situation)	4180186
43530735	History of - malignant melanoma of the skin (situation)	4180186
43530737	Laryngeal dystonia (disorder)	4180186
43530738	Disruptions of 24 hour sleep-wake cycle (disorder)	4180186
43530740	Ocular torticollis (disorder)	4180186
43530740	Ocular torticolis	4180186
43530741	Cystic malformation of posterior fossa (disorder)	4180186
43530741	Posterior fossa cystic anomaly	4180186
43530743	Degeneration of macula due to cyst or hole (disorder)	4180186
43530744	Weakness of face muscles as sequela of stroke (disorder)	4180186
43530746	Facial neuralgia (finding)	4180186
43530747	Steroid therapy for foetal lung maturation	4180186
43530747	Steroid therapy for fetal lung maturation (procedure)	4180186
43530748	Maternal antenatal administration of corticosteroids for fetal lung maturation (situation)	4180186
43530748	Maternal antenatal administration of corticosteroids for foetal lung maturation	4180186
43530749	Behavior disorder as sequela of cerebral infarction (disorder)	4180186
43530749	Behaviour disorder as sequela of cerebral infarction	4180186
43530750	Bacteremia caused by Gram-negative bacteria (finding)	4180186
43530750	Bacteraemia caused by Gram-negative bacteria	4180186
43530750	Bacteremia due to Gram-negative bacteria	4180186
43530750	Bacteraemia due to Gram-negative bacteria	4180186
43530751	Sleep disturbance in infancy (disorder)	4180186
43530755	History of MI less than 8 weeks	4180186
43530755	History of myocardial infarction in last eight weeks (situation)	4180186
43530758	History of allergy to bee venom	4180186
43530758	History of bee sting allergy (situation)	4180186
43530759	First generalised onset seizure	4180186
43530759	First generalized onset seizure (disorder)	4180186
43530760	Daily headache (disorder)	4180186
43530763	Endoscopic laser surgery on stomach	4180186
43530763	Endoscopic surgical procedure on stomach using laser (procedure)	4180186
43530763	Endoscopic laser therapy of stomach	4180186
43530767	Endoscopic injection of small intestine for control of hemorrhage (procedure)	4180186
43530767	Endoscopic injection of small intestine for control of haemorrhage	4180186
43530768	Microscopic examination of specimen from bone marrow for parasites (procedure)	4180186
43530769	Microscopic examination of specimen from operative wound for parasites	4180186
43530769	Microscopic examination of specimen from surgical wound for parasites (procedure)	4180186
43530773	Laparoscopic right oophorectomy after prior left oophorectomy (procedure)	4180186
43530777	Microscopic examination of blood specimen (procedure)	4180186
43530779	Microscopic cytologic examination of smear of stool specimen prepared using Papanicolaou technique (procedure)	4180186
43530780	Percutaneous thrombolysis of vein of transplanted pancreas using fluoroscopic guidance (procedure)	4180186
43530781	Pericardial cyst (disorder)	4180186
43530783	Cyst of Endolimax nana (organism)	4180186
43530783	Cyst of Endolimax nana	4180186
43530785	Microscopic cytologic examination of specimen from bladder (procedure)	4180186
43530786	Microscopic cytologic examination of specimen from female genital tract (procedure)	4180186
43530787	Microscopic cytologic examination of specimen from nervous system (procedure)	4180186
43530789	Microscopic cytologic examination of semen specimen (procedure)	4180186
43530791	Microscopic cytologic examination of specimen from prostate (procedure)	4180186
43530792	Microscopic cytologic examination cerebrospinal fluid specimen (procedure)	4180186
43530793	Microscopic cytologic examination of sputum specimen (procedure)	4180186
43530795	Microscopic cytologic examination of urine specimen (procedure)	4180186
43530796	Angioplasty of penile artery using fluoroscopic guidance with contrast (procedure)	4180186
43530796	Angioplasty of penile artery using fluoroscopic guidance with contrast	4180186
43530797	Fluoroscopic angiography of penile artery with contrast and insertion of stent (procedure)	4180186
43530797	Fluoroscopic arteriography of penile artery with contrast and insertion of stent	4180186
43530798	Revision of dacryocystorhinostomy (procedure)	4180186
43530799	Education about probiotic therapy (procedure)	4180186
43530800	Endoscopic bilateral occlusion of fallopian tubes using intrafallopian implants (procedure)	4180186
43530800	Endoscopic bilateral occlusion of fallopian tubes using intrafallopian implants	4180186
43530800	Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants	4180186
43530802	Endoscopic occlusion of remaining left fallopian tube using intrafallopian implant (procedure)	4180186
43530804	Entrapment of extraocular muscle (disorder)	4180186
43530805	Larva of Strongyloides stercoralis	4180186
43530805	Larva of Strongyloides stercoralis (organism)	4180186
43530807	Allergic disposition (finding)	4180186
43530807	Allergy	4180186
43530809	Map category value (foundation metadata concept)	4180186
43530810	Extended map from SNOMED CT	4180186
43530810	Extended map from SNOMED CT type reference set (foundation metadata concept)	4180186
43530810	Extended map from SNOMED CT type reference set	4180186
43530810	Extended map type reference set (foundation metadata concept)	4180186
43530811	Endoplasmic reticulum related to cell surface (cell structure)	4180186
43530811	Endoplasmic reticulum related to cell surface	4180186
43530814	Superficial injury of lower leg without infection (disorder)	4180186
43530815	Traumatic injury by site (disorder)	4180186
43530816	Infected insect bite by site (disorder)	4180186
43530818	Superficial incisional surgical site infection (disorder)	4180186
43530821	Infected superficial injury, by site (disorder)	4180186
43530822	Surgical incision	4180186
43530822	Operative incision	4180186
43530822	Surgical incision wound (morphologic abnormality)	4180186
43530823	Episiotomy wound (morphologic abnormality)	4180186
43530825	Disrupted laceration wound site (morphologic abnormality)	4180186
43530828	Abrasion and/or friction burn of lower leg with infection (disorder)	4180186
43530830	Escherichia coli serotype O1:nonmotile (organism)	4180186
43530830	E. coli serotype O1:nonmotile	4180186
43530831	E. coli serotype O127:H6	4180186
43530831	Escherichia coli serotype O127:H6 (organism)	4180186
43530837	Abrasion and/or friction burn of upper limb without infection (disorder)	4180186
43530839	E. coli serotype O167:nonmotile	4180186
43530839	Escherichia coli serotype O167:nonmotile (organism)	4180186
43530841	Frankl behavioral rating scale (assessment scale)	4180186
43530841	Frankl behavioural rating scale	4180186
43530843	Frankl behavioral rating negative (finding)	4180186
43530843	Frankl behavioural rating negative	4180186
43530845	Infected foreign body by site (disorder)	4180186
43530846	Abscess of lower leg (disorder)	4180186
43530847	Angulation deformity of lower leg (finding)	4180186
43530849	Bowing deformity of lower leg (finding)	4180186
43530850	Angulation deformity of lower limb (finding)	4180186
43530851	Chronic non-traumatic intracranial subdural hemorrhage (disorder)	4180186
43530851	Chronic non-traumatic intracranial subdural haemorrhage	4180186
43530852	Monochloramine (substance)	4180186
43530852	Chloramine	4180186
43530859	Structure of subdivision of somatic nerve plexus (body structure)	4180186
43530861	Entire nerve plexus (body structure)	4180186
43530866	At risk for dental caries (finding)	4180186
43530867	At low risk for dental caries (finding)	4180186
43530869	At high risk for dental caries (finding)	4180186
43530869	High caries risk subject	4180186
43530872	Nonallergic hypersensitivity condition	4180186
43530872	Pseudoallergic condition	4180186
43530872	Non-allergic hypersensitivity condition (finding)	4180186
43530873	Pseudoallergic reaction	4180186
43530873	Non-allergic hypersensitivity reaction (disorder)	4180186
43530874	Immune hypersensitivity reaction by mechanism (disorder)	4180186
43530876	Necrosis of anatomical site (disorder)	4180186
43530877	Traumatic and/or non-traumatic injury of anatomical site (disorder)	4180186
43530879	Finding suspected or known present (situation)	4180186
43530885	Suspected foetal damage from maternal toxoplasmosis	4180186
43530885	Suspected fetal damage from maternal toxoplasmosis (situation)	4180186
43530888	Suspected foetal damage from radiation	4180186
43530888	Suspected fetal damage from radiation (situation)	4180186
43530891	Suspected fetal damage from maternal drug use (situation)	4180186
43530891	Suspected foetal damage from maternal drug use	4180186
43530892	Suspected fetal damage from maternal listeriosis (situation)	4180186
43530892	Suspected foetal damage from maternal listeriosis	4180186
43530895	Concept model reference set (foundation metadata concept)	4180186
43530899	Fetal damage from maternal toxoplasmosis (disorder)	4180186
43530899	Foetal damage from maternal toxoplasmosis	4180186
43530901	Drug withdrawal syndrome in neonate of dependent mother (disorder)	4180186
43530901	Drug withdrawal syndrome in infant of dependent mother	4180186
43530903	Foetal or neonatal effect of breech delivery	4180186
43530903	Fetal or neonatal effect of breech delivery (disorder)	4180186
43530905	Influenza A virus subtype H7N9 (organism)	4180186
43530909	Induced termination of pregnancy complicated by delayed and/or excessive haemorrhage	4180186
43530909	Induced termination of pregnancy complicated by delayed and/or excessive hemorrhage (disorder)	4180186
43530909	Termination of pregnancy complicated by delayed and/or excessive haemorrhage	4180186
43530909	Termination of pregnancy complicated by delayed and/or excessive hemorrhage	4180186
43530910	Termination of pregnancy complicated by genital-pelvic infection	4180186
43530910	Induced termination of pregnancy complicated by genital-pelvic infection (disorder)	4180186
43530911	Induced termination of pregnancy complicated by metabolic disorder (disorder)	4180186
43530911	Termination of pregnancy complicated by metabolic disorder	4180186
43530913	Induced termination of pregnancy complicated by acute necrosis of liver (disorder)	4180186
43530915	Termination of pregnancy complicated by afibrinogenaemia	4180186
43530915	Induced termination of pregnancy complicated by afibrinogenaemia	4180186
43530915	Termination of pregnancy complicated by afibrinogenemia	4180186
43530915	Induced termination of pregnancy complicated by afibrinogenemia (disorder)	4180186
43530916	Termination of pregnancy complicated by air embolism	4180186
43530916	Induced termination of pregnancy complicated by air embolism (disorder)	4180186
43530917	Induced termination of pregnancy complicated by blood-clot embolism (disorder)	4180186
43530917	Termination of pregnancy complicated by blood-clot embolism	4180186
43530918	Induced termination of pregnancy complicated by cardiac arrest and/or failure (disorder)	4180186
43530918	Termination of pregnancy complicated by cardiac arrest and/or failure	4180186
43530920	Induced termination of pregnancy complicated by defibrination syndrome (disorder)	4180186
43530920	Termination of pregnancy complicated by defibrination syndrome	4180186
43530923	Termination of pregnancy complicated by intravascular hemolysis	4180186
43530923	Induced termination of pregnancy complicated by intravascular haemolysis	4180186
43530923	Termination of pregnancy complicated by intravascular haemolysis	4180186
43530923	Induced termination of pregnancy complicated by intravascular hemolysis (disorder)	4180186
43530926	Termination of pregnancy complicated by laceration of uterus	4180186
43530926	Induced termination of pregnancy complicated by laceration of uterus (disorder)	4180186
43530928	Induced termination of pregnancy complicated by acute renal failure with oliguria (disorder)	4180186
43530929	Induced termination of pregnancy complicated by parametritis (disorder)	4180186
43530929	Termination of pregnancy complicated by parametritis	4180186
43530930	Induced termination of pregnancy complicated by perforation of bowel (disorder)	4180186
43530930	Termination of pregnancy complicated by perforation of bowel	4180186
43530931	Induced termination of pregnancy complicated by perforation of cervix (disorder)	4180186
43530931	Termination of pregnancy complicated by perforation of cervix	4180186
43530936	Induced termination of pregnancy complicated by salpingitis (disorder)	4180186
43530936	Termination of pregnancy complicated by salpingitis	4180186
43530939	Termination of pregnancy complicated by sepsis	4180186
43530939	Induced termination of pregnancy complicated by sepsis (disorder)	4180186
43530942	Induced termination of pregnancy complicated by septicaemia	4180186
43530942	Induced termination of pregnancy complicated by septicemia (disorder)	4180186
43530942	Termination of pregnancy complicated by septicaemia	4180186
43530942	Termination of pregnancy complicated by septicemia	4180186
43530943	Induced termination of pregnancy complicated by soap embolism (disorder)	4180186
43530943	Termination of pregnancy complicated by soap embolism	4180186
43530945	Induced termination of pregnancy complicated by urinary tract infection (disorder)	4180186
43530945	Termination of pregnancy complicated by urinary tract infection	4180186
43530946	Induced termination of pregnancy without complication	4180186
43530946	Induced termination of pregnancy without complication (disorder)	4180186
43530947	Termination of pregnancy complicated by tetanus	4180186
43530947	Induced termination of pregnancy complicated by tetanus (disorder)	4180186
43530949	Sprain of ankle, third degree	4180186
43530949	Ankle sprain 3rd degree	4180186
43530949	Sprain of ankle grade III (disorder)	4180186
43530951	Postpartum venous complication	4180186
43530951	Puerperal venous complication	4180186
43530951	Venous complication of puerperium (disorder)	4180186
43530955	Induced termination of pregnancy complicated by perforation of broad ligament (disorder)	4180186
43530959	Induced termination of pregnancy complicated by broad ligament damage (disorder)	4180186
43530961	Induced termination of pregnancy complicated by cardiac failure (disorder)	4180186
43530962	Induced termination of pregnancy complicated by cervix damage (disorder)	4180186
43530964	Induced termination of pregnancy complicated by infectious disease (disorder)	4180186
43530965	Induced termination of pregnancy complicated by periurethral tissue damage (disorder)	4180186
43530968	Induced termination of pregnancy complicated by vaginal damage (disorder)	4180186
43530969	Epithelioid trophoblastic tumour	4180186
43530969	Epithelioid trophoblastic tumor (disorder)	4180186
43530972	Gestational trophoblastic disease (morphologic abnormality)	4180186
43530973	Persistent gestational trophoblastic disease	4180186
43530973	Persistent trophoblastic disease	4180186
43530973	Gestational trophoblastic neoplasia (disorder)	4180186
43530976	Disorder of extraembryonic membrane (disorder)	4180186
43530977	Structure of embryo proper	4180186
43530977	Structure of embryo proper (body structure)	4180186
43530977	Embryo proper	4180186
43530978	Entire embryo proper (body structure)	4180186
43530981	Acquired heterotopic structure (morphologic abnormality)	4180186
43530983	Common peroneal neuropathy at lateral popliteal branch (disorder)	4180186
43530985	Pentastarch allergy	4180186
43530985	Pseudoallergy to pentastarch	4180186
43530985	Non-allergic hypersensitivity to pentastarch (finding)	4180186
43530985	Nonallergic hypersensitivity to pentastarch	4180186
43530985	Pentastarch pseudoallergy	4180186
43530986	Losartan allergy	4180186
43530986	Pseudoallergy to losartan	4180186
43530986	Losartan pseudoallergy	4180186
43530986	Nonallergic hypersensitivity to losartan	4180186
43530986	Non-allergic hypersensitivity to losartan (finding)	4180186
43530987	Hetastarch allergy	4180186
43530987	Nonallergic hypersensitivity to hetastarch	4180186
43530987	Non-allergic hypersensitivity to hetastarch (finding)	4180186
43530987	Pseudoallergy to hetastarch	4180186
43530987	Hetastarch pseudoallergy	4180186
43530989	Cilazapril allergy	4180186
43530989	Non-allergic hypersensitivity to cilazapril (finding)	4180186
43530989	Pseudoallergy to cilazapril	4180186
43530989	Nonallergic hypersensitivity to cilazapril	4180186
43530989	Cilazapril pseudoallergy	4180186
43530991	Lisinopril pseudoallergy	4180186
43530991	Pseudoallergy to lisinopril	4180186
43530991	Non-allergic hypersensitivity to lisinopril (finding)	4180186
43530991	Nonallergic hypersensitivity to lisinopril	4180186
43530991	Lisinopril allergy	4180186
43530992	Perindopril allergy	4180186
43530992	Nonallergic hypersensitivity to perindopril	4180186
43530992	Non-allergic hypersensitivity to perindopril (finding)	4180186
43530992	Perindopril pseudoallergy	4180186
43530992	Pseudoallergy to perindopril	4180186
43530993	Rampiril pseudoallergy	4180186
43530993	Ramipril allergy	4180186
43530993	Nonallergic hypersensitivity to ramipril	4180186
43530993	Pseudoallergy to ramipril	4180186
43530993	Non-allergic hypersensitivity to ramipril (finding)	4180186
43530995	Aspartame pseudoallergy	4180186
43530995	Aspartame allergy	4180186
43530995	Non-allergic hypersensitivity to aspartame (finding)	4180186
43530995	Pseudoallergy to aspartame	4180186
43530995	Nonallergic hypersensitivity to aspartame	4180186
43530997	History of angiotensin converting enzyme inhibitor pseudoallergy (situation)	4180186
43530997	History of angiotensin converting enzyme inhibitor pseudoallergy	4180186
43531004	Hereditary essential tremor (disorder)	4180186
43531005	Mitempfindung	4180186
43531005	Distant referral of tactile sensation (finding)	4180186
43531007	Pre-existing diabetes mellitus in pregnancy (disorder)	4180186
43531009	Pregnancy and type 1 diabetes mellitus (disorder)	4180186
43531012	MODY3	4180186
43531012	Maturity-onset diabetes of the young, type 3 (disorder)	4180186
43531013	Maturity-onset diabetes of the young, type 4 (disorder)	4180186
43531013	MODY4	4180186
43531014	HNF1B (HNF1 homeobox B) monogenic diabetes mellitus	4180186
43531014	HNF1B-MODY - HNF1 homeobox B maturity-onset diabetes of the young type 5	4180186
43531014	HNF1B monogenic diabetes mellitus	4180186
43531014	Renal cysts and diabetes syndrome	4180186
43531014	Maturity-onset diabetes of the young, type 5 (disorder)	4180186
43531014	MODY5 - maturity-onset diabetes of the young type 5	4180186
43531014	RCAD (renal cysts and diabetes) syndrome	4180186
43531015	Maturity-onset diabetes of the young, type 7 (disorder)	4180186
43531015	MODY7	4180186
43531016	Maturity-onset diabetes of the young, type 9 (disorder)	4180186
43531016	MODY9	4180186
43531019	Diabetes mellitus, transient neonatal 2 (disorder)	4180186
43531019	TNDM2	4180186
43531021	Kicking other person (finding)	4180186
43531022	Resistance to care	4180186
43531022	Resistiveness to physical care (finding)	4180186
43531024	Congenital cataract (morphologic abnormality)	4180186
43531026	Radial nerve entrapment (disorder)	4180186
43531027	Mononeuropathy of upper limb (disorder)	4180186
43531030	Injury of branch of radial nerve (disorder)	4180186
43531034	Neuropathy of lower limb (disorder)	4180186
43531035	Suprascapular neuropathy (disorder)	4180186
43531043	Paralytic syndrome of one limb (disorder)	4180186
43531046	Disorder of nerve root and/or plexus (disorder)	4180186
43531047	Entrapment of common peroneal nerve (disorder)	4180186
43531047	Peroneal nerve entrapment	4180186
43531047	Common peroneal nerve entrapment	4180186
43531048	Entrapment neuropathy of lower limb (disorder)	4180186
43531049	Structure of wall of abdominal segment of trunk (body structure)	4180186
43531050	Structure of abdominal segment of trunk (body structure)	4180186
43531053	Disorder of pelvic region of trunk (disorder)	4180186
43531056	Disorder of thoracic segment of trunk (disorder)	4180186
43531058	Finding of abdomen (finding)	4180186
43531060	Finding of pelvis (finding)	4180186
43531067	Structure of supralevator space (body structure)	4180186
43531068	Structure of anal intersphincteric tissue (body structure)	4180186
43531070	Structure of connective tissue of anorectal region (body structure)	4180186
43531071	Procedure on pelvic region of trunk (procedure)	4180186
43531074	Compression neuropathy of genitofemoral nerve (disorder)	4180186
43531074	Genitofemoral nerve compression	4180186
43531075	Compression neuropathy of ilioinguinal nerve (disorder)	4180186
43531075	Ilioinguinal nerve compression	4180186
43531076	Concept model relationship type (foundation metadata concept)	4180186
43531076	Relationship type	4180186
43531080	Shiga toxin 1 (substance)	4180186
43531080	Stx-1 - Shiga toxin 1	4180186
43531081	Stx-2 - Shiga toxin 2	4180186
43531081	Shiga toxin 2 (substance)	4180186
43531085	Open reduction of fracture of scapula with internal fixation (procedure)	4180186
43531091	Open reduction of fracture of patella with internal fixation (procedure)	4180186
43531094	Laparoscopic repair of obturator hernia (procedure)	4180186
43531099	Open repair of femoral hernia (procedure)	4180186
43531101	Open repair of obstructed femoral hernia (procedure)	4180186
43531103	Open repair of strangulated inguinal hernia (procedure)	4180186
43531108	Laparoscopic assisted vaginal hysterectomy with repair of cystocoele and rectocoele	4180186
43531108	Laparoscopic assisted vaginal hysterectomy with repair of cystocele and rectocele (procedure)	4180186
43531109	Open reduction of fracture of pelvic bone with internal fixation (procedure)	4180186
43531109	Open reduction of fracture of bone of pelvis with internal fixation	4180186
43531110	Open reduction of fracture of acetabulum with internal fixation (procedure)	4180186
43531111	Open reduction of fracture of wall of acetabulum with internal fixation (procedure)	4180186
43531113	Open reduction of fracture of column of acetabulum with internal fixation (procedure)	4180186
43531115	Laparoscopic repair of femoral hernia with prosthesis (procedure)	4180186
43531116	Open reduction of fracture of bone of anterior ring of pelvis with internal fixation (procedure)	4180186
43531118	Pituicytoma (disorder)	4180186
43531119	Open reduction of epiphyseal fracture of humerus with internal fixation (procedure)	4180186
43531120	Open reduction of epiphyseal fracture of radius with internal fixation (procedure)	4180186
43531121	Open reduction of epiphyseal fracture of ulna with internal fixation (procedure)	4180186
43531122	Open reduction of epiphyseal fracture of femur with internal fixation (procedure)	4180186
43531124	Open reduction of epiphyseal fracture of tibia with internal fixation (procedure)	4180186
43531125	Open reduction of epiphyseal fracture of phalanx (procedure)	4180186
43531128	Open reduction of epiphyseal fracture of radius and ulna with internal fixation (procedure)	4180186
43531129	Open reduction of epiphyseal fracture of tibia and fibula with internal fixation (procedure)	4180186
43531130	Internal disruption of lumbar intervertebral disc (disorder)	4180186
43531130	Internal disruption of lumbar intervertebral disc	4180186
43531133	Lumbar discogenic pain (disorder)	4180186
43531134	Laparoscopic repair of incisional hernia (procedure)	4180186
43531138	History of migraine with aura (situation)	4180186
43531139	Microscopic examination of specimen from kidney (procedure)	4180186
43531142	Microscopic examination of specimen from lower gastrointestinal tract (procedure)	4180186
43531143	Specimen from upper gastrointestinal tract (specimen)	4180186
43531147	History of amputation of lower limb above knee (situation)	4180186
43531150	Laser eye surgery	4180186
43531150	Surgical procedure on eye proper using laser (procedure)	4180186
43531154	Microscopic examination of specimen from nervous system (procedure)	4180186
43531158	Microscopic examination of specimen from perirenal tissue (procedure)	4180186
43531159	Specimen from periureteral tissue (specimen)	4180186
43531160	Microscopic examination of specimen from periureteral tissue (procedure)	4180186
43531161	Specimen from perivesical tissue (specimen)	4180186
43531163	Microscopic examination of specimen from prostate (procedure)	4180186
43531164	Microscopic examination of specimen from spleen (procedure)	4180186
43531171	Specimen from female genital tract (specimen)	4180186
43531175	Eaton Lambert syndrome with underlying malignancy (disorder)	4180186
43531177	Removal of implant from radius and ulna (procedure)	4180186
43531178	Removal of implant from ulna (procedure)	4180186
43531179	Removal of implant from femur (procedure)	4180186
43531182	Removal of implant from tarsal and metatarsal bones (procedure)	4180186
43531183	Removal of implant from vertebra (procedure)	4180186
43531184	Laparoscopic left oophorectomy (procedure)	4180186
43531186	Laparoscopic right oophorectomy (procedure)	4180186
43531187	Laparoscopic left salpingo-oophorectomy (procedure)	4180186
43531188	Laparoscopic bilateral ovarian cystectomy	4180186
43531188	Laparoscopic excision of bilateral ovarian cysts (procedure)	4180186
43531189	Laparoscopic excision of cyst of left ovary (procedure)	4180186
43531189	Laparoscopic left ovarian cystectomy	4180186
43531190	Laparoscopic excision of cyst of right ovary (procedure)	4180186
43531190	Laparoscopic right ovarian cystectomy	4180186
43531193	Microscopic examination of specimen from lower gastrointestinal tract for parasites (procedure)	4180186
43531194	Microscopic examination of specimen from upper gastrointestinal tract for parasites (procedure)	4180186
43531195	Microscopic examination of specimen from spleen for parasites (procedure)	4180186
43531198	Microscopic examination of specimen from perirenal tissue for parasites (procedure)	4180186
43531203	Microscopic examination of specimen from female genital tract (procedure)	4180186
43531204	Microscopic examination of bacterial smear of specimen from female genital tract (procedure)	4180186
43531207	Microscopic examination of bacterial smear of specimen from lower gastrointestinal tract (procedure)	4180186
43531208	Microscopic examination of bacterial smear of specimen from lymph node (procedure)	4180186
43531211	Microscopic examination of bacterial smear of specimen from perirenal tissue (procedure)	4180186
43531213	Microscopic examination of bacterial smear of specimen from perivesical tissue (procedure)	4180186
43531214	Microscopic examination of bacterial smear of specimen from prostate (procedure)	4180186
43531216	Microscopic examination of bacterial smear of specimen from upper gastrointestinal tract (procedure)	4180186
43531219	Babesia trophozoite	4180186
43531219	Trophozoite of genus Babesia	4180186
43531219	Trophozoite of genus Babesia (organism)	4180186
43531225	Microscopic examination of specimen from seminal vesicle (procedure)	4180186
43531226	Trophozoite of Enteromonas hominis	4180186
43531226	Trophozoite of Enteromonas hominis (organism)	4180186
43531228	Trophozoite of Giardia lamblia (organism)	4180186
43531228	Trophozoite of Giardia lamblia	4180186
43531230	Plasmodium trophozoite	4180186
43531230	Trophozoite of genus Plasmodium (organism)	4180186
43531230	Trophozoite of genus Plasmodium	4180186
43531232	Trophozoite of Plasmodium malariae	4180186
43531232	Trophozoite of Plasmodium malariae (organism)	4180186
43531234	Trophozoite of Plasmodium vivax	4180186
43531234	Trophozoite of Plasmodium vivax (organism)	4180186
43531236	Trophozoite of Pentatrichomonas hominis (organism)	4180186
43531236	Trichomonas hominis trophozoite	4180186
43531236	Trophozoite of Pentatrichomonas hominis	4180186
43531238	Cyst of Blastocystis hominis	4180186
43531238	Cyst of Blastocystis hominis (organism)	4180186
43531239	Cyst of Chilomastix mesnili (organism)	4180186
43531239	Cyst of Chilomastix mesnili	4180186
43531241	Microscopic examination of vomit specimen	4180186
43531241	Microscopic examination of vomitus specimen (procedure)	4180186
43531242	Giardia cyst	4180186
43531242	Cyst of genus Giardia (organism)	4180186
43531242	Cyst of genus Giardia	4180186
43531243	Microscopic examination of bacterial smear of joint fluid specimen (procedure)	4180186
43531245	Cyst of Retortamonas intestinalis	4180186
43531245	Cyst of Retortamonas intestinalis (organism)	4180186
43531246	Microscopic examination of bacterial smear of lymph fluid specimen (procedure)	4180186
43531249	Microscopic examination of bacterial smear of specimen from seminal vesicle (procedure)	4180186
43531251	Microscopic examination of bacterial smear of sputum specimen (procedure)	4180186
43531252	Trophozoite of Toxoplasma gondii	4180186
43531252	Trophozoite of Toxoplasma gondii (organism)	4180186
43531253	Oocyst of genus Cryptosporidium	4180186
43531253	Oocyst of genus Cryptosporidium (organism)	4180186
43531253	Cryptosporidium oocyst	4180186
43531254	Oocyst of Cyclospora cayetanensis	4180186
43531254	Oocyst of Cyclospora cayetanensis (organism)	4180186
43531256	Oocyst of Cystoisospora belli (organism)	4180186
43531256	Oocyst of Cystoisospora belli	4180186
43531256	Oocyst of Isospora belli (organism)	4180186
43531256	Oocyst of Isospora belli	4180186
43531257	Oocyst of genus Sarcocystis	4180186
43531257	Sarcocystis oocyst	4180186
43531257	Oocyst of genus Sarcocystis (organism)	4180186
43531258	Plasmodium gametocyte	4180186
43531258	Gametocyte of genus Plasmodium (organism)	4180186
43531258	Gametocyte of genus Plasmodium	4180186
43531262	Gametocyte of Plasmodium vivax (organism)	4180186
43531262	Gametocyte of Plasmodium vivax	4180186
43531264	Microscopic examination of bacterial smear of specimen from integument (procedure)	4180186
43531268	Adult of Hymenolepis nana (organism)	4180186
43531268	Adult of Hymenolepis nana	4180186
43531270	Larva of Diphyllobothrium latum	4180186
43531270	Larva of Diphyllobothrium latum (organism)	4180186
43531271	Diphyllobothrium latum plerocercoid larva	4180186
43531271	Plerocercoid larva of Diphyllobothrium latum (organism)	4180186
43531271	Plerocercoid larva of Diphyllobothrium latum	4180186
43531273	Larva of Hymenolepis diminuta	4180186
43531273	Larva of Hymenolepis diminuta (organism)	4180186
43531274	Larva of genus Spirometra (organism)	4180186
43531274	Larva of genus Spirometra	4180186
43531275	Diphyllobothrium latum ovum	4180186
43531275	Egg of Diphyllobothrium latum (organism)	4180186
43531275	Egg of Diphyllobothrium latum	4180186
43531277	Egg of Hymenolepis nana	4180186
43531277	Hymenolepis nana ovum	4180186
43531277	Egg of Hymenolepis nana (organism)	4180186
43531280	Genus Fasciola adult	4180186
43531280	Adult of genus Fasciola (organism)	4180186
43531281	Adult of Fasciola hepatica	4180186
43531281	Adult of Fasciola hepatica (organism)	4180186
43531282	Adult of Fasciolopsis buski (organism)	4180186
43531282	Adult of Fasciolopsis buski	4180186
43531283	Adult of Metagonimus yokogawai (organism)	4180186
43531283	Adult of Metagonimus yokogawai	4180186
43531284	Adult of Opisthorchis viverrini	4180186
43531284	Adult of Opisthorchis viverrini (organism)	4180186
43531286	Microscopic examination of specimen from skin (procedure)	4180186
43531287	Adult of Schistosoma japonicum (organism)	4180186
43531287	Adult of Schistosoma japonicum	4180186
43531288	Microscopic examination of bacterial smear of specimen from skin (procedure)	4180186
43531289	Larva of Clonorchis sinensis (organism)	4180186
43531289	Larva of Clonorchis sinensis	4180186
43531291	Larva of Fasciola hepatica	4180186
43531291	Larva of Fasciola hepatica (organism)	4180186
43531292	Larva of Fasciolopsis buski	4180186
43531292	Larva of Fasciolopsis buski (organism)	4180186
43531294	Microscopic examination of specimen from eye	4180186
43531294	Microscopic examination of specimen from eye proper (procedure)	4180186
43531297	Clonorchis sinensis ovum	4180186
43531297	Egg of Clonorchis sinensis	4180186
43531297	Egg of Clonorchis sinensis (organism)	4180186
43531301	Fasciolopsis buski ovum	4180186
43531301	Egg of Fasciolopsis buski (organism)	4180186
43531301	Egg of Fasciolopsis buski	4180186
43531304	Microscopic examination of bacterial smear of specimen from retroperitoneum (procedure)	4180186
43531304	Microscopic examination of bacterial smear of specimen from retroperitoneal space	4180186
43531304	Microscopic examination of bacterial smear of retroperitoneal specimen	4180186
43531305	Microscopic examination of bacterial smear of specimen from peritoneum (procedure)	4180186
43531308	Microscopic examination of lymph fluid specimen for parasites (procedure)	4180186
43531313	Microscopic cytologic examination of smear of specimen from pancreas prepared using Papanicolaou technique (procedure)	4180186
43531314	Microscopic cytologic examination of smear of specimen from prostate prepared using Papanicolaou technique (procedure)	4180186
43531318	Microscopic cytologic examination of smear of specimen from urethra prepared using Papanicolaou technique (procedure)	4180186
43531319	Microscopic cytologic examination of smear of specimen from kidney prepared using Papanicolaou technique (procedure)	4180186
43531320	Microscopic cytologic examination of smear of specimen from liver prepared using Papanicolaou technique (procedure)	4180186
43531321	Microscopic cytologic examination of smear of specimen from lymph node prepared using Papanicolaou technique (procedure)	4180186
43531322	Microscopic cytologic examination of smear of specimen from musculoskeletal system prepared using Papanicolaou technique (procedure)	4180186
43531324	Microscopic cytologic examination of smear of specimen from skin prepared using Papanicolaou technique (procedure)	4180186
43531327	Microscopic cytologic examination of smear of specimen from bladder prepared using Papanicolaou technique (procedure)	4180186
43531328	Microscopic cytologic examination of smear of specimen from endocrine gland prepared using Papanicolaou technique (procedure)	4180186
43531329	Microscopic cytologic examination of smear of specimen from female genital tract prepared using Papanicolaou technique (procedure)	4180186
43531331	Microscopic cytologic examination of smear of specimen from perirenal tissue prepared using Papanicolaou technique (procedure)	4180186
43531334	Adult of genus Ascaris	4180186
43531334	Adult of genus Ascaris (organism)	4180186
43531335	Adult of Ascaris lumbricoides	4180186
43531335	Adult of Ascaris lumbricoides (organism)	4180186
43531342	Microscopic cytologic examination of smear of urine specimen prepared using Papanicolaou technique (procedure)	4180186
43531343	Adult of Strongyloides stercoralis (organism)	4180186
43531343	Adult of Strongyloides stercoralis	4180186
43531344	Adult of genus Trichinella	4180186
43531344	Adult of genus Trichinella (organism)	4180186
43531345	Adult of Trichinella spiralis (organism)	4180186
43531345	Adult of Trichinella spiralis	4180186
43531347	Adult of Trichuris trichiura (organism)	4180186
43531347	Adult of Trichuris trichiura	4180186
43531348	Microscopic cytologic examination of smear of cerebrospinal fluid specimen prepared using Papanicolaou technique (procedure)	4180186
43531350	Larva of genus Ascaris	4180186
43531350	Larva of genus Ascaris (organism)	4180186
43531353	Larva of Ascaris lumbricoides (organism)	4180186
43531353	Larva of Ascaris lumbricoides	4180186
43531355	Larva of Enterobius vermicularis	4180186
43531355	Larva of Enterobius vermicularis (organism)	4180186
43531357	Microscopic cytologic examination of smear of sputum specimen prepared using Papanicolaou technique (procedure)	4180186
43531358	Filariform larva of genus Strongyloides (organism)	4180186
43531358	Filariform larva of genus Strongyloides	4180186
43531359	Filariform larva of Strongyloides stercoralis	4180186
43531359	Filariform larva of Strongyloides stercoralis (organism)	4180186
43531360	Rhabditiform larva of genus Strongyloides (organism)	4180186
43531360	Rhabditiform larva of genus Strongyloides	4180186
43531362	Larva of Toxocara cati	4180186
43531362	Larva of Toxocara cati (organism)	4180186
43531366	Larva of Trichuris trichiura (organism)	4180186
43531366	Larva of Trichuris trichiura	4180186
43531368	Egg of genus Enterobius	4180186
43531368	Egg of genus Enterobius (organism)	4180186
43531368	Genus Enterobius ovum	4180186
43531369	Egg of Enterobius vermicularis (organism)	4180186
43531369	Enterobius vermicularis ovum	4180186
43531369	Egg of Enterobius vermicularis	4180186
43531370	Microscopic cytologic examination of smear of semen specimen prepared using Papanicolaou technique (procedure)	4180186
43531371	Hookworm adult	4180186
43531371	Adult of family Ancylostomatidae (organism)	4180186
43531371	Adult of family Ancylostomatidae	4180186
43531372	Adult of Ancylostoma braziliense	4180186
43531372	Adult of Ancylostoma braziliense (organism)	4180186
43531376	Larva of Ancylostoma duodenale	4180186
43531376	Larva of Ancylostoma duodenale (organism)	4180186
43531379	Adult of Schistosoma mansoni	4180186
43531379	Adult of Schistosoma mansoni (organism)	4180186
43531381	Main spoken language Bamun (finding)	4180186
43531383	Main spoken language Tetum (finding)	4180186
43531388	Educated about prostate cancer screening	4180186
43531388	Educated about screening for malignant neoplasm of prostate (situation)	4180186
43531390	Educated about weight management (situation)	4180186
43531392	Removal of device from trunk (procedure)	4180186
43531394	Removal of intraluminal foreign body from rectum without incision (procedure)	4180186
43531395	Removal of intraluminal foreign body from anus without incision (procedure)	4180186
43531396	Removal of intraluminal foreign body from nose without incision (procedure)	4180186
43531400	Microscopic examination of cell block of specimen from kidney (procedure)	4180186
43531401	Microscopic examination of cell block of specimen from lower gastrointestinal tract (procedure)	4180186
43531405	Removal of device from retropubic space (procedure)	4180186
43531405	Removal of retropubic device	4180186
43531406	Microscopic examination of cell block of sputum specimen (procedure)	4180186
43531407	Removal of female retropubic device	4180186
43531407	Removal of device from retropubic space of female (procedure)	4180186
43531408	Removal of device from retropubic space of male (procedure)	4180186
43531408	Removal of male retropubic device	4180186
43531409	Microscopic examination of cell block of urine specimen (procedure)	4180186
43531414	Revision of internal fixation of radius and ulna (procedure)	4180186
43531415	Revision of internal fixation of carpal and metacarpal bones (procedure)	4180186
43531417	Revision of internal fixation of fibula (procedure)	4180186
43531418	Revision of internal fixation of tibia (procedure)	4180186
43531419	Short cervical length in pregnancy (finding)	4180186
43531419	Short cervix in pregnancy	4180186
43531423	Revision of internal fixation of tarsal bone (procedure)	4180186
43531426	Revision of internal fixation of pelvic bone (procedure)	4180186
43531426	Revision of internal fixation of bone of pelvis	4180186
43531428	Revision of internal fixation of bone of anterior ring of pelvis (procedure)	4180186
43531430	Revision of internal fixation of bone of posterior ring of pelvis (procedure)	4180186
43531431	Revision of internal fixation of iliac spine of pelvis (procedure)	4180186
43531432	Revision of internal fixation of phalanx (procedure)	4180186
43531434	Percutaneous embolization of gastric vein using fluoroscopic guidance with contrast (procedure)	4180186
43531434	Percutaneous embolization of gastric vein using fluoroscopic guidance with contrast	4180186
43531434	Fluoroscopy guided percutaneous embolisation of gastric vein with contrast	4180186
43531434	Percutaneous embolisation of gastric vein using fluoroscopic guidance with contrast	4180186
43531435	Percutaneous embolization of splenic vein using fluoroscopic guidance with contrast (procedure)	4180186
43531435	Percutaneous embolisation of splenic vein using fluoroscopic guidance with contrast	4180186
43531436	Percutaneous embolisation of uterine vein using fluoroscopic guidance with contrast	4180186
43531436	Percutaneous embolization of uterine vein using fluoroscopic guidance with contrast (procedure)	4180186
43531438	Percutaneous insertion of stent into aneurysm of coronary artery using fluoroscopic guidance with contrast (procedure)	4180186
43531440	Percutaneous transluminal insertion of metal stent into coronary artery using fluoroscopic guidance with contrast (procedure)	4180186
43531440	Percutaneous transluminal insertion of metallic stent into coronary artery using fluoroscopic guidance with contrast	4180186
43531440	Endovascular insertion of metal stent into coronary artery using fluoroscopic guidance with contrast	4180186
43531442	Percutaneous transcatheter coil embolization of aneurysm of coronary artery using fluoroscopic guidance with contrast	4180186
43531442	Percutaneous transluminal coil embolisation of aneurysm of coronary artery using fluoroscopic guidance with contrast	4180186
43531442	Percutaneous transluminal coil embolization of aneurysm of coronary artery using fluoroscopic guidance with contrast (procedure)	4180186
43531442	Percutaneous transcatheter coil embolisation of aneurysm of coronary artery using fluoroscopic guidance with contrast	4180186
43531447	Percutaneous transluminal insertion of fenestrated stent graft into aorta (procedure)	4180186
43531447	Endovascular insertion of fenestrated stent graft into aorta	4180186
43531449	Percutaneous transluminal insertion of stent into hepatic artery (procedure)	4180186
43531450	Percutaneous transluminal laser ablation of vein (procedure)	4180186
43531453	CT guided percutaneous cryotherapy ablation of tumor of kidney	4180186
43531453	Percutaneous cryotherapy ablation of tumor of kidney using computed tomography guidance	4180186
43531453	Percutaneous cryotherapy ablation of tumour of kidney using computed tomography guidance	4180186
43531453	Percutaneous cryoablation of neoplasm of kidney using computed tomography guidance (procedure)	4180186
43531453	CT guided percutaneous cryotherapy ablation of tumour of kidney	4180186
43531455	Percutaneous cryoablation of neoplasm of lung using computed tomography guidance (procedure)	4180186
43531455	CT guided percutaneous cryotherapy ablation of tumor of lung	4180186
43531455	Percutaneous cryotherapy ablation of tumour of lung using computed tomography guidance	4180186
43531455	CT guided percutaneous cryotherapy ablation of tumour of lung	4180186
43531455	Percutaneous cryotherapy ablation of tumor of lung using computed tomography guidance	4180186
43531456	Revision of hybrid prosthetic replacement of shoulder joint using cement (procedure)	4180186
43531459	Revision of total prosthetic replacement of elbow joint (procedure)	4180186
43531460	Revision of component of total prosthetic replacement of joint (procedure)	4180186
43531461	Revision of component of total prosthetic replacement of joint not using cement (procedure)	4180186
43531462	Revision of component of total prosthetic replacement of joint using cement (procedure)	4180186
43531465	Revision of component of total prosthetic replacement of elbow joint not using cement (procedure)	4180186
43531466	Revision of replacement of joint of lower extremity	4180186
43531466	Revision of replacement of joint of lower limb (procedure)	4180186
43531468	Magnetic resonance imaging report received (finding)	4180186
43531471	Endoscopic destruction of tissue of anus (procedure)	4180186
43531472	Endoscopic destruction of tissue of pancreatic duct (procedure)	4180186
43531473	Endoscopic destruction of tissue of urethra (procedure)	4180186
43531474	Endoscopic excision of tissue of anus (procedure)	4180186
43531475	Endoscopic excision of tissue of pancreatic duct (procedure)	4180186
43531476	Endoscopic excision of tissue of urethra (procedure)	4180186
43531477	Endoscopic laser therapy of duodenum	4180186
43531477	Endoscopic surgical procedure on duodenum using laser	4180186
43531477	Endoscopic surgical procedure on duodenum using laser (procedure)	4180186
43531478	Endoscopic laser therapy of esophageal lesion	4180186
43531478	Endoscopic laser surgery on lesion of oesophagus	4180186
43531478	Endoscopic surgical procedure on lesion of esophagus using laser (procedure)	4180186
43531478	Endoscopic surgical procedure on lesion of esophagus using laser	4180186
43531478	Endoscopic surgical procedure on lesion of oesophagus using laser	4180186
43531478	Endoscopic laser therapy of oesophageal lesion	4180186
43531479	Endoscopic surgical procedure on rectum using laser (procedure)	4180186
43531479	Endoscopic laser therapy of rectum	4180186
43531479	Endoscopic surgical procedure on rectum using laser	4180186
43531480	Endoscopic surgical procedure on colon using laser (procedure)	4180186
43531480	Endoscopic laser therapy of colon	4180186
43531480	Endoscopic surgical procedure on colon using laser	4180186
43531489	Revision gastrectomy (procedure)	4180186
43531493	Abscess of preauricular sinus (disorder)	4180186
43531494	Revision of amputation stump of finger (procedure)	4180186
43531495	Revision of amputation stump of forearm (procedure)	4180186
43531501	Magnetic resonance imaging of chest for hilar lymphadenopathy	4180186
43531501	Magnetic resonance imaging of chest for hilar lymphadenopathy (procedure)	4180186
43531504	Magnetic resonance imaging of chest for hilar and mediastinal lymphadenopathy	4180186
43531504	Magnetic resonance imaging of chest for hilar and mediastinal lymphadenopathy (procedure)	4180186
43531506	Magnetic resonance imaging of pathological specimen (procedure)	4180186
43531506	Magnetic resonance imaging of pathological specimen	4180186
43531506	Magnetic resonance imaging of pathology specimen	4180186
43531507	Developmental regression (disorder)	4180186
43531508	Percutaneous aspiration of substance from gallbladder (procedure)	4180186
43531509	Percutaneous aspiration of substance from prostate (procedure)	4180186
43531515	Percutaneous radiofrequency ablation of epicardium (procedure)	4180186
43531517	Percutaneous transluminal closure of systemic to pulmonary collateral artery (procedure)	4180186
43531518	Percutaneous cardiopulmonary bypass	4180186
43531518	Peripheral cardiopulmonary support	4180186
43531518	Percutaneous cardiopulmonary bypass support (procedure)	4180186
43531519	Percutaneous choledochoscopy (procedure)	4180186
43531519	Percutaneous endoscopic inspection of bile duct	4180186
43531524	Lives in flat without elevator access	4180186
43531524	Lives in apartment without elevator access (finding)	4180186
43531526	Lives in terraced house (finding)	4180186
43531528	Open reduction of fracture of bone of spine with internal fixation (procedure)	4180186
43531529	Removal of intraluminal foreign body from trachea without incision (procedure)	4180186
43531530	Removal of intraluminal foreign body from bronchus without incision (procedure)	4180186
43531531	Removal of device from head (procedure)	4180186
43531532	Removal of device from neck (procedure)	4180186
43531533	Rhabditiform larva of Strongyloides stercoralis (organism)	4180186
43531533	Rhabditiform larva of Strongyloides stercoralis	4180186
43531535	Rhabditiform larva of family Ancylostomatidae	4180186
43531535	Rhabditiform larva of family Ancylostomatidae (organism)	4180186
43531535	Hookworm rhabditiform larva	4180186
43531539	Laparoscopic repair of obstructed inguinal hernia with prosthesis (procedure)	4180186
43531540	Laparoscopic repair of obturator hernia with prosthesis (procedure)	4180186
43531547	Open repair of obstructed femoral hernia with prosthesis (procedure)	4180186
43531548	Open repair of obstructed inguinal hernia with prosthesis (procedure)	4180186
43531552	Laparoscopic bilateral salpingo-oophorectomy with conversion to laparotomy (procedure)	4180186
43531553	Laparoscopic bilateral oophorectomy (procedure)	4180186
43531554	Removal of implant from radius (procedure)	4180186
43531555	Removal of implant from tibia (procedure)	4180186
43531556	Endoscopic destruction of tissue of stomach (procedure)	4180186
43531557	Endoscopic excision of tissue of oesophagus	4180186
43531557	Endoscopic excision of tissue of esophagus (procedure)	4180186
43531561	Myasthenia gravis without exacerbation (disorder)	4180186
43531563	Diabetic Charcot's arthropathy associated with type 2 diabetes mellitus	4180186
43531563	Neuropathic arthropathy due to type 2 diabetes mellitus (disorder)	4180186
43531564	Diabetic dyslipidemia associated with type 2 diabetes mellitus	4180186
43531564	Dyslipidemia due to type 2 diabetes mellitus (disorder)	4180186
43531564	Dyslipidemia associated with type II diabetes mellitus	4180186
43531566	Diabetic stage 2 chronic renal impairment due to type 2 diabetes mellitus	4180186
43531566	Chronic kidney disease stage 2 due to type II diabetes mellitus	4180186
43531566	Chronic kidney disease stage 2 due to type 2 diabetes mellitus (disorder)	4180186
43531568	Extension Namespace {1000153}	4180186
43531568	Extension Namespace {1000153} (namespace concept)	4180186
43531571	Extension Namespace {1000158} (namespace concept)	4180186
43531571	Extension Namespace {1000158}	4180186
43531575	Extension Namespace {1000164}	4180186
43531575	Extension Namespace {1000164} (namespace concept)	4180186
43531577	Chronic kidney disease stage 4 due to type 2 diabetes mellitus (disorder)	4180186
43531577	Diabetic stage 4 chronic renal impairment due to type 2 diabetes mellitus	4180186
43531577	Chronic kidney disease stage 4 due to type II diabetes mellitus	4180186
43531579	Lesion of scalp (disorder)	4180186
43531579	Scalp lesion	4180186
43531582	Atonic epilepsy (disorder)	4180186
43531583	Visual disturbance as sequela of cerebrovascular disease (disorder)	4180186
43531584	Stumbling due to lack of coordination (finding)	4180186
43531587	History of total hip arthroplasty (situation)	4180186
43531591	Ventriculitis of the brain (disorder)	4180186
43531593	Vaccine declined by parent	4180186
43531593	Vaccine declined by parent (situation)	4180186
43531593	Vaccine refused by parent (situation)	4180186
43531597	Disorder due to well controlled type 2 diabetes mellitus (disorder)	4180186
43531598	Limp occurring during childhood (finding)	4180186
43531598	Limp in childhood	4180186
43531599	Carotid sinus hypersensitivity (disorder)	4180186
43531601	Neurogenic bladder due to quadriplegia (disorder)	4180186
43531604	Subacute dyskinesia caused by drug	4180186
43531604	Subacute dyskinesia caused by drug (disorder)	4180186
43531606	History of lacunar cerebrovascular accident (situation)	4180186
43531607	Cerebral infarction due to stenosis of carotid artery (disorder)	4180186
43531610	Spasticity as sequela of stroke (disorder)	4180186
43531610	Spasticity as late effect of cerebrovascular accident	4180186
43531611	Hypothermia not associated with low environmental temperature (finding)	4180186
43531615	History of thrombotic stroke without residual deficits (situation)	4180186
43531616	Dermopathy due to type 2 diabetes mellitus (disorder)	4180186
43531617	Alteration of sensation as late effect of stroke (disorder)	4180186
43531618	History of actinic keratosis (situation)	4180186
43531619	Acquired caroticocavernous sinus fistula (disorder)	4180186
43531620	Symptomatic inflammatory myopathy (disorder)	4180186
43531621	Vertigo as sequela of cerebrovascular disease (disorder)	4180186
43531624	Severe recurrent major depression (disorder)	4180186
43531625	Intracranial epidural granuloma (disorder)	4180186
43531626	Rolandic seizures with status epilepticus	4180186
43531626	Status epilepticus in benign Rolandic epilepsy (disorder)	4180186
43531629	History of cow's milk protein sensitivity (situation)	4180186
43531631	Persistent Blake's pouch cyst (disorder)	4180186
43531632	Pseudoallergy to sodium thiosulfate	4180186
43531632	Sodium thiosulfate pseudoallergy	4180186
43531632	Nonallergic hypersensitivity to sodium thiosulfate	4180186
43531632	Sodium thiosulfate allergy	4180186
43531632	Non-allergic hypersensitivity to sodium thiosulfate (finding)	4180186
43531632	Sodium thiosulphate pseudoallergy	4180186
43531635	Pseudoallergy to fosinopril	4180186
43531635	Nonallergic hypersensitivity to fosinopril	4180186
43531635	Non-allergic hypersensitivity to fosinopril (finding)	4180186
43531635	Fosinopril pseudoallergy	4180186
43531635	Fosinoprill allergy	4180186
43531636	Non-allergic hypersensitivity to quinapril (finding)	4180186
43531636	Nonallergic hypersensitivity to quinapril	4180186
43531636	Pseudoallergy to quinapril	4180186
43531636	Quinapril allergy	4180186
43531636	Quinapril pseudoallergy	4180186
43531637	Allergy to sulfite based food preservative	4180186
43531637	Pseudoallergy to sulfite based food preservative (disorder)	4180186
43531637	Pseudoallergy to sulphite based food preservative	4180186
43531638	Paralytic syndrome of both lower limbs (disorder)	4180186
43531640	Maturity-onset diabetes of the young (disorder)	4180186
43531640	MODY - maturity onset diabetes of young	4180186
43531643	Maturity-onset diabetes of the young, type 6 (disorder)	4180186
43531643	MODY6	4180186
43531645	Diabetes mellitus, transient neonatal 1 (disorder)	4180186
43531645	TNDM1	4180186
43531646	Repetitive questioning (finding)	4180186
43531647	Combativeness (finding)	4180186
43531648	Total knee arthroplasty	4180186
43531648	Total knee replacement (procedure)	4180186
43531650	Structure of branch of femoral nerve (body structure)	4180186
43531651	Mixed hyperlipidaemia due to type 2 diabetes mellitus	4180186
43531651	Mixed hyperlipidemia due to type II diabetes mellitus	4180186
43531651	Mixed hyperlipidemia due to type 2 diabetes mellitus (disorder)	4180186
43531651	Mixed hyperlipidaemia due to type II diabetes mellitus	4180186
43531652	Ilioinguinal neuropathy (disorder)	4180186
43531653	Diabetic stage 3 chronic renal impairment due to type 2 diabetes mellitus	4180186
43531653	Chronic kidney disease stage 3 due to type 2 diabetes mellitus (disorder)	4180186
43531653	Chronic kidney disease stage 3 due to type II diabetes mellitus	4180186
43531656	Open reduction of fracture of nasoethmoid complex with internal fixation (procedure)	4180186
43531656	Open reduction of nasoethmoid fracture with internal fixation	4180186
43531659	Open repair of obstructed inguinal hernia (procedure)	4180186
43531663	Removal of implant from fibula (procedure)	4180186
43531664	Removal of implant from pelvic bone (procedure)	4180186
43531664	Removal of implant from bone of pelvis	4180186
43531665	Laparoscopic right salpingo-oophorectomy (procedure)	4180186
43531667	Microscopic examination of specimen from lymph node for parasites (procedure)	4180186
43531668	Adult of Clonorchis sinensis (organism)	4180186
43531668	Adult of Clonorchis sinensis	4180186
43531669	Adult of Heterophyes heterophyes	4180186
43531669	Adult of Heterophyes heterophyes (organism)	4180186
43531670	Adult of genus Schistosoma (organism)	4180186
43531670	Adult of genus Schistosoma	4180186
43531671	Microscopic examination of bacterial smear of vomitus specimen (procedure)	4180186
43531671	Microscopic examination of bacterial smear of vomit specimen	4180186
43531672	Larva of Paragonimus westermani (organism)	4180186
43531672	Larva of Paragonimus westermani	4180186
43531676	Role group (attribute)	4180186
43531681	Acute deep vein thrombosis of lower limb (disorder)	4180186
43531683	Disrupted wound (morphologic abnormality)	4180186
43531684	Escherichia coli serotype O127:H21 (organism)	4180186
43531684	E. coli serotype O127:H21	4180186
43531685	E. coli serotype O159:H20	4180186
43531685	Escherichia coli serotype O159:H20 (organism)	4180186
43531688	Finding of Frankl behavioural rating scale	4180186
43531688	Finding of Frankl behavioral rating scale (finding)	4180186
43531689	Frankl behavioural rating positive	4180186
43531689	Frankl behavioral rating positive (finding)	4180186
43531691	Bowing deformity of lower limb (finding)	4180186
43531692	Anterior interosseous neuritis (disorder)	4180186
43531693	At high risk for heart failure (finding)	4180186
43531695	Laparoscopic repair of inguinal hernia with prosthesis (procedure)	4180186
43531696	Laparoscopic repair of recurrent obturator hernia with prosthesis (procedure)	4180186
43531697	Open repair of strangulated femoral hernia with prosthesis (procedure)	4180186
43531698	Endoscopic excision of tissue of large intestine (procedure)	4180186
43531702	Extension Namespace {1000160} (namespace concept)	4180186
43531702	Extension Namespace {1000160}	4180186
43531704	Extension Namespace {1000166}	4180186
43531704	Extension Namespace {1000166} (namespace concept)	4180186
43531708	Foetal or neonatal effect of maternal alcohol addiction	4180186
43531708	Fetal or neonatal effect of maternal alcohol addiction (disorder)	4180186
43531709	Retained products of conception following induced termination of pregnancy (disorder)	4180186
43531709	Retained products of conception following induced abortion	4180186
43531710	Induced termination of pregnancy complicated by embolism (disorder)	4180186
43531710	Termination of pregnancy complicated by embolism	4180186
43531713	Induced termination of pregnancy complicated by electrolyte imbalance (disorder)	4180186
43531713	Termination of pregnancy complicated by electrolyte imbalance	4180186
43531714	Induced termination of pregnancy complicated by laceration of cervix (disorder)	4180186
43531714	Termination of pregnancy complicated by laceration of cervix	4180186
43531715	Termination of pregnancy complicated by pelvic peritonitis	4180186
43531715	Induced termination of pregnancy complicated by pelvic peritonitis (disorder)	4180186
43531718	Intractable partial temporal lobe epilepsy with impairment of consciousness (disorder)	4180186
43531719	Prosthetic knee joint present	4180186
43531719	Knee joint prosthesis present (finding)	4180186
43531719	Knee joint prosthesis present	4180186
43531719	Artificial knee joint present (finding)	4180186
43531722	Diminished ovarian reserve evidenced by low antral follicle count (finding)	4180186
43533382	Deprecated Resp depth comment Imp	4180186
43533382	Dpth; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; PhenX; Point in time; Random	4180186
43533383	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; GCMS; METD; Methadone pnl; Methadose; MTD; Oral fluid; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Sal	4180186
43533383	Methadone pnl Sal Cfm	4180186
43533383	美沙酮组套:-:时间点:唾液:-:毒理学确认试验	4182948
43533386	C1.functional Ser-aCnc	4180186
43533386	Arbitrary concentration; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
43533386	补体 C1.功能性:任意型浓度:时间点:血清:定量型	4182948
43533387	Cerebral spinal fluid; Cerebrospinal Fl; Icterus; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
43533387	Sample Icteric CSF Ql Spect	4180186
43533387	黄疸性标本:存在情况或阈值:时间点:脑脊液:序数型:分光光度测定法	4182948
43533388	Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;50 ng/mL; Scr; Screen; Scrn; THC; UA; UniversalLabOrders; UR; Urn	4180186
43533388	Cannabinoids Ur Ql Scn>50 ng/mL	4180186
43533388	大麻类:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 50 纳克/毫升	4182948
43533390	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; METD; Methadose; MTD; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
43533390	Methadone Ur Scn-mCnc	4180186
43533390	美沙酮:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
43533391	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;150 ng/mL; Scr; Screen; Scrn; UA; UR; Urn	4180186
43533391	Methadone Ur Ql Scn>150 ng/mL	4180186
43533391	美沙酮:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 150 纳克/毫升	4182948
43533392	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; Level; Mass concentration; OP; Opi; Opiate; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
43533392	Opiates Ur Scn-mCnc	4180186
43533392	阿片制剂:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
43533394	Chemistry; Endocrine; Endocrinology; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3; T-3; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T3; Total T4; Triodothyrne; TT4	4180186
43533394	T3/T4 SerPl	4180186
43533394	三碘甲状腺原氨酸/甲状腺素:质量比率:时间点:血清/血浆:定量型	4182948
43533398	FLUoxetine ind plt IgG SerPl Ql FC	4180186
43533398	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prozac; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533398	氟西汀 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533400	Fluconazole ind plt IgM SerPl Ql FC	4180186
43533400	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Diflucan; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533400	氟康唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533404	Fexofenadine ind plt IgG SerPl Ql FC	4180186
43533404	ABS; Aby; Allegra; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Fastofen; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Telfast; Thrombocyte; Thrombocytes; Tilfur; Vifas	4180186
43533404	非索非那定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533406	ABS; Aby; Actiq; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Duragesic; Durogesic; Dynamic; FC; Fenpat; fentanil; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sublimaze; Thrombocyte; Thrombocytes	4180186
43533406	fentaNYL ind plt IgM SerPl Ql FC	4180186
43533406	芬太尼 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533408	Fenofibrate ind plt IgG SerPl Ql FC	4180186
43533408	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tricor	4180186
43533408	非诺贝特 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533409	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pepcid; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533409	Famotidine ind plt IgM SerPl Ql FC	4180186
43533409	法莫替丁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533412	Ezetimibe ind plt IgG SerPl Ql FC	4180186
43533412	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Ezetrol; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zetia	4180186
43533412	依泽替米贝 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533413	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Nexium; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533413	Esomeprazole ind plt IgM SerPl Ql FC	4180186
43533413	埃索美拉唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533414	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Nexium; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533414	Esomeprazole ind plt IgG SerPl Ql FC	4180186
43533414	埃索美拉唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533415	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cipralex; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lexamil; Lexapro; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Seroplex; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533415	Escitalopram ind plt IgM SerPl Ql FC	4180186
43533415	右旋西酞普兰 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533416	Escitalopram ind plt IgG SerPl Ql FC	4180186
43533416	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cipralex; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lexamil; Lexapro; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Seroplex; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533416	右旋西酞普兰 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533417	Erythromycin ind plt IgM SerPl Ql FC	4180186
43533417	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c212; Circulating platelet ab; Dynamic; EES; Erygel; Erythromycn; FC; Ilosone; Ilotycin; Iltycin; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533417	红霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533418	Erythromycin ind plt IgG SerPl Ql FC	4180186
43533418	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c212; Circulating platelet ab; Dynamic; EES; Erygel; Erythromycn; FC; Ilosone; Ilotycin; Iltycin; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533418	红霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533419	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Integrilin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533419	Eptifibatide ind plt IgM SerPl Ql FC	4180186
43533419	依替巴肽 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533421	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; EPO; Epoetin; Erthropoyetin; Erythropoetin; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533421	EPO ind plt IgM SerPl Ql FC	4180186
43533421	促红细胞生成素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533424	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Enacard; Enaladex; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vasotec	4180186
43533424	Enalapril ind plt IgG SerPl Ql FC	4180186
43533424	依那普利 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533426	Doxycycline ind plt IgM SerPl Ql FC	4180186
43533426	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c206; c216; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vibramycin	4180186
43533426	强力霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533427	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cardura; Carduran; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533427	Doxazosin ind plt IgG SerPl Ql FC	4180186
43533427	多沙唑嗪 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533428	Doxazosin ind plt IgM SerPl Ql FC	4180186
43533428	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cardura; Carduran; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533428	多沙唑嗪 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533429	Donepezil ind plt IgG SerPl Ql FC	4180186
43533429	ABS; Aby; Antby; Anti; Antibodies; Antibody; Aricept; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533429	多奈哌齐 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533430	ABS; Aby; Antby; Anti; Antibodies; Antibody; Aricept; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533430	Donepezil ind plt IgM SerPl Ql FC	4180186
43533430	多奈哌齐 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533432	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dioctyl sodium sulfosuccinate; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533432	Docusate ind plt IgG SerPl Ql FC	4180186
43533432	多库酯 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533434	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Medication stress; Ordinal; Persantine; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533434	Dipyridamole ind plt IgG SerPl Ql FC	4180186
43533434	潘生丁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533435	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Co-phenotrope; Diphenox+Atropine; Dynamic; Enlon; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lomotil; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533435	Diphenox+Atropine ind plt IgM SP Ql FC	4180186
43533435	苯乙哌啶+阿托品 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533438	Diphenhy ind plt IgG SerPl Ql FC	4180186
43533438	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Benadryl; Circulating platelet ab; Diphenhydr; Diphenylhydramine; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533438	苯海拉明 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533439	dilTIAZem ind plt IgG SerPl Ql FC	4180186
43533439	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cardizem; Cartia; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tiamate; Tiazac	4180186
43533439	硫氮卓酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533445	diazePAM ind plt IgM SerPl Ql FC	4180186
43533445	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c311; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stesolid; Thrombocyte; Thrombocytes; Valium	4180186
43533445	安定 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533447	Amphet ind plt IgM SerPl Ql FC	4180186
43533447	ABS; Aby; Amph; Amphet; Amphetam; Amphetamines; Ampht; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Speed; SR; Thrombocyte; Thrombocytes	4180186
43533447	苯丙胺 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533448	ABS; Aby; Amph; Amphet; Amphetam; Amphetamines; Ampht; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Speed; SR; Thrombocyte; Thrombocytes	4180186
43533448	Amphet ind plt IgG SerPl Ql FC	4180186
43533448	苯丙胺 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533450	cycloSPORINE ind plt IgG SerPl Ql FC	4180186
43533450	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ciclosporin; Ciclosporine; Circulating platelet ab; CsA; Cyclosporin a; Cyclosporins; Dynamic; FC; Gengraf; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Neoral; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Restasis; Sandimmune; SangCya; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533450	环孢菌素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533452	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C22H25NO6; Circulating platelet ab; Colchiceine methyl ether; Colchineos; Colchisol; Colcin; Colgout; Colsaloid; Condylon; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; n-acetyltrimethylcolchicinic acid methyl ether; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533452	Colchicine ind plt IgM SerPl Ql FC	4180186
43533452	秋水仙碱 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533455	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Catapres; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533455	cloNIDine ind plt IgM SerPl Ql FC	4180186
43533455	可乐定 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533456	cloNIDine ind plt IgG SerPl Ql FC	4180186
43533456	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Catapres; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533456	可乐定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533457	clonazePAM ind plt IgG SerPl Ql FC	4180186
43533457	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Klonopin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533457	氯硝安定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533459	Clindamycin ind plt IgM SerPl Ql FC	4180186
43533459	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c306; Circulating platelet ab; Cleocin; CLIJ; Clindamycin.induced; Dalacin; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sobelin; SR; Thrombocyte; Thrombocytes; Topical	4180186
43533459	氯洁霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533462	Clavulanate ind plt IgG SerPl Ql FC	4180186
43533462	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c305; Circulating platelet ab; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533462	克拉维酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533466	Citalopram ind plt IgG SerPl Ql FC	4180186
43533466	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celexa; Cipramil; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533466	西酞普兰 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533467	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533467	Ciprofloxacin ind plt IgM SerPl Ql FC	4180186
43533467	环丙沙星 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533468	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533468	Ciprofloxacin ind plt IgG SerPl Ql FC	4180186
43533468	环丙沙星 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533469	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CIMJ; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tagamet; Tagj; Thrombocyte; Thrombocytes	4180186
43533469	Cimetidine ind plt IgM SerPl Ql FC	4180186
43533469	西咪替丁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533470	Cimetidine ind plt IgG SerPl Ql FC	4180186
43533470	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CIMJ; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tagamet; Tagj; Thrombocyte; Thrombocytes	4180186
43533470	西咪替丁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533474	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Hygroton; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thalitone; Thrombocyte; Thrombocytes	4180186
43533474	Chlorthalidone ind plt IgG SerPl Ql FC	4180186
43533474	氯噻酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533480	Chlordiazep ind plt IgG SerPl Ql FC	4180186
43533480	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chlordiaz; Chlordiaze; Chlordiazep; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Librium; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533480	甲氨二氮卓 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533484	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celebrex; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533484	Celecoxib ind plt IgG SerPl Ql FC	4180186
43533484	塞来昔布 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533485	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c308; C33; Ceftin; Cefuroxime Axetil; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zinacef	4180186
43533485	Cefuroxime ind plt IgG SerPl Ql FC	4180186
43533485	头孢呋辛 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533486	Cefuroxime ind plt IgM SerPl Ql FC	4180186
43533486	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c308; C33; Ceftin; Cefuroxime Axetil; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zinacef	4180186
43533486	头孢呋辛 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533488	cefTRIAXone ind plt IgM SerPl Ql FC	4180186
43533488	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c9; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rocephin; ROCJ; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533488	头孢三嗪 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533489	Ceftizoxime ind plt IgG SerPl Ql FC	4180186
43533489	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cefizox; Ceftrix; Circulating platelet ab; Dynamic; Eposelin; Eposerin; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533489	头孢唑肟 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533493	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cefipime; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Maxipime; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533493	Cefepime ind plt IgM SerPl Ql FC	4180186
43533493	头孢吡肟 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533495	ceFAZolin ind plt IgG SerPl Ql FC	4180186
43533495	ABS; Aby; Ancef; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C32; Cefamezin; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Kefj; Kefzol; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Totacef; Zolicef	4180186
43533495	头孢唑林 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533496	ABS; Aby; Ancef; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C32; Cefamezin; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Kefj; Kefzol; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Totacef; Zolicef	4180186
43533496	ceFAZolin ind plt IgM SerPl Ql FC	4180186
43533496	头孢唑林 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533497	Cefadroxil ind plt IgM SerPl Ql FC	4180186
43533497	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bidocef; Cefadril; Cefadrox; Cefamox; Cefroxil; Cehpos; Ceoxil; Circulating platelet ab; Crenodyn; Droxicef; Duracef; Duricef; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533497	头孢羟氨苄 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533498	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bidocef; Cefadril; Cefadrox; Cefamox; Cefroxil; Cehpos; Ceoxil; Circulating platelet ab; Crenodyn; Droxicef; Duracef; Duricef; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533498	Cefadroxil ind plt IgG SerPl Ql FC	4180186
43533498	头孢羟氨苄 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533500	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533500	Caspofungin ind plt IgG SerPl Ql FC	4180186
43533500	卡泊芬净 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533501	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Laxative; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533501	Casanthranol ind plt IgM SerPl Ql FC	4180186
43533501	鼠李蒽酚 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533502	Casanthranol ind plt IgG SerPl Ql FC	4180186
43533502	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Laxative; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533502	鼠李蒽酚 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533503	Carvedilol ind plt IgM SerPl Ql FC	4180186
43533503	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carvil; Circulating platelet ab; Coreg; Dilatrend; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533503	卡维地洛 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533507	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533507	Carbidopa ind plt IgM SerPl Ql FC	4180186
43533507	卡比多巴 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533508	Carbidopa ind plt IgG SerPl Ql FC	4180186
43533508	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533508	卡比多巴 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533510	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carbamazapine; Carbamezapine; Carbazepine; Circulating platelet ab; CRBM; Dynamic; Epitol; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril; Thrombocyte; Thrombocytes	4180186
43533510	carBAMazepine ind plt IgM SerPl Ql FC	4180186
43533510	卡马西平 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533511	Captopril ind plt IgM SerPl Ql FC	4180186
43533511	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c246; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533511	卡托普利 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533514	ABS; Aby; Amias; Antby; Anti; Antibodies; Antibody; Atacand; Autoantibodies; Autoantibody; Blopress; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Ratacand; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533514	Candesartan ind plt IgG SerPl Ql FC	4180186
43533514	坎地沙坦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533518	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Buspar; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533518	busPIRone ind plt IgG SerPl Ql FC	4180186
43533518	丁螺旋酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533519	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Wellbutrin; Zyban	4180186
43533519	buPROPion ind plt IgG SerPl Ql FC	4180186
43533519	丁氨苯丙酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533520	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Wellbutrin; Zyban	4180186
43533520	buPROPion ind plt IgM SerPl Ql FC	4180186
43533520	丁氨苯丙酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533522	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bumex; Burinex; Butinat; Circulating platelet ab; Dynamic; Farmadiuril; FC; Fontego; Fordiuran; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533522	Bumetanide ind plt IgG SerPl Ql FC	4180186
43533522	布美他尼 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533524	Budesonide ind plt IgG SerPl Ql FC	4180186
43533524	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Entocort; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rhinocort; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533524	布地缩松 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533528	Benztropine ind plt IgM SerPl Ql FC	4180186
43533528	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Cogentin; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533528	苯扎托品 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533530	Benazepril ind plt IgM SerPl Ql FC	4180186
43533530	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BZ; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lotensin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533530	苯那普利 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533533	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zithromax	4180186
43533533	Azithromycin ind plt IgM SerPl Ql FC	4180186
43533533	阿齐霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533535	Atorvastatin ind plt IgM SerPl Ql FC	4180186
43533535	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lipitor; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533535	阿托伐他汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533536	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lipitor; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533536	Atorvastatin ind plt IgG SerPl Ql FC	4180186
43533536	阿托伐他汀 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533538	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strattera; Thrombocyte; Thrombocytes	4180186
43533538	Atomoxetine ind plt IgG SerPl Ql FC	4180186
43533538	托莫西汀 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533539	Atenolol ind plt IgG SerPl Ql FC	4180186
43533539	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tenormin; Thrombocyte; Thrombocytes	4180186
43533539	氨酰心安 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533540	Atenolol ind plt IgM SerPl Ql FC	4180186
43533540	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tenormin; Thrombocyte; Thrombocytes	4180186
43533540	氨酰心安 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533541	ABS; Aby; Acetylsalicylic acid; Antby; Anti; Antibodies; Antibody; ASA; Aspirin; Autoantibodies; Autoantibody; c207; c217; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533541	Acetylsalicylate ind plt IgG SerPl Ql FC	4180186
43533541	乙酰水杨酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533542	ABS; Aby; Acetylsalicylic acid; Antby; Anti; Antibodies; Antibody; ASA; Aspirin; Autoantibodies; Autoantibody; c207; c217; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533542	Acetylsalicylate ind plt IgM SerPl Ql FC	4180186
43533542	乙酰水杨酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533543	Argatroban ind plt IgG SerPl Ql FC	4180186
43533543	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533543	阿加曲班 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533544	Argatroban ind plt IgM SerPl Ql FC	4180186
43533544	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533544	阿加曲班 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533546	ABS; Aby; Amcil; Amicil; Amp; Ampicilloyl; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c203; c5; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Omnipen; Ordinal; Penbritin; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Polycillin; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533546	Ampicillin ind plt IgG SerPl Ql FC	4180186
43533546	氨苄青霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533551	AM+BZ ind plt IgG SerPl Ql FC	4180186
43533551	ABS; Aby; AM; AM+BZ; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BZ; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lotensin; Lotrel; Norvasc; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533551	阿莫洛地平+苯那普利 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533552	ABS; Aby; AM; AM+BZ; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BZ; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lotensin; Lotrel; Norvasc; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533552	AM+BZ ind plt IgM SerPl Ql FC	4180186
43533552	阿莫洛地平+苯那普利 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533558	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Cordarone; Dynamic; Esoteric; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pacerone; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533558	Amiodarone ind plt IgM SerPl Ql FC	4180186
43533558	胺碘酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533559	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Niravam; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Xanax	4180186
43533559	Alpraz ind plt IgM SerPl Ql FC	4180186
43533559	阿普唑仑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533562	Allopurinol ind plt IgM SerPl Ql FC	4180186
43533562	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Lopurin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zyloprim	4180186
43533562	别嘌呤醇 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533564	Alendronate ind plt IgG SerPl Ql FC	4180186
43533564	ABS; Aby; Alendronic acid; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Fosamax; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533564	阿仑膦酸盐 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533565	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Proventil; QL; Qual; Qualitative; Random; Salbutamol; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Ventolin	4180186
43533565	Albuterol ind plt IgM SerPl Ql FC	4180186
43533565	舒喘宁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533567	ABS; Aby; Aciclovir; Acifur; ACV; Acycloguanosine; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avirax; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zovirax	4180186
43533567	Acyclovir ind plt IgG SerPl Ql FC	4180186
43533567	阿昔洛韦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533568	Acyclovir ind plt IgM SerPl Ql FC	4180186
43533568	ABS; Aby; Aciclovir; Acifur; ACV; Acycloguanosine; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avirax; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zovirax	4180186
43533568	阿昔洛韦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533571	ABS; Aby; Acecor; ALOL; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Monitan; Neptal; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prent; QL; Qual; Qualitative; Random; Rhotral; Screen; Sectral; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533571	Acebutolol ind plt IgM SerPl Ql FC	4180186
43533571	醋丁洛尔 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533576	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c7E3 Fab; Circulating platelet ab; Impression; Impression/interpretation of study; Impressions; ind plt Ab; Interp; Interpretation; Nominal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; Random; ReoPro; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533576	Abciximab ind plt Ab SerPl-Imp	4180186
43533576	阿昔单抗 诱导型血小板抗体:印象:时间点:血清/血浆:名义型	4182948
43533578	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c7E3 Fab; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; ReoPro; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533578	Abciximab ind plt IgG SerPl Ql FC	4180186
43533578	阿昔单抗 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533579	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Hematology; Heme; Immune globulin M; Immunoglobulin M; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43533579	Platelet IgM SerPl Ql FC	4180186
43533579	血小板 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43533584	Chemistry; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; SR; Standard score; Ultralente; Z score; Z value; Z-score	4180186
43533584	IGF-I Z-score SerPl	4180186
43533584	胰岛素样生长因子-I:Z评分:时间点:血清/血浆:定量型	4182948
43533586	7-amino clonazepam; 7Aminoclonazepam; Addiction; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass Content; Mec; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
43533586	7Aminoclonazepam Mec Cfm-mCnt	4180186
43533586	7-氨基氯硝安定:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
43533587	1-hydroxytriazolam; Alfa; Alpha hydroxy triazolam; A-OH-triazolam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy triazolam; Mass content; Mec; OH-Triazolam; OHTRZ; Point in time; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite	4180186
43533587	A-OH-triazolam Mec Cfm-mCnt	4180186
43533587	Alpha 羟基三唑仑:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
43533589	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; DXO; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43533589	DXO Ur-mCnc	4180186
43533589	去甲右美沙芬:质量浓度:时间点:尿液:定量型	4182948
43533590	Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mec; Napsalgesic; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
43533590	Propoxyph Mec Ql Scn	4180186
43533590	丙氧氨酚:存在情况或阈值:时间点:胎便:序数型:毒理学筛查试验	4182948
43533591	Comm critical results Doc	4180186
43533591	Comm critical results; Description; DOC.MISC; Document; MISC; Point in time; Random	4180186
43533591	危急结果的沟通与交流:描述:时间点:^患者:文档型	4182948
43533593	Testost/Epitestost Ur-Imp	4180186
43533593	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Testo; Testos; Testost; UA; UR; Urn	4180186
43533593	睾酮/表睾酮:印象:时间点:尿液:序数型	4182948
43533595	Mg Ionized Bld ISE-sCnc	4180186
43533595	Blood; Chemistry; IMg2+; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ionized magnesium; Ion-selective electrode; Level; MAG; Magnes; Mg; Mg Ionized; Mg2+; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43533595	镁.游离型:物质的量浓度:时间点:全血:定量型:离子选择电极法	4182948
43533596	Mg Ionized adj pH7.4 Bld ISE-sCnc	4180186
43533596	adj; adj pH7.4; Blood; Chemistry; IMg2+; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ionized magnesium; Ion-selective electrode; Level; MAG; Magnes; Mg; Mg Ionized; Mg2+; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43533596	镁.游离型^^调整至pH 7.4的:物质的量浓度:时间点:全血:定量型:离子选择电极法	4182948
43533604	Anion Gap4 BldMV-sCnc	4180186
43533604	Ag; AnGAP; Anion Gap4; Bld mixed venous; Blood - mixed venous; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
43533604	阴离子间隙 4:物质的量浓度:时间点:混合静脉全血:定量型	4182948
43533605	Anion Gap4 BldC-sCnc	4180186
43533605	Ag; AnGAP; Anion Gap4; Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
43533605	阴离子间隙 4:物质的量浓度:时间点:毛细血管全血:定量型	4182948
43533607	Ag; AnGAP; Anion Gap4; Blood; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43533607	Anion Gap4 Bld-sCnc	4180186
43533607	阴离子间隙 4:物质的量浓度:时间点:全血:定量型	4182948
43533609	Norcitalopram Ur-mCnc	4180186
43533609	Citalopram metabolite; Desmeth; Desmethylcitalopram; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43533609	去甲基西酞普兰:质量浓度:时间点:尿液:定量型	4182948
43533613	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533613	Sarafloxacin Susc Islt	4180186
43533613	沙拉沙星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533616	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533616	Premafloxacin Susc Islt	4180186
43533616	沛马沙星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533619	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533619	Omadacycline Susc Islt	4180186
43533619	奥玛环素:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533620	Alinia; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Nitaxide; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533620	Nitazoxanide Susc Islt	4180186
43533620	硝唑尼特:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533623	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533623	Finafloxacin Susc Islt	4180186
43533623	非那沙星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533624	ANTIBIOTIC SUSCEPTIBILITIES; AST; Dificid; Dificlir; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533624	Fidaxomicin Susc Islt	4180186
43533624	非达霉素:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533625	ANTIBIOTIC SUSCEPTIBILITIES; AST; Farom; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533625	Faropenem Susc Islt	4180186
43533625	法罗培南:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533626	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
43533626	Danofloxacin Susc Islt	4180186
43533626	达氟沙星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533627	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazobac; Zerbaxa	4180186
43533627	Ceftolozane+Tazobactam Susc Islt	4180186
43533627	头孢洛林+他唑巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533629	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Teflaro	4180186
43533629	Ceftaroline+Avibactam Susc Islt	4180186
43533629	头孢洛林+阿维巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533630	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Teflaro	4180186
43533630	Ceftaroline Susc Islt	4180186
43533630	头孢洛林:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
43533632	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533632	Tizoxanide Islt MIC	4180186
43533632	替唑尼特:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533633	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Torezolid	4180186
43533633	Tedizolid Islt MIC	4180186
43533633	泰地唑胺:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533636	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533636	rifAXIMin Islt MIC	4180186
43533636	利福昔明:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533637	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533637	Razupenem Islt MIC	4180186
43533637	阿祖培南:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533640	Acetylsulfamethoxazole; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c223; C61; Gantanol; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Primor; Random; SMX; Sulfa; Sulfamethox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
43533640	Ormetroprim+Sulfamethoxazole Islt MIC	4180186
43533640	奥美普林+磺胺甲噁唑:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533641	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533641	Omadacycline Islt MIC	4180186
43533641	奥玛环素:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533642	Alinia; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Nitaxide; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533642	Nitazoxanide Islt MIC	4180186
43533642	硝唑尼特:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533647	ANTIBIOTIC SUSCEPTIBILITIES; AST; Farom; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533647	Faropenem Islt MIC	4180186
43533647	法罗培南:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533648	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
43533648	Danofloxacin Islt MIC	4180186
43533648	达氟沙星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533649	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazobac; Zerbaxa	4180186
43533649	Ceftolozane+Tazobactam Islt MIC	4180186
43533649	头孢洛林+他唑巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533653	ANTIBIOTIC SUSCEPTIBILITIES; AST; Besivance; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533653	Besifloxacin Islt MIC	4180186
43533653	贝西沙星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43533654	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533654	Tizoxanide Islt KB	4180186
43533654	替唑尼特:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533657	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533657	Solithromycin Islt KB	4180186
43533657	索利霉素:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533659	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533659	rifAXIMin Islt KB	4180186
43533659	利福昔明:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533660	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533660	Razupenem Islt KB	4180186
43533660	阿祖培南:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533662	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533662	Plazomicin Islt KB	4180186
43533662	普拉佐米星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533663	Acetylsulfamethoxazole; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c223; C61; Disk diffusion; Gantanol; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Primor; Random; SMX; Sulfa; Sulfamethox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
43533663	Ormetroprim+Sulfamethoxazole Islt KB	4180186
43533663	奥美普林+磺胺甲噁唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533664	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533664	Omadacycline Islt KB	4180186
43533664	奥玛环素:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533666	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Marbocyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zeniquin	4180186
43533666	Marbofloxacin Islt KB	4180186
43533666	马波沙星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533667	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533667	Iclaprim Islt KB	4180186
43533667	艾拉普林:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533668	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533668	Finafloxacin Islt KB	4180186
43533668	非那沙星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533670	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Farom; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533670	Faropenem Islt KB	4180186
43533670	法罗培南:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533672	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazobac; Zerbaxa	4180186
43533672	Ceftolozane+Tazobactam Islt KB	4180186
43533672	头孢洛林+他唑巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533676	ANTIBIOTIC SUSCEPTIBILITIES; AST; Besivance; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43533676	Besifloxacin Islt KB	4180186
43533676	贝西沙星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
43533679	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HCV; HCV NS3; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Mut; Mut Det; Mutation; Muts; Nominal; Point in time; Random	4180186
43533679	HCV NS3 Mut Det Islt Genotyp	4180186
43533679	丙型肝炎病毒 NS3 基因 已检出的突变:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43533681	ANTIBIOTIC SUSCEPTIBILITIES; Chicken pox; Chicken pox virus; Chickenpox; DNA polymerase; Gentyp; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Nominal; Point in time; Pol; Random; Shingles; VZ; VZV; VZV ORF28; Zoster	4180186
43533681	VZV ORF28 Gentyp Islt	4180186
43533681	水痘带状疱疹病毒 ORF28 基因型:存在与否或特征标识:时间点:分离株:名义型	4182948
43533683	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Typ; Unspecified	4180186
43533683	HIV 1 subtype Spec NAA+probe	4180186
43533683	HIV 1 型亚型:类型:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
43533685	Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Napsalgesic; Oral fluid; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Propoxyph pnl; Random; Sal	4180186
43533685	Propoxyph pnl Sal	4180186
43533685	丙氧氨酚组套:-:时间点:唾液:-	4182948
43533687	Benz; Benzodiaz; Benzodiazepine; Benzodiazepines Pnl; DRUG/TOXICOLOGY; Drugs; Oral fluid; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Sal; Scn; Scr; Scrn	4180186
43533687	Benzodiazepines Pnl Sal Scn	4180186
43533687	苯二氮类组套:-:时间点:唾液:-:毒理学筛查试验	4182948
43533688	Barbiturates Pnl Sal Cfm	4180186
43533688	Barb; Barbiturate; Barbiturates Pnl; Barbs; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Oral fluid; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Sal	4180186
43533688	巴比妥酸类组套:-:时间点:唾液:-:毒理学确认试验	4182948
43533689	ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Yersinia YadA	4180186
43533689	Yersinia YadA Islt Ql	4180186
43533689	耶尔森氏菌粘附蛋白 YadA:存在情况或阈值:时间点:分离株:序数型	4182948
43533693	Bact; Bacteria soluble bile; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
43533693	Bacteria soluble bile Islt Ql	4180186
43533693	胆汁可溶性细菌:存在情况或阈值:时间点:分离株:序数型	4182948
43533694	Bact; Bacteria DNAse; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
43533694	Bacteria DNAse Islt Ql	4180186
43533694	DNAse 产生型细菌:存在情况或阈值:时间点:分离株:序数型	4182948
43533695	Bact; Bacteria coagulase+protein A; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Islt; Isol; LAT; Latex agglutination; Microbiology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen	4180186
43533695	Bacteria coagulase+protein A Islt Ql LA	4180186
43533695	凝固酶+蛋白 A 产生型细菌:存在情况或阈值:时间点:分离株:序数型:胶乳凝集试验法	4182948
43533696	Agg; Agglut; Agglutination; ID; Infectious Disease; InfectiousDisease; Islt; Isol; L pneumo; L pneumonphila; L pneumophila group; Legion; Legionela; Microbiology; Nominal; Pneu; pneum; Pneumophilia; Point in time; Random; Typ	4180186
43533696	L pneumophila group Islt Aggl	4180186
43533696	嗜肺军团菌血清群:类型:时间点:分离株:名义型:凝集试验法	4182948
43533701	DRUG/TOXICOLOGY; Drugs; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vfend	4180186
43533701	Voriconazole Trough SerPl-mCnc	4180186
43533701	伏立康唑^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43533702	Valproate Peak SerPl-mCnc	4180186
43533702	Depakene; Divalproex; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VALP; Valproic acid	4180186
43533702	2-丙基戊酸^波峰:质量浓度:时间点:血清/血浆:定量型	4182948
43533705	Cellcept; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MMF; MPA; Mycophenolate mofetil; Mycophenolic acid; Pl; Plasma; Plsm; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43533705	Mycophenolate Peak SerPl-mCnc	4180186
43533705	吗替麦考酚酯^波峰:质量浓度:时间点:血清/血浆:定量型	4182948
43533707	Blood; CPD6; CYP2D; CYP2D@; CYP2D6 allele; CYP2D6 allele 1; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; Cytochrome p450; cytochrome P450, family 2, subfamily D, polypeptide 6; Debrisoquine hydroxylation gene; HGNC:2629; i; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; P450C2D; P450DB1; P450-DB1; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43533707	CYP2D6 allele 1 Bld/T	4180186
43533707	CYP2D6 基因 等位基因 1:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43533708	Busulfan Trough SerPl-mCnc	4180186
43533708	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Myleran; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43533708	白消安^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
43533709	Atovaquone SerPl-mCnc	4180186
43533709	Atavaquone; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mepron; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43533709	阿托伐醌:质量浓度:时间点:血清/血浆:定量型	4182948
43533710	Antigen; Antigens; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Islt; Isol; LAT; Latex agglutination; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; Screen; Spn; Strep; Strept	4180186
43533710	S pneum Ag Islt Ql LA	4180186
43533710	肺炎链球菌 抗原:存在情况或阈值:时间点:分离株:序数型:胶乳凝集试验法	4182948
43533712	Addiction; Bath salts; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; MDPV; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
43533712	MDPV Ur Ql Scn	4180186
43533712	亚甲基二氧吡咯戊酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
43533714	Repaglinide Ur-mCnc	4180186
43533714	DRUG/TOXICOLOGY; Drugs; GlucoNorm; Level; Mass concentration; NovoNorm; Point in time; Prandin; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43533714	瑞格列奈:质量浓度:时间点:尿液:定量型	4182948
43533715	Nateglinide Ur-mCnc	4180186
43533715	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Starlix; UA; UR; Urn	4180186
43533715	那格列奈:质量浓度:时间点:尿液:定量型	4182948
43533716	Amaryl; DRUG/TOXICOLOGY; Drugs; Glista OD; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43533716	Glimepiride Ur-mCnc	4180186
43533716	格列美脲:质量浓度:时间点:尿液:定量型	4182948
43533719	Blood; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Potassium hydroxide preparation; Prep; Random; WB; Whole blood	4180186
43533719	KOH Prep Bld	4180186
43533719	显微镜观察:存在与否或特征标识:时间点:全血:名义型:氢氧化钾制片法	4182948
43533720	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; HIV RT+PR+IN; Human immunodeficiency virus; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Mut; Mut Det; Mutation; Muts; Nominal; Point in time; PR; Random; REV; RT	4180186
43533720	Deprecated HIV RT+PR+IN Mut Det Islt	4180186
43533722	Asympt; Asymptomatic; CCHD NBS used; H&P.HX.LAB; H+P; H+P.HX; Lab; Narrative; New born; P prime; Point in time; Random; Report; Scn; Typ	4180186
43533722	CCHD NBS used Patient	4180186
43533722	所采用的 CCHD 新生儿筛查方案:类型:时间点:^患者:叙述型	4182948
43533724	Num CCHD screen Patient Ql	4180186
43533724	Cnt; Count; H&P.HX.LAB; H+P; H+P.HX; Lab; No; Num; Num CCHD screen; Number; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
43533724	既往 CCHD 筛查数量:数量(计数):时间点:^患者:序数型	4182948
43533725	CCHD NBS interp	4180186
43533725	Asympt; Asymptomatic; CCHD NBS interp; H+P; H+P.PX; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; New born; Nominal; P prime; Point in time; Random; Scn	4180186
43533725	CCHD 新生儿筛查解释:印象:时间点:^患者:名义型	4182948
43533727	EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MEIA; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; Nominal; Point in time; Random; SUDS; Typ	4180186
43533727	N men serosubtyp Islt IA	4180186
43533727	脑膜炎奈瑟菌 血清亚型:类型:时间点:分离株:名义型:免疫测定法	4182948
43533728	Dx; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Path report.Prelimin dx; PATHOLOGY; Point in time; Random; Spec	4180186
43533728	Path report.Prelimin dx Spec-Imp	4180186
43533728	病理学报告.初步诊断:印象:时间点:标本:名义型	4182948
43533730	Est; estimation; Fld; H+P; H+P.PX; Intracell fld; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
43533730	Intracell fld Vol Est	4180186
43533730	细胞内液:体积型属性:时间点:^患者:定量型:估计法	4182948
43533732	H+P; H+P.PX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43533732	Visceral fat Area Measured	4180186
43533732	内脏脂肪:面积:时间点:^患者:定量型:测量法	4182948
43533733	Body fat Calc	4180186
43533733	bod; Bodies; BODY WEIGHT.ATOM; Calc; Calculation; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43533733	身体脂肪质量:质量:时间点:^患者:定量型:计算法	4182948
43533734	DOC.ONT; Document; Finding; Findings; PharmD; Point in time; Prescrip rqst; Random; Rx	4180186
43533734	PharmD Pharm Prescrip rqst	4180186
43533734	处方请求:发现:时间点:药房:文档型:药师	4182948
43533740	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; e003; e004; e070; e085; e3; e4; e70; e85; Equus spp; f083; f158; f83; Feathers; Gallus spp; Immune globulin E; Immunoglobulin E; Occup Allerg Mix1; pax1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
43533740	Occup Allerg Mix1 IgE Qn	4180186
43533740	(鸡羽毛+奶牛羽毛+鹅羽毛+马毛屑) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533741	Occup Allerg Mix6 IgE Qn	4180186
43533741	1,2-benzenedicarboxylic acid anhydride; 1,2-benzenedicarboxylic anhydride; 1,3-dioxophthalan; 1,3-isobenzofurandione; 1,3-phthalandione; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Anhydrid; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chloramine T; EO; Formalin; Immune globulin E; Immunoglobulin E; k78; k79; k80; k85; Occup Allerg Mix6; PAN; pax6; Phthalandione; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; T prime	4180186
43533741	(氯胺 T+环氧乙烷+甲醛+邻苯二甲酸酐) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
43533745	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c261; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
43533745	Pholcodine IgE Qn	4180186
43533745	福尔可定 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
43533746	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c200; CROC; Esmeron; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Zemuron	4180186
43533746	Rocuronium IgE Qn	4180186
43533746	罗库溴铵 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
43533748	Vit B2 Bld-sCnc	4180186
43533748	Blood; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vit B2; Vitamin B2; WB; Whole blood	4180186
43533748	核黄素:物质的量浓度:时间点:全血:定量型	4182948
43533749	Acd; Acids; Bile acid.total; Bile salt; Chemistry; Di+Tri-OH Bile ac pnl; Di-OH Bile Ac; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tri OH; Tri-OH	4180186
43533749	Di+Tri-OH Bile ac pnl SerPl	4180186
43533749	胆汁酸二羟基与三羟基组套:-:时间点:血清/血浆:-	4182948
43533750	Bile acid pnl 24h Stl	4180186
43533750	1 day; 24 hours; 24HR; Acd; Acids; Bile acid pnl; Bile acid.total; Bile salt; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Pan; PANEL.CHEMISTRY; Panl; Pnl; Stl; Stool = Fecal	4180186
43533750	胆汁酸组套:-:24小时:大便:-	4182948
43533753	DRUG/TOXICOLOGY; Drugs; Mec; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
43533753	Norcocaine Mec Ql	4180186
43533753	去甲基可卡因:存在情况或阈值:时间点:胎便:序数型	4182948
43533754	Addiction; Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Ordinal; Pethidine; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
43533754	Meperidine Hair Ql	4180186
43533754	哌替啶:存在情况或阈值:时间点:毛发:序数型	4182948
43533755	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; LSD; Lysergic acid; Lysergic acid diethylamide; Mec; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
43533755	LSD Mec Ql	4180186
43533755	麦角二乙胺:存在情况或阈值:时间点:胎便:序数型	4182948
43533756	Catalytic Content; Chemistry; Lymphblst; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43533756	Transaldolase Lymphblst-cCnt	4180186
43533756	转醛醇酶:催化含量:时间点:淋巴母细胞:定量型	4182948
43533760	ACAD6; ACADVL known mut; acyl-CoA dehydrogenase, very long chain; Blood; Document; Fam Mut Anl; Finding; Findings; Genetics; Heredity; Heritable; Inherited; LCACD; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; PCR; Point in time; Random; Tissue; Tissue, unspecified; VLCAD; WB; Whole blood; Whole blood or Tissue	4180186
43533760	ACADVL Fam Mut Anl Bld/T	4180186
43533760	ACADVL 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
43533763	NBS reason not prfmed Ear-L	4180186
43533763	Ear-L; Finding; Findings; H+P; H+P.PX; Hearing; L; LT; NB hearing; NB hearing scn; NBS; NBS reason not prfmed; New born; Nominal; Otologic; P prime; Point in time; Random; Scn; Scr; Scrn	4180186
43533763	关于未进行新生儿听力筛查的原因:发现:时间点:耳.左侧:名义型	4182948
43533765	Audiology; Ear-L; H+P; Hearing; L; LT; NB hearing; NB hearing scn; NBS; NBS hear pnl; New born; Otologic; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn	4180186
43533765	NBS hear pnl Ear-L	4180186
43533765	新生儿听力筛查组套:-:时间点:耳.左侧:-	4182948
43533766	NBS reason not prfmed Ear-R	4180186
43533766	Ear-R; Finding; Findings; H+P; H+P.PX; Hearing; NB hearing; NB hearing scn; NBS; NBS reason not prfmed; New born; Nominal; Otologic; P prime; Point in time; R; Random; RT; Scn; Scr; Scrn	4180186
43533766	关于未进行新生儿听力筛查的原因:发现:时间点:耳.右侧:名义型	4182948
43533767	Screen dur Ear-R	4180186
43533767	Asympt; Asymptomatic; Durat; Ear-R; H+P; H+P.PX; Hearing; Otologic; P prime; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; Scn; Screen dur	4180186
43533767	筛查持续时间:时间:时间点:耳.右侧:定量型	4182948
43533768	Audiology; Ear-R; H+P; Hearing; NB hearing; NB hearing scn; NBS; NBS hear pnl; New born; Otologic; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; R; Random; RT; Scn; Scr; Scrn	4180186
43533768	NBS hear pnl Ear-R	4180186
43533768	新生儿听力筛查组套:-:时间点:耳.右侧:-	4182948
43533769	KLH IgA Ser-mCnc	4180186
43533769	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin A; Immunoglobulin A; KLH; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
43533769	钥孔戚血蓝蛋白 抗体.IgA:质量浓度:时间点:血清:定量型	4182948
43533770	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; KLH; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
43533770	KLH IgG Ser-mCnc	4180186
43533770	钥孔戚血蓝蛋白 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
43533771	KLH IgM Ser-mCnc	4180186
43533771	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin M; Immunoglobulin M; KLH; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
43533771	钥孔戚血蓝蛋白 抗体.IgM:质量浓度:时间点:血清:定量型	4182948
43533775	Blood; Chromosom; Chromosomes; Del; Deletions; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43533775	5p15.2 Del Bld/T FISH	4180186
43533775	5p15.2 染色体 缺失:存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
43533776	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Neurosyphilis; Nominal; Pl; Plasma; Plsm; Point in time; Random; Reagin+T pallidum; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Syphilis; T pallidum; Treponema; Treponemal	4180186
43533776	Reagin+T pallidum IgG+IgM SerPl-Imp	4180186
43533776	反应素抗体与梅毒螺旋体 抗体.IgG 与 IgM:印象:时间点:血清/血浆:名义型	4182948
43533777	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Lortab; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Vicodin	4180186
43533777	oxyCODONE Hair Ql	4180186
43533777	羟考酮:存在情况或阈值:时间点:毛发:序数型	4182948
43533782	Echography; Finding; Findings; Infant transferred 24H deliv; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533783	Echography; Finding; Findings; Hyst; Hysterot or hysterec; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US fetal death	4180186
43533785	@ birth; Echography; Fet pres; New born; Newborn; Nominal; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; Typ; ULS; Ultrasound; US live birth	4180186
43533786	Echography; Meth; Nominal; Point in time; Random; Route+delivery method; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; Typ; ULS; Ultrasound; US live birth	4180186
43533787	Echography; Finding; Findings; Mother transferred deliv; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533788	Echography; Nominal; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; Typ; ULS; Ultrasound; US live birth	4180186
43533790	Echography; Nominal; Place birth occur; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; Typ; ULS; Ultrasound; US live birth	4180186
43533792	Autopsy performed; Echography; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US fetal death	4180186
43533793	Echography; Gestation; Gestations; Gravida; Identity or presence; Nominal; Point in time; Pregnancies; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US fetal death	4180186
43533794	Admin; Fclty infnt tranfrd to; Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
43533797	Cnt; Count; No; Num; Num infants alive; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
43533799	Echography; Finding; Findings; Gestation; Gestations; Gravida; Mat; Maternal; Matnl; Nominal; Point in time; Pregnancies; Random; Risk factors in preg; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533800	Echography; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533801	Admin; Admitted; Ident; Identifier; Mother transfer deliv; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
43533802	Chromo kryotpe stat; Chromosome analysis; Echography; Finding; Findings; Genotype; Karyogram; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533806	Assessment; Eval; H&P; History and physical; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Neonate ulcer risk eval; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NSRAS; Ulcer	4180186
43533808	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NSRAS	4180186
43533809	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NSRAS	4180186
43533811	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NSRAS	4180186
43533812	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NSRAS	4180186
43533815	Infant active postductal Patient	4180186
43533815	Activ; Actvty; Finding; Findings; H&P.HX.LAB; H+P; H+P.HX; Infant active postductal; Lab; Movements; Nominal; O2; P prime; Point in time; Random; SaO2; SAT; Satn; SO2; tO2	4180186
43533815	在导管后氧饱和度测定过程中的婴儿活动:发现:时间点:^患者:名义型	4182948
43533817	Bld Postductal; Bld.foot; BldA.foot; Blood; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Lung; PF; Point in time; Postductal blood; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Ratios; Respiratory; Rto; SpO2; WB; Whole blood	4180186
43533817	Perfusion index Bld Postductal PulseOx	4180186
43533817	灌注指数:比率:时间点:全血.导管后:定量型:脉搏血氧定量法	4182948
43533818	Bld Postductal; Bld.foot; BldA.foot; Blood; Cardio; Cardiology; CARDIO-PULM; Count/time; Heart beat; Heart Disease; nRate; Number rate; Number Rate = Count/Time; Point in time; Postductal blood; PULMONARY; Pulse; PulseOx; QNT; Quan; Quant; Quantitative; Random; SpO2; WB; Whole blood	4180186
43533818	Heart rate Bld Postductal PulseOx	4180186
43533818	心率:计数型速率:时间点:全血.导管后:定量型:脉搏血氧定量法	4182948
43533819	Activ; Actvty; Finding; Findings; H&P.HX.LAB; H+P; H+P.HX; Infant active preductal; Lab; Movements; Nominal; O2; P prime; Point in time; Random; SaO2; SAT; Satn; SO2; tO2	4180186
43533819	Infant active preductal Patient	4180186
43533819	在导管前氧饱和度测定过程中的婴儿活动:发现:时间点:^患者:名义型	4182948
43533820	Bld Preductal; Bld.right hand; BldA.right hand; Blood; Cardio; Cardiology; CARDIO-PULM; Finding; Findings; Heart Disease; Lung; Ordinal; Point in time; Preductal blood; PULMONARY; Pulmonology; PulseOx; Ql; Qual; Qualitative; Random; Respiratory; Screen; SpO2; WB; Whole blood	4180186
43533820	Signal quality Bld Preductal PulseOx	4180186
43533820	信号质量:发现:时间点:全血.导管前:序数型:脉搏血氧定量法	4182948
43533821	Bld Preductal; Bld.right hand; BldA.right hand; Blood; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Lung; PF; Point in time; Preductal blood; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Ratios; Respiratory; Rto; SpO2; WB; Whole blood	4180186
43533821	Perfusion index Bld Preductal PulseOx	4180186
43533821	灌注指数:比率:时间点:全血.导管前:定量型:脉搏血氧定量法	4182948
43533822	Bld Preductal; Bld.right hand; BldA.right hand; Blood; Cardio; Cardiology; CARDIO-PULM; Count/time; Heart beat; Heart Disease; nRate; Number rate; Number Rate = Count/Time; Point in time; Preductal blood; PULMONARY; Pulse; PulseOx; QNT; Quan; Quant; Quantitative; Random; SpO2; WB; Whole blood	4180186
43533822	Heart rate Bld Preductal PulseOx	4180186
43533822	心率:计数型速率:时间点:全血.导管前:定量型:脉搏血氧定量法	4182948
43533823	Nominal; O2; Point in time; Random; SaO2; SaO2% Device; SaO2% sensor wrap size; SAT; Satn; SO2; tO2; Typ	4180186
43533823	SaO2% Device SaO2% sensor wrap size	4180186
43533823	氧饱和度传感器绑带尺寸:类型:时间点:氧饱和度装置:名义型	4182948
43533824	Nominal; O2; Point in time; Random; SaO2; SaO2% Device; SaO2% sensor wrp type; SAT; Satn; SO2; tO2; Typ	4180186
43533824	SaO2% Device SaO2% sensor wrp type	4180186
43533824	氧饱和度传感器绑带类型:类型:时间点:氧饱和度装置:名义型	4182948
43533828	Asympt; Asymptomatic; CCHD NBS Pnl; H+P; NB Screen Pnl; NBS; New born; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Scn	4180186
43533828	CCHD NBS Pnl	4180186
43533828	CCHD 新生儿筛查组套:-:时间点:^患者:-	4182948
43533829	H+P; H+P.PX; New born; Nwbrn age hours; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
43533829	Nwbrn age hours	4180186
43533829	按小时数计算的新生儿年龄:时间:时间点:^患者:定量型	4182948
43533831	B+T cell XM Ser+Bld FC-Imp	4180186
43533831	B 细胞+T 细胞交叉配型:印象:时间点:血清+全血:序数型:流式细胞测量术	4182948
43533831	B+T cell; B+T cell XM; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; Blood; BLOOD BANK; Both serum and blood; Dynamic; FC; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SerBld; Serum; Serum or whole blood; SR; T Cell XM; T prime; UCHL-1; WB; Whole blood	4180186
43533832	B+T cell XM Ser+Bld CDC-Imp	4180186
43533832	B 细胞+T 细胞交叉配型:印象:时间点:血清+全血:序数型:补体依赖的细胞毒性试验	4182948
43533832	B+T cell; B+T cell XM; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; Blood; BLOOD BANK; Both serum and blood; CDC; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SerBld; Serum; Serum or whole blood; SR; T Cell XM; T prime; UCHL-1; WB; Whole blood	4180186
43533836	Characteristics of L+D; Echography; Finding; Findings; Nominal; Point in time; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533837	Echography; Finding; Findings; Nominal; OB; Obstetrical; Obstetrics; Point in time; Pregnancy; Prenatal; Random; Sonogram; Sonograph; Sonography; Survey; SURVEY.CDC; ULS; Ultrasound; US live birth	4180186
43533839	PF4 heparin cmplx IgG Ser-Imp	4180186
43533839	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Compx; Fac; Fact; HAT; Hep; Hepar; Heparin associated thrombycytopenia; Heparin dependent antibodies; Heparin induced thromocytopenia; Heparn; HIT; HITA; Immune globulin G; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; PF; PF4; PF4 heparin cmplx; PF4-heparin Ab; PI-factor 4; Pl; Platelet Ab.heparin induced; Platelet type heparin inactivator; Platelets; Platelt; Plt; Point in time; Random; Report; Serology; Serum; SR; Thrombocyte; Thrombocytes	4180186
43533839	血小板因子 4 肝素复合物诱导型 抗体.IgG:印象:时间点:血清:叙述型	4182948
43533840	Prcnt hep inhibited Ser-Rto	4180186
43533840	Hep; Hepar; Heparn; Point in time; Prcnt hep inhibited; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Serology; Serum; SR	4180186
43533840	肝素抑制百分数:比率:时间点:血清:定量型	4182948
43533842	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Compx; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; HAT; Hep; Hepar; Heparin associated thrombycytopenia; Heparin dependent antibodies; Heparin induced thromocytopenia; Heparn; HIT; HITA; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; PF; PF4; PF4 heparin cmplx; PF4-heparin Ab; PI-factor 4; Pl; Plasma; Platelet Ab.heparin induced; Platelet type heparin inactivator; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Thrombocyte; Thrombocytes	4180186
43533842	PF4 heparin cmplx IgG SerPl Ql IA	4180186
43533842	血小板因子 4 肝素复合物诱导型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
43533844	Chr X + Y aneup; Chr X + Y aneup risk; Chromosom; Chromosomes; Molecular pathology; MOLPATH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Spec	4180186
43533844	Fet Chr X + Y aneup risk Plas.cfDNA Qn	4180186
43533844	胎儿染色体 X 与 Y 非整倍体性风险:似然性:时间点:血浆.cfDNA:定量型:染色体特异性 cfDNA 剂量测定	4182948
43533845	Chr X + Y aneup; Chromosom; Chromosomes; Finding; Findings; Molecular pathology; MOLPATH; Nominal; Pl; Plasma; Plsm; Point in time; Random; Spec	4180186
43533845	Chr X + Y aneup Plas.cfDNA	4180186
43533845	胎儿染色体 X & Y 非整倍体性:发现:时间点:血浆.cfDNA:名义型:染色体特异性 cfDNA 剂量测定	4182948
43533848	Chromosom; Chromosomes; Edward syndrome; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; T18 risk; Ts; Ts 18 risk	4180186
43533848	Fet Ts 18 risk Plas.cfDNA Ql	4180186
43533848	胎儿三体型 18 风险:印象:时间点:血浆.cfDNA:序数型:染色体特异性 cfDNA 剂量测定	4182948
43533849	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dalmane; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Flurazepam+Desalkyl; GCMS; Level; Mass concentration; norfludiazepam; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
43533849	Flurazepam+Desalkyl SerPlBld Cfm-mCnc	4180186
43533849	氟胺安定+N-去烷基氟胺安定:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
43533850	4-hydroxybutyrate; 4-hydroxybutyric acid; Blood; DRUG/TOXICOLOGY; Drugs; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Level; Liquidx; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
43533850	G-OH-Butyr SerPlBld-mCnc	4180186
43533850	Gamma 羟基丁酸:质量浓度:时间点:血清/血浆/全血:定量型	4182948
43533852	7-amino flunitrazepam; 7Aminoflunitrazepam; Blood; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
43533852	7Aminoflunitrazepam SerPlBld-mCnc	4180186
43533852	7-氨基氟硝安定:质量浓度:时间点:血清/血浆/全血:定量型	4182948
43533854	Adlscnt depress scrn assess	4180186
43533854	Adlscnt depress scrn assess; Asympt; Asymptomatic; H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Scn; Screen	4180186
43533854	青少年抑郁筛查评估:印象:时间点:^患者:序数型	4182948
43533856	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Legion; Legionela; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; species; spp; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
43533856	Legionella Ab Spec Ql IF	4180186
43533856	军团菌属单个未知种 抗体:存在情况或阈值:时间点:XXX:序数型:免疫荧光法	4182948
43533859	Anus; Bact; Bacteria.Flqr; Bacteria.fluoroq resist; C&S; Cult; Cultures; FLQ; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Rectal specimen; Spec	4180186
43533859	Bacteria.fluoroq resist Anal Cult	4180186
43533859	细菌.氟喹诺酮耐药性 已鉴定的:存在与否或特征标识:时间点:肛门:名义型:微生物特异性培养	4182948
43533861	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; THA; UA; UR; Urn	4180186
43533861	THA Ur-sCnc	4180186
43533861	11-脱氢四氢皮质酮:物质的量浓度:时间点:尿液:定量型	4182948
43533862	THA 24h Ur-sCnc	4180186
43533862	1 day; 24 hours; 24HR; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; THA; UA; UR; Urn	4180186
43533862	11-脱氢四氢皮质酮:物质的量浓度:24小时:尿液:定量型	4182948
43533863	THA 24h Ur-sRate	4180186
43533863	1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; THA; UA; UR; Urn	4180186
43533863	11-脱氢四氢皮质酮:物质的量速率:24小时:尿液:定量型	4182948
43533866	1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; tetrahydro-11-deoxycortisol; TH-DC; UA; UR; Urn	4180186
43533866	TH-DC 24h Ur-sRate	4180186
43533866	四氢脱氧皮质醇:物质的量速率:24小时:尿液:定量型	4182948
43533867	16A OH-DHEA Ur-sCnc	4180186
43533867	16 alphaOH-DHEA; 16A OH-DHEA; 16-Alpha hydroxy dehydroepiandrosterone; 16-alpha-hydroxy-DHEA; Alfa; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533867	16-Alpha 羟-脱氢表雄甾酮:物质的量浓度:时间点:尿液:定量型	4182948
43533872	16-Ketoandrostenediol Ur-sCnc	4180186
43533872	16-oxoandrostenediol; 3 beta,17 beta-dihydroxyandrost-5-en-16-one; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533872	16-酮雄烯二醇:物质的量浓度:时间点:尿液:定量型	4182948
43533874	GRA 24h Ur-mCnc	4180186
43533874	1 day; 24 hours; 24HR; B; Chemistry; GRA; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
43533874	18-Beta 甘草次酸:质量浓度:24小时:尿液:定量型	4182948
43533875	7-DHC; 7-DHC+8-DHC Pnl; 8-DHC; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43533875	7-DHC+8-DHC Pnl SerPl	4180186
43533875	7-脱氢胆固醇与8-脱氢胆固醇组套:-:时间点:血清/血浆:-	4182948
43533878	Aldost-18 G; Aldosterone metabolite; Chemistry; Gluc; Glucouronide; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533878	Aldost-18 G Ur-sCnc	4180186
43533878	醛固酮-18-葡糖苷酸:物质的量浓度:时间点:尿液:定量型	4182948
43533880	Allo-pregnanediol 24h Ur-sRate	4180186
43533880	1 day; 24 hours; 24HR; 5alpha-pregnane-3alpha-20alpha-diol; Chemistry; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533880	别-孕二醇:物质的量速率:24小时:尿液:定量型	4182948
43533883	Allo-THB 24h Ur-sCnc	4180186
43533883	1 day; 24 hours; 24HR; 5-alpha tetrahydrocorticosterone; 5a-tetrahydrocorticosterone; Allo-THB; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; THB; UA; UR; Urn	4180186
43533883	别-四氢皮质酮:物质的量浓度:24小时:尿液:定量型	4182948
43533885	1 day; 24 hours; 24HR; Allo THC; Allo-THF; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; THC; THF; UA; UR; Urn	4180186
43533885	Allo-THF 24h Ur-sRate	4180186
43533885	别-四氢皮质醇:物质的量速率:24小时:尿液:定量型	4182948
43533889	Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines 3 + creat Pnl; Catecholamines.total; Catechols; Chemistry; CR; Crea; Creat; Creat Pnl; Epinephrine+norepinephrine+dopamine; III; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
43533889	Catecholamines 3 + creat Pnl Ur-sRto	4180186
43533889	儿茶酚胺类 3 项与肌酐组套:物质的量比率:时间点:尿液:-	4182948
43533890	1 day; 24 hours; 24HR; A-Cortol; Alfa; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533890	A-Cortol 24h Ur-sRate	4180186
43533890	Alpha 皮五醇:物质的量速率:24小时:尿液:定量型	4182948
43533891	A-Cortol; Alfa; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533891	A-Cortol Ur-sCnc	4180186
43533891	Alpha 皮五醇:物质的量浓度:时间点:尿液:定量型	4182948
43533892	1 day; 24 hours; 24HR; A-Cortol; Alfa; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533892	A-Cortol 24h Ur-sCnc	4180186
43533892	Alpha 皮五醇:物质的量浓度:24小时:尿液:定量型	4182948
43533893	A-cortolone 24h Ur-sRate	4180186
43533893	1 day; 24 hours; 24HR; A-cortolone; Alfa; Chemistry; Cortisol metabolite; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533893	Alpha-皮酮四醇:物质的量速率:24小时:尿液:定量型	4182948
43533894	A-cortolone; Alfa; Chemistry; Cortisol metabolite; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43533894	A-cortolone Ur-sCnc	4180186
43533894	Alpha-皮酮四醇:物质的量浓度:时间点:尿液:定量型	4182948
43533897	AET 24h Ur-sRate	4180186
43533897	1 day; 24 hours; 24HR; 5 androstene, 3beta, 7beta, 17beta triol; 5-androstene-3 beta-7 beta-17 beta-triol; 5-AT; AET; beta AET; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
43533897	雄烯三醇:物质的量速率:24小时:尿液:定量型	4182948
43533901	B-cortolone 24h Ur-sCnc	4180186
43533901	1 day; 24 hours; 24HR; B; B-cortolone; Chemistry; Cortisol metabolite; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533901	Beta-皮酮四醇:物质的量浓度:24小时:尿液:定量型	4182948
43533905	1 day; 24 hours; 24HR; Chemistry; Glycolic acid; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
43533905	Glycolate 24h Ur-sCnc	4180186
43533905	羟乙酸:物质的量浓度:24小时:尿液:定量型	4182948
43533908	1 day; 24 hours; 24HR; CAH; Chemistry; Congenital adrenal hyperplasia; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pnl; Steroid Fract Pnl; UA; UR; Urn	4180186
43533908	Steroid Fract Pnl 24h Ur	4180186
43533908	类固醇类成分组套:-:24小时:尿液:-	4182948
43533909	CAH; Chemistry; Congenital adrenal hyperplasia; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Steroid Fract Pnl; UA; UR; Urn	4180186
43533909	Steroid Fract Pnl Ur	4180186
43533909	类固醇类成分组套:-:时间点:尿液:-	4182948
43533912	THB Ur-sCnc	4180186
43533912	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; THB; UA; UR; Urn	4180186
43533912	四氢皮质酮:物质的量浓度:时间点:尿液:定量型	4182948
43533916	THcortisone 24h Ur-sCnc	4180186
43533916	1 day; 24 hours; 24HR; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; THcortisone; UA; UR; Urn	4180186
43533916	四氢可的松:物质的量浓度:24小时:尿液:定量型	4182948
43533917	THcortisone Ur-sCnc	4180186
43533917	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; THcortisone; UA; UR; Urn	4180186
43533917	四氢可的松:物质的量浓度:时间点:尿液:定量型	4182948
43533919	Blood; CELL MARKERS; Chronic lyme dis Pnl; Dis; Diseases; Dynamic; Dz; FC; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
43533919	Chronic lyme dis Pnl Bld FC	4180186
43533919	慢性莱姆病组套:-:时间点:全血:-:流式细胞测量术	4182948
43533920	CD8-CD57+ Cells/lymph NFr Bld FC	4180186
43533920	Blood; CD8 Cells; CD8+CD57+ Cells; CD8-CD57+ Cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HNK1; Leu2; Leu-2; Leu7; Leu-7; Lyme disease; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Natural killer cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
43533920	细胞.CD8-CD57+/100 个淋巴细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
43533922	100WBC; Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD57+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HNK1; Leu2; Leu-2; Leu4; Leu-4; Leu7; Leu-7; Leuc; Leuk; Leukocyte; Lkcs; Lyme disease; Natural killer cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43533922	CD3-CD8-CD57+/leuk NFr Bld FC	4180186
43533922	细胞.CD3-CD8-CD57+/100 个白细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
43533923	Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD57+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HNK1; Leu2; Leu-2; Leu4; Leu-4; Leu7; Leu-7; Lyme disease; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Natural killer cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood	4180186
43533923	CD3-CD8-CD57+/lymph NFr Bld FC	4180186
43533923	细胞.CD3-CD8-CD57+/100 个淋巴细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
43533925	100WBC; Blood; CD3 Cells; CD3+CD57+ Cells; CD3-CD57+ Cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HNK1; Leu4; Leu-4; Leu7; Leu-7; Leuc; Leuk; Leukocyte; Lkcs; Lyme disease; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
43533925	CD3-CD57+ Cells/leuk NFr Bld FC	4180186
43533925	细胞.CD3-CD57+/100 个白细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
43533927	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 & 2; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
43533927	HIV1+2 IgG SerPl Ql IA.rapid	4180186
43533927	HIV 1 型+2 型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法.快速	4182948
43533928	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 & 2; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; WB; Whole blood	4180186
43533928	HIV1+2 IgG Bld Ql IA.rapid	4180186
43533928	HIV 1 型+2 型 抗体.IgG:存在情况或阈值:时间点:全血:序数型:免疫测定法.快速	4182948
43533929	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Poliovirus; PV; Random; Spec; To be specified in another part of the message; Unspecified	4180186
43533929	PV Spec Cult	4180186
43533929	脊髓灰质炎病毒 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:微生物特异性培养	4182948
43533933	SOX10 Ag Tiss Ql ImStn	4180186
43533933	Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
43533933	SOX10 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
43533934	Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
43533934	DOG1 Ag Tiss Ql ImStn	4180186
43533934	DOG1 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
43533935	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Gly; Glycine CSF:Pl; Glycine encephalopathy; NKH; non-ketotic hyperglycinemia; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RlSCnc; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
43533935	Glycine CSF/Glycine plas	4180186
43533935	脑脊液甘氨酸/血浆甘氨酸:相对物质的量浓度:时间点:血浆+脑脊液:定量型	4182948
43533937	DMAA; DRUG/TOXICOLOGY; Drugs; Forthane; Geranamine; Geranium Oil; i; III; Methylhexanamine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
43533937	DMAA Ur Ql Scn	4180186
43533937	1,3-二甲基戊胺:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
43533938	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DMAA; DRUG/TOXICOLOGY; Drugs; Forthane; GCMS; Geranamine; Geranium Oil; i; III; Level; Mass concentration; Methylhexanamine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43533938	DMAA Ur Cfm-mCnc	4180186
43533938	1,3-二甲基戊胺:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43533939	JWH-250 4/5-OH-pentyl Ur Ql Cfm	4180186
43533939	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; JWH-250 4/5-OH-pentyl; K2; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43533939	JWH-250 4+5-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
43533943	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; III; Illicit; JWH-073 3OH-butyl; JWH-073 N-(3-hydroxybutyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533943	JWH-073 3OH-butyl Bld Ql	4180186
43533943	JWH-073 3-羟丁基:存在情况或阈值:时间点:全血:序数型	4182948
43533948	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-073 4OH-butyl; JWH-073 N-(4-hydroxybutyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533948	JWH-073 4OH-butyl Bld Ql	4180186
43533948	JWH-073 4-羟丁基:存在情况或阈值:时间点:全血:序数型	4182948
43533949	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-073 N-Butanoic acid metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533949	JWH-073 butanoate Bld Ql	4180186
43533949	JWH-073 丁酸:存在情况或阈值:时间点:全血:序数型	4182948
43533950	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; JWH-250 5OH-pentyl; JWH-250 N-(5-hydroxypentyl) metabolite; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533950	JWH-250 5OH-pentyl Bld Ql	4180186
43533950	JWH-250 5-羟戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533952	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; RCS-4 N-(5-carboxypentyl) metabolite; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533952	RCS-4 5-carboxypentyl Bld Ql	4180186
43533952	RCS-4 5-羧戊基:存在情况或阈值:时间点:全血:序数型	4182948
43533953	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; n-propanol; n-propyl alcohol; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
43533953	Propanol Ur-mCnc	4180186
43533953	丙醇:质量浓度:时间点:尿液:定量型	4182948
43533954	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tramal; Ultram; WB; Whole blood	4180186
43533954	traMADol Bld-mCnc	4180186
43533954	曲马多:质量浓度:时间点:全血:定量型	4182948
43533955	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Meperidine metabolite; Norpethidine; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
43533955	Normeperidine SerPlBld-mCnc	4180186
43533955	去甲基哌替啶:质量浓度:时间点:血清/血浆/全血:定量型	4182948
43533956	Addiction; Algil; Alodan; Blood; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Pethidine; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
43533956	Meperidine SerPlBld-mCnc	4180186
43533956	哌替啶:质量浓度:时间点:血清/血浆/全血:定量型	4182948
43533958	Actiq; Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sublimaze; WB; Whole blood	4180186
43533958	fentaNYL Bld Ql Scn	4180186
43533958	芬太尼:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
43533960	Actiq; Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sublimaze; WB; Whole blood	4180186
43533960	fentaNYL Bld Cfm-mCnc	4180186
43533960	芬太尼:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
43533961	HYDROcodone Free Bld-mCnc	4180186
43533961	Anexsia; Blood; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; FR; HYDROcodone Free; Level; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Vicodin; WB; Whole blood	4180186
43533961	氢可酮.游离型:质量浓度:时间点:全血:定量型	4182948
43533962	Blood; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; FR; Hydromorphinone; HYDROmorphone Free; Level; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
43533962	HYDROmorphone Free Bld-mCnc	4180186
43533962	二氢吗啡酮.游离型:质量浓度:时间点:全血:定量型	4182948
43533967	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533967	UR-144 Bld Ql	4180186
43533967	UR-144:存在情况或阈值:时间点:全血:序数型	4182948
43533968	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533968	JWH-200 Bld Ql	4180186
43533968	JWH-200:存在情况或阈值:时间点:全血:序数型	4182948
43533970	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533970	JWH-122 Bld Ql	4180186
43533970	JWH-122:存在情况或阈值:时间点:全血:序数型	4182948
43533972	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533972	JWH-250 Bld Ql	4180186
43533972	JWH-250:存在情况或阈值:时间点:全血:序数型	4182948
43533973	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; WB; Whole blood; Yucatan Fire	4180186
43533973	RCS-4 Bld Ql	4180186
43533973	RCS-4:存在情况或阈值:时间点:全血:序数型	4182948
43533983	Bld Pos; Blood; E coli; Ecoli+Kpneu+Paer rRNA; Ecoli+Kpneu+Paeru; Fluorescent in situ hybridization; ID; Identity or presence; Infectious Disease; InfectiousDisease; K pneumon; Microbiology; Nominal; o002; P aeruginosa; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Random; ribosomal RNA; WB; Whole blood	4180186
43533983	Ecoli+Kpneu+Paeru rRNA Bld Pos FISH	4180186
43533983	大肠埃希菌与肺炎克雷伯菌与铜绿假单胞菌 rRNA:存在与否或特征标识:时间点:血液.生长阳性:名义型:FISH	4182948
43533988	Chromosom; Chromosomes; Down syndrome; Downs; Down's syndrome; ds; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Ts; Ts 21 risk	4180186
43533988	Fet Ts 21 risk Plas.cfDNA Ql	4180186
43533988	胎儿三体型 21 风险:印象:时间点:血浆.cfDNA:序数型:染色体特异性 cfDNA 剂量测定	4182948
43533989	Molecular pathology; MOLPATH; NIP fet aneu Pnl; NIPS; Non-invasive prenatal screening; Noninvasive prenatal testing; NPT; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random	4180186
43533989	NIP fet aneu Pnl Plas.cfDNA	4180186
43533989	无创性产前胎儿非整倍体性试验组套:-:时间点:血浆.cfDNA:-	4182948
43533990	Chromosom; Chromosomes; Edward syndrome; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Spec; T18 risk; Ts; Ts 18 risk	4180186
43533990	Fet Ts 18 risk Plas.cfDNA Qn	4180186
43533990	胎儿三体型 18 风险:似然性:时间点:血浆.cfDNA:定量型:染色体特异性 cfDNA 剂量测定	4182948
43533992	Chromosom; Chromosomes; Down syndrome; Downs; Down's syndrome; ds; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Spec; Ts; Ts 21 risk	4180186
43533992	Fet Ts 21 risk Plas.cfDNA Qn	4180186
43533992	胎儿三体型 21 风险:似然性:时间点:血浆.cfDNA:定量型:染色体特异性 cfDNA 剂量测定	4182948
43533993	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MDA; MDEA; MDMA; MDMA+MDEA+MDA; Methylenedioxymethamphetamine metabolite; Ordinal; Point in time; PotentialForAbuse; Ql; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
43533993	MDMA+MDEA+MDA Ur-Imp	4180186
43533993	亚甲基二氧甲基苯丙胺+亚甲基二乙氧基苯丙胺+亚甲基二氧苯丙胺:印象:时间点:尿液:序数型	4182948
43533994	Blood; c260; DRUG/TOXICOLOGY; Drugs; FR; Level; Mass concentration; Morphine Free; Morphine sulfate; MS; MSO4; Non-protein bound; OMPH; Point in time; QNT; Quan; Quant; Quantitative; Random; unconjugated morphine; WB; Whole blood	4180186
43533994	Morphine Free Bld-mCnc	4180186
43533994	吗啡.游离型:质量浓度:时间点:全血:定量型	4182948
43533996	Cell; CELL MARKERS; Cellularity; Gated cells; Killer cell Immunoglobulin-like Recptor; KIR family; KIR3DL1; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
43533996	Cells.CD158e NFr Spec	4180186
43533996	细胞.CD158e/100 个细胞:计数型分数:时间点:XXX:定量型	4182948
43533997	CD158a cells NFr Spec	4180186
43533997	CD158a cells; Cell; CELL MARKERS; Cellularity; Gated cells; Killer cell Immunoglobulin-like Recptor; KIR family; KIR2DL1; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
43533997	细胞.CD158a/100 个细胞:计数型分数:时间点:XXX:定量型	4182948
43533999	癌症相关多基因分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
43533999	Blood; Cancer multigene analysis; Document; Finding; Findings; Gene; Gene panel; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43533999	Cancer multigene analysis Bld/T	4180186
43534004	Bil; Bilat; Both; Cardio; Cardiology; Document; DOP; DUPLEX; Echography; EXT; Extr aa-Bl; Extr-Bl; Finding; Findings; Heart Disease; Imaging; LMTED; LTD; Phys stdy Ltd; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound	4180186
43534004	DOP Extr aa-Bl Phys stdy Ltd	4180186
43534004	针对生理学动脉检查的局部多层:发现:时间点:肢体.双侧>肢体动脉类:文档型:超声.多普勒	4182948
43534010	ANTIBIOTIC SUSCEPTIBILITIES; Bact; c162; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; VANC; Vancocin; Vancomycin resistance gene; Vancor	4180186
43534010	vanC1 Islt/Spm Ql	4180186
43534010	细菌万古霉素耐药 vanC1 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534015	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 233; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534015	HBV 233 Islt Genotyp	4180186
43534015	乙型肝炎病毒 密码子 233:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534018	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 202; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534018	HBV 202 Islt Genotyp	4180186
43534018	乙型肝炎病毒 密码子 202:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534019	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 194; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534019	HBV 194 Islt Genotyp	4180186
43534019	乙型肝炎病毒 密码子 194:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534020	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 191; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534020	HBV 191 Islt Genotyp	4180186
43534020	乙型肝炎病毒 密码子 191:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534022	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HBV; HBV 169; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Nominal; Point in time; Random	4180186
43534022	HBV 169 Islt Genotyp	4180186
43534022	乙型肝炎病毒 密码子 169:存在与否或特征标识:时间点:分离株:名义型:基因分型	4182948
43534025	CMV resis Pnl Islt Genotyp	4180186
43534025	ANTIBIOTIC SUSCEPTIBILITIES; CMV; CMV resis Pnl; Cytomegalo virus; Cytomgal; Genotype; Genotypic; HHV-5; Human Herpesvirus-5; Islt; Isol; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent	4180186
43534025	巨细胞病毒耐药组套:-:时间点:分离株:-:基因分型	4182948
43534026	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBV; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43534026	Maribavir Islt Genotyp	4180186
43534026	马立巴韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43534027	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cytovene; GCV; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Valcyte; Valganciclovir	4180186
43534027	Ganciclovir Islt Genotyp	4180186
43534027	更昔洛韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43534029	ANTIBIOTIC SUSCEPTIBILITIES; AST; CDV; Genotype; Genotypic; HPMPC; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vistide	4180186
43534029	Cidofovir Islt Genotyp	4180186
43534029	西多福韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43534030	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43534030	Dolutegravir Islt Genotyp	4180186
43534030	度鲁特韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43534031	ANTIBIOTIC SUSCEPTIBILITIES; AST; Fuzeon; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
43534031	Enfuvirtide Islt Genotyp	4180186
43534031	恩夫韦地:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43534032	ANTIBIOTIC SUSCEPTIBILITIES; AST; BOC; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Victrelis	4180186
43534032	Boceprevir Islt Genotyp	4180186
43534032	波普瑞韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43534033	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Incivek; Incivo; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TVR; VX-950	4180186
43534033	Telaprevir Islt Genotyp	4180186
43534033	特拉匹韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
43534034	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cytovene; GCV; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Pheno; Phenotype; Phenotypic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Valcyte; Valganciclovir; Virtual Phenotype	4180186
43534034	Ganciclovir Islt Phenotyp	4180186
43534034	更昔洛韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
43534035	ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HCV; HCV resis panell; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent	4180186
43534035	HCV resis panell Islt Genotyp	4180186
43534035	丙型肝炎病毒耐药组套:-:时间点:分离株:-:基因分型	4182948
43534036	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; FLQ; Hansen Disease; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M leprae gyrB FLQ res mut; Molecular genetics; Mut; Mutations; Myco; Mycobact; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Tuberculosis	4180186
43534036	M leprae gyrB FLQ res mut Islt/Spm Ql	4180186
43534036	麻风分枝杆菌 gyrB 基因氟喹诺酮耐药突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534037	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amikacin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; c288; Gentamicin; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M tb; M tuberculosis; Molecular genetics; Mtb; MTB rpsL+rrs AMG res mut; Mut; Mutations; Myco; Mycobact; Mycobacterium tuberculosum; Neomycin; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Streptomycin; TB; Tobramycin; Tuberculosis	4180186
43534037	MTB rpsL+rrs AMG res mut Islt/Spm Ql	4180186
43534037	结核分枝杆菌 rpsL+rrs 基因氨基糖苷类耐药突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534039	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M tb; M tuberculosis; Molecular genetics; Mtb; MTB ethA ethion res mut; Mut; Mutations; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; TB; Trecator; Tuberculosis	4180186
43534039	MTB ethA ethion res mut Islt/Spm Ql	4180186
43534039	结核分枝杆菌 ethA 基因乙硫异烟胺耐药突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534040	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; FLQ; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M tb; M tuberculosis; Molecular genetics; Mtb; MTB gyrB fluoroquin res mut; Mut; Mutations; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; TB; Tuberculosis	4180186
43534040	MTB gyrB fluoroquin res mut Islt/Spm Ql	4180186
43534040	结核分枝杆菌 gyrB 基因氟喹诺酮类药物耐药突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534041	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; DDS; Hansen Disease; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M leprae folP1 dap res mut; Molecular genetics; Mut; Mutations; Myco; Mycobact; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Tuberculosis	4180186
43534041	M leprae folP1 dap res mut Islt/Spm Ql	4180186
43534041	麻风分枝杆菌 folP1 基因氨苯砜耐药突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534042	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; FLQ; Hansen Disease; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M leprae gyrA FLQ res mut; Molecular genetics; Mut; Mutations; Myco; Mycobact; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Tuberculosis	4180186
43534042	M leprae gyrA FLQ res mut Islt/Spm Ql	4180186
43534042	麻风分枝杆菌 gyrA 基因氟喹诺酮耐药突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
43534044	DOCUMENT.REGULATORY; Drugs; FDA label; Narrative; NDC lbl rqst.anml drg; Report	4180186
43534044	FDA label NDC lbl rqst.anml drg	4180186
43534044	NDC 贴签厂商代码申请.兽药:-:-:^FDA 产品标签:叙述型	4182948
43534045	Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Lactase; lactase persistence; lactase tolerance; MCG40308; MCM6 -13910C&gt;T + -13915T&gt;G; minichromosome maintenance complex component 6; Mis5; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; P105MCM; PCR; Point in time; Random; rs4988235; T prime; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43534045	MCM6 -13910C>T + -13915T>G Bld/T	4180186
43534045	MCM6 基因.c.-13910C>T 与 -13915T>G:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43534047	JWH-073 butanol/Creat Ur	4180186
43534047	1-butanol; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; K2; Mass concentration ratio; Mass ratio; MCRto; n-butanol; n-butyl alcohol; Point in time; Propyl carbinol; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UCr; UR; Urn; Yucatan Fire	4180186
43534047	JWH-073 丁醇/肌酐:质量比率:时间点:尿液:定量型	4182948
43534048	1-butanol; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; K2; Level; Mass concentration; n-butanol; n-butyl alcohol; Point in time; Propyl carbinol; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
43534048	JWH-073 butanol Ur Cfm-mCnc	4180186
43534048	JWH-073 丁醇:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
43534050	Document; Films; Finding; Findings; Imaging; Plain Films; Point in time; Rad; RADIOLOGY; Random; Spec; Surg; Surg Spec; View; VWS; Xray; X-ray	4180186
43534050	XR Surg Spec Views	4180186
43534050	多重视图:发现:时间点:^外科手术标本:文档型:X射线摄影术	4182948
43534051	Bld/T/S; Blood; CPB6; CYP2B; CYP2B7; CYP2B7P; CYPIIB6; cytochrome P450, family 2, subfamily B, polypeptide 6; drg metab interp; Drug metab analysis interp; Drugs; EFVM; Genetics; Heredity; Heritable; IIB1; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P450; PCR; Point in time; predicted phenotype; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43534051	Deprecated CYP2B6 drg metab interp Bld/T/S-Imp	4180186
43534054	Bld/T/S; Blood; CPD6; CYP2D; CYP2D@; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; Cytochrome p450; cytochrome P450, family 2, subfamily D, polypeptide 6; Debrisoquine hydroxylation gene; drg metab interp; Drug metab analysis interp; Drugs; Genetics; Heredity; Heritable; HGNC:2629; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P450C2D; P450DB1; P450-DB1; PCR; Point in time; predicted phenotype; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43534054	Deprecated CYP2D6 drg metab interp Bld/T/S-Imp	4180186
43534055	Blood; Genetics; Heredity; Heritable; HLUG4; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 2 family, polypeptide B15; UDPGT 2B8; UDPGT2B15; UDPGTH3; UGT2B8; WB; Whole blood; Whole blood or Tissue	4180186
43534055	UGT2B15 Mut Anl Bld/T	4180186
43534055	UGT2B15 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43534056	Blood; CPB6; CYP2B; CYP2B6 allele; CYP2B7; CYP2B7P; CYPIIB6; cytochrome P450, family 2, subfamily B, polypeptide 6; EFVM; Genetics; Heredity; Heritable; IIB1; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; P450; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43534056	CYP2B6 allele Geno Bld/T	4180186
43534056	CYP2B6 基因等位基因:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43534057	Blood; CPE1; CYP2E; cytochrome P450, family 2, subfamily E, polypeptide 1; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; P450C2E; P450-J; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43534057	CYP2E1 Mut Anl Bld/T	4180186
43534057	CYP2E1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
43534059	Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; HRSV; IAA; ID; Infectious Disease; InfectiousDisease; Lung; MEIA; Microbiology; Nasopharynx; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RSV; Screen; SUDS	4180186
43534059	RSV Ag Nph Ql IA.rapid	4180186
43534059	呼吸道合胞病毒 抗原:存在情况或阈值:时间点:鼻咽:序数型:免疫测定法.快速	4182948
43534060	CYP2D6+CYP2C19 pnl Bld/T	4180186
43534060	Blood; CPCJ; CPD6; CYP2C; CYP2D; CYP2D@; CYP2D6+CYP2C19; CYP2D6+CYP2C19 pnl; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIIC17; CYPIIC19; CYPIID6; Cytochrome p450; cytochrome P-450 II C; cytochrome P450, family 2, subfamily C, polypeptide 19; cytochrome P450, family 2, subfamily D, polypeptide 6; Debrisoquine hydroxylation gene; HGNC:2629; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mutations; P450C2C; P450C2D; P450DB1; P450-DB1; P450IIC19; Pan; Panel.molpath; Panel.molpath.pharmg; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
43534060	CYP2D6 基因与 CYP2C19 基因突变分析组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
43534062	25-OH Vit D; 3-epi-25(OH)D3; 3-epi-25-Hydroxy vitamin D3; C-3 epimer of 25OHD3; Chemistry; Dextro; III; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
43534062	3-epi-25(OH)D3/25-OH Vit D MFr SerPl	4180186
43534062	3-表-25-羟维生素 D3/25-羟维生素 D.总计:质量分数:时间点:血清/血浆:定量型	4182948
43534063	Progest Free SerPl-mCnc	4180186
43534063	Chemistry; FR; Level; Mass concentration; Non-protein bound; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progest Free; Progestin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534063	孕酮.游离型:质量浓度:时间点:血清/血浆:定量型	4182948
43534065	葡萄球菌蛋白 A (spa) 基因:存在情况或阈值:时间点:分离株/标本:序数型:探针法.基因扩增.靶向	4182948
43534065	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prot; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
43534065	Spa gene Islt/Spm Ql NAA+probe	4180186
43534066	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; o71; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Resist; Resistanc; Resistant; Resistent; S aureus; SCCmec + mecA pnl; SDA; Smell; Staficyn; Staph; Staphicillin; Staphylococcus cassette chromosome (SCCmec); Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
43534066	SCCmec + mecA pnl Nose NAA+probe	4180186
43534066	金黄色葡萄球菌与甲氧西林 SCCmec 与 mecA 基因组套:-:时间点:鼻:-:探针法.基因扩增.靶向	4182948
43534068	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vibativ	4180186
43534068	Telavancin Islt MIC	4180186
43534068	特拉万星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
43534069	2.5h p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43534069	Glucose 2.5h p Lac PO SerPl-sCnc	4180186
43534069	葡萄糖^在口服剂量乳糖之后2.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
43534070	15M p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43534070	Glucose 15M p Lac PO SerPl-sCnc	4180186
43534070	葡萄糖^在口服剂量乳糖之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
43534072	Bilirub Skin-sCnc	4180186
43534072	Bili; Bilirubins; Billirubin; Chemistry; Dermatologic; Epidermis; Integument; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Skn; Substance concentration; TBIL; TcB	4180186
43534072	胆红素:物质的量浓度:时间点:皮肤:定量型:经皮测定仪	4182948
43534073	Chemistry; Ile; Ile+Leu; Leu; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
43534073	Ile+Leu SerPl-sCnc	4180186
43534073	异亮氨酸+亮氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
43534075	Insulin 2h p 75 g Glc PO SerPl-sCnc	4180186
43534075	120 min; 120 minutes; 120min; 2 hours; 2h p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
43534075	胰岛素^在口服75 g葡萄糖之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
43534076	1 hour; 1.0Hr; 1h p 75 g Glc PO; 60 min; 60 minutes; 60M; 60min; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
43534076	Insulin 1h p 75 g Glc PO SerPl-sCnc	4180186
43534076	胰岛素^在口服75 g葡萄糖之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
43534077	Blood; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
43534077	Urea Bld-sCnc	4180186
43534077	尿素:物质的量浓度:时间点:全血:定量型	4182948
43534079	Cytotoxic-lymphocytic antibody; Granulocytic Ab; HNA; Human Leukocyte Antigen; Human Neutrophil Antigen; Human Neutrophil Antigens; Lymphocyte antibody; Lymphocytotoxic antibody; Neut; Neutr; Neutrophil+HLA Ab screen pnl; Neutrophils; Pan; Panel Reactive AB; Panel Reactive antibody; PANEL.HNA; Panl; Pl; Plasma; Plsm; PMN; Pnl; PNM; Point in time; PRA; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534079	Neutrophil+HLA Ab screen pnl SerPl	4180186
43534079	嗜中性粒细胞抗体与 HLA 抗体筛查组套:-:时间点:血清/血浆:-	4182948
43534081	HNA genotype pnl SerPl	4180186
43534081	HNA genotype pnl; Human Neutrophil Antigen; Human Neutrophil Antigens; Pan; PANEL.HNA; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534081	HNA 基因型组套:-:时间点:血清/血浆:-	4182948
43534082	Circulating platelet ab; Drug induced platelet Ab pnl; Drugs; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534082	Drug induced platelet Ab pnl SerPl	4180186
43534082	药物诱导型血小板抗体组套:-:时间点:血清/血浆:-	4182948
43534085	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HNA 4b/4b; Human Neutrophil Antigen; Human Neutrophil Antigens; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43534085	HNA 4b/4b Ab Ser Ql IA	4180186
43534085	HNA 4b-4b 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43534086	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HNA 4a/4a; Human Neutrophil Antigen; Human Neutrophil Antigens; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43534086	HNA 4a/4a Ab Ser Ql IA	4180186
43534086	HNA 4a-4a 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43534091	Blood; Gentyp; Human Neutrophil Antigen; Human Neutrophil Antigens; Nominal; Point in time; Random; Typ; WB; Whole blood	4180186
43534091	HNA 5 Gentyp Bld	4180186
43534091	HNA 5 基因型:类型:时间点:全血:名义型	4182948
43534092	HNA 4 Gentyp Bld	4180186
43534092	Blood; Gentyp; Human Neutrophil Antigen; Human Neutrophil Antigens; Nominal; Point in time; Random; Typ; WB; Whole blood	4180186
43534092	HNA 4 基因型:类型:时间点:全血:名义型	4182948
43534093	Blood; Gentyp; Human Neutrophil Antigen; Human Neutrophil Antigens; III; Nominal; Point in time; Random; Typ; WB; Whole blood	4180186
43534093	HNA 3 Gentyp Bld	4180186
43534093	HNA 3 基因型:类型:时间点:全血:名义型	4182948
43534094	Blood; Gentyp; Human Neutrophil Antigen; Human Neutrophil Antigens; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
43534094	HNA 1c Gentyp Bld Ql	4180186
43534094	HNA 1c 基因型:存在情况或阈值:时间点:全血:序数型	4182948
43534096	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Human Neutrophil Antigen; Human Neutrophil Antigens; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
43534096	HNA 1a-1a Ab Ser Ql IA	4180186
43534096	HNA 1a-1a 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
43534098	Barium Ur-sCnc	4180186
43534098	Ba; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
43534098	钡:物质的量浓度:时间点:尿液:定量型	4182948
43534099	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Bili; Bilirubins; Billirubin; Chemistry; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL	4180186
43534099	Bilirub Amn-sCnc	4180186
43534099	胆红素:物质的量浓度:时间点:羊水:定量型	4182948
43534101	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
43534101	Urea BldA-sCnc	4180186
43534101	尿素:物质的量浓度:时间点:动脉全血:定量型	4182948
43534102	Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Secobarb; Seconal; Substance concentration; UA; UR; Urn	4180186
43534102	Secobarbital Ur-sCnc	4180186
43534102	司可巴比妥:物质的量浓度:时间点:尿液:定量型	4182948
43534107	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c162; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VANC; Vancocin; Vancor	4180186
43534107	Vancomycin (neut) IgM SerPl Ql FC	4180186
43534107	万古霉素 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534115	Terazosin (neut) IgM SerPl Ql FC	4180186
43534115	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Hytrin; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534115	特拉唑嗪 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534119	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; FK506; FK-506; Fujimycin; Granulocytic Ab; Hecoria; Immune globulin M; Immunoglobulin M; L04AD02; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Prograf; Protopic; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534119	Tacrolimus (neut) IgM SerPl Ql FC	4180186
43534119	他克莫司 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534122	Sulfamethoxazole (neut) IgG SerPl Ql FC	4180186
43534122	(neut) Ab; (neut) IgG; ABS; Aby; Acetylsulfamethoxazole; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c203; c223; C61; Dynamic; FC; Gantanol; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SMX; SR; Sulfa; Sulfamethox	4180186
43534122	磺胺甲噁唑 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534124	(neut) Ab; (neut) IgG; ABS; Aby; Aldactone; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Novospiroton; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534124	Spironolactone (neut) IgG SerPl Ql FC	4180186
43534124	螺内酯 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534126	Simvastatin (neut) IgG SerPl Ql FC	4180186
43534126	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zocor	4180186
43534126	辛伐他汀 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534127	Sildenafil cit (neut) IgM SerPl Ql FC	4180186
43534127	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Citric acid; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Revatio; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Viagra	4180186
43534127	枸橼酸西地那非 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534129	Sertraline (neut) IgM SerPl Ql FC	4180186
43534129	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zoloft	4180186
43534129	舍曲林 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534130	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zoloft	4180186
43534130	Sertraline (neut) IgG SerPl Ql FC	4180186
43534130	舍曲林 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534131	risperiDONE (neut) IgM SerPl Ql FC	4180186
43534131	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Risperidal; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534131	利培酮 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534132	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Risperidal; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534132	risperiDONE (neut) IgG SerPl Ql FC	4180186
43534132	利培酮 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534133	raNITIdine (neut) IgM SerPl Ql FC	4180186
43534133	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zantac	4180186
43534133	雷尼替丁 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534134	raNITIdine (neut) IgG SerPl Ql FC	4180186
43534134	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zantac	4180186
43534134	雷尼替丁 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534136	(neut) Ab; (neut) IgG; ABS; Aby; Altace; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534136	Ramipril (neut) IgG SerPl Ql FC	4180186
43534136	雷米普利 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534137	quiNINE (neut) IgM SerPl Ql FC	4180186
43534137	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534137	奎宁 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534138	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534138	quiNINE (neut) IgG SerPl Ql FC	4180186
43534138	奎宁 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534140	quiNIDine (neut) IgG SerPl Ql FC	4180186
43534140	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chinidine; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534140	奎尼丁 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534142	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Ketipinor; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Seroquel; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xeroquel	4180186
43534142	QUEtiapine (neut) IgG SerPl Ql FC	4180186
43534142	喹硫平 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534144	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Piper; PIPJ; Pipracil; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534144	Piperacillin (neut) IgG SerPl Ql FC	4180186
43534144	氧哌嗪青霉素 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534145	Phenytoin (neut) IgM SerPl Ql FC	4180186
43534145	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; Dynamic; Epanutin; FC; Fenantoin; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Lehydan; Neut; Neutr; Neutrophils; Ordinal; Phenhydan; PHYT; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Zentropil	4180186
43534145	苯妥英 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534147	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barbiturate; c417; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Luminal; Neut; Neutr; Neutrophils; Nirvonal; Ordinal; PHBR; Phenobarb; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534147	Phenobarb (neut) IgM SerPl Ql FC	4180186
43534147	苯巴比妥 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534148	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barbiturate; c417; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Luminal; Neut; Neutr; Neutrophils; Nirvonal; Ordinal; PHBR; Phenobarb; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534148	Phenobarb (neut) IgG SerPl Ql FC	4180186
43534148	苯巴比妥 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534150	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; PCN; Pen; Penicilloyl; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Wycillin	4180186
43534150	Penicillin (neut) IgG SerPl Ql FC	4180186
43534150	青霉素 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534151	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Paxil; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534151	PARoxetine (neut) IgM SerPl Ql FC	4180186
43534151	帕罗西汀 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534154	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Protonix; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534154	Pantoprazole (neut) IgG SerPl Ql FC	4180186
43534154	泮托拉唑 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534155	Omeprazole (neut) IgM SerPl Ql FC	4180186
43534155	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Prilosec; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534155	奥美拉唑 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534156	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Prilosec; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534156	Omeprazole (neut) IgG SerPl Ql FC	4180186
43534156	奥美拉唑 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534157	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Lanzek; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zypadhera; Zyprexa	4180186
43534157	OLANZapine (neut) IgM SerPl Ql FC	4180186
43534157	奥氮平 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534158	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Lanzek; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zypadhera; Zyprexa	4180186
43534158	OLANZapine (neut) IgG SerPl Ql FC	4180186
43534158	奥氮平 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534161	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Monteflo; Montelo-10; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Singulair; SR	4180186
43534161	Montelukast (neut) IgM SerPl Ql FC	4180186
43534161	孟鲁司特 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534164	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; LO; Lopressor; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534164	Metoprolol (neut) IgG SerPl Ql FC	4180186
43534164	美多洛尔 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534165	Metoclopramide (neut) IgM SerPl Ql FC	4180186
43534165	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Reglan; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534165	灭吐灵 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534171	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cozaar; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534171	Losartan (neut) IgM SerPl Ql FC	4180186
43534171	氯沙坦 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534172	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cozaar; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534172	Losartan (neut) IgG SerPl Ql FC	4180186
43534172	氯沙坦 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534173	Loratadine (neut) IgM SerPl Ql FC	4180186
43534173	(neut) Ab; (neut) IgM; ABS; Aby; Alavert; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Claritin; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534173	氯雷他定 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534176	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Prinivil; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tensopril	4180186
43534176	Lisinopril (neut) IgG SerPl Ql FC	4180186
43534176	赖诺普利 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534179	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Keppra; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534179	levETIRAcetam (neut) IgM SerPl Ql FC	4180186
43534179	左乙拉西坦 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534181	Lansoprazole (neut) IgM SerPl Ql FC	4180186
43534181	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Prevacid; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534181	兰索拉唑 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534182	Lansoprazole (neut) IgG SerPl Ql FC	4180186
43534182	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; Prevacid; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534182	兰索拉唑 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534185	HTCZ (neut) IgM SerPl Ql FC	4180186
43534185	(neut) Ab; (neut) IgM; ABS; Aby; Aldactizide; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c381; Dynamic; Esidrix; FC; Granulocytic Ab; HCTZ; HTCZ; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534185	氢氯噻嗪 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534186	HTCZ (neut) IgG SerPl Ql FC	4180186
43534186	(neut) Ab; (neut) IgG; ABS; Aby; Aldactizide; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c381; Dynamic; Esidrix; FC; Granulocytic Ab; HCTZ; HTCZ; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534186	氢氯噻嗪 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534190	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Horizant; Immune globulin G; Immunoglobulin G; Neurontin; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534190	Gabapentin (neut) IgG SerPl Ql FC	4180186
43534190	加巴喷丁 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534195	(neut) Ab; (neut) IgM; ABS; Aby; Allegra; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; Fastofen; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Telfast; Tilfur; Vifas	4180186
43534195	Fexofenadine (neut) IgM SerPl Ql FC	4180186
43534195	非索非那定 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534196	(neut) Ab; (neut) IgG; ABS; Aby; Allegra; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; Fastofen; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Telfast; Tilfur; Vifas	4180186
43534196	Fexofenadine (neut) IgG SerPl Ql FC	4180186
43534196	非索非那定 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534197	Fenofibrate (neut) IgM SerPl Ql FC	4180186
43534197	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tricor	4180186
43534197	非诺贝特 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534198	Fenofibrate (neut) IgG SerPl Ql FC	4180186
43534198	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tricor	4180186
43534198	非诺贝特 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534200	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cipralex; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Lexamil; Lexapro; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Seroplex; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534200	Escitalopram (neut) IgG SerPl Ql FC	4180186
43534200	右旋西酞普兰 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534201	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; Enacard; Enaladex; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vasotec	4180186
43534201	Enalapril (neut) IgM SerPl Ql FC	4180186
43534201	依那普利 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534202	Enalapril (neut) IgG SerPl Ql FC	4180186
43534202	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; Enacard; Enaladex; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vasotec	4180186
43534202	依那普利 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534203	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plavix; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534203	Clopidogrel (neut) IgM SerPl Ql FC	4180186
43534203	氯吡格雷 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534208	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c306; Cleocin; CLIJ; Clindamycin.induced; Dalacin; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sobelin; SR; Topical	4180186
43534208	Clindamycin (neut) IgG SerPl Ql FC	4180186
43534208	氯洁霉素 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534209	Citalopram (neut) IgM SerPl Ql FC	4180186
43534209	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celexa; Cipramil; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534209	西酞普兰 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534213	Celecoxib (neut) IgM SerPl Ql FC	4180186
43534213	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celebrex; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534213	塞来昔布 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534215	cefTRIAXone (neut) IgM SerPl Ql FC	4180186
43534215	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c9; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Rocephin; ROCJ; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534215	头孢三嗪 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534216	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c9; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Rocephin; ROCJ; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534216	cefTRIAXone (neut) IgG SerPl Ql FC	4180186
43534216	头孢三嗪 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534217	cefTAZidime (neut) IgM SerPl Ql FC	4180186
43534217	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ceftaz; Dynamic; FC; Forj; Fortaz; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazicef; Tazj	4180186
43534217	头孢他啶 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534218	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ceftaz; Dynamic; FC; Forj; Fortaz; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tazicef; Tazj	4180186
43534218	cefTAZidime (neut) IgG SerPl Ql FC	4180186
43534218	头孢他啶 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534219	Cefepime (neut) IgM SerPl Ql FC	4180186
43534219	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cefipime; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Maxipime; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534219	头孢吡肟 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534220	Cefepime (neut) IgG SerPl Ql FC	4180186
43534220	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cefipime; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Maxipime; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534220	头孢吡肟 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534221	(neut) Ab; (neut) IgM; ABS; Aby; Ancef; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C32; Cefamezin; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Kefj; Kefzol; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Totacef; Zolicef	4180186
43534221	ceFAZolin (neut) IgM SerPl Ql FC	4180186
43534221	头孢唑林 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534224	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carbamazapine; Carbamezapine; Carbazepine; CRBM; Dynamic; Epitol; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril	4180186
43534224	carBAMazepine (neut) IgG SerPl Ql FC	4180186
43534224	卡马西平 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534226	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Wellbutrin; Zyban	4180186
43534226	buPROPion (neut) IgG SerPl Ql FC	4180186
43534226	丁氨苯丙酮 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534227	Atorvastatin (neut) IgM SerPl Ql FC	4180186
43534227	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Lipitor; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534227	阿托伐他汀 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534229	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tenormin	4180186
43534229	Atenolol (neut) IgM SerPl Ql FC	4180186
43534229	氨酰心安 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534236	Amoxicillin (neut) IgG SerPl Ql FC	4180186
43534236	(neut) Ab; (neut) IgG; ABS; Aby; Amox; Amoxicilloyl; Amoxil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bristamox; c204; c6; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Larotid; Moxalin; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; Polymox; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sumox; Trimox; Wymox	4180186
43534236	羟氨苄青霉素 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534237	(neut) Ab; (neut) IgM; ABS; Aby; AM; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Norvasc; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534237	amLODIPine (neut) IgM SerPl Ql FC	4180186
43534237	阿莫洛地平 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534238	amLODIPine (neut) IgG SerPl Ql FC	4180186
43534238	(neut) Ab; (neut) IgG; ABS; Aby; AM; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Norvasc; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534238	阿莫洛地平 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534239	Amitrip (neut) IgM SerPl Ql FC	4180186
43534239	(neut) Ab; (neut) IgM; ABS; Aby; Amit; Amitrip; Amitriptylene; Amitriptyln; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; Elatrol; Elavil; Endep; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trepiline; Tryptanol; Tryptizol	4180186
43534239	阿米替林 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534243	(neut) Ab; (neut) IgM; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin M; Immunoglobulin M; Lopurin; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zyloprim	4180186
43534243	Allopurinol (neut) IgM SerPl Ql FC	4180186
43534243	别嘌呤醇 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534244	(neut) Ab; (neut) IgG; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Lopurin; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zyloprim	4180186
43534244	Allopurinol (neut) IgG SerPl Ql FC	4180186
43534244	别嘌呤醇 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534247	APAP (neut) IgG SerPl Ql FC	4180186
43534247	(neut) Ab; (neut) IgG; ABS; Aby; ACET; Acetamidophenol; Acetaminoph; Acetominophen; Antby; Anti; Antibodies; Antibody; APAP; Autoantibodies; Autoantibody; c209; C55; Dynamic; FC; Granulocytic Ab; Hydroxyacetanilide; Immune globulin G; Immunoglobulin G; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Neut; Neutr; Neutrophils; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tylenol; u209	4180186
43534247	对乙酰氨基酚 诱导型嗜中性粒细胞抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534248	(neut) Ab; (neut) IgM; ABS; Aby; ACET; Acetamidophenol; Acetaminoph; Acetominophen; Antby; Anti; Antibodies; Antibody; APAP; Autoantibodies; Autoantibody; c209; C55; Dynamic; FC; Granulocytic Ab; Hydroxyacetanilide; Immune globulin M; Immunoglobulin M; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Neut; Neutr; Neutrophils; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tylenol; u209	4180186
43534248	APAP (neut) IgM SerPl Ql FC	4180186
43534248	对乙酰氨基酚 诱导型嗜中性粒细胞抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534251	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Immune globulin G; Immunoglobulin G; Neut; Neutr; Neutrophils; Ordinal; Pl; Plasma; Plsm; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
43534251	Neutrophil IgG SerPl Ql FC	4180186
43534251	嗜中性粒细胞 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534252	4-Hydroxycoumarin; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Coumadin; Coumarin; Coumarins; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Panwarfin; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sofarin; SR; Thrombocyte; Thrombocytes	4180186
43534252	Warfarin ind plt IgG SerPl Ql FC	4180186
43534252	丙酮苄羟香豆素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534253	4-Hydroxycoumarin; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Coumadin; Coumarin; Coumarins; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Panwarfin; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sofarin; SR; Thrombocyte; Thrombocytes	4180186
43534253	Warfarin ind plt IgM SerPl Ql FC	4180186
43534253	丙酮苄羟香豆素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534256	Verapamil ind plt IgM SerPl Ql FC	4180186
43534256	ABS; Aby; Antby; Anti; Antibodies; Antibody; APO-TRIMIP; Autoantibodies; Autoantibody; Calan; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Isoptin; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534256	维拉帕米 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534259	Venlafaxine ind plt IgG SerPl Ql FC	4180186
43534259	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Efexor; Effexor; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Venlafaxin	4180186
43534259	文拉法辛 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534260	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c162; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; VANC; Vancocin; Vancor	4180186
43534260	Vancomycin ind plt IgG SerPl Ql FC	4180186
43534260	万古霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534261	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c162; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; VANC; Vancocin; Vancor	4180186
43534261	Vancomycin ind plt IgM SerPl Ql FC	4180186
43534261	万古霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534263	Valsartan ind plt IgM SerPl Ql FC	4180186
43534263	ABS; Aby; Angiotan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Diovan; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534263	缬沙坦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534264	Valproate ind plt IgM SerPl Ql FC	4180186
43534264	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Depakene; Divalproex; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; VALP; Valproic acid	4180186
43534264	2-丙基戊酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534266	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534266	valGANciclovir ind plt IgM SerPl Ql FC	4180186
43534266	缬更昔洛韦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534267	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534267	valGANciclovir ind plt IgG SerPl Ql FC	4180186
43534267	缬更昔洛韦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534270	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Valaciclovir; Valtrex; Zelitrex	4180186
43534270	valACYclovir ind plt IgG SerPl Ql FC	4180186
43534270	伐昔洛韦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534271	valACYclovir ind plt IgM SerPl Ql FC	4180186
43534271	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Valaciclovir; Valtrex; Zelitrex	4180186
43534271	伐昔洛韦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534272	Ursodeoxycholate ind plt IgG SerPl Ql FC	4180186
43534272	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; UDC; UDCA; Ursodeoxycholic acid; Ursodiol	4180186
43534272	熊去氧胆酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534276	ABS; Aby; Antby; Anti; Antibodies; Antibody; APO-TRIAZO; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Halcion; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Novo-triolam; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534276	Triazolam ind plt IgG SerPl Ql FC	4180186
43534276	三唑苯二氮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534277	ABS; Aby; Antby; Anti; Antibodies; Antibody; APO-TRIAZO; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Halcion; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Novo-triolam; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534277	Triazolam ind plt IgM SerPl Ql FC	4180186
43534277	三唑苯二氮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534282	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Tramal; Ultram	4180186
43534282	traMADol ind plt IgM SerPl Ql FC	4180186
43534282	曲马多 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534285	Topiramate ind plt IgG SerPl Ql FC	4180186
43534285	ABS; Aby; Antby; Anti; Antibodies; Antibody; Atracurium besylate; Autoantibodies; Autoantibody; C12H21NO8S; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lennox-Gastaut syndrome; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Qudexy XR; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Topamax; Toprimate; Tracrium; Trokendi XR	4180186
43534285	托吡酯 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534286	Tolterodine ind plt IgG SerPl Ql FC	4180186
43534286	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Detrol; Detrusitol; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534286	托特罗定 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534292	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Timoptic	4180186
43534292	Timolol ind plt IgM SerPl Ql FC	4180186
43534292	噻吗洛尔 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534293	Timolol ind plt IgG SerPl Ql FC	4180186
43534293	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Timoptic	4180186
43534293	噻吗洛尔 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534297	Terazosin ind plt IgG SerPl Ql FC	4180186
43534297	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Hytrin; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534297	特拉唑嗪 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534298	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Micardis; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534298	Telmisartan ind plt IgM SerPl Ql FC	4180186
43534298	替米沙坦 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534299	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Micardis; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534299	Telmisartan ind plt IgG SerPl Ql FC	4180186
43534299	替米沙坦 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534303	Tamsulosin ind plt IgG SerPl Ql FC	4180186
43534303	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Flomax; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534303	坦索罗辛 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534304	Tamoxifen ind plt IgM SerPl Ql FC	4180186
43534304	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Nolvadex; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534304	他莫西芬 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534306	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; FK506; FK-506; Fujimycin; Hecoria; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; L04AD02; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prograf; Protopic; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534306	Tacrolimus ind plt IgM SerPl Ql FC	4180186
43534306	他克莫司 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534307	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; FK506; FK-506; Fujimycin; Hecoria; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; L04AD02; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prograf; Protopic; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534307	Tacrolimus ind plt IgG SerPl Ql FC	4180186
43534307	他克莫司 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534308	Sulindac ind plt IgM SerPl Ql FC	4180186
43534308	ABS; Aby; ACLIN; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C20H17FO3S; Circulating platelet ab; Clinoril; Clusinol; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Saldac; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534308	舒林酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534311	Sulfisoxaz ind plt IgG SerPl Ql FC	4180186
43534311	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Gantrisin; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sulfizole; Thrombocyte; Thrombocytes	4180186
43534311	磺胺异嘧唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534313	sulfaSALAzine ind plt IgG SerPl Ql FC	4180186
43534313	ABS; Aby; Accucol; Antby; Anti; Antibodies; Antibody; Asulfidine; Autoantibodies; Autoantibody; Azopyrin; Azulfidine; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Rorasul; Salazopyrin; Salazosulfapyridine; Salicylazosulfapyridine; SASP; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SSZ; Sulcolon; Thrombocyte; Thrombocytes	4180186
43534313	柳氮磺胺吡啶 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534315	Sulfamethoxazole ind plt IgM SerPl Ql FC	4180186
43534315	ABS; Aby; Acetylsulfamethoxazole; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c203; c223; C61; Circulating platelet ab; Dynamic; FC; Gantanol; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SMX; SR; Sulfa; Sulfamethox; Thrombocyte; Thrombocytes	4180186
43534315	磺胺甲噁唑 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534317	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carafate; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534317	Sucralfate ind plt IgG SerPl Ql FC	4180186
43534317	硫糖铝 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534319	ABS; Aby; Aldactone; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Novospiroton; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534319	Spironolactone ind plt IgM SerPl Ql FC	4180186
43534319	螺内酯 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534320	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beta-cardone; Betapace; Betudes; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solalex; Sotacor; SR; Thrombocyte; Thrombocytes	4180186
43534320	Sotalol ind plt IgG SerPl Ql FC	4180186
43534320	索他洛尔 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534321	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beta-cardone; Betapace; Betudes; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solalex; Sotacor; SR; Thrombocyte; Thrombocytes	4180186
43534321	Sotalol ind plt IgM SerPl Ql FC	4180186
43534321	索他洛尔 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534324	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Maalox; Mylanta; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534324	Simethicone ind plt IgM SerPl Ql FC	4180186
43534324	聚二甲基硅氧烷 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534331	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Crestor; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534331	Rosuvastatin ind plt IgG SerPl Ql FC	4180186
43534331	罗伐他汀 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534332	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avandia; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534332	Rosiglitazone ind plt IgM SerPl Ql FC	4180186
43534332	罗格列酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534333	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avandia; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534333	Rosiglitazone ind plt IgG SerPl Ql FC	4180186
43534333	罗格列酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534336	risperiDONE ind plt IgM SerPl Ql FC	4180186
43534336	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Risperidal; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534336	利培酮 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534337	risperiDONE ind plt IgG SerPl Ql FC	4180186
43534337	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Risperidal; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534337	利培酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534338	ABS; Aby; Actonel; Antby; Anti; Antibodies; Antibody; Atelvia; Autoantibodies; Autoantibody; Benet; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Risedronic acid; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534338	Risedronate ind plt IgM SerPl Ql FC	4180186
43534338	利塞膦酸 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534343	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Zantac	4180186
43534343	raNITIdine ind plt IgM SerPl Ql FC	4180186
43534343	雷尼替丁 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534344	ABS; Aby; Altace; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534344	Ramipril ind plt IgM SerPl Ql FC	4180186
43534344	雷米普利 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534345	Ramipril ind plt IgG SerPl Ql FC	4180186
43534345	ABS; Aby; Altace; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534345	雷米普利 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534346	Raloxifene ind plt IgM SerPl Ql FC	4180186
43534346	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Evista; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534346	雷洛昔芬 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534347	Raloxifene ind plt IgG SerPl Ql FC	4180186
43534347	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Evista; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534347	雷洛昔芬 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534348	RABEprazole ind plt IgG SerPl Ql FC	4180186
43534348	ABS; Aby; AcipHex; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534348	雷贝拉唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534351	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534351	quiNINE ind plt IgG SerPl Ql FC	4180186
43534351	奎宁 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534354	ABS; Aby; Accupril; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534354	Quinapril ind plt IgM SerPl Ql FC	4180186
43534354	喹那普利 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534355	ABS; Aby; Accupril; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534355	Quinapril ind plt IgG SerPl Ql FC	4180186
43534355	喹那普利 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534358	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cenafed; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Pseudoephed; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sudafed; Thrombocyte; Thrombocytes	4180186
43534358	Pseudoephedrine ind plt IgM SerPl Ql FC	4180186
43534358	伪麻黄碱 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534359	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cenafed; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Pseudoephed; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sudafed; Thrombocyte; Thrombocytes	4180186
43534359	Pseudoephedrine ind plt IgG SerPl Ql FC	4180186
43534359	伪麻黄碱 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534360	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Inderal; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534360	Propranolol ind plt IgM SerPl Ql FC	4180186
43534360	普萘洛尔 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534364	ABS; Aby; Algaphan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Napsalgesic; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534364	Propoxyph ind plt IgG SerPl Ql FC	4180186
43534364	丙氧氨酚 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534366	Procainamide ind plt IgM SerPl Ql FC	4180186
43534366	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; PA; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Procan; Pronestyl; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534366	普鲁卡因胺 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534369	Primidone ind plt IgG SerPl Ql FC	4180186
43534369	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Mysoline; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534369	扑米酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534372	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Pravachol; QL; Qual; Qualitative; Random; Screen; Selektine; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534372	Pravastatin ind plt IgM SerPl Ql FC	4180186
43534372	普伐他汀 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534373	Pravastatin ind plt IgG SerPl Ql FC	4180186
43534373	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Pravachol; QL; Qual; Qualitative; Random; Screen; Selektine; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534373	普伐他汀 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534376	Piperacillin ind plt IgG SerPl Ql FC	4180186
43534376	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Piper; PIPJ; Pipracil; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534376	氧哌嗪青霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534379	Pioglitazone ind plt IgG SerPl Ql FC	4180186
43534379	ABS; Aby; Actos; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534379	吡格列酮 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534380	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; Dynamic; Epanutin; FC; Fenantoin; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lehydan; Ordinal; Phenhydan; PHYT; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Thrombocyte; Thrombocytes; Zentropil	4180186
43534380	Phenytoin ind plt IgG SerPl Ql FC	4180186
43534380	苯妥英 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534383	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barbiturate; c417; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Luminal; Nirvonal; Ordinal; PHBR; Phenobarb; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534383	Phenobarb ind plt IgG SerPl Ql FC	4180186
43534383	苯巴比妥 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534385	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Trilafon	4180186
43534385	Perphenazine ind plt IgG SerPl Ql FC	4180186
43534385	奋乃静 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534386	Penicillin ind plt IgM SerPl Ql FC	4180186
43534386	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; PCN; Pen; Penicilloyl; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Wycillin	4180186
43534386	青霉素 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534387	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; PCN; Pen; Penicilloyl; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Wycillin	4180186
43534387	Penicillin ind plt IgG SerPl Ql FC	4180186
43534387	青霉素 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534389	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Paxil; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534389	PARoxetine ind plt IgG SerPl Ql FC	4180186
43534389	帕罗西汀 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534390	Papaverine ind plt IgG SerPl Ql FC	4180186
43534390	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CereSer; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pavobid; Pl; Plasan; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534390	罂粟碱 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534393	Pantoprazole ind plt IgG SerPl Ql FC	4180186
43534393	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Protonix; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534393	泮托拉唑 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534395	ABS; Aby; Acetylsalicylic acid; Antby; Anti; Antibodies; Antibody; ASA; Aspirin; Autoantibodies; Autoantibody; c207; c217; Circulating platelet ab; Dynamic; Endodan; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Lortab; Ordinal; oxyCODONE+ASA; OxyContin; Percocet; Percodan; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Roxiprin; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Vicodin	4180186
43534395	oxyCODONE+ASA ind plt IgG SerPl Ql FC	4180186
43534395	羟考酮+乙酰水杨酸 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534398	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin G; Immunoglobulin G; ind plt Ab; ind plt IgG; Ordinal; OXC; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Trileptal	4180186
43534398	OXcarbazepine ind plt IgG SerPl Ql FC	4180186
43534398	奥卡西平 诱导型血小板抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534399	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; OXC; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes; Trileptal	4180186
43534399	OXcarbazepine ind plt IgM SerPl Ql FC	4180186
43534399	奥卡西平 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534400	Oxaliplatin ind plt IgM SerPl Ql FC	4180186
43534400	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circulating platelet ab; Dynamic; Eloxatin; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
43534400	奥沙利铂 诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术	4182948
43534402	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bactocill; c116; Circulating platelet ab; Dynamic; FC; Immune globulin M; Immunoglobulin M; ind plt Ab; ind plt IgM; Ordinal; Pl; Plasma; Platelet ab.free; Platelet auto-antibodies; Platelets; Platelt; Plsm; Plt; Point in time; PR; Prostaphlin; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
